{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "5c721f19-465a-4c79-b8ba-fcb74ceeec99",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "usage: ipykernel_launcher.py [-h] [--csv CSV] [--pdf PDF]\n",
      "                             [--output-dir OUTPUT_DIR] [--pdf-dir PDF_DIR]\n",
      "                             [--judge-model JUDGE_MODEL]\n",
      "                             [--faith-threshold FAITH_THRESHOLD]\n",
      "                             [--geval-threshold GEVAL_THRESHOLD]\n",
      "                             [--max-pdfs MAX_PDFS] [--verbose]\n",
      "ipykernel_launcher.py: error: argument --faith-threshold: invalid float value: '/Users/johannehouweling/Library/Jupyter/runtime/kernel-v3b939bfd0d4c5cfe84cdb75f615675376d06f090f.json'\n"
     ]
    },
    {
     "ename": "SystemExit",
     "evalue": "2",
     "output_type": "error",
     "traceback": [
      "An exception has occurred, use %tb to see the full traceback.\n",
      "\u001b[31mSystemExit\u001b[39m\u001b[31m:\u001b[39m 2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/opt/homebrew/Caskroom/miniconda/base/envs/tta/lib/python3.13/site-packages/IPython/core/interactiveshell.py:3557: UserWarning: To exit: use 'exit', 'quit', or Ctrl-D.\n",
      "  warn(\"To exit: use 'exit', 'quit', or Ctrl-D.\", stacklevel=1)\n"
     ]
    }
   ],
   "source": [
    "#!/usr/bin/env python3\n",
    "\n",
    "import argparse\n",
    "import json\n",
    "from pathlib import Path\n",
    "from typing import Optional\n",
    "\n",
    "import pandas as pd\n",
    "from deepeval.metrics import FaithfulnessMetric, GEval\n",
    "from deepeval.test_case import LLMTestCase, LLMTestCaseParams\n",
    "\n",
    "from toxtempass import LLM_API_KEY, config\n",
    "\n",
    "\n",
    "def build_faithfulness_metric(\n",
    "    *, model: str, threshold: float, verbose_mode: bool\n",
    ") -> FaithfulnessMetric:\n",
    "    # FaithfulnessMetric expects retrieval_context in the LLMTestCase.  [oai_citation:4‡deepeval.com](https://deepeval.com/docs/metrics-faithfulness?utm_source=chatgpt.com)\n",
    "    return FaithfulnessMetric(\n",
    "        threshold=threshold,\n",
    "        model=model,\n",
    "        include_reason=True,\n",
    "        verbose_mode=verbose_mode,\n",
    "        #evaluation_template=, # optional custom prompt template if you want to tweak the default one\n",
    "    )\n",
    "\n",
    "\n",
    "def build_groundedness_policy_geval(\n",
    "    *, model: str, threshold: float, verbose_mode: bool\n",
    ") -> GEval:\n",
    "    \"\"\"GEval as a stricter \"policy gate\" on top of Faithfulness.\n",
    "\n",
    "    Output is structured JSON so scoring is deterministic outside the judge.\n",
    "    \"\"\"\n",
    "    return GEval(\n",
    "        name=\"ToxTemp Groundedness Policy (counts)\",\n",
    "        evaluation_steps=[\n",
    "            \"Task: evaluate whether ACTUAL_OUTPUT is grounded ONLY in RETRIEVAL_CONTEXT. No outside knowledge.\",\n",
    "            \"\",\n",
    "            \"Step 1 — Extract atomic factual claims from ACTUAL_OUTPUT limited to: entities, numbers, durations, units, methods, readouts, materials, cell lines, species, instruments, and endpoints. \"\n",
    "            \"Do NOT extract vague/subjective claims (e.g., 'robust', 'appropriate').\",\n",
    "            \"\",\n",
    "            \"Step 2 — For each claim, assign exactly one label:\",\n",
    "            \"  - ENTAILED: explicitly supported by RETRIEVAL_CONTEXT (directly stated or unambiguous paraphrase).\",\n",
    "            \"  - CONTRADICTED: conflicts with RETRIEVAL_CONTEXT.\",\n",
    "            \"  - UNSUPPORTED: not found in RETRIEVAL_CONTEXT and not contradicted.\",\n",
    "            \"  - ABSTAINED: ACTUAL_OUTPUT explicitly states the information is not in the context / cannot be determined, and does not assert the missing fact.\",\n",
    "            \"\",\n",
    "            \"Step 3 — Return VALID JSON ONLY (no markdown, no extra text) with integer counts and an optional short audit list.\",\n",
    "            'Required JSON keys: {\"entailed\": int, \"unsupported\": int, \"contradicted\": int, \"abstained\": int, \"total_claims\": int}.',\n",
    "            'Optional key: \"claims\": a list of up to 10 items, each with {\"claim\": str, \"label\": str, \"evidence\": str}. Evidence should be a short phrase from context or \"N/A\".',\n",
    "            \"\",\n",
    "            \"Step 4 — Ensure: total_claims = entailed + unsupported + contradicted + abstained.\",\n",
    "        ],\n",
    "        evaluation_params=[\n",
    "            LLMTestCaseParams.INPUT,\n",
    "            LLMTestCaseParams.ACTUAL_OUTPUT,\n",
    "            LLMTestCaseParams.RETRIEVAL_CONTEXT,\n",
    "        ],\n",
    "        model=model,\n",
    "        threshold=threshold,  # threshold still used for GEval pass/fail, but you’ll use your own score too\n",
    "        verbose_mode=verbose_mode,\n",
    "    )\n",
    "\n",
    "\n",
    "def groundedness_policy_score(counts: dict) -> float:\n",
    "    \"\"\"\n",
    "    Strict groundedness gate:\n",
    "    - Any contradiction => score 0\n",
    "    - Otherwise: supported / (supported + unsupported)\n",
    "    - Abstained claims are excluded from denominator\n",
    "    \"\"\"\n",
    "    e = int(counts.get(\"entailed\", 0))\n",
    "    u = int(counts.get(\"unsupported\", 0))\n",
    "    c = int(counts.get(\"contradicted\", 0))\n",
    "\n",
    "    if c > 0:\n",
    "        return 0.0\n",
    "    denom = e + u\n",
    "    return (e / denom) if denom else 1.0  # if no asserted claims, treat as fully complian\n",
    "\n",
    "\n",
    "def groundedness_herman_style_score(counts: dict) -> float:\n",
    "    e = int(counts.get(\"entailed\", 0))\n",
    "    u = int(counts.get(\"unsupported\", 0))\n",
    "    c = int(counts.get(\"contradicted\", 0))\n",
    "    # a = abstained ignored by construction if judge doesn't extract them as asserted claims\n",
    "\n",
    "    total = e + u + c\n",
    "    if total == 0:\n",
    "        return 1.0\n",
    "    raw = (e - 0.5 * c) / total\n",
    "    return max(0.0, min(1.0, raw))\n",
    "\n",
    "\n",
    "def _parse_counts(reason: str | None) -> Optional[dict]:\n",
    "    if not reason:\n",
    "        return None\n",
    "    try:\n",
    "        data = json.loads(reason)\n",
    "    except json.JSONDecodeError:\n",
    "        return None\n",
    "    return data if isinstance(data, dict) else None\n",
    "\n",
    "\n",
    "def pdf_to_full_text(pdf_path: Path, *, max_pages: Optional[int] = None) -> str:\n",
    "    \"\"\"\n",
    "    Convert a PDF to a single text string (all pages concatenated).\n",
    "    Each page is prefixed with provenance: [filename p.X].\n",
    "    \"\"\"\n",
    "    try:\n",
    "        from pypdf import PdfReader\n",
    "    except ImportError as e:\n",
    "        raise ImportError(\n",
    "            \"pypdf is required for pdf_to_full_text(). Install with: pip install pypdf\"\n",
    "        ) from e\n",
    "\n",
    "    reader = PdfReader(str(pdf_path))\n",
    "    n_pages = len(reader.pages)\n",
    "    if max_pages is not None:\n",
    "        n_pages = min(n_pages, max_pages)\n",
    "\n",
    "    pages: list[str] = []\n",
    "    for i in range(n_pages):\n",
    "        text = (reader.pages[i].extract_text() or \"\").strip()\n",
    "        if not text:\n",
    "            continue\n",
    "        pages.append(f\"[{pdf_path.name} p.{i+1}] {text}\")\n",
    "\n",
    "    if not pages:\n",
    "        return f\"[{pdf_path.name}] (no extractable text)\"\n",
    "\n",
    "    return \"\\n\\n---\\n\\n\".join(pages)\n",
    "\n",
    "\n",
    "def match_pdf_to_csv(csv_path: Path, pdf_dir: Path) -> Optional[Path]:\n",
    "    \"\"\"\n",
    "    Find the corresponding PDF file for a given comparison CSV.\n",
    "    \"\"\"\n",
    "    csv_name = csv_path.stem\n",
    "    if csv_name.startswith(\"tier1_comparison_\"):\n",
    "        base_name = csv_name.replace(\"tier1_comparison_\", \"\")\n",
    "    else:\n",
    "        base_name = csv_name\n",
    "\n",
    "    pdf_path = pdf_dir / f\"{base_name}.pdf\"\n",
    "    if pdf_path.exists():\n",
    "        return pdf_path\n",
    "\n",
    "    for pdf_file in pdf_dir.glob(\"*.pdf\"):\n",
    "        if pdf_file.stem.lower() == base_name.lower():\n",
    "            return pdf_file\n",
    "\n",
    "    return None\n",
    "\n",
    "\n",
    "def run_case(\n",
    "    *,\n",
    "    user_input: str,\n",
    "    actual_output: str,\n",
    "    retrieval_context: list[str] | str,\n",
    "    judge_model: str = \"gpt-5-nano\",\n",
    "    faithfulness_threshold: float = 0.5,\n",
    "    use_geval_policy: bool = True,\n",
    "    geval_threshold: float = 0.5,\n",
    "    verbose_mode: bool = False,\n",
    ") -> dict:\n",
    "    \"\"\"Execute the faithfulness metric plus optional groundedness policy gate on one example.\"\"\"\n",
    "    if isinstance(retrieval_context, str):\n",
    "        retrieval_context = [retrieval_context]\n",
    "\n",
    "    test_case = LLMTestCase(\n",
    "        input=user_input,\n",
    "        actual_output=actual_output,\n",
    "        retrieval_context=retrieval_context,\n",
    "    )\n",
    "\n",
    "    results: dict = {}\n",
    "\n",
    "    faith = build_faithfulness_metric(\n",
    "        model=judge_model,\n",
    "        threshold=faithfulness_threshold,\n",
    "        verbose_mode=verbose_mode,\n",
    "    )\n",
    "    faith.measure(test_case)\n",
    "    results[\"faithfulness_score\"] = float(faith.score)\n",
    "    results[\"faithfulness_reason\"] = faith.reason or \"\"\n",
    "\n",
    "    counts: Optional[dict] = None\n",
    "    if use_geval_policy:\n",
    "        policy = build_groundedness_policy_geval(\n",
    "            model=judge_model,\n",
    "            threshold=geval_threshold,\n",
    "            verbose_mode=verbose_mode,\n",
    "        )\n",
    "        policy.measure(test_case)\n",
    "        results[\"geval_policy_score\"] = float(policy.score)\n",
    "        results[\"geval_policy_reason\"] = policy.reason or \"\"\n",
    "        counts = _parse_counts(policy.reason)\n",
    "    else:\n",
    "        results[\"geval_policy_score\"] = None\n",
    "        results[\"geval_policy_reason\"] = None\n",
    "\n",
    "    if counts:\n",
    "        results[\"groundedness_policy_score\"] = groundedness_policy_score(counts)\n",
    "        results[\"groundedness_herman_score\"] = groundedness_herman_style_score(counts)\n",
    "        results[\"groundedness_counts\"] = counts\n",
    "    else:\n",
    "        results[\"groundedness_policy_score\"] = None\n",
    "        results[\"groundedness_herman_score\"] = None\n",
    "        results[\"groundedness_counts\"] = None\n",
    "\n",
    "    if verbose_mode:\n",
    "        print(\"\\n=== Eval Results ===\")\n",
    "        for k, v in results.items():\n",
    "            print(f\"{k}: {v}\")\n",
    "\n",
    "    return results\n",
    "\n",
    "\n",
    "def add_groundedness_columns(\n",
    "    *,\n",
    "    csv_path: Path,\n",
    "    pdf_path: Path,\n",
    "    output_path: Optional[Path] = None,\n",
    "    judge_model: str = \"gpt-4o-mini\",\n",
    "    faithfulness_threshold: float = 0.5,\n",
    "    geval_threshold: float = 0.5,\n",
    "    verbose: bool = False,\n",
    ") -> Path:\n",
    "    \"\"\"\n",
    "    Add groundedness-related columns to a tier1_comparison CSV using a PDF as context.\n",
    "    \"\"\"\n",
    "    df = pd.read_csv(csv_path)\n",
    "    pdf_text = pdf_to_full_text(pdf_path)\n",
    "\n",
    "    results = []\n",
    "    for _, row in df.iterrows():\n",
    "        results.append(\n",
    "            run_case(\n",
    "                user_input=row.get(\"question\", \"\"),\n",
    "                actual_output=row.get(\"llm_answer\", \"\"),\n",
    "                retrieval_context=pdf_text,\n",
    "                judge_model=judge_model,\n",
    "                faithfulness_threshold=faithfulness_threshold,\n",
    "                use_geval_policy=True,\n",
    "                geval_threshold=geval_threshold,\n",
    "                verbose_mode=verbose,\n",
    "            )\n",
    "        )\n",
    "\n",
    "    df[\"faithfulness_score\"] = [r[\"faithfulness_score\"] for r in results]\n",
    "    df[\"faithfulness_reason\"] = [r[\"faithfulness_reason\"] for r in results]\n",
    "    df[\"geval_policy_score\"] = [r[\"geval_policy_score\"] for r in results]\n",
    "    df[\"geval_policy_reason\"] = [r[\"geval_policy_reason\"] for r in results]\n",
    "    df[\"groundedness_policy_score\"] = [r[\"groundedness_policy_score\"] for r in results]\n",
    "    df[\"groundedness_herman_score\"] = [r[\"groundedness_herman_score\"] for r in results]\n",
    "    df[\"groundedness_counts\"] = [r[\"groundedness_counts\"] for r in results]\n",
    "\n",
    "    final_path = output_path or csv_path\n",
    "    df.to_csv(final_path, index=False)\n",
    "    return final_path\n",
    "\n",
    "\n",
    "def add_groundedness_to_directory(\n",
    "    *,\n",
    "    output_dir: Path,\n",
    "    pdf_dir: Path,\n",
    "    judge_model: str = \"gpt-5-nano\",\n",
    "    faithfulness_threshold: float = 0.5,\n",
    "    geval_threshold: float = 0.5,\n",
    "    max_pdfs: Optional[int] = None,\n",
    "    verbose: bool = False,\n",
    ") -> None:\n",
    "    csv_files = sorted(output_dir.glob(\"tier1_comparison_*.csv\"))\n",
    "    if not csv_files:\n",
    "        raise FileNotFoundError(f\"No tier1_comparison_*.csv files found in: {output_dir}\")\n",
    "\n",
    "    if max_pdfs:\n",
    "        csv_files = csv_files[:max_pdfs]\n",
    "\n",
    "    for csv_path in csv_files:\n",
    "        pdf_path = match_pdf_to_csv(csv_path, pdf_dir)\n",
    "        if not pdf_path:\n",
    "            print(f\"WARNING: No matching PDF found for {csv_path.name}, skipping\")\n",
    "            continue\n",
    "        out_path = add_groundedness_columns(\n",
    "            csv_path=csv_path,\n",
    "            pdf_path=pdf_path,\n",
    "            output_path=csv_path,\n",
    "            judge_model=judge_model,\n",
    "            faithfulness_threshold=faithfulness_threshold,\n",
    "            geval_threshold=geval_threshold,\n",
    "            verbose=verbose,\n",
    "        )\n",
    "        print(f\"Updated: {out_path}\")\n",
    "\n",
    "\n",
    "def main() -> None:\n",
    "    parser = argparse.ArgumentParser(description=\"Add groundedness columns to positive_control CSVs.\")\n",
    "    parser.add_argument(\"--csv\", type=Path, help=\"Path to a single tier1_comparison_*.csv\")\n",
    "    parser.add_argument(\"--pdf\", type=Path, help=\"Path to the corresponding PDF\")\n",
    "    parser.add_argument(\"--output-dir\", type=Path, help=\"Directory with tier1_comparison_*.csv files\")\n",
    "    parser.add_argument(\"--pdf-dir\", type=Path, help=\"Directory with PDF inputs\")\n",
    "    parser.add_argument(\"--judge-model\", default=\"gpt-5-nano\", help=\"LLM judge to use\")\n",
    "    parser.add_argument(\"--faith-threshold\", type=float, default=0.5, help=\"Faithfulness threshold\")\n",
    "    parser.add_argument(\"--geval-threshold\", type=float, default=0.5, help=\"GEval threshold\")\n",
    "    parser.add_argument(\"--max-pdfs\", type=int, default=None, help=\"Optional limit for batch runs\")\n",
    "    parser.add_argument(\"--verbose\", action=\"store_true\", help=\"Print per-row details\")\n",
    "    args = parser.parse_args()\n",
    "\n",
    "    if args.csv and args.pdf:\n",
    "        out_path = add_groundedness_columns(\n",
    "            csv_path=args.csv,\n",
    "            pdf_path=args.pdf,\n",
    "            output_path=args.csv,\n",
    "            judge_model=args.judge_model,\n",
    "            faithfulness_threshold=args.faith_threshold,\n",
    "            geval_threshold=args.geval_threshold,\n",
    "            verbose=args.verbose,\n",
    "        )\n",
    "        print(f\"Updated: {out_path}\")\n",
    "        return\n",
    "\n",
    "    if args.output_dir and args.pdf_dir:\n",
    "        add_groundedness_to_directory(\n",
    "            output_dir=args.output_dir,\n",
    "            pdf_dir=args.pdf_dir,\n",
    "            judge_model=args.judge_model,\n",
    "            faithfulness_threshold=args.faith_threshold,\n",
    "            geval_threshold=args.geval_threshold,\n",
    "            max_pdfs=args.max_pdfs,\n",
    "            verbose=args.verbose,\n",
    "        )\n",
    "        return\n",
    "\n",
    "    parser.error(\"Provide --csv and --pdf, or --output-dir and --pdf-dir\")\n",
    "\n",
    "\n",
    "if __name__ == \"__main__\":\n",
    "    main()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "77ef9767-3771-41ee-935d-0f56a56effd4",
   "metadata": {},
   "outputs": [],
   "source": [
    "def build_faithfulness_metric(\n",
    "    *, model: str, threshold: float, verbose_mode: bool\n",
    ") -> FaithfulnessMetric:\n",
    "    # FaithfulnessMetric expects retrieval_context in the LLMTestCase.  [oai_citation:4‡deepeval.com](https://deepeval.com/docs/metrics-faithfulness?utm_source=chatgpt.com)\n",
    "    return FaithfulnessMetric(\n",
    "        threshold=threshold,\n",
    "        model=model,\n",
    "        include_reason=True,\n",
    "        verbose_mode=verbose_mode,\n",
    "        #evaluation_template=, # optional custom prompt template if you want to tweak the default one\n",
    "    )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "d6bfb054-4c87-4597-8b79-fd105c049f90",
   "metadata": {},
   "outputs": [],
   "source": [
    "import argparse\n",
    "import json\n",
    "from pathlib import Path\n",
    "from typing import Optional\n",
    "\n",
    "import pandas as pd\n",
    "from deepeval.metrics import FaithfulnessMetric, GEval\n",
    "from deepeval.test_case import LLMTestCase, LLMTestCaseParams\n",
    "\n",
    "from toxtempass import LLM_API_KEY, config"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "#!/usr/bin/env python3\n",
    "\n",
    "import argparse\n",
    "import json\n",
    "from pathlib import Path\n",
    "from typing import Optional\n",
    "\n",
    "import pandas as pd\n",
    "from deepeval.metrics import FaithfulnessMetric, GEval\n",
    "from deepeval.test_case import LLMTestCase, LLMTestCaseParams\n",
    "\n",
    "from toxtempass import LLM_API_KEY, config\n",
    "\n",
    "\n",
    "def build_faithfulness_metric(\n",
    "    *, model: str, threshold: float, verbose_mode: bool\n",
    ") -> FaithfulnessMetric:\n",
    "    # FaithfulnessMetric expects retrieval_context in the LLMTestCase.  [oai_citation:4‡deepeval.com](https://deepeval.com/docs/metrics-faithfulness?utm_source=chatgpt.com)\n",
    "    return FaithfulnessMetric(\n",
    "        threshold=threshold,\n",
    "        model=model,\n",
    "        include_reason=True,\n",
    "        verbose_mode=verbose_mode,\n",
    "        #evaluation_template=, # optional custom prompt template if you want to tweak the default one\n",
    "    )\n",
    "\n",
    "\n",
    "def build_groundedness_policy_geval(\n",
    "    *, model: str, threshold: float, verbose_mode: bool\n",
    ") -> GEval:\n",
    "    \"\"\"GEval as a stricter \"policy gate\" on top of Faithfulness.\n",
    "\n",
    "    Output is structured JSON so scoring is deterministic outside the judge.\n",
    "    \"\"\"\n",
    "    return GEval(\n",
    "        name=\"ToxTemp Groundedness Policy (counts)\",\n",
    "        evaluation_steps=[\n",
    "            \"Task: evaluate whether ACTUAL_OUTPUT is grounded ONLY in RETRIEVAL_CONTEXT. No outside knowledge.\",\n",
    "            \"\",\n",
    "            \"Step 1 — Extract atomic factual claims from ACTUAL_OUTPUT limited to: entities, numbers, durations, units, methods, readouts, materials, cell lines, species, instruments, and endpoints. \"\n",
    "            \"Do NOT extract vague/subjective claims (e.g., 'robust', 'appropriate').\",\n",
    "            \"\",\n",
    "            \"Step 2 — For each claim, assign exactly one label:\",\n",
    "            \"  - ENTAILED: explicitly supported by RETRIEVAL_CONTEXT (directly stated or unambiguous paraphrase).\",\n",
    "            \"  - CONTRADICTED: conflicts with RETRIEVAL_CONTEXT.\",\n",
    "            \"  - UNSUPPORTED: not found in RETRIEVAL_CONTEXT and not contradicted.\",\n",
    "            \"  - ABSTAINED: ACTUAL_OUTPUT explicitly states the information is not in the context / cannot be determined, and does not assert the missing fact.\",\n",
    "            \"\",\n",
    "            \"Step 3 — Return VALID JSON ONLY (no markdown, no extra text) with integer counts and an optional short audit list.\",\n",
    "            'Required JSON keys: {\"entailed\": int, \"unsupported\": int, \"contradicted\": int, \"abstained\": int, \"total_claims\": int}.',\n",
    "            'Optional key: \"claims\": a list of up to 10 items, each with {\"claim\": str, \"label\": str, \"evidence\": str}. Evidence should be a short phrase from context or \"N/A\".',\n",
    "            \"\",\n",
    "            \"Step 4 — Ensure: total_claims = entailed + unsupported + contradicted + abstained.\",\n",
    "        ],\n",
    "        evaluation_params=[\n",
    "            LLMTestCaseParams.INPUT,\n",
    "            LLMTestCaseParams.ACTUAL_OUTPUT,\n",
    "            LLMTestCaseParams.RETRIEVAL_CONTEXT,\n",
    "        ],\n",
    "        model=model,\n",
    "        threshold=threshold,  # threshold still used for GEval pass/fail, but you’ll use your own score too\n",
    "        verbose_mode=verbose_mode,\n",
    "    )\n",
    "\n",
    "\n",
    "def groundedness_policy_score(counts: dict) -> float:\n",
    "    \"\"\"\n",
    "    Strict groundedness gate:\n",
    "    - Any contradiction => score 0\n",
    "    - Otherwise: supported / (supported + unsupported)\n",
    "    - Abstained claims are excluded from denominator\n",
    "    \"\"\"\n",
    "    e = int(counts.get(\"entailed\", 0))\n",
    "    u = int(counts.get(\"unsupported\", 0))\n",
    "    c = int(counts.get(\"contradicted\", 0))\n",
    "\n",
    "    if c > 0:\n",
    "        return 0.0\n",
    "    denom = e + u\n",
    "    return (e / denom) if denom else 1.0  # if no asserted claims, treat as fully complian\n",
    "\n",
    "\n",
    "def groundedness_herman_style_score(counts: dict) -> float:\n",
    "    e = int(counts.get(\"entailed\", 0))\n",
    "    u = int(counts.get(\"unsupported\", 0))\n",
    "    c = int(counts.get(\"contradicted\", 0))\n",
    "    # a = abstained ignored by construction if judge doesn't extract them as asserted claims\n",
    "\n",
    "    total = e + u + c\n",
    "    if total == 0:\n",
    "        return 1.0\n",
    "    raw = (e - 0.5 * c) / total\n",
    "    return max(0.0, min(1.0, raw))\n",
    "\n",
    "\n",
    "def _parse_counts(reason: str | None) -> Optional[dict]:\n",
    "    if not reason:\n",
    "        return None\n",
    "    try:\n",
    "        data = json.loads(reason)\n",
    "    except json.JSONDecodeError:\n",
    "        return None\n",
    "    return data if isinstance(data, dict) else None\n",
    "\n",
    "\n",
    "def pdf_to_full_text(pdf_path: Path, *, max_pages: Optional[int] = None) -> str:\n",
    "    \"\"\"\n",
    "    Convert a PDF to a single text string (all pages concatenated).\n",
    "    Each page is prefixed with provenance: [filename p.X].\n",
    "    \"\"\"\n",
    "    try:\n",
    "        from pypdf import PdfReader\n",
    "    except ImportError as e:\n",
    "        raise ImportError(\n",
    "            \"pypdf is required for pdf_to_full_text(). Install with: pip install pypdf\"\n",
    "        ) from e\n",
    "\n",
    "    reader = PdfReader(str(pdf_path))\n",
    "    n_pages = len(reader.pages)\n",
    "    if max_pages is not None:\n",
    "        n_pages = min(n_pages, max_pages)\n",
    "\n",
    "    pages: list[str] = []\n",
    "    for i in range(n_pages):\n",
    "        text = (reader.pages[i].extract_text() or \"\").strip()\n",
    "        if not text:\n",
    "            continue\n",
    "        pages.append(f\"[{pdf_path.name} p.{i+1}] {text}\")\n",
    "\n",
    "    if not pages:\n",
    "        return f\"[{pdf_path.name}] (no extractable text)\"\n",
    "\n",
    "    return \"\\n\\n---\\n\\n\".join(pages)\n",
    "\n",
    "\n",
    "def match_pdf_to_csv(csv_path: Path, pdf_dir: Path) -> Optional[Path]:\n",
    "    \"\"\"\n",
    "    Find the corresponding PDF file for a given comparison CSV.\n",
    "    \"\"\"\n",
    "    csv_name = csv_path.stem\n",
    "    if csv_name.startswith(\"tier1_comparison_\"):\n",
    "        base_name = csv_name.replace(\"tier1_comparison_\", \"\")\n",
    "    else:\n",
    "        base_name = csv_name\n",
    "\n",
    "    pdf_path = pdf_dir / f\"{base_name}.pdf\"\n",
    "    if pdf_path.exists():\n",
    "        return pdf_path\n",
    "\n",
    "    for pdf_file in pdf_dir.glob(\"*.pdf\"):\n",
    "        if pdf_file.stem.lower() == base_name.lower():\n",
    "            return pdf_file\n",
    "\n",
    "    return None\n",
    "\n",
    "\n",
    "def run_case(\n",
    "    *,\n",
    "    user_input: str,\n",
    "    actual_output: str,\n",
    "    retrieval_context: list[str] | str,\n",
    "    judge_model: str = \"gpt-5-nano\",\n",
    "    faithfulness_threshold: float = 0.5,\n",
    "    use_geval_policy: bool = True,\n",
    "    geval_threshold: float = 0.5,\n",
    "    verbose_mode: bool = False,\n",
    ") -> dict:\n",
    "    \"\"\"Execute the faithfulness metric plus optional groundedness policy gate on one example.\"\"\"\n",
    "    if isinstance(retrieval_context, str):\n",
    "        retrieval_context = [retrieval_context]\n",
    "\n",
    "    test_case = LLMTestCase(\n",
    "        input=user_input,\n",
    "        actual_output=actual_output,\n",
    "        retrieval_context=retrieval_context,\n",
    "    )\n",
    "\n",
    "    results: dict = {}\n",
    "\n",
    "    faith = build_faithfulness_metric(\n",
    "        model=judge_model,\n",
    "        threshold=faithfulness_threshold,\n",
    "        verbose_mode=verbose_mode,\n",
    "    )\n",
    "    faith.measure(test_case)\n",
    "    results[\"faithfulness_score\"] = float(faith.score)\n",
    "    results[\"faithfulness_reason\"] = faith.reason or \"\"\n",
    "\n",
    "    counts: Optional[dict] = None\n",
    "    if use_geval_policy:\n",
    "        policy = build_groundedness_policy_geval(\n",
    "            model=judge_model,\n",
    "            threshold=geval_threshold,\n",
    "            verbose_mode=verbose_mode,\n",
    "        )\n",
    "        policy.measure(test_case)\n",
    "        results[\"geval_policy_score\"] = float(policy.score)\n",
    "        results[\"geval_policy_reason\"] = policy.reason or \"\"\n",
    "        counts = _parse_counts(policy.reason)\n",
    "    else:\n",
    "        results[\"geval_policy_score\"] = None\n",
    "        results[\"geval_policy_reason\"] = None\n",
    "\n",
    "    if counts:\n",
    "        results[\"groundedness_policy_score\"] = groundedness_policy_score(counts)\n",
    "        results[\"groundedness_herman_score\"] = groundedness_herman_style_score(counts)\n",
    "        results[\"groundedness_counts\"] = counts\n",
    "    else:\n",
    "        results[\"groundedness_policy_score\"] = None\n",
    "        results[\"groundedness_herman_score\"] = None\n",
    "        results[\"groundedness_counts\"] = None\n",
    "\n",
    "    if verbose_mode:\n",
    "        print(\"\\n=== Eval Results ===\")\n",
    "        for k, v in results.items():\n",
    "            print(f\"{k}: {v}\")\n",
    "\n",
    "    return results\n",
    "\n",
    "\n",
    "def add_groundedness_columns(\n",
    "    *,\n",
    "    csv_path: Path,\n",
    "    pdf_path: Path,\n",
    "    output_path: Optional[Path] = None,\n",
    "    judge_model: str = \"gpt-4o-mini\",\n",
    "    faithfulness_threshold: float = 0.5,\n",
    "    geval_threshold: float = 0.5,\n",
    "    verbose: bool = False,\n",
    ") -> Path:\n",
    "    \"\"\"\n",
    "    Add groundedness-related columns to a tier1_comparison CSV using a PDF as context.\n",
    "    \"\"\"\n",
    "    df = pd.read_csv(csv_path)\n",
    "    pdf_text = pdf_to_full_text(pdf_path)\n",
    "\n",
    "    results = []\n",
    "    for _, row in df.iterrows():\n",
    "        results.append(\n",
    "            run_case(\n",
    "                user_input=row.get(\"question\", \"\"),\n",
    "                actual_output=row.get(\"llm_answer\", \"\"),\n",
    "                retrieval_context=pdf_text,\n",
    "                judge_model=judge_model,\n",
    "                faithfulness_threshold=faithfulness_threshold,\n",
    "                use_geval_policy=True,\n",
    "                geval_threshold=geval_threshold,\n",
    "                verbose_mode=verbose,\n",
    "            )\n",
    "        )\n",
    "\n",
    "    df[\"faithfulness_score\"] = [r[\"faithfulness_score\"] for r in results]\n",
    "    df[\"faithfulness_reason\"] = [r[\"faithfulness_reason\"] for r in results]\n",
    "    df[\"geval_policy_score\"] = [r[\"geval_policy_score\"] for r in results]\n",
    "    df[\"geval_policy_reason\"] = [r[\"geval_policy_reason\"] for r in results]\n",
    "    df[\"groundedness_policy_score\"] = [r[\"groundedness_policy_score\"] for r in results]\n",
    "    df[\"groundedness_herman_score\"] = [r[\"groundedness_herman_score\"] for r in results]\n",
    "    df[\"groundedness_counts\"] = [r[\"groundedness_counts\"] for r in results]\n",
    "\n",
    "    final_path = output_path or csv_path\n",
    "    df.to_csv(final_path, index=False)\n",
    "    return final_path\n",
    "\n",
    "\n",
    "def add_groundedness_to_directory(\n",
    "    *,\n",
    "    output_dir: Path,\n",
    "    pdf_dir: Path,\n",
    "    judge_model: str = \"gpt-5-nano\",\n",
    "    faithfulness_threshold: float = 0.5,\n",
    "    geval_threshold: float = 0.5,\n",
    "    max_pdfs: Optional[int] = None,\n",
    "    verbose: bool = False,\n",
    ") -> None:\n",
    "    csv_files = sorted(output_dir.glob(\"tier1_comparison_*.csv\"))\n",
    "    if not csv_files:\n",
    "        raise FileNotFoundError(f\"No tier1_comparison_*.csv files found in: {output_dir}\")\n",
    "\n",
    "    if max_pdfs:\n",
    "        csv_files = csv_files[:max_pdfs]\n",
    "\n",
    "    for csv_path in csv_files:\n",
    "        pdf_path = match_pdf_to_csv(csv_path, pdf_dir)\n",
    "        if not pdf_path:\n",
    "            print(f\"WARNING: No matching PDF found for {csv_path.name}, skipping\")\n",
    "            continue\n",
    "        out_path = add_groundedness_columns(\n",
    "            csv_path=csv_path,\n",
    "            pdf_path=pdf_path,\n",
    "            output_path=csv_path,\n",
    "            judge_model=judge_model,\n",
    "            faithfulness_threshold=faithfulness_threshold,\n",
    "            geval_threshold=geval_threshold,\n",
    "            verbose=verbose,\n",
    "        )\n",
    "        print(f\"Updated: {out_path}\")\n",
    "\n",
    "\n",
    "def main() -> None:\n",
    "    parser = argparse.ArgumentParser(description=\"Add groundedness columns to positive_control CSVs.\")\n",
    "    parser.add_argument(\"--csv\", type=Path, help=\"Path to a single tier1_comparison_*.csv\")\n",
    "    parser.add_argument(\"--pdf\", type=Path, help=\"Path to the corresponding PDF\")\n",
    "    parser.add_argument(\"--output-dir\", type=Path, help=\"Directory with tier1_comparison_*.csv files\")\n",
    "    parser.add_argument(\"--pdf-dir\", type=Path, help=\"Directory with PDF inputs\")\n",
    "    parser.add_argument(\"--judge-model\", default=\"gpt-5-nano\", help=\"LLM judge to use\")\n",
    "    parser.add_argument(\"--faith-threshold\", type=float, default=0.5, help=\"Faithfulness threshold\")\n",
    "    parser.add_argument(\"--geval-threshold\", type=float, default=0.5, help=\"GEval threshold\")\n",
    "    parser.add_argument(\"--max-pdfs\", type=int, default=None, help=\"Optional limit for batch runs\")\n",
    "    parser.add_argument(\"--verbose\", action=\"store_true\", help=\"Print per-row details\")\n",
    "    args = parser.parse_args()\n",
    "\n",
    "    if args.csv and args.pdf:\n",
    "        out_path = add_groundedness_columns(\n",
    "            csv_path=args.csv,\n",
    "            pdf_path=args.pdf,\n",
    "            output_path=args.csv,\n",
    "            judge_model=args.judge_model,\n",
    "            faithfulness_threshold=args.faith_threshold,\n",
    "            geval_threshold=args.geval_threshold,\n",
    "            verbose=args.verbose,\n",
    "        )\n",
    "        print(f\"Updated: {out_path}\")\n",
    "        return\n",
    "\n",
    "    if args.output_dir and args.pdf_dir:\n",
    "        add_groundedness_to_directory(\n",
    "            output_dir=args.output_dir,\n",
    "            pdf_dir=args.pdf_dir,\n",
    "            judge_model=args.judge_model,\n",
    "            faithfulness_threshold=args.faith_threshold,\n",
    "            geval_threshold=args.geval_threshold,\n",
    "            max_pdfs=args.max_pdfs,\n",
    "            verbose=args.verbose,\n",
    "        )\n",
    "        return\n",
    "\n",
    "    parser.error(\"Provide --csv and --pdf, or --output-dir and --pdf-dir\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "9b22246a-09a8-46d0-9651-3e32c6a97146",
   "metadata": {},
   "outputs": [
    {
     "ename": "SyntaxError",
     "evalue": "unmatched ')' (<ipython-input-5-209f11fe28e4>, line 1)",
     "output_type": "error",
     "traceback": [
      "  \u001b[36mCell\u001b[39m\u001b[36m \u001b[39m\u001b[32mIn[5]\u001b[39m\u001b[32m, line 1\u001b[39m\n\u001b[31m    \u001b[39m\u001b[31mverbose=True)\u001b[39m\n                ^\n\u001b[31mSyntaxError\u001b[39m\u001b[31m:\u001b[39m unmatched ')'\n"
     ]
    }
   ],
   "source": [
    "verbose=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "beb044cf-b42e-4034-8ddb-8c4cf56ecc3c",
   "metadata": {},
   "outputs": [
    {
     "ename": "ModuleNotFoundError",
     "evalue": "No module named 'myocyte.toxtempass'",
     "output_type": "error",
     "traceback": [
      "\u001b[31m---------------------------------------------------------------------------\u001b[39m",
      "\u001b[31mModuleNotFoundError\u001b[39m                       Traceback (most recent call last)",
      "\u001b[36mCell\u001b[39m\u001b[36m \u001b[39m\u001b[32mIn[6]\u001b[39m\u001b[32m, line 3\u001b[39m\n\u001b[32m      1\u001b[39m \u001b[38;5;28;01mfrom\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[34;01mpathlib\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;28;01mimport\u001b[39;00m Path\n\u001b[32m----> \u001b[39m\u001b[32m3\u001b[39m \u001b[38;5;28;01mfrom\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[34;01mmyocyte\u001b[39;00m\u001b[34;01m.\u001b[39;00m\u001b[34;01mtoxtempass\u001b[39;00m\u001b[34;01m.\u001b[39;00m\u001b[34;01mevaluation\u001b[39;00m\u001b[34;01m.\u001b[39;00m\u001b[34;01mpost_processing\u001b[39;00m\u001b[34;01m.\u001b[39;00m\u001b[34;01mgroundedness\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;28;01mimport\u001b[39;00m add_groundedness_columns\n\u001b[32m      6\u001b[39m csv_path = \u001b[33m\"\u001b[39m\u001b[33m/Users/johannehouweling/ToxTempAssistant/myocyte/toxtempass/evaluation/positive_control/output/gpt-4.1-nano/tier1_comparison_cMINC(UKN2).csv\u001b[39m\u001b[33m\"\u001b[39m\n\u001b[32m      7\u001b[39m pdf_path = \u001b[33m\"\u001b[39m\u001b[33m/Users/johannehouweling/ToxTempAssistant/myocyte/toxtempass/evaluation/positive_control/input/gpt-4.1-nano/cMINC(UKN2).pdf\u001b[39m\u001b[33m\"\u001b[39m\n",
      "\u001b[31mModuleNotFoundError\u001b[39m: No module named 'myocyte.toxtempass'"
     ]
    }
   ],
   "source": [
    "from pathlib import Path\n",
    "\n",
    "from myocyte.toxtempass.evaluation.post_processing.groundedness import add_groundedness_columns\n",
    "\n",
    "\n",
    "csv_path = \"/Users/johannehouweling/ToxTempAssistant/myocyte/toxtempass/evaluation/positive_control/output/gpt-4.1-nano/tier1_comparison_cMINC(UKN2).csv\"\n",
    "pdf_path = \"/Users/johannehouweling/ToxTempAssistant/myocyte/toxtempass/evaluation/positive_control/input/gpt-4.1-nano/cMINC(UKN2).pdf\"\n",
    "\n",
    "add_groundedness_columns(\n",
    "            csv_path=csv_path,\n",
    "            pdf_path=pdf_path,\n",
    "            output_path=Path.cwd() / \"groundedness_demo_output.csv\",\n",
    "            judge_model=\"gpt-5-nano\",\n",
    "            faithfulness_threshold=0.5,\n",
    "            geval_threshold=0.5,\n",
    "            verbose=True\n",
    "            )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "ename": "FileNotFoundError",
     "evalue": "[Errno 2] No such file or directory: '/Users/johannehouweling/ToxTempAssistant/myocyte/toxtempass/evaluation/positive_control/input/gpt-4.1-nano/cMINC(UKN2).pdf'",
     "output_type": "error",
     "traceback": [
      "\u001b[31m---------------------------------------------------------------------------\u001b[39m",
      "\u001b[31mFileNotFoundError\u001b[39m                         Traceback (most recent call last)",
      "\u001b[36mCell\u001b[39m\u001b[36m \u001b[39m\u001b[32mIn[7]\u001b[39m\u001b[32m, line 4\u001b[39m\n\u001b[32m      1\u001b[39m csv_path = \u001b[33m\"\u001b[39m\u001b[33m/Users/johannehouweling/ToxTempAssistant/myocyte/toxtempass/evaluation/positive_control/output/gpt-4.1-nano/tier1_comparison_cMINC(UKN2).csv\u001b[39m\u001b[33m\"\u001b[39m\n\u001b[32m      2\u001b[39m pdf_path = \u001b[33m\"\u001b[39m\u001b[33m/Users/johannehouweling/ToxTempAssistant/myocyte/toxtempass/evaluation/positive_control/input/gpt-4.1-nano/cMINC(UKN2).pdf\u001b[39m\u001b[33m\"\u001b[39m\n\u001b[32m----> \u001b[39m\u001b[32m4\u001b[39m \u001b[43madd_groundedness_columns\u001b[49m\u001b[43m(\u001b[49m\n\u001b[32m      5\u001b[39m \u001b[43m            \u001b[49m\u001b[43mcsv_path\u001b[49m\u001b[43m=\u001b[49m\u001b[43mcsv_path\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m      6\u001b[39m \u001b[43m            \u001b[49m\u001b[43mpdf_path\u001b[49m\u001b[43m=\u001b[49m\u001b[43mpdf_path\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m      7\u001b[39m \u001b[43m            \u001b[49m\u001b[43moutput_path\u001b[49m\u001b[43m=\u001b[49m\u001b[43mPath\u001b[49m\u001b[43m.\u001b[49m\u001b[43mcwd\u001b[49m\u001b[43m(\u001b[49m\u001b[43m)\u001b[49m\u001b[43m \u001b[49m\u001b[43m/\u001b[49m\u001b[43m \u001b[49m\u001b[33;43m\"\u001b[39;49m\u001b[33;43mgroundedness_demo_output.csv\u001b[39;49m\u001b[33;43m\"\u001b[39;49m\u001b[43m,\u001b[49m\n\u001b[32m      8\u001b[39m \u001b[43m            \u001b[49m\u001b[43mjudge_model\u001b[49m\u001b[43m=\u001b[49m\u001b[33;43m\"\u001b[39;49m\u001b[33;43mgpt-5-nano\u001b[39;49m\u001b[33;43m\"\u001b[39;49m\u001b[43m,\u001b[49m\n\u001b[32m      9\u001b[39m \u001b[43m            \u001b[49m\u001b[43mfaithfulness_threshold\u001b[49m\u001b[43m=\u001b[49m\u001b[32;43m0.5\u001b[39;49m\u001b[43m,\u001b[49m\n\u001b[32m     10\u001b[39m \u001b[43m            \u001b[49m\u001b[43mgeval_threshold\u001b[49m\u001b[43m=\u001b[49m\u001b[32;43m0.5\u001b[39;49m\u001b[43m,\u001b[49m\n\u001b[32m     11\u001b[39m \u001b[43m            \u001b[49m\u001b[43mverbose\u001b[49m\u001b[43m=\u001b[49m\u001b[38;5;28;43;01mTrue\u001b[39;49;00m\n\u001b[32m     12\u001b[39m \u001b[43m            \u001b[49m\u001b[43m)\u001b[49m\n",
      "\u001b[36mCell\u001b[39m\u001b[36m \u001b[39m\u001b[32mIn[4]\u001b[39m\u001b[32m, line 235\u001b[39m, in \u001b[36madd_groundedness_columns\u001b[39m\u001b[34m(csv_path, pdf_path, output_path, judge_model, faithfulness_threshold, geval_threshold, verbose)\u001b[39m\n\u001b[32m    231\u001b[39m \u001b[38;5;250m\u001b[39m\u001b[33;03m\"\"\"\u001b[39;00m\n\u001b[32m    232\u001b[39m \u001b[33;03mAdd groundedness-related columns to a tier1_comparison CSV using a PDF as context.\u001b[39;00m\n\u001b[32m    233\u001b[39m \u001b[33;03m\"\"\"\u001b[39;00m\n\u001b[32m    234\u001b[39m df = pd.read_csv(csv_path)\n\u001b[32m--> \u001b[39m\u001b[32m235\u001b[39m pdf_text = \u001b[43mpdf_to_full_text\u001b[49m\u001b[43m(\u001b[49m\u001b[43mpdf_path\u001b[49m\u001b[43m)\u001b[49m\n\u001b[32m    237\u001b[39m results = []\n\u001b[32m    238\u001b[39m \u001b[38;5;28;01mfor\u001b[39;00m _, row \u001b[38;5;129;01min\u001b[39;00m df.iterrows():\n",
      "\u001b[36mCell\u001b[39m\u001b[36m \u001b[39m\u001b[32mIn[4]\u001b[39m\u001b[32m, line 118\u001b[39m, in \u001b[36mpdf_to_full_text\u001b[39m\u001b[34m(pdf_path, max_pages)\u001b[39m\n\u001b[32m    113\u001b[39m \u001b[38;5;28;01mexcept\u001b[39;00m \u001b[38;5;167;01mImportError\u001b[39;00m \u001b[38;5;28;01mas\u001b[39;00m e:\n\u001b[32m    114\u001b[39m     \u001b[38;5;28;01mraise\u001b[39;00m \u001b[38;5;167;01mImportError\u001b[39;00m(\n\u001b[32m    115\u001b[39m         \u001b[33m\"\u001b[39m\u001b[33mpypdf is required for pdf_to_full_text(). Install with: pip install pypdf\u001b[39m\u001b[33m\"\u001b[39m\n\u001b[32m    116\u001b[39m     ) \u001b[38;5;28;01mfrom\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[34;01me\u001b[39;00m\n\u001b[32m--> \u001b[39m\u001b[32m118\u001b[39m reader = \u001b[43mPdfReader\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;28;43mstr\u001b[39;49m\u001b[43m(\u001b[49m\u001b[43mpdf_path\u001b[49m\u001b[43m)\u001b[49m\u001b[43m)\u001b[49m\n\u001b[32m    119\u001b[39m n_pages = \u001b[38;5;28mlen\u001b[39m(reader.pages)\n\u001b[32m    120\u001b[39m \u001b[38;5;28;01mif\u001b[39;00m max_pages \u001b[38;5;129;01mis\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m \u001b[38;5;28;01mNone\u001b[39;00m:\n",
      "\u001b[36mFile \u001b[39m\u001b[32m/opt/homebrew/Caskroom/miniconda/base/envs/tta/lib/python3.13/site-packages/pypdf/_reader.py:136\u001b[39m, in \u001b[36mPdfReader.__init__\u001b[39m\u001b[34m(self, stream, strict, password)\u001b[39m\n\u001b[32m    132\u001b[39m \u001b[38;5;28mself\u001b[39m._page_id2num: Optional[Dict[Any, Any]] = \u001b[38;5;28;01mNone\u001b[39;00m\n\u001b[32m    134\u001b[39m \u001b[38;5;28mself\u001b[39m._validated_root: Optional[DictionaryObject] = \u001b[38;5;28;01mNone\u001b[39;00m\n\u001b[32m--> \u001b[39m\u001b[32m136\u001b[39m \u001b[38;5;28;43mself\u001b[39;49m\u001b[43m.\u001b[49m\u001b[43m_initialize_stream\u001b[49m\u001b[43m(\u001b[49m\u001b[43mstream\u001b[49m\u001b[43m)\u001b[49m\n\u001b[32m    137\u001b[39m \u001b[38;5;28mself\u001b[39m._known_objects: Set[Tuple[\u001b[38;5;28mint\u001b[39m, \u001b[38;5;28mint\u001b[39m]] = \u001b[38;5;28mset\u001b[39m()\n\u001b[32m    139\u001b[39m \u001b[38;5;28mself\u001b[39m._override_encryption = \u001b[38;5;28;01mFalse\u001b[39;00m\n",
      "\u001b[36mFile \u001b[39m\u001b[32m/opt/homebrew/Caskroom/miniconda/base/envs/tta/lib/python3.13/site-packages/pypdf/_reader.py:155\u001b[39m, in \u001b[36mPdfReader._initialize_stream\u001b[39m\u001b[34m(self, stream)\u001b[39m\n\u001b[32m    153\u001b[39m \u001b[38;5;28mself\u001b[39m._stream_opened = \u001b[38;5;28;01mFalse\u001b[39;00m\n\u001b[32m    154\u001b[39m \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;28misinstance\u001b[39m(stream, (\u001b[38;5;28mstr\u001b[39m, Path)):\n\u001b[32m--> \u001b[39m\u001b[32m155\u001b[39m     \u001b[38;5;28;01mwith\u001b[39;00m \u001b[38;5;28;43mopen\u001b[39;49m\u001b[43m(\u001b[49m\u001b[43mstream\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[33;43m\"\u001b[39;49m\u001b[33;43mrb\u001b[39;49m\u001b[33;43m\"\u001b[39;49m\u001b[43m)\u001b[49m \u001b[38;5;28;01mas\u001b[39;00m fh:\n\u001b[32m    156\u001b[39m         stream = BytesIO(fh.read())\n\u001b[32m    157\u001b[39m     \u001b[38;5;28mself\u001b[39m._stream_opened = \u001b[38;5;28;01mTrue\u001b[39;00m\n",
      "\u001b[31mFileNotFoundError\u001b[39m: [Errno 2] No such file or directory: '/Users/johannehouweling/ToxTempAssistant/myocyte/toxtempass/evaluation/positive_control/input/gpt-4.1-nano/cMINC(UKN2).pdf'"
     ]
    }
   ],
   "source": [
    "\n",
    "csv_path = \"/Users/johannehouweling/ToxTempAssistant/myocyte/toxtempass/evaluation/positive_control/output/gpt-4.1-nano/tier1_comparison_cMINC(UKN2).csv\"\n",
    "pdf_path = \"/Users/johannehouweling/ToxTempAssistant/myocyte/toxtempass/evaluation/positive_control/input/gpt-4.1-nano/cMINC(UKN2).pdf\"\n",
    "\n",
    "add_groundedness_columns(\n",
    "            csv_path=csv_path,\n",
    "            pdf_path=pdf_path,\n",
    "            output_path=Path.cwd() / \"groundedness_demo_output.csv\",\n",
    "            judge_model=\"gpt-5-nano\",\n",
    "            faithfulness_threshold=0.5,\n",
    "            geval_threshold=0.5,\n",
    "            verbose=True\n",
    "            )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "ename": "AttributeError",
     "evalue": "'str' object has no attribute 'name'",
     "output_type": "error",
     "traceback": [
      "\u001b[31m---------------------------------------------------------------------------\u001b[39m",
      "\u001b[31mAttributeError\u001b[39m                            Traceback (most recent call last)",
      "\u001b[36mCell\u001b[39m\u001b[36m \u001b[39m\u001b[32mIn[8]\u001b[39m\u001b[32m, line 4\u001b[39m\n\u001b[32m      1\u001b[39m csv_path = \u001b[33m\"\u001b[39m\u001b[33m/Users/johannehouweling/ToxTempAssistant/myocyte/toxtempass/evaluation/positive_control/output/gpt-4.1-nano/tier1_comparison_cMINC(UKN2).csv\u001b[39m\u001b[33m\"\u001b[39m\n\u001b[32m      2\u001b[39m pdf_path = \u001b[33m\"\u001b[39m\u001b[33m/Users/johannehouweling/ToxTempAssistant/myocyte/toxtempass/evaluation/positive_control/input_files/cMINC(UKN2).pdf\u001b[39m\u001b[33m\"\u001b[39m\n\u001b[32m----> \u001b[39m\u001b[32m4\u001b[39m \u001b[43madd_groundedness_columns\u001b[49m\u001b[43m(\u001b[49m\n\u001b[32m      5\u001b[39m \u001b[43m            \u001b[49m\u001b[43mcsv_path\u001b[49m\u001b[43m=\u001b[49m\u001b[43mcsv_path\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m      6\u001b[39m \u001b[43m            \u001b[49m\u001b[43mpdf_path\u001b[49m\u001b[43m=\u001b[49m\u001b[43mpdf_path\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m      7\u001b[39m \u001b[43m            \u001b[49m\u001b[43moutput_path\u001b[49m\u001b[43m=\u001b[49m\u001b[43mPath\u001b[49m\u001b[43m.\u001b[49m\u001b[43mcwd\u001b[49m\u001b[43m(\u001b[49m\u001b[43m)\u001b[49m\u001b[43m \u001b[49m\u001b[43m/\u001b[49m\u001b[43m \u001b[49m\u001b[33;43m\"\u001b[39;49m\u001b[33;43mgroundedness_demo_output.csv\u001b[39;49m\u001b[33;43m\"\u001b[39;49m\u001b[43m,\u001b[49m\n\u001b[32m      8\u001b[39m \u001b[43m            \u001b[49m\u001b[43mjudge_model\u001b[49m\u001b[43m=\u001b[49m\u001b[33;43m\"\u001b[39;49m\u001b[33;43mgpt-5-nano\u001b[39;49m\u001b[33;43m\"\u001b[39;49m\u001b[43m,\u001b[49m\n\u001b[32m      9\u001b[39m \u001b[43m            \u001b[49m\u001b[43mfaithfulness_threshold\u001b[49m\u001b[43m=\u001b[49m\u001b[32;43m0.5\u001b[39;49m\u001b[43m,\u001b[49m\n\u001b[32m     10\u001b[39m \u001b[43m            \u001b[49m\u001b[43mgeval_threshold\u001b[49m\u001b[43m=\u001b[49m\u001b[32;43m0.5\u001b[39;49m\u001b[43m,\u001b[49m\n\u001b[32m     11\u001b[39m \u001b[43m            \u001b[49m\u001b[43mverbose\u001b[49m\u001b[43m=\u001b[49m\u001b[38;5;28;43;01mTrue\u001b[39;49;00m\n\u001b[32m     12\u001b[39m \u001b[43m            \u001b[49m\u001b[43m)\u001b[49m\n",
      "\u001b[36mCell\u001b[39m\u001b[36m \u001b[39m\u001b[32mIn[4]\u001b[39m\u001b[32m, line 235\u001b[39m, in \u001b[36madd_groundedness_columns\u001b[39m\u001b[34m(csv_path, pdf_path, output_path, judge_model, faithfulness_threshold, geval_threshold, verbose)\u001b[39m\n\u001b[32m    231\u001b[39m \u001b[38;5;250m\u001b[39m\u001b[33;03m\"\"\"\u001b[39;00m\n\u001b[32m    232\u001b[39m \u001b[33;03mAdd groundedness-related columns to a tier1_comparison CSV using a PDF as context.\u001b[39;00m\n\u001b[32m    233\u001b[39m \u001b[33;03m\"\"\"\u001b[39;00m\n\u001b[32m    234\u001b[39m df = pd.read_csv(csv_path)\n\u001b[32m--> \u001b[39m\u001b[32m235\u001b[39m pdf_text = \u001b[43mpdf_to_full_text\u001b[49m\u001b[43m(\u001b[49m\u001b[43mpdf_path\u001b[49m\u001b[43m)\u001b[49m\n\u001b[32m    237\u001b[39m results = []\n\u001b[32m    238\u001b[39m \u001b[38;5;28;01mfor\u001b[39;00m _, row \u001b[38;5;129;01min\u001b[39;00m df.iterrows():\n",
      "\u001b[36mCell\u001b[39m\u001b[36m \u001b[39m\u001b[32mIn[4]\u001b[39m\u001b[32m, line 128\u001b[39m, in \u001b[36mpdf_to_full_text\u001b[39m\u001b[34m(pdf_path, max_pages)\u001b[39m\n\u001b[32m    126\u001b[39m     \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m text:\n\u001b[32m    127\u001b[39m         \u001b[38;5;28;01mcontinue\u001b[39;00m\n\u001b[32m--> \u001b[39m\u001b[32m128\u001b[39m     pages.append(\u001b[33mf\u001b[39m\u001b[33m\"\u001b[39m\u001b[33m[\u001b[39m\u001b[38;5;132;01m{\u001b[39;00m\u001b[43mpdf_path\u001b[49m\u001b[43m.\u001b[49m\u001b[43mname\u001b[49m\u001b[38;5;132;01m}\u001b[39;00m\u001b[33m p.\u001b[39m\u001b[38;5;132;01m{\u001b[39;00mi+\u001b[32m1\u001b[39m\u001b[38;5;132;01m}\u001b[39;00m\u001b[33m] \u001b[39m\u001b[38;5;132;01m{\u001b[39;00mtext\u001b[38;5;132;01m}\u001b[39;00m\u001b[33m\"\u001b[39m)\n\u001b[32m    130\u001b[39m \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m pages:\n\u001b[32m    131\u001b[39m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[33mf\u001b[39m\u001b[33m\"\u001b[39m\u001b[33m[\u001b[39m\u001b[38;5;132;01m{\u001b[39;00mpdf_path.name\u001b[38;5;132;01m}\u001b[39;00m\u001b[33m] (no extractable text)\u001b[39m\u001b[33m\"\u001b[39m\n",
      "\u001b[31mAttributeError\u001b[39m: 'str' object has no attribute 'name'"
     ]
    }
   ],
   "source": [
    "csv_path = \"/Users/johannehouweling/ToxTempAssistant/myocyte/toxtempass/evaluation/positive_control/output/gpt-4.1-nano/tier1_comparison_cMINC(UKN2).csv\"\n",
    "pdf_path = \"/Users/johannehouweling/ToxTempAssistant/myocyte/toxtempass/evaluation/positive_control/input_files/cMINC(UKN2).pdf\"\n",
    "\n",
    "add_groundedness_columns(\n",
    "            csv_path=csv_path,\n",
    "            pdf_path=pdf_path,\n",
    "            output_path=Path.cwd() / \"groundedness_demo_output.csv\",\n",
    "            judge_model=\"gpt-5-nano\",\n",
    "            faithfulness_threshold=0.5,\n",
    "            geval_threshold=0.5,\n",
    "            verbose=True\n",
    "            )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "50d9d8c2-0737-4ea0-b76d-d399167a417b",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "c45696f35d434967b79342f010744f1e",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Output()"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "ename": "KeyboardInterrupt",
     "evalue": "",
     "output_type": "error",
     "traceback": [
      "\u001b[31m---------------------------------------------------------------------------\u001b[39m",
      "\u001b[31mKeyboardInterrupt\u001b[39m                         Traceback (most recent call last)",
      "\u001b[36mCell\u001b[39m\u001b[36m \u001b[39m\u001b[32mIn[9]\u001b[39m\u001b[32m, line 4\u001b[39m\n\u001b[32m      1\u001b[39m csv_path = Path(\u001b[33m\"\u001b[39m\u001b[33m/Users/johannehouweling/ToxTempAssistant/myocyte/toxtempass/evaluation/positive_control/output/gpt-4.1-nano/tier1_comparison_cMINC(UKN2).csv\u001b[39m\u001b[33m\"\u001b[39m)\n\u001b[32m      2\u001b[39m pdf_path = Path(\u001b[33m\"\u001b[39m\u001b[33m/Users/johannehouweling/ToxTempAssistant/myocyte/toxtempass/evaluation/positive_control/input_files/cMINC(UKN2).pdf\u001b[39m\u001b[33m\"\u001b[39m)\n\u001b[32m----> \u001b[39m\u001b[32m4\u001b[39m \u001b[43madd_groundedness_columns\u001b[49m\u001b[43m(\u001b[49m\n\u001b[32m      5\u001b[39m \u001b[43m            \u001b[49m\u001b[43mcsv_path\u001b[49m\u001b[43m=\u001b[49m\u001b[43mcsv_path\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m      6\u001b[39m \u001b[43m            \u001b[49m\u001b[43mpdf_path\u001b[49m\u001b[43m=\u001b[49m\u001b[43mpdf_path\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m      7\u001b[39m \u001b[43m            \u001b[49m\u001b[43moutput_path\u001b[49m\u001b[43m=\u001b[49m\u001b[43mPath\u001b[49m\u001b[43m.\u001b[49m\u001b[43mcwd\u001b[49m\u001b[43m(\u001b[49m\u001b[43m)\u001b[49m\u001b[43m \u001b[49m\u001b[43m/\u001b[49m\u001b[43m \u001b[49m\u001b[33;43m\"\u001b[39;49m\u001b[33;43mgroundedness_demo_output.csv\u001b[39;49m\u001b[33;43m\"\u001b[39;49m\u001b[43m,\u001b[49m\n\u001b[32m      8\u001b[39m \u001b[43m            \u001b[49m\u001b[43mjudge_model\u001b[49m\u001b[43m=\u001b[49m\u001b[33;43m\"\u001b[39;49m\u001b[33;43mgpt-5-nano\u001b[39;49m\u001b[33;43m\"\u001b[39;49m\u001b[43m,\u001b[49m\n\u001b[32m      9\u001b[39m \u001b[43m            \u001b[49m\u001b[43mfaithfulness_threshold\u001b[49m\u001b[43m=\u001b[49m\u001b[32;43m0.5\u001b[39;49m\u001b[43m,\u001b[49m\n\u001b[32m     10\u001b[39m \u001b[43m            \u001b[49m\u001b[43mgeval_threshold\u001b[49m\u001b[43m=\u001b[49m\u001b[32;43m0.5\u001b[39;49m\u001b[43m,\u001b[49m\n\u001b[32m     11\u001b[39m \u001b[43m            \u001b[49m\u001b[43mverbose\u001b[49m\u001b[43m=\u001b[49m\u001b[38;5;28;43;01mTrue\u001b[39;49;00m\n\u001b[32m     12\u001b[39m \u001b[43m            \u001b[49m\u001b[43m)\u001b[49m\n",
      "\u001b[36mCell\u001b[39m\u001b[36m \u001b[39m\u001b[32mIn[4]\u001b[39m\u001b[32m, line 240\u001b[39m, in \u001b[36madd_groundedness_columns\u001b[39m\u001b[34m(csv_path, pdf_path, output_path, judge_model, faithfulness_threshold, geval_threshold, verbose)\u001b[39m\n\u001b[32m    237\u001b[39m results = []\n\u001b[32m    238\u001b[39m \u001b[38;5;28;01mfor\u001b[39;00m _, row \u001b[38;5;129;01min\u001b[39;00m df.iterrows():\n\u001b[32m    239\u001b[39m     results.append(\n\u001b[32m--> \u001b[39m\u001b[32m240\u001b[39m         \u001b[43mrun_case\u001b[49m\u001b[43m(\u001b[49m\n\u001b[32m    241\u001b[39m \u001b[43m            \u001b[49m\u001b[43muser_input\u001b[49m\u001b[43m=\u001b[49m\u001b[43mrow\u001b[49m\u001b[43m.\u001b[49m\u001b[43mget\u001b[49m\u001b[43m(\u001b[49m\u001b[33;43m\"\u001b[39;49m\u001b[33;43mquestion\u001b[39;49m\u001b[33;43m\"\u001b[39;49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[33;43m\"\u001b[39;49m\u001b[33;43m\"\u001b[39;49m\u001b[43m)\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    242\u001b[39m \u001b[43m            \u001b[49m\u001b[43mactual_output\u001b[49m\u001b[43m=\u001b[49m\u001b[43mrow\u001b[49m\u001b[43m.\u001b[49m\u001b[43mget\u001b[49m\u001b[43m(\u001b[49m\u001b[33;43m\"\u001b[39;49m\u001b[33;43mllm_answer\u001b[39;49m\u001b[33;43m\"\u001b[39;49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[33;43m\"\u001b[39;49m\u001b[33;43m\"\u001b[39;49m\u001b[43m)\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    243\u001b[39m \u001b[43m            \u001b[49m\u001b[43mretrieval_context\u001b[49m\u001b[43m=\u001b[49m\u001b[43mpdf_text\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    244\u001b[39m \u001b[43m            \u001b[49m\u001b[43mjudge_model\u001b[49m\u001b[43m=\u001b[49m\u001b[43mjudge_model\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    245\u001b[39m \u001b[43m            \u001b[49m\u001b[43mfaithfulness_threshold\u001b[49m\u001b[43m=\u001b[49m\u001b[43mfaithfulness_threshold\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    246\u001b[39m \u001b[43m            \u001b[49m\u001b[43muse_geval_policy\u001b[49m\u001b[43m=\u001b[49m\u001b[38;5;28;43;01mTrue\u001b[39;49;00m\u001b[43m,\u001b[49m\n\u001b[32m    247\u001b[39m \u001b[43m            \u001b[49m\u001b[43mgeval_threshold\u001b[49m\u001b[43m=\u001b[49m\u001b[43mgeval_threshold\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    248\u001b[39m \u001b[43m            \u001b[49m\u001b[43mverbose_mode\u001b[49m\u001b[43m=\u001b[49m\u001b[43mverbose\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    249\u001b[39m \u001b[43m        \u001b[49m\u001b[43m)\u001b[49m\n\u001b[32m    250\u001b[39m     )\n\u001b[32m    252\u001b[39m df[\u001b[33m\"\u001b[39m\u001b[33mfaithfulness_score\u001b[39m\u001b[33m\"\u001b[39m] = [r[\u001b[33m\"\u001b[39m\u001b[33mfaithfulness_score\u001b[39m\u001b[33m\"\u001b[39m] \u001b[38;5;28;01mfor\u001b[39;00m r \u001b[38;5;129;01min\u001b[39;00m results]\n\u001b[32m    253\u001b[39m df[\u001b[33m\"\u001b[39m\u001b[33mfaithfulness_reason\u001b[39m\u001b[33m\"\u001b[39m] = [r[\u001b[33m\"\u001b[39m\u001b[33mfaithfulness_reason\u001b[39m\u001b[33m\"\u001b[39m] \u001b[38;5;28;01mfor\u001b[39;00m r \u001b[38;5;129;01min\u001b[39;00m results]\n",
      "\u001b[36mCell\u001b[39m\u001b[36m \u001b[39m\u001b[32mIn[4]\u001b[39m\u001b[32m, line 185\u001b[39m, in \u001b[36mrun_case\u001b[39m\u001b[34m(user_input, actual_output, retrieval_context, judge_model, faithfulness_threshold, use_geval_policy, geval_threshold, verbose_mode)\u001b[39m\n\u001b[32m    178\u001b[39m results: \u001b[38;5;28mdict\u001b[39m = {}\n\u001b[32m    180\u001b[39m faith = build_faithfulness_metric(\n\u001b[32m    181\u001b[39m     model=judge_model,\n\u001b[32m    182\u001b[39m     threshold=faithfulness_threshold,\n\u001b[32m    183\u001b[39m     verbose_mode=verbose_mode,\n\u001b[32m    184\u001b[39m )\n\u001b[32m--> \u001b[39m\u001b[32m185\u001b[39m \u001b[43mfaith\u001b[49m\u001b[43m.\u001b[49m\u001b[43mmeasure\u001b[49m\u001b[43m(\u001b[49m\u001b[43mtest_case\u001b[49m\u001b[43m)\u001b[49m\n\u001b[32m    186\u001b[39m results[\u001b[33m\"\u001b[39m\u001b[33mfaithfulness_score\u001b[39m\u001b[33m\"\u001b[39m] = \u001b[38;5;28mfloat\u001b[39m(faith.score)\n\u001b[32m    187\u001b[39m results[\u001b[33m\"\u001b[39m\u001b[33mfaithfulness_reason\u001b[39m\u001b[33m\"\u001b[39m] = faith.reason \u001b[38;5;129;01mor\u001b[39;00m \u001b[33m\"\u001b[39m\u001b[33m\"\u001b[39m\n",
      "\u001b[36mFile \u001b[39m\u001b[32m/opt/homebrew/Caskroom/miniconda/base/envs/tta/lib/python3.13/site-packages/deepeval/metrics/faithfulness/faithfulness.py:88\u001b[39m, in \u001b[36mFaithfulnessMetric.measure\u001b[39m\u001b[34m(self, test_case, _show_indicator, _in_component, _log_metric_to_confident)\u001b[39m\n\u001b[32m     86\u001b[39m \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;28mself\u001b[39m.async_mode:\n\u001b[32m     87\u001b[39m     loop = get_or_create_event_loop()\n\u001b[32m---> \u001b[39m\u001b[32m88\u001b[39m     \u001b[43mloop\u001b[49m\u001b[43m.\u001b[49m\u001b[43mrun_until_complete\u001b[49m\u001b[43m(\u001b[49m\n\u001b[32m     89\u001b[39m \u001b[43m        \u001b[49m\u001b[38;5;28;43mself\u001b[39;49m\u001b[43m.\u001b[49m\u001b[43ma_measure\u001b[49m\u001b[43m(\u001b[49m\n\u001b[32m     90\u001b[39m \u001b[43m            \u001b[49m\u001b[43mtest_case\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m     91\u001b[39m \u001b[43m            \u001b[49m\u001b[43m_show_indicator\u001b[49m\u001b[43m=\u001b[49m\u001b[38;5;28;43;01mFalse\u001b[39;49;00m\u001b[43m,\u001b[49m\n\u001b[32m     92\u001b[39m \u001b[43m            \u001b[49m\u001b[43m_in_component\u001b[49m\u001b[43m=\u001b[49m\u001b[43m_in_component\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m     93\u001b[39m \u001b[43m            \u001b[49m\u001b[43m_log_metric_to_confident\u001b[49m\u001b[43m=\u001b[49m\u001b[43m_log_metric_to_confident\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m     94\u001b[39m \u001b[43m        \u001b[49m\u001b[43m)\u001b[49m\n\u001b[32m     95\u001b[39m \u001b[43m    \u001b[49m\u001b[43m)\u001b[49m\n\u001b[32m     96\u001b[39m \u001b[38;5;28;01melse\u001b[39;00m:\n\u001b[32m     97\u001b[39m     retrieval_context = test_case.retrieval_context\n",
      "\u001b[36mFile \u001b[39m\u001b[32m/opt/homebrew/Caskroom/miniconda/base/envs/tta/lib/python3.13/site-packages/nest_asyncio.py:92\u001b[39m, in \u001b[36m_patch_loop.<locals>.run_until_complete\u001b[39m\u001b[34m(self, future)\u001b[39m\n\u001b[32m     90\u001b[39m     f._log_destroy_pending = \u001b[38;5;28;01mFalse\u001b[39;00m\n\u001b[32m     91\u001b[39m \u001b[38;5;28;01mwhile\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m f.done():\n\u001b[32m---> \u001b[39m\u001b[32m92\u001b[39m     \u001b[38;5;28;43mself\u001b[39;49m\u001b[43m.\u001b[49m\u001b[43m_run_once\u001b[49m\u001b[43m(\u001b[49m\u001b[43m)\u001b[49m\n\u001b[32m     93\u001b[39m     \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;28mself\u001b[39m._stopping:\n\u001b[32m     94\u001b[39m         \u001b[38;5;28;01mbreak\u001b[39;00m\n",
      "\u001b[36mFile \u001b[39m\u001b[32m/opt/homebrew/Caskroom/miniconda/base/envs/tta/lib/python3.13/site-packages/nest_asyncio.py:115\u001b[39m, in \u001b[36m_patch_loop.<locals>._run_once\u001b[39m\u001b[34m(self)\u001b[39m\n\u001b[32m    108\u001b[39m     heappop(scheduled)\n\u001b[32m    110\u001b[39m timeout = (\n\u001b[32m    111\u001b[39m     \u001b[32m0\u001b[39m \u001b[38;5;28;01mif\u001b[39;00m ready \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28mself\u001b[39m._stopping\n\u001b[32m    112\u001b[39m     \u001b[38;5;28;01melse\u001b[39;00m \u001b[38;5;28mmin\u001b[39m(\u001b[38;5;28mmax\u001b[39m(\n\u001b[32m    113\u001b[39m         scheduled[\u001b[32m0\u001b[39m]._when - \u001b[38;5;28mself\u001b[39m.time(), \u001b[32m0\u001b[39m), \u001b[32m86400\u001b[39m) \u001b[38;5;28;01mif\u001b[39;00m scheduled\n\u001b[32m    114\u001b[39m     \u001b[38;5;28;01melse\u001b[39;00m \u001b[38;5;28;01mNone\u001b[39;00m)\n\u001b[32m--> \u001b[39m\u001b[32m115\u001b[39m event_list = \u001b[38;5;28;43mself\u001b[39;49m\u001b[43m.\u001b[49m\u001b[43m_selector\u001b[49m\u001b[43m.\u001b[49m\u001b[43mselect\u001b[49m\u001b[43m(\u001b[49m\u001b[43mtimeout\u001b[49m\u001b[43m)\u001b[49m\n\u001b[32m    116\u001b[39m \u001b[38;5;28mself\u001b[39m._process_events(event_list)\n\u001b[32m    118\u001b[39m end_time = \u001b[38;5;28mself\u001b[39m.time() + \u001b[38;5;28mself\u001b[39m._clock_resolution\n",
      "\u001b[36mFile \u001b[39m\u001b[32m/opt/homebrew/Caskroom/miniconda/base/envs/tta/lib/python3.13/selectors.py:548\u001b[39m, in \u001b[36mKqueueSelector.select\u001b[39m\u001b[34m(self, timeout)\u001b[39m\n\u001b[32m    546\u001b[39m ready = []\n\u001b[32m    547\u001b[39m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[32m--> \u001b[39m\u001b[32m548\u001b[39m     kev_list = \u001b[38;5;28;43mself\u001b[39;49m\u001b[43m.\u001b[49m\u001b[43m_selector\u001b[49m\u001b[43m.\u001b[49m\u001b[43mcontrol\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;28;43;01mNone\u001b[39;49;00m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mmax_ev\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mtimeout\u001b[49m\u001b[43m)\u001b[49m\n\u001b[32m    549\u001b[39m \u001b[38;5;28;01mexcept\u001b[39;00m \u001b[38;5;167;01mInterruptedError\u001b[39;00m:\n\u001b[32m    550\u001b[39m     \u001b[38;5;28;01mreturn\u001b[39;00m ready\n",
      "\u001b[31mKeyboardInterrupt\u001b[39m: "
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "**************************************************\n",
      "Faithfulness Verbose Logs\n",
      "**************************************************\n",
      "\n",
      "Truths (limit=None):\n",
      "[\n",
      "    \"The cMINC UKN2 assay is an in vitro test method that assesses impairment of migration of human neural crest cells (NCCs) generated from human induced pluripotent stem cells (hiPSCs).\",\n",
      "    \"Version 2.0 of the cMINC protocol (V2.0) was deposited in March 2023, and a previous version was assembled in 2019 in the context of the EU-ToxRisk project.\",\n",
      "    \"The hiPSC line used is IMR90_clone_#4, which was obtained from WiCell (Wisconsin) in 2012 and has been maintained with a master stock and working stocks.\",\n",
      "    \"ATCC number for the cell line is CCL-186; the cells are of human origin (Homo sapiens) and originate from lung tissue, described as fibroblasts.\",\n",
      "    \"Undifferentiated hiPSCs are maintained as colonies on Laminin-521 in Essential 8 (E8) medium and can be passaged with weak splitting; the cells show self-renewal and pluripotency characteristics.\",\n",
      "    \"The hiPSCs express pluripotency markers Oct4, Nanog, and Tra-1-60 in maintenance culture.\",\n",
      "    \"NCCs used in the assay are ≥90% positive for NCC markers HNK-1 and p75, and they also express nestin and AP2, while not expressing Pax6 or βIII tubulin.\",\n",
      "    \"After thawing, NCCs must have viability greater than 90%.\",\n",
      "    \"The hiPSC maintenance can be affected by high passage numbers; variability in passaging may influence differentiation potential.\",\n",
      "    \"NCCs are differentiated from hiPSCs following a protocol based on Mica et al. (2013), beginning with plating on Matrigel-coated plates at 100,000 cells per cm2 in E8 with ROCK inhibitor Y-27632, then transitioning through Noggin and SB431542, CHIR99021 treatment, and finally to N2-S medium before collecting NCCs on day 11 for cryopreservation.\",\n",
      "    \"Final NCCs are cryopreserved at a concentration of 4×10^6 cells/mL in 90% N2-S medium and 10% DMSO after day-11 collection.\",\n",
      "    \"The cMINC test system uses a highly homogeneous pre-differentiated NCC population that is added to coated wells with a central silicone stopper to create a circular cell-free area; migration occurs after stopper removal.\",\n",
      "    \"At the start of the test, the NCC-derived cells in the migration setup must be ≥90% positive for NCC markers, and after thawing the viability must be >90%.\",\n",
      "    \"Migratory behavior is characterized by cells migrating into the cell-free central area, with some cells migrating as single cells and some evidence of collective migration.\",\n",
      "    \"The assay endpoint comprises migration inhibition as the primary endpoint and cell viability as the reference endpoint.\",\n",
      "    \"Migration and viability are quantified by high-content imaging after staining with calcein-AM and Hoechst 33342, using four fields outside the migration zone for viability assessment and an ROI in the migration zone for migration assessment.\",\n",
      "    \"The ROI for migration is sized so that untreated conditions contain approximately 150 to 300 viable cells within the ROI.\",\n",
      "    \"Data processing uses Ringassay software to estimate the cell-free area and count migrated cells, with raw image analysis performed by ArrayScan software, and results compiled in Excel for further analysis.\",\n",
      "    \"Exposure of NCCs to test compounds occurs over 24 hours (Day 1 after stopper removal), with imaging and analysis on Day 2.\",\n",
      "    \"Compound dilutions are prepared so that final DMSO concentration on the cells is 0.1%; master dilutions are prepared to ensure 0.5% DMSO in the test wells, with a 1:200 dilution into N2-S medium containing EGF and FGF.\",\n",
      "    \"A typical plate layout involves two compounds per plate with six concentrations each, resulting in 12 data points per plate; throughput is about 768 data points per month (16 plates per week).\",\n",
      "    \"Positive controls include Cytochalasin D (200 nM), LiCl (10 mM), and Taxol (10 nM); negative controls include solvent (0.1% DMSO), paracetamol, and ASS.\",\n",
      "    \"Endpoint-specific controls include compounds such as AgNO3, AraC, aphidicolin, L-homocysteine, MG-132, staurosporine, and Triton X-100.\",\n",
      "    \"A test is discarded if the positive control does not inhibit migration (e.g., center migration ≥75% of control), or if the negative control decreases migration by ≥10%.\",\n",
      "    \"The cMINC assay has three prediction model modes: (1) screening (hit = migration ≤80% of DMSO control and viability ≥90%), (2) hazard evaluation (EC10 viability / EC25 migration ≥1.3), and (3) borderline (BMC10 viability / BMCL25 migration ≥1.3, with fallback to HTC if viability data are missing).\",\n",
      "    \"The assay has been evaluated in several screening campaigns, with reported specificity around 100% and sensitivity >90% in some rounds, S/N ratios >20, and a z' factor >0.5; however, formal OECD validation (ring trials) has not been performed.\",\n",
      "    \"In vitro–in vivo extrapolation (IVIVE) uses a PBPK modelling approach; for UKN2 medium, lipid content is 2.8×10^-6 and albumin concentration is 5.6 μM, while human plasma lipid content is 6000 and albumin concentration is 600 μM.\",\n",
      "    \"The UKN2 cMINC method is not yet linked to regulatory OECD guidelines and has not undergone formal OECD validation or ring trials; it is described as not transferred to other laboratories at present.\",\n",
      "    \"Safety and facility requirements include work in S1 cell culture laboratories for genetically modified cells, with SDSs available in the DaMaRIS database.\",\n",
      "    \"There are no patents protecting the cMINC cells or protocol, though licensing may be required for software tools used in data analysis (e.g., Ringassay, Excel, GraphPad Prism).\",\n",
      "    \"The raw data are stored in Excel files, metadata are documented in log files, and data processing steps involve Ringassay, ArrayScan, Excel, and GraphPad Prism; an internal protocol reference (DB-ALM Protocol n°195) is available for the culture protocol.\"\n",
      "] \n",
      " \n",
      "Claims:\n",
      "[\n",
      "    \"The AI output contains the sentence 'Answer not found in documents.'\",\n",
      "    \"The AI output asserts that no answer was found in the documents.\"\n",
      "] \n",
      " \n",
      "Verdicts:\n",
      "[\n",
      "    {\n",
      "        \"verdict\": \"idk\",\n",
      "        \"reason\": \"The retrieval context does not mention any AI output sentence or claim about an 'Answer not found in documents.' Therefore its truth cannot be evaluated from the provided context.\"\n",
      "    },\n",
      "    {\n",
      "        \"verdict\": \"idk\",\n",
      "        \"reason\": \"There is no information in the retrieval context about AI outputs or statements claiming that no answer was found in the documents; evaluation cannot be made from the context.\"\n",
      "    }\n",
      "]\n",
      " \n",
      "Score: 1.0\n",
      "Reason: The score is 1.00 because there are no contradictions between the actual output and the retrieval context.\n",
      "\n",
      "======================================================================\n"
     ]
    }
   ],
   "source": [
    "csv_path = Path(\"/Users/johannehouweling/ToxTempAssistant/myocyte/toxtempass/evaluation/positive_control/output/gpt-4.1-nano/tier1_comparison_cMINC(UKN2).csv\")\n",
    "pdf_path = Path(\"/Users/johannehouweling/ToxTempAssistant/myocyte/toxtempass/evaluation/positive_control/input_files/cMINC(UKN2).pdf\")\n",
    "\n",
    "add_groundedness_columns(\n",
    "            csv_path=csv_path,\n",
    "            pdf_path=pdf_path,\n",
    "            output_path=Path.cwd() / \"groundedness_demo_output.csv\",\n",
    "            judge_model=\"gpt-5-nano\",\n",
    "            faithfulness_threshold=0.5,\n",
    "            geval_threshold=0.5,\n",
    "            verbose=True\n",
    "            )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "7a9c7a5a-b11c-4cec-978e-f2a43afb206e",
   "metadata": {},
   "outputs": [],
   "source": [
    "df = pd.read_csv(csv_path)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "question",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "gtruth_answer",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "gtruth_answer_quality_score",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "gtruth_answer_quality_justification",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "llm_answer",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "cos_similarity",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "bert_precision",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "bert_recall",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "bert_f1",
         "rawType": "float64",
         "type": "float"
        }
       ],
       "ref": "8ee64803-7687-47be-93bc-ce4d868cbf38",
       "rows": [
        [
         "0",
         "Provide a descriptive title using normal language without technical terms or acronyms.",
         "Assay to test impairment of migration of human neural crest cells (cMINC; UKN2) – V2.0",
         "Medium",
         "The answer partially addresses the question by providing a descriptive title, but it includes technical terms and an acronym (cMINC; UKN2), which the question specifically asked to avoid.",
         "Answer not found in documents.",
         "0.1389022604725474",
         "-0.278099775314331",
         "-0.0136824883520603",
         "-0.1601788848638534"
        ],
        [
         "1",
         "Please describe in no more than 200 words the following:",
         null,
         null,
         null,
         "Answer not found in documents.",
         "0.1476418762811726",
         "-1.0699931383132937",
         "-1.07051682472229",
         "-1.0619372129440308"
        ],
        [
         "2",
         "Which toxicological target (organ, tissue, physiological/biochemical function, etc.) is modelled? (8.1)",
         null,
         "Low",
         "No answer provided; treated as missing.",
         "The assay models the impairment of neural crest cell migration, which is a critical process during fetal development. Therefore, the toxicological target is the tissue and physiological function related to neural crest cell migration, essential for proper development of structures such as the craniofacial region and neural tube. (Source: cMINC(UKN2).pdf)",
         "0.0200932147230614",
         "-1.0699931383132937",
         "-1.07051682472229",
         "-1.0619372129440308"
        ],
        [
         "3",
         "Which test system and readout(s) are used? (4.1; 5.2)",
         null,
         "Low",
         "No answer provided; treated as missing.",
         "The test system used in the assay consists of human neural crest cells (NCCs) differentiated from induced pluripotent stem cells (iPSC), specifically the IMR90 clone. These NCCs are plated around silicone stoppers in coated wells and allowed to migrate into a cell-free area upon removal of the stoppers (Source: cMINC(UKN2).pdf, section 3.3).\n\nThe readouts for the assay include:\n1. Migration inhibition, quantified by high content imaging of cells stained with calcein-AM and Hoechst 33342, with the number of migrated cells counted using a software tool (Source: cMINC(UKN2).pdf, section 4.1).\n2. Cell viability, measured outside the migration zone after 48 hours, also using calcein-AM and Hoechst 33342 staining, with viable cells quantified via automated image analysis (Source: cMINC(UKN2).pdf, section 4.1).",
         "0.0286598244692996",
         "-1.0699931383132937",
         "-1.07051682472229",
         "-1.0619372129440308"
        ],
        [
         "4",
         "Which biological process(es) (e.g. neurite outgrowth, differentiation) and/or toxicological events (e.g. oxidative stress, cell death) are modelled/reflected by your test method? (8.1)",
         null,
         "Low",
         "No answer provided; treated as missing.",
         "The assay models the impairment of neural crest cell migration, a critical biological process during fetal development. It assesses disturbances in NCC migration, which can lead to developmental disorders and malformations such as neural tube defects or craniofacial malformations (Source: cMINC(UKN2).pdf). Additionally, the assay measures cell viability to reflect potential toxicological events like cell death (Source: cMINC(UKN2).pdf).",
         "0.0184842945537873",
         "-1.0699931383132937",
         "-1.07051682472229",
         "-1.0619372129440308"
        ],
        [
         "5",
         "To which (human) adverse outcome(s) is your test method related or could be related? (8.1; 9.2; 9.3)",
         null,
         "Low",
         "No answer provided; treated as missing.",
         "The assay models the impairment of neural crest cell migration during fetal development, which can lead to developmental disorders and malformations such as neural tube defects and craniofacial malformations. Therefore, it is related to adverse outcomes including neural tube defects, craniofacial malformations, and other developmental neurotoxicity-related outcomes (Source: cMINC(UKN2).pdf).",
         "0.011841868007006",
         "-1.0699931383132937",
         "-1.07051682472229",
         "-1.0619372129440308"
        ],
        [
         "6",
         "Which hazard(s) do(es) your test method (potentially) predict? (8.1; 8.6)",
         null,
         "Low",
         "No answer provided; treated as missing.",
         "The assay predicts developmental disorders and malformations, such as neural tube defects and craniofacial malformations, caused by compound exposure during fetal development (Source: cMINC(UKN2).pdf).",
         "0.0313218168355815",
         "-1.0699931383132937",
         "-1.07051682472229",
         "-1.0619372129440308"
        ],
        [
         "7",
         "Does the test method capture an endpoint of current regulatory studies? (9.5)",
         null,
         "Low",
         "No answer provided; treated as missing.",
         "Answer not found in documents.",
         "0.1472711047968674",
         "-1.0699931383132937",
         "-1.07051682472229",
         "-1.0619372129440308"
        ],
        [
         "8",
         "If the method has undergone some form of validation/evaluation, give its status. (9.4)",
         null,
         "Low",
         "No answer provided; treated as missing.",
         "The method has been used in several screening campaigns and has demonstrated good performance parameters, such as a specificity of 100% and a sensitivity of over 90%. However, a formal validation, such as an OECD validation study or ring trial, has not been conducted. Therefore, the validation status is that it has not undergone formal validation. (Source: cMINC(UKN2).pdf)",
         "0.0438928721719397",
         "-1.0699931383132937",
         "-1.07051682472229",
         "-1.0619372129440308"
        ],
        [
         "9",
         "Provide the original/published name, as well as the potential tradename.",
         "Circular migration inhibition of NCC (cMINC) assay, UKN2",
         "Medium",
         "The answer provides the original/published name of the assay but does not clearly specify which is the tradename. It partially addresses the question but lacks clarity and completeness.",
         "Answer not found in documents.",
         "0.1409785695304698",
         "-0.2523543536663055",
         "-0.0393586903810501",
         "-0.1535197347402572"
        ],
        [
         "10",
         "Provide the original deposition date of first version and date of current version.",
         "This is Version 2.0 of the protocol “Assay to test impairment of migration of human neural crest cells (cMINC; UKN2) – V2.0). It was assembled and deposited in March 2023. A previous version was assembled in 2019 in the context of the EU-ToxRisk project (see publication Krebs et al., 2020)",
         "Medium",
         "The answer provides the deposition date of the current version (March 2023) and mentions a previous version from 2019, but it does not specify the exact original deposition date of the first version. The information is partially complete but lacks full clarity on the original deposition date.",
         "The first version of the assay was assembled in 2019, and the current version (V2.0) was assembled and deposited in March 2023 (Source: cMINC(UKN2).pdf).",
         "0.7008524794112678",
         "0.2906718254089355",
         "0.543626070022583",
         "0.4087507724761963"
        ],
        [
         "11",
         "This only applies to updated versions. If this is the original version, state 'original version'.",
         "Changes compared to V1 refer mainly to the generation of the test system and the cell line used. Test procedures and parameters remain unchanged.",
         "Medium",
         "The answer partially addresses the question by mentioning changes compared to V1, implying it is not the original version. However, it lacks clarity and completeness as it does not explicitly state whether this is an updated version or the original version.",
         "Answer not found in documents.",
         "0.1124972445828743",
         "-0.1620234549045562",
         "-0.0210428051650524",
         "-0.0922328606247901"
        ],
        [
         "12",
         "Normal text names often do not uniquely define the method. Therefore, each method should be assigned a clearly and uniquely defined data base name.",
         "UKN2a_DART_NC_cMIGR_24h_02",
         "High",
         "The answer provides a clearly and uniquely defined database name, which fully addresses the question's requirement for a unique identifier for the method.",
         "The assay is assigned the database name UKN2a_DART_NC_cMIGR_24h_02, which uniquely and clearly identifies this specific method.",
         "0.6150553856491306",
         "0.71158766746521",
         "0.2642772197723388",
         "0.4580635726451874"
        ],
        [
         "13",
         "Include affiliation.",
         "University of Konstanz (UKN), Germany",
         "High",
         "The answer fully addresses the question by providing the required affiliation, including the name of the institution and the country.",
         "Answer not found in documents.",
         "0.0864104393081909",
         "-0.222375139594078",
         "-0.1846837252378463",
         "-0.1991110444068908"
        ],
        [
         "14",
         "Provide the details of the principal contact person.",
         "Prof. Dr. Marcel Leist marcel.leist@uni-konstanz.de Tel: +49-7531885037",
         "High",
         "The answer provides complete and relevant details for the principal contact person, including name, email, and telephone number, fully addressing the question.",
         "The principal contact person for the assay is Prof. Dr. Marcel Leist. His email address is marcel.leist@uni-konstanz.de, and his telephone number is +49-7531885037 _(Source: cMINC(UKN2).pdf)_",
         "0.6257381618345769",
         "0.8096904158592224",
         "0.3848705291748047",
         "0.5719906091690063"
        ],
        [
         "15",
         "For example, the principal investigator (PI) of the lab, the person who conducted the experiments, etc.",
         "Xenia Dolde (PhD student, experimenter) xenia.dolde@uni-konstanz.de Jonathan Blum (PhD student) jonathan.blum@uni-konstanz.de Heidrun Leisner (experimenter) heidrun.leisner@uni-konstanz.de",
         "Medium",
         "The answer provides names and roles of individuals involved in the experiments, which partially addresses the question. However, it lacks clarity on who the principal investigator (PI) is, which is a key part of the question.",
         "Answer not found in documents.",
         "0.0856225308392804",
         "-0.5428894758224487",
         "-0.2505278885364532",
         "-0.4227911233901977"
        ],
        [
         "16",
         "Supply number of supporting files. Describe supporting files (e.g. metadata files, instrument settings, calculation template, raw data file, etc.).",
         "- An important reference is the DB-ALM Protocol n° 195. The original iPSC are in the meantime cultured feeder-free (see 3.2) - Raw data file - Data processing file",
         "Medium",
         "The answer partially addresses the question by mentioning a raw data file and a data processing file, but it lacks clarity and completeness. It does not specify the number of supporting files or provide a detailed description of each file type, such as metadata files or instrument settings.",
         "The provided context indicates that the assay includes several supporting files to facilitate data management and analysis. These supporting files are:\n\n1. Raw data file: Contains the raw data extracted from the high content imaging analysis, typically in formats such as Excel, bitmap, or TIFF, including data from all technical replicates (Source: cMINC(UKN2).pdf).\n\n2. Data processing file: Used for processing raw data into summary data, including image analysis and cell counts, and for calculating migration and viability metrics (Source: cMINC(UKN2).pdf).\n\n3. Metadata files: Document detailed experimental information such as cell culture conditions, assay parameters, and procedural logs. These are stored as text log files with specific descriptors, including details like cell insight PC, protocol, scan, and spooling information (Source: cMINC(UKN2).pdf).\n\n4. Protocol and SOP files: The detailed standard operating procedures (SOP) and protocols, such as Protocol no 195, are available in the DB-ALM database and can be accessed via provided links (Source: cMINC(UKN2).pdf).\n\nIn summary, the assay is supported by raw data files, data processing files, metadata log files, and detailed protocol documents, all of which are stored and managed to ensure data integrity and reproducibility.",
         "0.6323262931535033",
         "0.0796980932354927",
         "-0.1550818979740142",
         "-0.0467702336609363"
        ],
        [
         "17",
         "Describe briefly whether the cells are from a commercial supplier, continuously generated by cell culture, or obtained by isolation from human/animal tissue (or other).",
         "The human induced pluripotent stem cell (hiPSC) line IMR90_clone_#4 has been bought from WiCell, Wisconsin in 2012 and a masterstock has been frozen. From the masterstock several working stocks have been prepared. The working stocks are regularly thawed and can be continously maintained due to self- renewal and pluripotency capabilities of the cells. The cells are maintained up to 10 passages before a new vial of the working stock is thawed.",
         "High",
         "The answer fully addresses the question by specifying that the cells were initially obtained from a commercial supplier (WiCell) and are continuously generated by cell culture. It provides details on the process of maintaining the cells, including the creation of master and working stocks, and the self-renewal and pluripotency capabilities that allow for continuous culture. This response is relevant and complete.",
         "The cells used in the assay are human induced pluripotent stem cells (hiPSCs) derived from a commercial supplier, WiCell, Wisconsin. They are maintained as monocultures and are continuously generated through cell culture (Source: cMINC(UKN2).pdf).",
         "0.7843962500969945",
         "0.1914535760879516",
         "0.372706264257431",
         "0.2788918316364288"
        ],
        [
         "18",
         "Give a brief overview of your biological source system, i.e. the source or starting cells that you use. Which cell type(s) are used or obtained (e.g. monoculture/co-culture, differentiation state, 2D/3D, etc.)? If relevant, give human donor specifications (e.g. sex, age, pool of 10 donors, from healthy tissue, etc.).",
         "Undifferentiated hiPSC cells (IMR90, WiCell) are maintained as monoculture on Laminin-521 coating in essential 8 (E8) medium. The cells grow in colonies, and are split weakly. The cells show self-renewal and pluripotency characteristics (regular testing). The cells can be differentiated into several different cell types.",
         "Medium",
         "The answer provides information about the cell type (undifferentiated hiPSC cells), culture conditions (monoculture on Laminin-521 in E8 medium), and characteristics (self-renewal and pluripotency). However, it lacks details on the differentiation state (beyond pluripotency), dimensionality (2D/3D), and human donor specifications such as sex, age, or health status, which are relevant to fully address the question.",
         "The assay uses human induced pluripotent stem cells (hiPSCs) as the source cells, specifically the IMR90_clone_#4 line obtained from WiCell. These undifferentiated hiPSCs are maintained as monocultures on Laminin-521 coating in essential 8 (E8) medium, growing in colonies with self-renewal and pluripotency characteristics. The cells are characterized by the expression of pluripotency markers Oct4, Nanog, and Tra-1-60, and are regularly tested for pathogen-free status, including mycoplasma. The source cells are derived from a human female lung fibroblast tissue, at 16 weeks gestation, of Caucasian ethnicity, and are used as a starting point for differentiation into neural crest cells (NCCs). The differentiation process results in a highly homogeneous population of NCCs, which are then used in the migration assay (Source: cMINC(UKN2).pdf).",
         "0.7451747093067259",
         "0.5487285256385803",
         "0.2327926009893417",
         "0.3762338757514953"
        ],
        [
         "19",
         "List quantitative and semi-quantitative features that define your cell source/starting cell population. For test methods that are based on differentiation, describe your initial cells, e.g. iPSC, proliferating SH-SY5Y; the differentiated cells are described in section 4. Define cell identity, e.g. by STR signature (where available), karyotype information, sex (where available and relevant), ATCC number, passage number, source (supplier), sub-line (where relevant), source of primary material, purity of the cells, etc. Describe defining biological features you have measured or that are FIRMLY established (use simple listing, limit to max. 0.5 pages), e.g. the cells express specific marker genes, have specific surface antigens, lack certain markers, have or lack a relevant metabolic or transporting capacity, have a doubling time of x hours, etc. Transgenic cell lines have particular requirements concerning the characterization of the genetic manipulation (type of transgene, type of vector, integration/deletion site(s), stability, etc.). Organoids and microphysiological systems (MPS) may need some special/additional considerations as detailed in Pamies et al. (2018) and Marx et al. (2016), e.g. ratio of cell types used, percent of normal cells in tumor spheroids created from resected tissue; derivation of cells for re-aggregating brain cultures.",
         "• ATCC number: CCL-186 • Origin: Homo sapiens, human • Tissue: lung • Cell type: fibroblast • Gender: female • Morphology: fibroblast • Culture properties: adherent • Disease: no disease was diagnosed • Age: 16 weeks gestation • Ethnicity: Caucasian • Expression: Cells express the pluripotency markers Oct4, nanog and Tra-1-60 Table 1. Short tandem repeat (STR) signature of cell line confirms 100% loci homology",
         "Medium",
         "The answer provides some relevant quantitative and semi-quantitative features of the cell source, such as ATCC number, origin, tissue, cell type, gender, morphology, culture properties, disease status, age, ethnicity, and expression of specific markers. However, it lacks information on other aspects like karyotype information, passage number, source of primary material, purity of the cells, and details on transgenic cell lines or organoids if applicable. The answer is partially complete but could be more comprehensive.",
         "The cell source for the assay comprises human induced pluripotent stem cells (hiPSCs) of the IMR90 line (ATCC number CCL-186), sourced from WiCell, Wisconsin. The initial cells are fibroblasts derived from a 16-week gestation female donor of Caucasian ethnicity, cultured as adherent colonies on Laminin-521 in Essential 8 (E8) medium. They are characterized by the expression of pluripotency markers Oct4, Nanog, and Tra-1-60, confirmed through immunocytochemistry and STR signature matching 100% loci homology (D5, D5', D13, D13', D7, D7', D16, D16', vWA, TH01, TPOX, CSF1, Amel X, Amel Y). The cells are pathogen-free (mycoplasma tested) and maintained up to 10 passages, with high viability (>90%) post-thawing. \n\nThe cells exhibit typical pluripotent morphology, express key pluripotency markers, and are capable of differentiation into neural crest cells (NCCs). The differentiation process involves specific protocols leading to a homogeneous population of NCCs, which are ≥90% positive for NCC markers HNK-1 and p75, and express nestin and AP2. These NCCs show functional migration behavior, invasive capacity in 3D environments, and express relevant surface antigens. The population is maintained as colonies, with controlled passage number to prevent spontaneous differentiation or variability. \n\nBiologically, the source cells are characterized by their pluripotency marker expression, STR signature, and differentiation capacity into NCCs, which are essential for the migration assay. The cells' doubling time, metabolic capacity, and surface antigen profile are consistent with their pluripotent and neural crest lineage status, ensuring reproducibility and biological relevance for the assay.",
         "0.6918297718969108",
         "0.2674421072006225",
         "0.023849943652749",
         "0.1369644701480865"
        ],
        [
         "20",
         "Describe the acceptance criteria (AC) for your initial cells (i.e. the quality criteria for your proliferating cell line, tissue for isolation, organism, etc.). Which specifications do you consider to describe the material, which quality control criteria have to be fulfilled (e.g. pathogen-free)? Which functional parameters (e.g. certain biological responses to reference substances) are important? For iPSC maintenance: How do you control pluripotency? How stable are your cells over several passages? Which passage(s) are valid? For primary cells: Show stability and identity of supply; demonstrate stability of function (e.g. xenobiotic metabolism). Quantitative definitions for AC should be given based on this defining information. Exclusion criteria (features to be absent) are also important. As in 3.3., special/additional requirements apply to genetically-modified cells and microphysiological systems.",
         "The cells have to be pathogen-free (regular testing for mycoplasma). The iPSC maintenance is regularly checked for expression of pluripotency markers (Oct4, Nanog, Tra-1-60) by immunocytochemistry. Figure 12: Immunostaining of relevant pluripotency markers in maintenance culture",
         "Medium",
         "The answer partially addresses the question by mentioning pathogen-free criteria and checking for pluripotency markers in iPSC maintenance. However, it lacks details on other aspects such as specifications for the material, functional parameters, stability over passages, valid passages, and exclusion criteria. It also does not address primary cells or genetically-modified cells and microphysiological systems.",
         "Answer not found in documents.",
         "0.0891102245524364",
         "-0.2860725820064544",
         "-0.0465665310621261",
         "-0.1774889379739761"
        ],
        [
         "21",
         "Name known causes of variability of the initial cells/source cells. Indicate critical consumables or batch effects (e.g. relevance of the plate format and supplier, batch effects of fetal calf serum (FCS) or serum replacement, critical additives like type of trypsin, apo-transferrin vs. holo-transferrin, etc.). Indicate critical handling steps and influencing factors (e.g. special care needed in pipetting, steps that need to be performed quickly, cell density, washing procedures, etc.). As in 3.3., special/additional requirements apply to genetically-modified cells and microphysiological systems, e.g. dependence on matrix chemistry and geometry, dependence on microfluidics system, consideration of surface cells vs core cells, etc. Give recommendations to increase/ensure reproducibility and performance.",
         "- hiPSC can be maintained up to 10 passages, high passage number might influence performance of cells - Too little or too high cell density leads to detachment of cells or spontaneous differentiation - If cells start to differentiate, cells should be discarded immediately - Cells have to be maintained as colonies and not as single cells. Therefore splitting should be performed as fast as possible - Batch effects of critical additives (e.g. holo-transferrin for iron supply of cells or TGF-β which maintains cell pluripotency) can lead to differentiation of cells at low passage number.",
         "Medium",
         "The answer partially addresses the question by mentioning some causes of variability such as passage number, cell density, and batch effects of critical additives. However, it lacks detail on critical consumables, handling steps, and specific recommendations for genetically-modified cells and microphysiological systems. The response could be more comprehensive and specific to fully address the question.",
         "Answer not found in documents.",
         "0.0941772805964676",
         "-0.3674789071083069",
         "-0.0596944652497768",
         "-0.2363198846578598"
        ],
        [
         "22",
         "Describe the principles of the selected differentiation protocol, including a scheme and graphical overview, indicating all phases, media, substrates, manipulation steps (medium change/re-plating, medium additives, etc.). Special/additional requirements apply to microphysiological systems and organoids: e.g. cell printing, self-aggregation/self-organisation process, interaction with the matrix, geometrical characterization (size/shape), etc.",
         "Figure 2: Differentiation scheme from hiPSCs to neural crest cells NCCs were differentiated from hiPSCs following the modified protocol of Mica et al. (2013) (https://doi.org/10.1016/j.celrep.2013.03.025). Therefore, IMR90 iPSCs were plated on Matrigel coated 6- well plates at a density of 100’000 cells/cm2 in E8 medium containing 10 μM ROCK (Rho-associated protein kinase)-inhibitor Y-27632. After one day cells reached a confluency of 80-100% and differentiation was initiated (day 0’) by a medium change to KSR medium (Knock out DMEM (Dulbecco's Modified Eagle Medium), 15% knock out serum replacement, 1% GlutaMax, 1% MEM NEAA (minimum essential medium - non-essential amino acids) solution, 50 µM 2-mercaptoethanol) supplemented with 20 ng/ml Noggin and 10 µM SB431542. From day 2 on cells were treated with 3 µM CHIR99021. Noggin and SB431542 were withdrawn at day 3 and 4, respectively. Beginning at day 4, the KSR medium was gradually replaced with N2-S medium (DMEM/F12 (Dulbecco's Modified Eagle Medium/Ham's F-12), 1.55 mg/ml glucose, 1% GlutaMax, 0.1 mg/ml apotransferin, 25 µg/ml insulin, 20 nM progesterone, 100 μM putrescine, 30 nM selenium) in 25% increments. Cells were collected at day 11, resuspended in N2-S medium supplemented with 20 ng/ml EGF (epidermal growth factor) and 20 ng/ml FGF2 (fibroblast growth factor 2) and seeded as droplets (10 µl) on poly-L-ornithine (PLO)/Laminin/Fibronectin coated 10 cm dishes. Cells were expanded by weekly splitting. From now on seeding as droplets was not necessary and medium was changed every second day. After 35-39 days, cells were cryopreserved at a concentration of 4*106 cells/ml in 90% N2-S medium and 10% dimethyl sulfoxide (DMSO) (Merck Millipore) until further use.",
         "Medium",
         "The answer provides a detailed description of the differentiation protocol, including media, substrates, and manipulation steps. However, it lacks a graphical overview and does not address special/additional requirements for microphysiological systems and organoids, such as cell printing or interaction with the matrix. The absence of a scheme or graphical representation limits the completeness of the response.",
         "The assay described, cMINC (UKN2), utilizes human neural crest cells (NCCs) derived from induced pluripotent stem cells (iPSC). The differentiation protocol from iPSCs to NCCs involves several phases, media, substrates, and manipulation steps, which are summarized below:\n\n**Differentiation Scheme and Phases:**\n\n1. **Plating of iPSCs:**  \n   - iPSCs (IMR90 clone #4) are plated on Matrigel-coated 6-well plates at a density of 100,000 cells/cm² in Essential 8 (E8) medium containing 10 μM ROCK inhibitor Y-27632 to promote survival and attachment.  \n   - Cells grow in colonies and reach 80–100% confluency within one day.\n\n2. **Initiation of Differentiation (Day 0):**  \n   - Medium is changed to KSR medium (Knockout DMEM with serum replacement, GlutaMax, NEAA, 2-mercaptoethanol).  \n   - Supplemented with 20 ng/ml Noggin and 10 μM SB431542 to promote neural crest lineage specification.  \n   - Cells are treated with these factors for 2 days.\n\n3. **Patterning and Induction (Days 2–4):**  \n   - From Day 2, cells are treated with 3 μM CHIR99021 to activate Wnt signaling, supporting NCC induction.  \n   - Noggin and SB431542 are withdrawn at Days 3 and 4, respectively.\n\n4. **Transition to N2-S Medium (Days 4–11):**  \n   - Gradual medium change from KSR to N2-S medium (a defined medium with glucose, GlutaMax, apotransferin, insulin, progesterone, putrescine, selenium).  \n   - Medium is replaced in 25% increments daily, starting at Day 4, until fully transitioned by Day 11.\n\n5. **Expansion and Seeding (Days 11–35/39):**  \n   - Cells are collected at Day 11, resuspended in N2-S medium supplemented with EGF and FGF2, and seeded as droplets (10 μl) onto poly-L-ornithine (PLO)/Laminin/Fibronectin coated dishes.  \n   - Cells are expanded by weekly splitting, with medium changes every second day.\n\n6. **Cryopreservation:**  \n   - After 35–39 days, NCCs are cryopreserved at 4×10^6 cells/ml in N2-S medium with 10% DMSO.\n\n**Substrates and Interaction with Matrix:**\n\n- The final NCCs are seeded on coated substrates: poly-L-ornithine, Laminin, and Fibronectin, which support adhesion, migration, and mimic aspects of the extracellular matrix (ECM) in vivo.\n\n**Manipulation Steps:**\n\n- **Medium Changes:**  \n  - Regular medium changes are performed during differentiation, with gradual medium transition from KSR to N2-S medium.  \n  - During expansion, medium is changed every second day.\n\n- **Cell Seeding:**  \n  - Cells are seeded as droplets on coated dishes, allowing self-aggregation and organization into a migratory monolayer.\n\n- **Cryopreservation:**  \n  - Cells are frozen at the end of differentiation for storage and subsequent use.\n\n**Special Requirements for Microphysiological Systems and Organoids:**\n\n- The protocol emphasizes the importance of cell–matrix interactions, as cells are seeded on ECM-coated substrates to facilitate adhesion and migration.  \n- For organoid or microphysiological system development, additional steps such as cell printing, self-aggregation, or self-organization may be necessary, although not explicitly detailed here.  \n- Geometrical characterization (size, shape) of cell clusters or organoids can be performed to assess uniformity and reproducibility.  \n- Interaction with the matrix is critical, as the ECM components influence cell behavior, migration, and differentiation pathways.\n\n**Graphical Overview:**\n\nWhile a visual diagram cannot be provided here, the scheme involves:\n\n- **Phase 1:** Plating iPSCs on Matrigel → Confluency (Day 1)  \n- **Phase 2:** Medium change to induction medium with Noggin/SB431542 → Days 0–2  \n- **Phase 3:** Wnt activation with CHIR99021, withdrawal of initial factors → Days 2–4  \n- **Phase 4:** Gradual medium transition to N2-S → Days 4–11  \n- **Phase 5:** Cell collection, resuspension, and seeding as droplets on coated substrates → Day 11 onward  \n- **Phase 6:** Expansion, cryopreservation, or further maturation.\n\nThis protocol ensures the generation of a homogeneous NCC population capable of migration, suitable for the in vitro assessment of developmental toxicity effects.",
         "0.8153749180158556",
         "0.0693682432174682",
         "-0.0691901221871376",
         "-0.0003346595040056"
        ],
        [
         "23",
         "Provide the SOP of the general maintenance procedure as a database link. This should also include the following information: How are the cells maintained outside the experiment (basic cell propagation)? How pure is the cell population (average, e.g. 95% of iPSC cells Oct4-positive)? What are the quality control measures and acceptance criteria for each cell batch? Which number(s) passage(s) can be used in the test? Is Good Cell Culture Practice (GCCP) and/or Good In Vitro Method Practice (GIVIMP) followed? How long can same cell batches be used? How are frozen stocks and cell banks prepared? For primary cells: how are they obtained in general and what are they characterized for (and what are inclusion and exclusion criteria).",
         "DB-ALM Protocol n° 195",
         "Low",
         "The answer only provides a reference to a protocol number without addressing any of the specific details requested in the question. It lacks information on cell maintenance, purity, quality control, passage numbers, compliance with practices, cell batch usage duration, preparation of frozen stocks, and characterization of primary cells.",
         "Answer not found in documents.",
         "0.2040911067865233",
         "-0.1394036710262298",
         "0.0018908017082139",
         "-0.0694539546966552"
        ],
        [
         "24",
         "Describe the test system as it is used in the test. If the generation of the test system involves differentiation steps or complex technical manipulation (e.g. formation of microtissues), this is described in 3.6. Give details on the general features/principles of the culture protocol (collagen embedding, 3D structuring, addition of mitotic inhibitors, addition of particular hormones/growth factors, etc.) of the cells that are used for the test. What is the percentage of contaminating cells; in co-cultures what is the percentage of each subpopulation? Are there subpopulations that are generally more sensitive to cytotoxicity than others, and could this influence viability measures? Is it known whether specific chemicals/chemical classes show differential cytotoxicity for the cell sub-populations used?",
         "A highly homogeneous pre-differentiated population of neural crest cells is added to coated wells. In the middle of the well is a silicone stopper that prevents cells from settling in a circular area in the middle of the well. The cells are kept viable and alive by the presence of EGF and FGF in the medium, and they become adherent overnight. When the stopper is removed, the cells form a dense monolayer in the culture dish, with a sharply demarcated circular area in the middle that is free of cells. Due to their natural spontaneous migration behaviour, the cells move into the cell-free area. The cells are still in a proliferative state. Proliferation at the edge of the cell free area contributes to a small extent to “apparent migration behaviour”. This has been characterized and quantified in detail (Nyffeler et al. 2016). It is accounted for by counting cells in a narrower circle than the original circular area.",
         "Medium",
         "The answer provides a detailed description of the test system, including the culture protocol and cell behavior. However, it lacks information on the percentage of contaminating cells, the percentage of each subpopulation in co-cultures, and whether specific chemicals show differential cytotoxicity for the cell sub-populations used. These omissions prevent a 'High' score.",
         "The assay uses human neural crest cells (NCCs) derived from induced pluripotent stem cells (iPSCs). The differentiation process involves several steps: starting from undifferentiated hiPSCs maintained on Laminin-521 in E8 medium, cells are plated on Matrigel-coated plates and induced to differentiate into NCCs following a modified protocol based on Mica et al. (2013). During differentiation, cells are treated with specific growth factors and signaling molecules, such as Noggin, SB431542, CHIR99021, EGF, and FGF2, over a period of approximately 35-39 days, culminating in a highly homogeneous population of NCCs.\n\nThe derived NCCs are characterized by expressing typical NCC markers (HNK-1, p75, nestin, AP2) and lack expression of markers for other cell types such as GFAP, Pax6, and βIII tubulin, indicating a predominantly NCC phenotype. The cells are maintained as a monolayer on coated surfaces (PLO/Laminin/Fibronectin) and are kept viable with growth factors (EGF and FGF2). They are cryopreserved at a concentration of 4×10^6 cells/ml in N2-S medium with DMSO until use.\n\nIn the test system, NCCs are seeded as a highly homogeneous population (>90% positive for NCC markers) into wells with a silicone stopper creating a circular cell-free zone. After attachment, the stopper is removed, allowing cells to migrate into the free area, which models in vivo NCC migration. The assay measures the impairment of migration and cell viability after exposure to test compounds.\n\nRegarding contamination and subpopulations, the NCC cultures are characterized to be ≥90% positive for NCC markers, indicating minimal contamination with other cell types. The protocol does not specify the presence of other subpopulations or their proportions, but the high purity suggests that the culture is predominantly NCCs. There is no detailed information on whether specific subpopulations within NCCs show differential sensitivity to cytotoxicity; however, since the cultures are highly homogeneous, the influence of subpopulation sensitivity on viability measures is likely minimal.\n\nAs for differential cytotoxicity among chemical classes, the document does not specify whether certain chemicals or classes preferentially affect subpopulations within NCCs. The assay primarily assesses overall migration impairment and viability of the NCC population as a whole, and the high homogeneity of the cells used reduces the likelihood of subpopulation-specific effects influencing the overall viability measures.",
         "0.6605110180921907",
         "0.2072174996137619",
         "0.0189544204622507",
         "0.1092212870717048"
        ],
        [
         "25",
         "What are the endpoint(s) that you use to control that your culture(s) is/are as expected at the start of toxicity testing (e.g. gene expression, staining, morphology, responses to reference chemicals, etc.)? Describe the acceptance criteria for your test system, i.e. the quality criteria for your cells/tissues/organoids: Which endpoints do you consider to describe the cells or other source material, which parameters are important? Describe the (analytical) methods that you use to evaluate your culture (PCR, ATP measurement) and to measure the acceptance criteria (AC). Which values (e.g. degree of differentiation or cell density) need to be reached/should not be reached? Historical controls: How does your test system perform with regard to the acceptance criteria, e.g. when differentiation is performed 10 times, what is the average and variation of the values for the acceptance criteria parameters)? Indicate actions if the AC are not met. Examples: cell are > 90% viable, or > 98% of cells express marker x (e.g. AP-2), or > 80% of the cells attach, etc.",
         "Figure 3: Characterization of the cellular system. (A) Differentiation schema of NCCs from human induced pluripotent stem cells. (B) Expression of the NCC markers HNK-1 and p75 was monitored by FACS analysis. (C) After thawing the cells were immunofluorescently labelled for the typical NCC markers p75, HNK1 and AP2. Scale bar: 50 µm. (D) Typical mesenchymal like cell morphology of NCCs. Cells were double-stained for nestin and f-actin. Scale bar: 10 µm. The derived NCCs are ≥ 90% positive for the NCC marker human natural killer-1 (HNK1) and the nerve low affinity nerve growth factor receptor p75. Additionally, the cells express the stem cell microfilament protein nestin and AP2. On the other hand, none of the cells show expression of the astrocyte marker GFAP, the central nervous system precursor cell marker Pax6 and the neuronal marker βIII tubulin. Furthermore, the functional capability of the cells is checked by performing the cMINC assay with endpoint specific controls. The cells have to be pathogen-free to be used in further experiments (regular testing for mycoplasma after thawing). After thawing the viability should be > 90%.",
         "Medium",
         "The answer provides some relevant information about the characterization of the cellular system, including markers and morphology, and mentions viability criteria. However, it lacks detailed acceptance criteria, specific analytical methods, and historical control data. It also does not specify actions if acceptance criteria are not met.",
         "Answer not found in documents.",
         "0.1396155404212514",
         "-0.4960272014141083",
         "-0.0303580984473228",
         "-0.3251430988311767"
        ],
        [
         "26",
         "Describe the acceptance criteria for your test system, i.e. the quality criteria for your cells/tissues/organoids: Which endpoints do you consider to describe the cells or other source material, which parameters are important? Which values (e.g. degree of differentiation or cell density) need to be reached/should not be reached? Historical controls: How does your test system perform with regard to the acceptance criteria, e.g. when differentiation is performed 10 times, what is the average and variation of the values for the acceptance criteria parameters)? Indicate actions if the AC are not met. Examples: Usual neurite length is 50 ±15 μm; experiments with average neurite length below 25 μm in the negative controls (NC) are discarded. Usual nestin induction is 200 ±40 fold, experiments with inductions below 80-fold for NC are discarded.",
         "After compound treatment, the negative controls should fulfil the following: - cells should be migrated into the cell free area - cell viability should be > 90%",
         "Low",
         "The answer does not adequately address the question. It provides minimal information about acceptance criteria, focusing only on cell migration and viability, without discussing endpoints, parameters, historical controls, or actions if criteria are not met. It lacks detail and completeness required to fully address the question.",
         "The acceptance criteria for the cMINC (UKN2) assay's source cells focus on ensuring the quality and consistency of the neural crest cell (NCC) population used in the test. The key endpoints and parameters include:\n\n- **Expression of NCC markers:** The cells must be ≥ 90% positive for the NCC markers HNK-1 and p75, as confirmed by FACS analysis and immunofluorescence labeling (Source: cMINC(UKN2).pdf).\n- **Pathogen-free status:** Cells must be free of pathogens, including mycoplasma, verified through regular testing (Source: cMINC(UKN2).pdf).\n- **Viability after thawing:** Viability should be > 90% immediately after thawing (Source: cMINC(UKN2).pdf).\n- **Differentiation and characterization:** The cells should express pluripotency markers (Oct4, Nanog, Tra-1-60) prior to differentiation, and after differentiation, they should exhibit typical NCC marker expression and morphology, with ≥ 90% positivity for HNK-1 and p75 (Source: cMINC(UKN2).pdf).\n\n**Historical performance and variation:**\n- The source cells are maintained up to 10 passages, with high consistency in marker expression and viability.\n- Variability between plates within a single experiment is lower than 5%, and between different experiments is lower than 20% (Source: cMINC(UKN2).pdf).\n- When differentiation is performed 10 times, the average expression of NCC markers (HNK-1 and p75) remains ≥ 90%, with a variation typically within ±5–10%. Cell viability consistently exceeds 90%.\n\n**Actions if acceptance criteria are not met:**\n- Cells showing less than 90% marker expression or viability are discarded.\n- Differentiation batches with marker expression below the threshold are not used for testing.\n- If cell morphology or marker expression indicates spontaneous differentiation or contamination, the batch is rejected and replaced.\n\nThese criteria ensure the source material's quality, reproducibility, and reliability for the migration impairment assay.",
         "0.5561523408506475",
         "0.1792346537113189",
         "-0.2403205186128616",
         "-0.0684783086180687"
        ],
        [
         "27",
         "Give known causes of variability for final test system state. Indicate critical consumables or batch effects (e.g. plate format and supplier, batch effects of FCS or serum replacement, additives). Indicate critical handling steps, and/or influencing factors identified (e.g. special care needed in pipetting, steps that need to be performed quickly, cell density). Indicate positive and negative controls and their expected values, and accepted deviation within and between the test repeats. Give recommendations to increase/ensure reproducibility and performance.",
         "Causes of variability: - High passage number of iPSC maintenance might influence NCC differentiation - Too little cell density at the start of differentiation can cause problems (confluency should be 80- 100%) - For the freeze and thaw processes a fast handling is important to avoid cells to stay at 10% DMSO for too long. This can decrease number of viable cells after thawing.",
         "Medium",
         "The answer partially addresses the question by mentioning some causes of variability such as high passage number, cell density, and handling during freeze and thaw processes. However, it lacks details on critical consumables, batch effects, specific handling steps, controls, expected values, and recommendations for reproducibility and performance.",
         "The known causes of variability for the final test system state in the cMINC (UKN2) assay include several factors related to cell maintenance, differentiation, handling, and assay execution. Critical consumables and batch effects encompass batch effects of critical additives such as holo-transferrin and TGF-β, which can influence cell differentiation and performance. Variability can also arise from differences in plate format and supplier, as well as from batch effects of fetal calf serum (FCS) or serum replacements used during cell culture.\n\nCritical handling steps and influencing factors include:\n- Maintaining cells at low passage numbers (up to 10 passages) to prevent performance decline.\n- Ensuring proper cell density at seeding (80–100% confluency) during differentiation; too low or too high density can cause detachment or spontaneous differentiation.\n- Handling of cells during thawing and freezing, where rapid processing is essential to preserve viability (>90%) and prevent DMSO toxicity.\n- Precise pipetting, especially during compound addition, as errors can lead to variability in exposure concentrations.\n- Performing medium changes and compound additions swiftly to minimize time cells spend at room temperature, which can affect cell viability and behavior.\n- Consistent coating procedures and well handling to prevent edge effects, with inner wells used for testing.\n\nPositive controls (e.g., cytochalasin D, LiCl, taxol) are expected to inhibit migration significantly, with migration reduced to ≤75% of control, and viability >90%. Negative controls (solvent DMSO, paracetamol, ASS) should show no significant inhibition, with migration >80% of control and viability >90%. Deviations beyond these thresholds (e.g., negative control decreasing migration by ≥10%) may lead to test discard.\n\nRecommendations to increase reproducibility and performance include:\n- Using well-characterized, consistent batches of critical additives and reagents.\n- Limiting cell passage number and verifying pluripotency markers regularly.\n- Standardizing cell seeding density and differentiation protocols.\n- Ensuring rapid and precise pipetting, with operator training to minimize technical variability.\n- Including internal controls in each run and monitoring their responses to detect assay drift.\n- Performing assay runs with multiple replicates and normalizing data to untreated controls.\n- Documenting all handling steps meticulously and adhering to SOPs.\n- Regularly calibrating and maintaining imaging equipment to ensure consistent image quality.\n- Conducting inter-operator training and, if possible, cross-validation between operators to reduce operator-dependent variability.",
         "0.653235214537423",
         "0.2374215871095657",
         "-0.0786594972014427",
         "0.0614935308694839"
        ],
        [
         "28",
         "What is known about endogenous metabolic capacity (CYP system (phase I); relevant conjugation reactions (phase II))? What is known about other pathways relevant to xenobiotic metabolism? What specific information is there on transporter activity?",
         "No specific information available.",
         "Low",
         "The answer does not address the question as it provides no information about the endogenous metabolic capacity, relevant pathways, or transporter activity. It simply states that no specific information is available, which does not contribute to answering the question.",
         "Answer not found in documents.",
         "0.3188048178824792",
         "0.3032091856002807",
         "0.2845627665519714",
         "0.2966619729995727"
        ],
        [
         "29",
         "Are there transcriptomics data or other omics data available that describe the test system (characterization of cells without compounds)? Briefly list and describe such data. Indicate the type of data available (e.g. RNASeq or proteomics data). Refer to data file, data base or publication.",
         "Transcriptomics data (unpublished) will become available from the originator lab (Leist) upon request.",
         "Low",
         "The answer does not provide a list or description of the available omics data, nor does it specify the type of data (e.g., RNASeq or proteomics). It only mentions that transcriptomics data will be available upon request, which does not address the question adequately.",
         "Answer not found in documents.",
         "0.1304111291782479",
         "-0.0027272182051092",
         "0.0901263654232025",
         "0.045598741620779"
        ],
        [
         "30",
         "Give information on where the test system differs from the mimicked human tissue and which gaps of analogy need to be considered.",
         "- The cells are able to migrate mostly as single cells; they show some evidence of collective migration - Cells show invasive behaviour in a 3D environment (e.g. transwell assay)",
         "Low",
         "The answer does not address the question about differences between the test system and mimicked human tissue or the gaps of analogy. It only describes cell behavior without comparing it to human tissue.",
         "Answer not found in documents.",
         "0.0918829473527212",
         "-0.1728177815675735",
         "-0.0041292561218142",
         "-0.0913514196872711"
        ],
        [
         "31",
         "Are there elements of the test system that are protected by patents or any other means?",
         "The cells are not protected by patents or any other licences.",
         "Medium",
         "The answer addresses the question regarding patent protection for the cells but does not mention other elements of the test system that might be protected by patents or other means. It lacks completeness.",
         "Answer not found in documents.",
         "0.1879438574153945",
         "0.1285031288862228",
         "0.2187772691249847",
         "0.1753157377243042"
        ],
        [
         "32",
         "Fill only if section 3 has not been answered. Provide the SOP for the general maintenance procedure as a database link. This should also include the following information: How are the cells maintained outside the experiment (basic cell propagation)? How pure is the cell population (average, e.g. 95% of iPSC cells Oct4-positive)? What are the quality control measures and acceptance criteria for each cell batch? Which number(s) passage(s) can be used in the test? Is Good Cell Culture Practice (GCCP) and/or Good In Vitro Method Practice (GIVIMP) followed? How long can same cell batches be used? How are freezing stocks and cell banks prepared? For primary cells: how are they obtained in general and what are they characterized for (and what are inclusion and exclusion criteria).",
         "Brief description is in section 3 of this file. Detailed maintenance is described in the DB-ALM SOP n° 195 available at: http://cidportal.jrc.ec.europa.eu/ftp/jrc-opendata/EURL-ECVAM/datasets/DBALM/VER2- 0/online/DBALM_docs/195_P_cMINC.pdf A lab-internal handling protocol is also available upon request to the Leist-lab.",
         "Medium",
         "The answer provides a link to a detailed SOP and mentions an internal protocol, which partially addresses the question. However, it lacks specific information on cell maintenance, purity, quality control, passage numbers, GCCP/GIVIMP compliance, cell batch usage duration, freezing stocks preparation, and primary cell characterization. The answer is incomplete and lacks clarity on several required details.",
         "Answer not found in documents.",
         "0.1657412021722263",
         "-0.4586300253868103",
         "0.0792196691036224",
         "-0.2668550312519073"
        ],
        [
         "33",
         "Provide an exposure scheme (graphically, show timelines, addition of medium supplements and compounds, sampling, etc.), within the context of the overall cell culture scheme (e.g. freshly re-plated cells or confluent cells at start, certain coatings, etc.). Include medium changes, cell re-plating, whether compounds are re-added in cases of medium change, critical medium supplements, etc.",
         "Figure 4: Exposure scheme and assay procedure. Day -1: The wells are coated with PLO/laminin/fibronectin. Then, silicone stoppers are placed into the wells of a 96-well plate. Cells are seeded around the stoppers and allowed to attach. Day 0: The silicone stoppers are removed and the medium is replaced with pre-warmed, fresh N2-S medium containing the cytokines EGF and FGF. Cells are allowed to migrate into the cell free area. Day 1: 25 µl of the 5x concentrated toxicants are added to the wells. The cells plus toxicants are incubated for 24 h. Day 2: Cells are stained with calcein-AM and Hoechst (H-33342) for 30 min before imaging with a high content imaging microscope. Quantification of migration and viability is done by high content imaging analysis.",
         "High",
         "The answer provides a detailed and clear exposure scheme, including timelines, medium changes, and the addition of supplements and compounds. It specifies the initial cell culture conditions, the use of coatings, and the procedure for medium changes and compound addition. The description of the assay procedure and sampling is comprehensive and relevant to the question.",
         "The exposure scheme for the cMINC (UKN2) assay is integrated into the overall cell culture process as follows:\n\n- **Day -1:** Coating of wells with PLO/laminin/fibronectin, placement of silicone stoppers in 96-well plates, and seeding of neural crest cells (NCCs) around the stoppers. Cells are allowed to attach overnight.\n\n- **Day 0:** Removal of silicone stoppers to create a cell-free zone. The medium is replaced with pre-warmed N2-S medium containing EGF and FGF to promote cell viability and migration. Cells are allowed to adhere and start migrating into the free zone.\n\n- **Day 1:** Addition of test compounds (toxicants) at specified concentrations (25 µl of 5x concentrated solutions). The compounds are present during the 24-hour incubation period, allowing assessment of migration inhibition and viability.\n\n- **Day 2:** Post-exposure, cells are stained with calcein-AM and Hoechst 33342 for 30 minutes. Imaging is performed to quantify migration and viability.\n\n**Additional details:**\n\n- **Medium changes:** The medium is replaced at Day 0 after initial cell attachment and at the start of the migration phase. During the compound exposure (Day 1), no medium change occurs; compounds are added directly to the existing medium.\n\n- **Compound re-addition:** Compounds are only added once at Day 1; they are not re-added after medium changes, as the exposure duration is 24 hours.\n\n- **Critical medium supplements:** EGF and FGF are maintained in the medium throughout the migration phase to sustain cell viability and migration capacity.\n\n- **Cell culture context:** Cells are freshly seeded around the silicone stoppers on Day -1, ensuring they are in a proliferative, migratory state at the start of exposure. The assay duration from Day 0 to Day 2 is 24 hours of compound exposure.\n\nThis scheme ensures that the cells are in optimal conditions for migration during the exposure period, with compounds present throughout the critical migration window, and medium supplemented with necessary growth factors.",
         "0.8063022638028429",
         "0.4278606176376343",
         "0.1050155758857727",
         "0.2500127851963043"
        ],
        [
         "34",
         "Define the specific endpoint(s) of the test system that you use for toxicity testing (e.g. cytotoxicity, cell migration, etc.). Indicate whether cytotoxicity is the primary endpoint. What are secondary/further endpoints? Also describe here potential reference/normalization endpoints (e.g. cytotoxicity, protein content, housekeeping gene expression) that are used for normalization of the primary endpoint.",
         "Specific Endpoint: Migration inhibition Reference endpoint: Cell viability Note: Migration induction is also possible to assess, but complex in its toxicological interpretation. Therefore only unidirectional migration is assessed as an endpoint if the method is used in a standardized testing procedure in the prediction model.",
         "Medium",
         "The answer partially addresses the question by identifying migration inhibition as a specific endpoint and cell viability as a reference endpoint. However, it lacks clarity and completeness as it does not explicitly state whether cytotoxicity is the primary endpoint, nor does it mention any secondary endpoints or further reference/normalization endpoints beyond cell viability.",
         "The specific endpoint of the assay is migration inhibition of human neural crest cells (NCCs). Cell migration is the primary endpoint used for toxicity testing in this system. Cell viability is measured as a secondary endpoint to assess cytotoxicity and is used for normalization purposes. The assay quantifies the number of migrated NCCs into the cell-free zone after exposure to potential toxicants, with migration inhibition being the main focus. Cell viability is also measured to ensure that observed migration effects are not solely due to cytotoxicity, and it serves as a reference or normalization endpoint to interpret migration data accurately (Source: cMINC(UKN2).pdf).",
         "0.7786172728061955",
         "0.1705653965473175",
         "0.0301336105912923",
         "0.0997917056083679"
        ],
        [
         "35",
         "Define and describe the principle(s) of the analytical methods used. Provide here a general overview of the method’s key steps (e.g. cells are fixed or not, homogenized sample or not, etc.), sufficient for reviewers/regulators to understand what was done, but not in all detail for direct repetition. If you have two or more endpoints (e.g. viability and neurite outgrowth), do you measure both in the same well, under same conditions in parallel, or independently of each other? For imaging endpoints: Explain in general how quantification algorithm or how semi-quantitative estimates are obtained and how many cells are imaged (roughly).",
         "Migration inhibition: NCCs are plated around silicone stoppers in a culture dish and are allowed to migrate into the cell free area upon removal of the stopper. The number of migrated cells into the cell free zone is quantified 24 h after toxicant treatment. Migration inhibition of NCCs after treatment with toxicants is measured relative to control conditions (solvent control cells). For the quantification the cells are stained with calcein-AM and H-33342 for 30 min at 37 °C. The center of the well (migration zone) is imaged in four tiles with a 5x objective. Afterwards the four images are stitched together to obtain one image. For migration quantification, a software tool has been developed (http://invitrotox.uni-konstanz.de/). With the help of this software the previously cell-free area can be estimated and the number of H-33342 and calcein double-positive cells in the region of interest (ROI) can be counted. The diameter of the ROI was chosen so that 150 to 300 cells were in the ROI in untreated conditions. An Excel table containing the number of viable cells in the ROI of all wells of the plate is generated by the software. Cell viability: Cell viability is measured after 48 h outside the migration zone in the same well. The cells are stained with calcein-AM and H-33342 and four fields outside the migration zone are imaged with a 10x objective. Viability is defined as the number of H-33342 and calcein double-positive cells, viable cells are determined by an automated algorithm. An excel file is generated with the number of viable cells in each well. Migration and Viability are normalized to untreated controls.",
         "High",
         "The answer provides a comprehensive overview of the analytical methods used, including the key steps involved in the migration inhibition and cell viability assays. It describes the plating and imaging process, the staining procedure, and the software used for quantification. The explanation includes how endpoints are measured, both in the same well and under different conditions, and details the imaging and quantification process. This level of detail is sufficient for reviewers to understand the methodology without being able to directly replicate it, which aligns well with the requirements of the question.",
         "The assay employs high content imaging to assess two key endpoints: migration inhibition and cell viability, in human neural crest cells (NCCs). The process involves staining the cells with calcein-AM (for live cells) and Hoechst 33342 (for nuclei), followed by automated imaging. The cells are not fixed; live-cell dyes are used to enable real-time assessment of viability and migration behavior.\n\nFor the migration endpoint, NCCs are seeded around a silicone stopper in a well, allowed to adhere, and then the stopper is removed to create a cell-free zone. Cells migrate into this zone over 24 hours. After exposure to test compounds, the cells are stained with calcein-AM and Hoechst 33342, and images are acquired in four tiles per well using a high content imaging system. The quantification algorithm estimates the previously cell-free area and counts the number of double-positive (calcein and Hoechst) cells within a defined region of interest (ROI). Typically, 150–300 cells are imaged per ROI, and the software automatically counts viable cells based on fluorescence signals.\n\nCell viability is measured in the same wells, outside the migration zone, by imaging four fields per well with a 10x objective. The same fluorescent dyes are used, and automated algorithms determine the number of double-positive cells, representing viable nuclei. Both endpoints are measured under the same conditions and in parallel within the same well, allowing direct comparison of migration and viability data.\n\nThe quantification relies on automated image analysis software that estimates the number of viable cells based on fluorescence intensity and cell morphology, providing semi-quantitative counts. The software calculates the number of double-positive cells in the ROI, enabling objective and reproducible measurement of migration and viability.",
         "0.8323899274357207",
         "0.3053684830665588",
         "0.2706019878387451",
         "0.2906288802623749"
        ],
        [
         "36",
         "Provide information on machine settings, analytical standards, data processing and normalization procedures. For imaging endpoints: provide detailed algorithm. This information should also be covered in an SOP, preferably in DB-ALM format (see link in 6.6).",
         "Quantification of migration An automated microplate reading microscope (Array-ScanII HCS Reader, Cellomics, PA) equipped with a Hamamatsu ORCA-ER camera (resolution 1024 x 1024; run at 2 x 2 binning) was used for image acquisition. Four fields per well were imaged. Images were recorded in 2 channels using a 5x objective and excitation/emission wavelengths of 365 ± 50/535 ± 45 to detect H-33342 in channel 1 and 474 ± 40/535 ± 45 to detect calcein in channel 2. Pictures were exported from the microscope and for migration quantification, a software tool has been developed (http://invitrotox.uni-konstanz.de/). With the help of this software the previously cell-free area can be estimated and the number of H-33342 and calcein double-positive cells in the region of interest (ROI) can be counted. The diameter of the ROI was chosen so that 150 to 300 cells were in the ROI in untreated conditions. An Excel table containing the number of viable cells in the ROI of all wells of the plate is generated by the software. Quantification of individual viable cells by imaging For a quantitative assessment of viable cells, the same wells that were used to assess migration were analyzed using another image analysis algorithm of the ArrayScan VTI 700 Series software (v. 7.6.2.4) as described earlier in Stiegler et al. (2011) (doi: 10.1093/toxsci/kfr034) and Krug et al. (2013) (doi: 10.1007/s00204-013-1072-y). Nuclei were identified in channel 1 as objects according to their size, area, shape, and intensity. Nuclei of apoptotic cells with increased fluorescence were excluded. Viable nuclei were defined as H-33342 and calcein double-positive cells. An Excel table containing the number of viable cells is generated.",
         "Medium",
         "The answer provides detailed information on machine settings, imaging endpoints, and some data processing procedures, including the use of specific software and algorithms for image analysis. However, it lacks information on analytical standards, data normalization procedures, and does not mention an SOP or the DB-ALM format as requested. The response is partially complete but lacks clarity and completeness in addressing all aspects of the question.",
         "Answer not found in documents.",
         "0.1556087337535995",
         "-0.5698603987693787",
         "-0.1125947684049606",
         "-0.4073907434940338"
        ],
        [
         "37",
         "MCC are chemicals/manipulations that show biologically plausible changes of the endpoint. List such controls (up to 10), indicate why you consider them as MCC, and describe expected data on such controls. Highlight the compounds to be used for testing day-to-day test performance, i.e. for setting acceptance criteria (AC). If available, indicate MCC that each increase or decrease the activity of the relevant pathway. Do pathway inhibitions or activations correlate with the test method response?",
         "Example 1: Cell migration requires dynamic variability of the cytoskeleton, e.g. actin reorganisation. Cytochalasin D is a known inhibitor of actin polymerisation and therefore inhibits cell migration at non-cytotoxic concentrations. Example 2: Migration depends on the dynamic instability of microtubules in the leading edge of a migrating cell. Taxol inhibits breakdown of microtubules and leads to migration inhibition at non-cytotoxic concentrations.",
         "Medium",
         "The answer provides examples of chemicals (Cytochalasin D and Taxol) that affect cell migration, explaining their mechanisms of action. However, it does not list up to 10 controls, lacks a description of expected data, does not highlight compounds for setting acceptance criteria, and does not address whether pathway inhibitions or activations correlate with the test method response.",
         "Answer not found in documents.",
         "0.1129252798311988",
         "-0.3817243576049804",
         "-0.1178715154528617",
         "-0.2659723460674286"
        ],
        [
         "38",
         "What chemicals/manipulations are used as positive controls? Describe the expected data on such controls (signal and its uncertainty)? How good are in vivo reference data on the positive controls? Are in vivo relevant threshold concentrations known?",
         "Positive control: Cytochalasin D (200 nM), LiCl (10 mM), taxol (10 nM)",
         "Low",
         "The answer lists chemicals used as positive controls but does not describe the expected data on these controls, such as signal and its uncertainty. It also does not address the quality of in vivo reference data or whether in vivo relevant threshold concentrations are known.",
         "The positive controls used in the cMINC (UKN2) assay include cytochalasin D (200 nM), LiCl (10 mM), and taxol (10 nM). These compounds are known to inhibit cell migration through different mechanisms: cytochalasin D inhibits actin polymerization, and taxol stabilizes microtubules, both leading to migration inhibition. The expected data on these positive controls should show a significant inhibition of NCC migration, with the cell number in the migration zone reduced to less than 75% of control levels, and cell viability remaining above 90%. The variability of the positive control response across different assay runs has an average coefficient of variation of about 50%, indicating some degree of uncertainty but generally consistent inhibition effects (Source: cMINC(UKN2).pdf).\n\nRegarding in vivo reference data, the document states that the in vivo relevance of the positive controls has not been formally validated, and no specific threshold concentrations are provided. The assay's prediction model and validation focus primarily on in vitro data, and while the positive controls are well-characterized mechanistically, their in vivo thresholds for developmental neurotoxicity or migration impairment are not explicitly known or established.",
         "0.715292398302983",
         "0.5444532632827759",
         "-0.1594725400209427",
         "0.0981311947107315"
        ],
        [
         "39",
         "What chemicals/manipulations are used as negative controls? Describe the expected data on such controls (signal and its uncertainty)? (Such data define the background noise of the test method) What is the rationale for the concentration setting of negative controls? Do you use unspecific controls? If yes, indicate the compounds and the respective rationale for their use and the concentration selection.",
         "Negative control: solvent (0.1% DMSO final concentration), paracetamol, ASS",
         "Low",
         "The answer lists some chemicals used as negative controls but does not describe the expected data on these controls, the rationale for concentration settings, or whether unspecific controls are used. It lacks completeness and clarity in addressing the question.",
         "The negative controls used in the assay include solvent (0.1% DMSO), paracetamol, and ASS (unspecified in detail). The expected data for these negative controls should show normal migration of NCCs into the cell-free area and viability greater than 90%, with minimal variation, typically within a 6% coefficient of variation for intra-experimental baseline (Source: cMINC(UKN2).pdf). These controls establish the background signal and noise level of the test method, providing a reference for detecting significant migration inhibition or toxicity.\n\nThe rationale for the concentration setting of negative controls is to use the solvent at the highest concentration used in test conditions (0.1% DMSO) to ensure that the solvent itself does not interfere with cell migration or viability. This concentration is chosen because it is generally considered non-toxic and non-inhibitory to cell migration, serving as a baseline for comparison.\n\nYes, the assay also employs unspecific controls, such as cytarabine (AraC), aphidicolin, MG-132, staurosporine, and triton X-100. These compounds are used at concentrations known to induce toxicity or inhibit cell functions nonspecifically, to assess the assay's response to general cytotoxic effects and to distinguish specific migration inhibition from general toxicity. The concentrations for these controls are selected based on prior knowledge of their toxicological profiles to produce measurable effects without causing excessive cell death, thus helping to define the assay's dynamic range and background noise (Source: cMINC(UKN2).pdf).",
         "0.6943547222429032",
         "0.3113435804843902",
         "-0.2674206495285034",
         "-0.0503682866692543"
        ],
        [
         "40",
         "Does the test system have a particular apoptosis sensitivity or resistance? Is cytotoxicity hard to capture for minor cellular subpopulations? In multicellular systems, which cell population is the most sensitive? Are specific markers known for each cell population? Are there issues with distinguishing slowed proliferation from cell death? For repeated/prolonged dosing: Is early death and compensatory growth considered? For very short-term endpoints (e.g. electrophysiology measured 30 min after toxicant exposure): Is a delayed measure of cytotoxicity provided?",
         "Cells still proliferate after thawing and proliferation can interfere with the migration result. About 30% of the cells undergo mitosis during the assay.",
         "Low",
         "The answer does not address the specific questions about apoptosis sensitivity, cytotoxicity in minor subpopulations, sensitivity of cell populations, specific markers, distinguishing proliferation from cell death, early death and compensatory growth, or delayed measures of cytotoxicity. It only mentions cell proliferation and mitosis, which are not directly relevant to the questions asked.",
         "Answer not found in documents.",
         "0.0915356012576384",
         "-0.1328837871551513",
         "0.0515809617936611",
         "-0.044734563678503"
        ],
        [
         "41",
         "Which rule do you apply to test whether a test run is within the normal performance frame? How do you document this decision? Indicate actions if the AC are not met.",
         "A test is discarded if the positive control did not inhibit migration, e.g. if the cell number in the migration zone is ≥ 75% of control. If the negative control decreases migration ≥ 10%, the test is discarded.",
         "Medium",
         "The answer partially addresses the question by specifying rules for discarding a test based on control performance. However, it lacks clarity on how the decision is documented and does not explicitly indicate actions if acceptance criteria (AC) are not met beyond discarding the test.",
         "Answer not found in documents.",
         "0.1641426692299568",
         "-0.3172697722911834",
         "-0.0354819968342781",
         "-0.1938329935073852"
        ],
        [
         "42",
         "Indicate 'real data points per month' (not per week/per quarter, etc.): count three working weeks per month. Each concentration is a data point. Necessary controls that are required for calibration and for acceptability criteria are NOT counted as data points. All technical replicates of one condition are counted as one single data point (see notes for explanation) Indicate possibility/extent of repeated measures (over time) from same dish. Explain your estimate.",
         "Data point = one biological replicate (→ usually 4 technical replicates); each concentration/condition of a compound counts as a data point. 768 data points per month 2 compounds per plate, 6 different concentrations of each compound per plate (see figure 6) → 12 data points (1 plate) 16 plates can be done per week → correlates to 32 compounds → 192 data points per week 4 weeks per month → 768 data points per month. Figure 6: A typical 96-well plate layout of the cMINC",
         "Medium",
         "The answer provides a detailed calculation of data points per month, including the number of compounds, concentrations, and plates per week. However, it does not address the possibility or extent of repeated measures from the same dish, which is part of the question. This omission affects the completeness of the response.",
         "The assay has a throughput estimate of 768 data points per month, based on 16 plates per week, with each plate containing 2 compounds at 6 concentrations each (total 12 data points per plate). Since three working weeks are considered per month, this results in approximately 768 data points per month. \n\nEach concentration per condition is counted as one data point, and controls used for calibration and acceptability are not included in this count. All technical replicates for a given condition are consolidated into a single data point, meaning multiple replicates do not increase the data point count.\n\nRegarding repeated measures over time from the same dish, the protocol involves a single measurement after 24 hours of exposure, with no indication of repeated measures from the same dish over time. The assay is designed for a single endpoint measurement per exposure, so repeated measures from the same dish are not part of the standard procedure. Any estimate of repeated measures would be speculative and is not supported by the provided protocol.",
         "0.7901623500644862",
         "0.260970264673233",
         "0.0321995355188846",
         "0.1393391638994217"
        ],
        [
         "43",
         "Give an overview of the range of volumes, particular lab ware/instruments for dispensing, temperature/lighting considerations, particular media/buffers for dilution, decision rules for the solvent, tests of solubility as stocks and in culture medium, etc. How are compound stocks prepared (fold concentration, verification, storage, etc.)? How are dilutions prepared? What solvent is used? Is filtering used to obtain sterility? How does the final addition to the test system take place? Give details of addition of test compounds to test systems (e.g. in which compartment of compartmentalized cultures, in which volume, before after or during medium change, etc.).",
         "- Compounds are stored according to the manufacturer’s instructions (e.g., 4°C, room temperature, -20°C). - Preferable solvent is DMSO. The used DMSO is stored in a lightproof, air-tight bottle at room temperature. - Final DMSO concentration on the cells is 0.1% - After dissolving the compounds which are delivered in a solid/powder form, all compound solutions are aliquoted into volumes sufficient for one experiment (i.e., one biological replicate). In this way repeated freezing and thawing and therefore damaging the compound’s stability and efficiency can be avoided. - For conducting an experiment, a compound aliquot is thawed and diluted with ‘DMEM/F12 Advanced’ without supplements in a separate deepwell-plate. - All compound dilutions in the master plate contain 0.5 % DMSO, so that a final concentration of 0.1 % DMSO is reached on the cells. The highest compound concentration is diluted with medium 1:200 without DMSO as 0.5 % is already reached with the DMSO the compound is solved in, the serial dilution is done with N2-S medium supplemented with 20 ng/ml EGF and FGF and 0.5 % DMSO. - 25 µl of the 5x concentrated compound dilutions are added to the cells using a multichannel pipette.",
         "Medium",
         "The answer provides some relevant details about solvent choice, storage conditions, and dilution preparation, but lacks comprehensive information on the range of volumes, specific lab ware/instruments, temperature/lighting considerations, and tests of solubility. It also does not fully address the decision rules for the solvent, filtering for sterility, or detailed procedures for adding test compounds to test systems.",
         "Answer not found in documents.",
         "0.1691844664445733",
         "-0.4938696324825287",
         "-0.0733109265565872",
         "-0.3345308899879455"
        ],
        [
         "44",
         "How are day-to-day procedures documented (type of ‘lab book’ organisation, templates)? Define lab-specific procedures used for each practical experiment on how to calculate test compound concentrations (and to document this). How are plate maps defined and reported? Detailed information should also be covered in an SOP, preferably in DB-ALM format (see link in 6.6).",
         "Plate maps are defined prior to the experiment and documented in the lab book and files (Excel files) are stored on the work group server. Concentrations and compound dilutions are calculated prior to the experiment. Experimental procedures are noted manually in a paper lab book.",
         "Medium",
         "The answer partially addresses the question by mentioning the documentation of plate maps and the calculation of concentrations and dilutions. However, it lacks details on lab-specific procedures, the type of lab book organization, and does not mention the use of templates or SOPs in DB-ALM format. The response is incomplete and lacks clarity on several aspects of the question.",
         "Answer not found in documents.",
         "0.1673570700280981",
         "-0.190487265586853",
         "-0.0011729116085916",
         "-0.1006243601441383"
        ],
        [
         "45",
         "How is the time plan of pipetting established, followed, and documented? How is adherence to plate maps during pipetting documented? What are the routine procedures to document intermediate steps with potential errors, mistakes and uncertainties? How are errors documented (e.g. pipetting twice in one well)? How are the plate wells used sequentially – following which pattern? Detailed information should also be included in an SOP, preferably in DB-ALM format (see link in 6.6).",
         "The experimenter plans the experiment according to Cellomics microscope availability (has to be booked in advance). Pipetting errors are marked directly on the plate maps and are documented in the lab book. The paper lab book is taken to cell culture rooms and errors are documented in there right away. The technical replicates were pipetted from left to right. The highest concentration is located at the top row.",
         "Medium",
         "The answer partially addresses the question by mentioning the documentation of pipetting errors on plate maps and in a lab book, and describes the pattern of pipetting (left to right, highest concentration at the top row). However, it lacks details on the time plan of pipetting, routine procedures for documenting intermediate steps, and does not mention adherence to an SOP or the DB-ALM format. The response is incomplete and lacks clarity on several aspects of the question.",
         "Answer not found in documents.",
         "0.1354475557674951",
         "-0.2013079077005386",
         "0.0831191316246986",
         "-0.0748160630464553"
        ],
        [
         "46",
         "How is the concentration range of test compounds defined (e.g. only single concentrations, always 1:10 serial dilutions or variable dilution factors, ten different concentrations, etc.)? Is there a rule for defining starting dilutions? For functional endpoints that may not provide full concentration-response, how is the test concentration defined? E.g. EC10 of viability data are usually tested for gene expression endpoints. Detailed information should also be included in an SOP, preferably in DB-ALM format (see link in 6.6).",
         "2 compounds per plate with 6 concentrations. As default a serial dilution 1:3 is used, i.e., a concentration range from e.g. 100 µM → 0.4 µM. Serial dilutions of compounds are prepared in a separate deepwell-plate, from which 25 µl are transferred to the according plates with attached cells using a multichannel-multistepper pipette. N2-S medium supplemented with 20 ng/ml EGF and FGF is used for dilution. Dilution steps can be adapted to be more narrow (e.g., 1:1.5)",
         "Medium",
         "The answer provides information on the concentration range and dilution method (1:3 serial dilution), but it lacks details on rules for defining starting dilutions and how test concentrations are defined for functional endpoints that may not provide full concentration-response. It also does not mention any SOP or DB-ALM format documentation.",
         "The assay employs a serial dilution scheme for test compounds, typically using a 1:3 dilution factor, resulting in a concentration range from a high starting concentration (e.g., 100 µM) down to a low concentration (e.g., 0.4 µM). The serial dilutions are prepared in a separate deepwell plate, with 25 µl transferred to the assay plates, ensuring a consistent and reproducible concentration gradient (Source: cMINC(UKN2).pdf). The highest concentration is chosen based on the solubility and cytotoxicity considerations of the compound, and the serial dilution is performed to generate a concentration-response curve.\n\nRegarding the rule for defining starting dilutions, the protocol recommends a serial dilution starting from a concentration that is sufficiently high to observe potential effects without causing non-specific toxicity, with a typical dilution factor of 1:3. The exact starting concentration can be adapted depending on the compound's solubility and known activity.\n\nFor endpoints that may not produce a full concentration-response curve, such as gene expression or other mechanistic endpoints, the test concentration is often selected based on the EC10 or EC25 values derived from viability or migration data. These concentrations are used to assess specific mechanistic effects, and the assay can include testing at these biologically relevant concentrations to better understand the compound's effect at sub-toxic levels (Source: cMINC(UKN2).pdf).\n\nDetailed SOPs, including the rules for selecting test concentrations and serial dilution procedures, are available in the DB-ALM protocol n° 195, which provides comprehensive guidance on compound preparation, dilution schemes, and concentration selection criteria (Source: cMINC(UKN2).pdf).",
         "0.7756825226086875",
         "0.3668257892131805",
         "0.0484951585531234",
         "0.1911445409059524"
        ],
        [
         "47",
         "What types of compounds are problematic, e.g. interference with analytical endpoint, low solubility, precipitation of medium components, etc.? What experimental variables are hard to control (e.g. because they are fluorescent)? What are critical handling steps during the execution of the assay? Robustness issues, e.g. known variations of test performance due to operator training, season, use of certain consumable or unknown causes, etc. Describe known pitfalls (or potential operator mistakes).",
         "• Compound solubility in stock and during dilution is too low (stock solved in 100% DMSO, final concentration of the solvent on the cells is 0.1% DMSO) • Some compounds show autofluorescence and interfere with the detection of calcein-AM or H- 33342. • To prevent negative edge effects, only the inner 60 wells of a 96-well plate are used and the edge wells were filled with PBS. • Focusing failure of Array Scan VTI HCS Reader (Cellomics, PA) can be a problem that produces outliers; as well as imaging only one channel. • Highly trained/automated handling with multichannel and multistepper pipette is necessary to achieve little variance. • Different cell batches vary in the cell number due to freezing conditions and the differing proliferation rates of the lots. The variation between the plates of one experiment is lower than 5% and the variation between different experiments is lower than 20%. The results were always normalized to untreated controls. • Operators can get trained within 2-4 weeks. Cell seeding and medium change should be performed as fast as possible to keep cells as short as possible at room temperature. The more practice an operator has, the faster the critical steps can be performed. • Substances are added when pipette tips are touching the wall of the wells right above the medium surface. When the substance solution is pipetted too high above the medium surface, the droplet may just stick to the wall of the well without flowing down into the medium.",
         "High",
         "The answer comprehensively addresses the question by identifying problematic compounds (e.g., low solubility, autofluorescence), experimental variables (e.g., focusing failure), critical handling steps (e.g., pipetting technique, cell seeding), and robustness issues (e.g., operator training, cell batch variability). It also describes known pitfalls and potential operator mistakes, providing a complete and relevant response.",
         "Answer not found in documents.",
         "0.1378140960046533",
         "-0.4056740701198578",
         "0.0380511358380317",
         "-0.2344651222229004"
        ],
        [
         "48",
         "Ideally the SOP follows the DB-ALM or a comparable format: https://ecvam-dbalm.jrc.ec.europa.eu/home/contribute Refer to additional file(s) (containing information covered in sections 3 and 4), containing all details and explanations. Has the SOP been deposited in an accessible data base? Has the SOP been reviewed externally and if yes, how?",
         "Protocol no 195 in DB-ALM data base http://cidportal.jrc.ec.europa.eu/ftp/jrc-opendata/EURL-ECVAM/datasets/DBALM/VER2- 0/online/DBALM_docs/195_P_cMINC.pdf Updated SOP can be made available by laboratory upon request: marcel.leist@uni-konstanz.de",
         "Medium",
         "The answer provides a link to the protocol in the DB-ALM database, indicating that the SOP is deposited in an accessible database. However, it does not address whether the SOP has been reviewed externally, which is part of the question. The answer is partially complete but lacks information on external review.",
         "Answer not found in documents.",
         "0.1967934226007274",
         "-0.4617649018764496",
         "0.0839835107326507",
         "-0.2683880925178528"
        ],
        [
         "49",
         "Does the method require specialized instrumentation that is not found in standard laboratories? Is there a need for custom-made instrumentation or material? Is there a need for equipment that is not commercially available (anymore)?",
         "- The method requires a Cellomics Array Scan VTI HCS high content reader that may not be present in the standard lab. (Alternative automated microscopes and software tools to perform migration assays exist and the method might be transferred in the future) - Silicone stoppers (Platypus Technologies, Madison, WI, US).",
         "High",
         "The answer fully addresses the question by specifying the need for a specialized instrument (Cellomics Array Scan VTI HCS high content reader) that may not be found in standard laboratories. It also mentions the requirement for specific materials (Silicone stoppers from Platypus Technologies), indicating potential custom or non-standard needs. The answer is relevant and complete.",
         "Yes, the method requires specialized instrumentation that may not be available in standard laboratories. Specifically, it requires a Cellomics Array Scan VTI high content reader (Cellomics, PA) for image acquisition and analysis. Additionally, silicone stoppers are used as part of the assay setup. These instruments and materials are commercially available but are specialized equipment not typically found in standard labs, and the Array Scan VTI HCS high content reader may not be present in all laboratories (Source: cMINC(UKN2).pdf).",
         "0.7814715479411318",
         "0.3117051124572754",
         "0.2403111308813095",
         "0.2779835760593414"
        ]
       ],
       "shape": {
        "columns": 9,
        "rows": 77
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>question</th>\n",
       "      <th>gtruth_answer</th>\n",
       "      <th>gtruth_answer_quality_score</th>\n",
       "      <th>gtruth_answer_quality_justification</th>\n",
       "      <th>llm_answer</th>\n",
       "      <th>cos_similarity</th>\n",
       "      <th>bert_precision</th>\n",
       "      <th>bert_recall</th>\n",
       "      <th>bert_f1</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Provide a descriptive title using normal langu...</td>\n",
       "      <td>Assay to test impairment of migration of human...</td>\n",
       "      <td>Medium</td>\n",
       "      <td>The answer partially addresses the question by...</td>\n",
       "      <td>Answer not found in documents.</td>\n",
       "      <td>0.138902</td>\n",
       "      <td>-0.278100</td>\n",
       "      <td>-0.013682</td>\n",
       "      <td>-0.160179</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Please describe in no more than 200 words the ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Answer not found in documents.</td>\n",
       "      <td>0.147642</td>\n",
       "      <td>-1.069993</td>\n",
       "      <td>-1.070517</td>\n",
       "      <td>-1.061937</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Which toxicological target (organ, tissue, phy...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Low</td>\n",
       "      <td>No answer provided; treated as missing.</td>\n",
       "      <td>The assay models the impairment of neural cres...</td>\n",
       "      <td>0.020093</td>\n",
       "      <td>-1.069993</td>\n",
       "      <td>-1.070517</td>\n",
       "      <td>-1.061937</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Which test system and readout(s) are used? (4....</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Low</td>\n",
       "      <td>No answer provided; treated as missing.</td>\n",
       "      <td>The test system used in the assay consists of ...</td>\n",
       "      <td>0.028660</td>\n",
       "      <td>-1.069993</td>\n",
       "      <td>-1.070517</td>\n",
       "      <td>-1.061937</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Which biological process(es) (e.g. neurite out...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Low</td>\n",
       "      <td>No answer provided; treated as missing.</td>\n",
       "      <td>The assay models the impairment of neural cres...</td>\n",
       "      <td>0.018484</td>\n",
       "      <td>-1.069993</td>\n",
       "      <td>-1.070517</td>\n",
       "      <td>-1.061937</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>72</th>\n",
       "      <td>Has the test system been transferred to other ...</td>\n",
       "      <td>The assay hasn’t been transferred or applied i...</td>\n",
       "      <td>Low</td>\n",
       "      <td>The answer does not address the majority of th...</td>\n",
       "      <td>Answer not found in documents.</td>\n",
       "      <td>0.189700</td>\n",
       "      <td>0.177304</td>\n",
       "      <td>0.217136</td>\n",
       "      <td>0.200128</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>73</th>\n",
       "      <td>Are there special legal requirements for runni...</td>\n",
       "      <td>No specific requirements.</td>\n",
       "      <td>Low</td>\n",
       "      <td>The answer is too brief and lacks detail. It d...</td>\n",
       "      <td>Answer not found in documents.</td>\n",
       "      <td>0.194032</td>\n",
       "      <td>0.259338</td>\n",
       "      <td>0.114473</td>\n",
       "      <td>0.186037</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>74</th>\n",
       "      <td>Are the SDSs for all hazardous reagents used i...</td>\n",
       "      <td>SDS are available in the university of Konstan...</td>\n",
       "      <td>Low</td>\n",
       "      <td>The answer only partially addresses the availa...</td>\n",
       "      <td>Answer not found in documents.</td>\n",
       "      <td>0.178659</td>\n",
       "      <td>-0.166175</td>\n",
       "      <td>0.148642</td>\n",
       "      <td>-0.028020</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75</th>\n",
       "      <td>Are special permits (e.g. genetic work, stem c...</td>\n",
       "      <td>Work requires S1 cell culture laboratories (ge...</td>\n",
       "      <td>Medium</td>\n",
       "      <td>The answer partially addresses the question by...</td>\n",
       "      <td>Answer not found in documents.</td>\n",
       "      <td>0.114859</td>\n",
       "      <td>-0.126483</td>\n",
       "      <td>0.071457</td>\n",
       "      <td>-0.032778</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>76</th>\n",
       "      <td>List elements of the test method (e.g. consuma...</td>\n",
       "      <td>To our best knowledge, no elements needed to c...</td>\n",
       "      <td>High</td>\n",
       "      <td>The answer fully addresses the question by sta...</td>\n",
       "      <td>The elements of the test method are not protec...</td>\n",
       "      <td>0.617420</td>\n",
       "      <td>0.111207</td>\n",
       "      <td>0.198983</td>\n",
       "      <td>0.156911</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>77 rows × 9 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                             question  \\\n",
       "0   Provide a descriptive title using normal langu...   \n",
       "1   Please describe in no more than 200 words the ...   \n",
       "2   Which toxicological target (organ, tissue, phy...   \n",
       "3   Which test system and readout(s) are used? (4....   \n",
       "4   Which biological process(es) (e.g. neurite out...   \n",
       "..                                                ...   \n",
       "72  Has the test system been transferred to other ...   \n",
       "73  Are there special legal requirements for runni...   \n",
       "74  Are the SDSs for all hazardous reagents used i...   \n",
       "75  Are special permits (e.g. genetic work, stem c...   \n",
       "76  List elements of the test method (e.g. consuma...   \n",
       "\n",
       "                                        gtruth_answer  \\\n",
       "0   Assay to test impairment of migration of human...   \n",
       "1                                                 NaN   \n",
       "2                                                 NaN   \n",
       "3                                                 NaN   \n",
       "4                                                 NaN   \n",
       "..                                                ...   \n",
       "72  The assay hasn’t been transferred or applied i...   \n",
       "73                          No specific requirements.   \n",
       "74  SDS are available in the university of Konstan...   \n",
       "75  Work requires S1 cell culture laboratories (ge...   \n",
       "76  To our best knowledge, no elements needed to c...   \n",
       "\n",
       "   gtruth_answer_quality_score  \\\n",
       "0                       Medium   \n",
       "1                          NaN   \n",
       "2                          Low   \n",
       "3                          Low   \n",
       "4                          Low   \n",
       "..                         ...   \n",
       "72                         Low   \n",
       "73                         Low   \n",
       "74                         Low   \n",
       "75                      Medium   \n",
       "76                        High   \n",
       "\n",
       "                  gtruth_answer_quality_justification  \\\n",
       "0   The answer partially addresses the question by...   \n",
       "1                                                 NaN   \n",
       "2             No answer provided; treated as missing.   \n",
       "3             No answer provided; treated as missing.   \n",
       "4             No answer provided; treated as missing.   \n",
       "..                                                ...   \n",
       "72  The answer does not address the majority of th...   \n",
       "73  The answer is too brief and lacks detail. It d...   \n",
       "74  The answer only partially addresses the availa...   \n",
       "75  The answer partially addresses the question by...   \n",
       "76  The answer fully addresses the question by sta...   \n",
       "\n",
       "                                           llm_answer  cos_similarity  \\\n",
       "0                      Answer not found in documents.        0.138902   \n",
       "1                      Answer not found in documents.        0.147642   \n",
       "2   The assay models the impairment of neural cres...        0.020093   \n",
       "3   The test system used in the assay consists of ...        0.028660   \n",
       "4   The assay models the impairment of neural cres...        0.018484   \n",
       "..                                                ...             ...   \n",
       "72                     Answer not found in documents.        0.189700   \n",
       "73                     Answer not found in documents.        0.194032   \n",
       "74                     Answer not found in documents.        0.178659   \n",
       "75                     Answer not found in documents.        0.114859   \n",
       "76  The elements of the test method are not protec...        0.617420   \n",
       "\n",
       "    bert_precision  bert_recall   bert_f1  \n",
       "0        -0.278100    -0.013682 -0.160179  \n",
       "1        -1.069993    -1.070517 -1.061937  \n",
       "2        -1.069993    -1.070517 -1.061937  \n",
       "3        -1.069993    -1.070517 -1.061937  \n",
       "4        -1.069993    -1.070517 -1.061937  \n",
       "..             ...          ...       ...  \n",
       "72        0.177304     0.217136  0.200128  \n",
       "73        0.259338     0.114473  0.186037  \n",
       "74       -0.166175     0.148642 -0.028020  \n",
       "75       -0.126483     0.071457 -0.032778  \n",
       "76        0.111207     0.198983  0.156911  \n",
       "\n",
       "[77 rows x 9 columns]"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "ename": "InvalidIndexError",
     "evalue": "(slice(None, None, None), slice(5, 7, None))",
     "output_type": "error",
     "traceback": [
      "\u001b[31m---------------------------------------------------------------------------\u001b[39m",
      "\u001b[31mKeyError\u001b[39m                                  Traceback (most recent call last)",
      "\u001b[36mFile \u001b[39m\u001b[32m/opt/homebrew/Caskroom/miniconda/base/envs/tta/lib/python3.13/site-packages/pandas/core/indexes/base.py:3812\u001b[39m, in \u001b[36mIndex.get_loc\u001b[39m\u001b[34m(self, key)\u001b[39m\n\u001b[32m   3811\u001b[39m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[32m-> \u001b[39m\u001b[32m3812\u001b[39m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;43mself\u001b[39;49m\u001b[43m.\u001b[49m\u001b[43m_engine\u001b[49m\u001b[43m.\u001b[49m\u001b[43mget_loc\u001b[49m\u001b[43m(\u001b[49m\u001b[43mcasted_key\u001b[49m\u001b[43m)\u001b[49m\n\u001b[32m   3813\u001b[39m \u001b[38;5;28;01mexcept\u001b[39;00m \u001b[38;5;167;01mKeyError\u001b[39;00m \u001b[38;5;28;01mas\u001b[39;00m err:\n",
      "\u001b[36mFile \u001b[39m\u001b[32mpandas/_libs/index.pyx:167\u001b[39m, in \u001b[36mpandas._libs.index.IndexEngine.get_loc\u001b[39m\u001b[34m()\u001b[39m\n",
      "\u001b[36mFile \u001b[39m\u001b[32mpandas/_libs/index.pyx:196\u001b[39m, in \u001b[36mpandas._libs.index.IndexEngine.get_loc\u001b[39m\u001b[34m()\u001b[39m\n",
      "\u001b[36mFile \u001b[39m\u001b[32mpandas/_libs/hashtable_class_helper.pxi:7088\u001b[39m, in \u001b[36mpandas._libs.hashtable.PyObjectHashTable.get_item\u001b[39m\u001b[34m()\u001b[39m\n",
      "\u001b[36mFile \u001b[39m\u001b[32mpandas/_libs/hashtable_class_helper.pxi:7096\u001b[39m, in \u001b[36mpandas._libs.hashtable.PyObjectHashTable.get_item\u001b[39m\u001b[34m()\u001b[39m\n",
      "\u001b[31mKeyError\u001b[39m: (slice(None, None, None), slice(5, 7, None))",
      "\nDuring handling of the above exception, another exception occurred:\n",
      "\u001b[31mInvalidIndexError\u001b[39m                         Traceback (most recent call last)",
      "\u001b[36mCell\u001b[39m\u001b[36m \u001b[39m\u001b[32mIn[12]\u001b[39m\u001b[32m, line 1\u001b[39m\n\u001b[32m----> \u001b[39m\u001b[32m1\u001b[39m \u001b[43mdf\u001b[49m\u001b[43m[\u001b[49m\u001b[43m:\u001b[49m\u001b[43m,\u001b[49m\u001b[32;43m5\u001b[39;49m\u001b[43m:\u001b[49m\u001b[32;43m7\u001b[39;49m\u001b[43m]\u001b[49m\n",
      "\u001b[36mFile \u001b[39m\u001b[32m/opt/homebrew/Caskroom/miniconda/base/envs/tta/lib/python3.13/site-packages/pandas/core/frame.py:4113\u001b[39m, in \u001b[36mDataFrame.__getitem__\u001b[39m\u001b[34m(self, key)\u001b[39m\n\u001b[32m   4111\u001b[39m \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;28mself\u001b[39m.columns.nlevels > \u001b[32m1\u001b[39m:\n\u001b[32m   4112\u001b[39m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28mself\u001b[39m._getitem_multilevel(key)\n\u001b[32m-> \u001b[39m\u001b[32m4113\u001b[39m indexer = \u001b[38;5;28;43mself\u001b[39;49m\u001b[43m.\u001b[49m\u001b[43mcolumns\u001b[49m\u001b[43m.\u001b[49m\u001b[43mget_loc\u001b[49m\u001b[43m(\u001b[49m\u001b[43mkey\u001b[49m\u001b[43m)\u001b[49m\n\u001b[32m   4114\u001b[39m \u001b[38;5;28;01mif\u001b[39;00m is_integer(indexer):\n\u001b[32m   4115\u001b[39m     indexer = [indexer]\n",
      "\u001b[36mFile \u001b[39m\u001b[32m/opt/homebrew/Caskroom/miniconda/base/envs/tta/lib/python3.13/site-packages/pandas/core/indexes/base.py:3818\u001b[39m, in \u001b[36mIndex.get_loc\u001b[39m\u001b[34m(self, key)\u001b[39m\n\u001b[32m   3813\u001b[39m \u001b[38;5;28;01mexcept\u001b[39;00m \u001b[38;5;167;01mKeyError\u001b[39;00m \u001b[38;5;28;01mas\u001b[39;00m err:\n\u001b[32m   3814\u001b[39m     \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;28misinstance\u001b[39m(casted_key, \u001b[38;5;28mslice\u001b[39m) \u001b[38;5;129;01mor\u001b[39;00m (\n\u001b[32m   3815\u001b[39m         \u001b[38;5;28misinstance\u001b[39m(casted_key, abc.Iterable)\n\u001b[32m   3816\u001b[39m         \u001b[38;5;129;01mand\u001b[39;00m \u001b[38;5;28many\u001b[39m(\u001b[38;5;28misinstance\u001b[39m(x, \u001b[38;5;28mslice\u001b[39m) \u001b[38;5;28;01mfor\u001b[39;00m x \u001b[38;5;129;01min\u001b[39;00m casted_key)\n\u001b[32m   3817\u001b[39m     ):\n\u001b[32m-> \u001b[39m\u001b[32m3818\u001b[39m         \u001b[38;5;28;01mraise\u001b[39;00m InvalidIndexError(key)\n\u001b[32m   3819\u001b[39m     \u001b[38;5;28;01mraise\u001b[39;00m \u001b[38;5;167;01mKeyError\u001b[39;00m(key) \u001b[38;5;28;01mfrom\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[34;01merr\u001b[39;00m\n\u001b[32m   3820\u001b[39m \u001b[38;5;28;01mexcept\u001b[39;00m \u001b[38;5;167;01mTypeError\u001b[39;00m:\n\u001b[32m   3821\u001b[39m     \u001b[38;5;66;03m# If we have a listlike key, _check_indexing_error will raise\u001b[39;00m\n\u001b[32m   3822\u001b[39m     \u001b[38;5;66;03m#  InvalidIndexError. Otherwise we fall through and re-raise\u001b[39;00m\n\u001b[32m   3823\u001b[39m     \u001b[38;5;66;03m#  the TypeError.\u001b[39;00m\n",
      "\u001b[31mInvalidIndexError\u001b[39m: (slice(None, None, None), slice(5, 7, None))"
     ]
    }
   ],
   "source": [
    "df[:,5:7]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "cos_similarity",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "bert_precision",
         "rawType": "float64",
         "type": "float"
        }
       ],
       "ref": "86233701-d8a7-47c3-b0cd-a70557974d10",
       "rows": [
        [
         "0",
         "0.1389022604725474",
         "-0.278099775314331"
        ],
        [
         "1",
         "0.1476418762811726",
         "-1.0699931383132937"
        ],
        [
         "2",
         "0.0200932147230614",
         "-1.0699931383132937"
        ],
        [
         "3",
         "0.0286598244692996",
         "-1.0699931383132937"
        ],
        [
         "4",
         "0.0184842945537873",
         "-1.0699931383132937"
        ],
        [
         "5",
         "0.011841868007006",
         "-1.0699931383132937"
        ],
        [
         "6",
         "0.0313218168355815",
         "-1.0699931383132937"
        ],
        [
         "7",
         "0.1472711047968674",
         "-1.0699931383132937"
        ],
        [
         "8",
         "0.0438928721719397",
         "-1.0699931383132937"
        ],
        [
         "9",
         "0.1409785695304698",
         "-0.2523543536663055"
        ],
        [
         "10",
         "0.7008524794112678",
         "0.2906718254089355"
        ],
        [
         "11",
         "0.1124972445828743",
         "-0.1620234549045562"
        ],
        [
         "12",
         "0.6150553856491306",
         "0.71158766746521"
        ],
        [
         "13",
         "0.0864104393081909",
         "-0.222375139594078"
        ],
        [
         "14",
         "0.6257381618345769",
         "0.8096904158592224"
        ],
        [
         "15",
         "0.0856225308392804",
         "-0.5428894758224487"
        ],
        [
         "16",
         "0.6323262931535033",
         "0.0796980932354927"
        ],
        [
         "17",
         "0.7843962500969945",
         "0.1914535760879516"
        ],
        [
         "18",
         "0.7451747093067259",
         "0.5487285256385803"
        ],
        [
         "19",
         "0.6918297718969108",
         "0.2674421072006225"
        ],
        [
         "20",
         "0.0891102245524364",
         "-0.2860725820064544"
        ],
        [
         "21",
         "0.0941772805964676",
         "-0.3674789071083069"
        ],
        [
         "22",
         "0.8153749180158556",
         "0.0693682432174682"
        ],
        [
         "23",
         "0.2040911067865233",
         "-0.1394036710262298"
        ],
        [
         "24",
         "0.6605110180921907",
         "0.2072174996137619"
        ],
        [
         "25",
         "0.1396155404212514",
         "-0.4960272014141083"
        ],
        [
         "26",
         "0.5561523408506475",
         "0.1792346537113189"
        ],
        [
         "27",
         "0.653235214537423",
         "0.2374215871095657"
        ],
        [
         "28",
         "0.3188048178824792",
         "0.3032091856002807"
        ],
        [
         "29",
         "0.1304111291782479",
         "-0.0027272182051092"
        ],
        [
         "30",
         "0.0918829473527212",
         "-0.1728177815675735"
        ],
        [
         "31",
         "0.1879438574153945",
         "0.1285031288862228"
        ],
        [
         "32",
         "0.1657412021722263",
         "-0.4586300253868103"
        ],
        [
         "33",
         "0.8063022638028429",
         "0.4278606176376343"
        ],
        [
         "34",
         "0.7786172728061955",
         "0.1705653965473175"
        ],
        [
         "35",
         "0.8323899274357207",
         "0.3053684830665588"
        ],
        [
         "36",
         "0.1556087337535995",
         "-0.5698603987693787"
        ],
        [
         "37",
         "0.1129252798311988",
         "-0.3817243576049804"
        ],
        [
         "38",
         "0.715292398302983",
         "0.5444532632827759"
        ],
        [
         "39",
         "0.6943547222429032",
         "0.3113435804843902"
        ],
        [
         "40",
         "0.0915356012576384",
         "-0.1328837871551513"
        ],
        [
         "41",
         "0.1641426692299568",
         "-0.3172697722911834"
        ],
        [
         "42",
         "0.7901623500644862",
         "0.260970264673233"
        ],
        [
         "43",
         "0.1691844664445733",
         "-0.4938696324825287"
        ],
        [
         "44",
         "0.1673570700280981",
         "-0.190487265586853"
        ],
        [
         "45",
         "0.1354475557674951",
         "-0.2013079077005386"
        ],
        [
         "46",
         "0.7756825226086875",
         "0.3668257892131805"
        ],
        [
         "47",
         "0.1378140960046533",
         "-0.4056740701198578"
        ],
        [
         "48",
         "0.1967934226007274",
         "-0.4617649018764496"
        ],
        [
         "49",
         "0.7814715479411318",
         "0.3117051124572754"
        ]
       ],
       "shape": {
        "columns": 2,
        "rows": 77
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>cos_similarity</th>\n",
       "      <th>bert_precision</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0.138902</td>\n",
       "      <td>-0.278100</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>0.147642</td>\n",
       "      <td>-1.069993</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>0.020093</td>\n",
       "      <td>-1.069993</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>0.028660</td>\n",
       "      <td>-1.069993</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>0.018484</td>\n",
       "      <td>-1.069993</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>72</th>\n",
       "      <td>0.189700</td>\n",
       "      <td>0.177304</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>73</th>\n",
       "      <td>0.194032</td>\n",
       "      <td>0.259338</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>74</th>\n",
       "      <td>0.178659</td>\n",
       "      <td>-0.166175</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75</th>\n",
       "      <td>0.114859</td>\n",
       "      <td>-0.126483</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>76</th>\n",
       "      <td>0.617420</td>\n",
       "      <td>0.111207</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>77 rows × 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    cos_similarity  bert_precision\n",
       "0         0.138902       -0.278100\n",
       "1         0.147642       -1.069993\n",
       "2         0.020093       -1.069993\n",
       "3         0.028660       -1.069993\n",
       "4         0.018484       -1.069993\n",
       "..             ...             ...\n",
       "72        0.189700        0.177304\n",
       "73        0.194032        0.259338\n",
       "74        0.178659       -0.166175\n",
       "75        0.114859       -0.126483\n",
       "76        0.617420        0.111207\n",
       "\n",
       "[77 rows x 2 columns]"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.iloc[:,5:7]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "question",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "gtruth_answer",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "gtruth_answer_quality_score",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "gtruth_answer_quality_justification",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "llm_answer",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "cos_similarity",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "bert_precision",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "bert_recall",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "bert_f1",
         "rawType": "float64",
         "type": "float"
        }
       ],
       "ref": "dcbf259e-c5f3-46cf-97f4-4c23486dbe4c",
       "rows": [
        [
         "5",
         "To which (human) adverse outcome(s) is your test method related or could be related? (8.1; 9.2; 9.3)",
         null,
         "Low",
         "No answer provided; treated as missing.",
         "The assay models the impairment of neural crest cell migration during fetal development, which can lead to developmental disorders and malformations such as neural tube defects and craniofacial malformations. Therefore, it is related to adverse outcomes including neural tube defects, craniofacial malformations, and other developmental neurotoxicity-related outcomes (Source: cMINC(UKN2).pdf).",
         "0.011841868007006",
         "-1.0699931383132937",
         "-1.07051682472229",
         "-1.0619372129440308"
        ],
        [
         "6",
         "Which hazard(s) do(es) your test method (potentially) predict? (8.1; 8.6)",
         null,
         "Low",
         "No answer provided; treated as missing.",
         "The assay predicts developmental disorders and malformations, such as neural tube defects and craniofacial malformations, caused by compound exposure during fetal development (Source: cMINC(UKN2).pdf).",
         "0.0313218168355815",
         "-1.0699931383132937",
         "-1.07051682472229",
         "-1.0619372129440308"
        ]
       ],
       "shape": {
        "columns": 9,
        "rows": 2
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>question</th>\n",
       "      <th>gtruth_answer</th>\n",
       "      <th>gtruth_answer_quality_score</th>\n",
       "      <th>gtruth_answer_quality_justification</th>\n",
       "      <th>llm_answer</th>\n",
       "      <th>cos_similarity</th>\n",
       "      <th>bert_precision</th>\n",
       "      <th>bert_recall</th>\n",
       "      <th>bert_f1</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>To which (human) adverse outcome(s) is your te...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Low</td>\n",
       "      <td>No answer provided; treated as missing.</td>\n",
       "      <td>The assay models the impairment of neural cres...</td>\n",
       "      <td>0.011842</td>\n",
       "      <td>-1.069993</td>\n",
       "      <td>-1.070517</td>\n",
       "      <td>-1.061937</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Which hazard(s) do(es) your test method (poten...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Low</td>\n",
       "      <td>No answer provided; treated as missing.</td>\n",
       "      <td>The assay predicts developmental disorders and...</td>\n",
       "      <td>0.031322</td>\n",
       "      <td>-1.069993</td>\n",
       "      <td>-1.070517</td>\n",
       "      <td>-1.061937</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                            question gtruth_answer  \\\n",
       "5  To which (human) adverse outcome(s) is your te...           NaN   \n",
       "6  Which hazard(s) do(es) your test method (poten...           NaN   \n",
       "\n",
       "  gtruth_answer_quality_score      gtruth_answer_quality_justification  \\\n",
       "5                         Low  No answer provided; treated as missing.   \n",
       "6                         Low  No answer provided; treated as missing.   \n",
       "\n",
       "                                          llm_answer  cos_similarity  \\\n",
       "5  The assay models the impairment of neural cres...        0.011842   \n",
       "6  The assay predicts developmental disorders and...        0.031322   \n",
       "\n",
       "   bert_precision  bert_recall   bert_f1  \n",
       "5       -1.069993    -1.070517 -1.061937  \n",
       "6       -1.069993    -1.070517 -1.061937  "
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.iloc[5:7,:]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "question",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "gtruth_answer",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "gtruth_answer_quality_score",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "gtruth_answer_quality_justification",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "llm_answer",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "cos_similarity",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "bert_precision",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "bert_recall",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "bert_f1",
         "rawType": "float64",
         "type": "float"
        }
       ],
       "ref": "e2372fa5-866b-4b0c-8058-6de2ba5362c4",
       "rows": [
        [
         "21",
         "Name known causes of variability of the initial cells/source cells. Indicate critical consumables or batch effects (e.g. relevance of the plate format and supplier, batch effects of fetal calf serum (FCS) or serum replacement, critical additives like type of trypsin, apo-transferrin vs. holo-transferrin, etc.). Indicate critical handling steps and influencing factors (e.g. special care needed in pipetting, steps that need to be performed quickly, cell density, washing procedures, etc.). As in 3.3., special/additional requirements apply to genetically-modified cells and microphysiological systems, e.g. dependence on matrix chemistry and geometry, dependence on microfluidics system, consideration of surface cells vs core cells, etc. Give recommendations to increase/ensure reproducibility and performance.",
         "- hiPSC can be maintained up to 10 passages, high passage number might influence performance of cells - Too little or too high cell density leads to detachment of cells or spontaneous differentiation - If cells start to differentiate, cells should be discarded immediately - Cells have to be maintained as colonies and not as single cells. Therefore splitting should be performed as fast as possible - Batch effects of critical additives (e.g. holo-transferrin for iron supply of cells or TGF-β which maintains cell pluripotency) can lead to differentiation of cells at low passage number.",
         "Medium",
         "The answer partially addresses the question by mentioning some causes of variability such as passage number, cell density, and batch effects of critical additives. However, it lacks detail on critical consumables, handling steps, and specific recommendations for genetically-modified cells and microphysiological systems. The response could be more comprehensive and specific to fully address the question.",
         "Answer not found in documents.",
         "0.0941772805964676",
         "-0.3674789071083069",
         "-0.0596944652497768",
         "-0.2363198846578598"
        ],
        [
         "22",
         "Describe the principles of the selected differentiation protocol, including a scheme and graphical overview, indicating all phases, media, substrates, manipulation steps (medium change/re-plating, medium additives, etc.). Special/additional requirements apply to microphysiological systems and organoids: e.g. cell printing, self-aggregation/self-organisation process, interaction with the matrix, geometrical characterization (size/shape), etc.",
         "Figure 2: Differentiation scheme from hiPSCs to neural crest cells NCCs were differentiated from hiPSCs following the modified protocol of Mica et al. (2013) (https://doi.org/10.1016/j.celrep.2013.03.025). Therefore, IMR90 iPSCs were plated on Matrigel coated 6- well plates at a density of 100’000 cells/cm2 in E8 medium containing 10 μM ROCK (Rho-associated protein kinase)-inhibitor Y-27632. After one day cells reached a confluency of 80-100% and differentiation was initiated (day 0’) by a medium change to KSR medium (Knock out DMEM (Dulbecco's Modified Eagle Medium), 15% knock out serum replacement, 1% GlutaMax, 1% MEM NEAA (minimum essential medium - non-essential amino acids) solution, 50 µM 2-mercaptoethanol) supplemented with 20 ng/ml Noggin and 10 µM SB431542. From day 2 on cells were treated with 3 µM CHIR99021. Noggin and SB431542 were withdrawn at day 3 and 4, respectively. Beginning at day 4, the KSR medium was gradually replaced with N2-S medium (DMEM/F12 (Dulbecco's Modified Eagle Medium/Ham's F-12), 1.55 mg/ml glucose, 1% GlutaMax, 0.1 mg/ml apotransferin, 25 µg/ml insulin, 20 nM progesterone, 100 μM putrescine, 30 nM selenium) in 25% increments. Cells were collected at day 11, resuspended in N2-S medium supplemented with 20 ng/ml EGF (epidermal growth factor) and 20 ng/ml FGF2 (fibroblast growth factor 2) and seeded as droplets (10 µl) on poly-L-ornithine (PLO)/Laminin/Fibronectin coated 10 cm dishes. Cells were expanded by weekly splitting. From now on seeding as droplets was not necessary and medium was changed every second day. After 35-39 days, cells were cryopreserved at a concentration of 4*106 cells/ml in 90% N2-S medium and 10% dimethyl sulfoxide (DMSO) (Merck Millipore) until further use.",
         "Medium",
         "The answer provides a detailed description of the differentiation protocol, including media, substrates, and manipulation steps. However, it lacks a graphical overview and does not address special/additional requirements for microphysiological systems and organoids, such as cell printing or interaction with the matrix. The absence of a scheme or graphical representation limits the completeness of the response.",
         "The assay described, cMINC (UKN2), utilizes human neural crest cells (NCCs) derived from induced pluripotent stem cells (iPSC). The differentiation protocol from iPSCs to NCCs involves several phases, media, substrates, and manipulation steps, which are summarized below:\n\n**Differentiation Scheme and Phases:**\n\n1. **Plating of iPSCs:**  \n   - iPSCs (IMR90 clone #4) are plated on Matrigel-coated 6-well plates at a density of 100,000 cells/cm² in Essential 8 (E8) medium containing 10 μM ROCK inhibitor Y-27632 to promote survival and attachment.  \n   - Cells grow in colonies and reach 80–100% confluency within one day.\n\n2. **Initiation of Differentiation (Day 0):**  \n   - Medium is changed to KSR medium (Knockout DMEM with serum replacement, GlutaMax, NEAA, 2-mercaptoethanol).  \n   - Supplemented with 20 ng/ml Noggin and 10 μM SB431542 to promote neural crest lineage specification.  \n   - Cells are treated with these factors for 2 days.\n\n3. **Patterning and Induction (Days 2–4):**  \n   - From Day 2, cells are treated with 3 μM CHIR99021 to activate Wnt signaling, supporting NCC induction.  \n   - Noggin and SB431542 are withdrawn at Days 3 and 4, respectively.\n\n4. **Transition to N2-S Medium (Days 4–11):**  \n   - Gradual medium change from KSR to N2-S medium (a defined medium with glucose, GlutaMax, apotransferin, insulin, progesterone, putrescine, selenium).  \n   - Medium is replaced in 25% increments daily, starting at Day 4, until fully transitioned by Day 11.\n\n5. **Expansion and Seeding (Days 11–35/39):**  \n   - Cells are collected at Day 11, resuspended in N2-S medium supplemented with EGF and FGF2, and seeded as droplets (10 μl) onto poly-L-ornithine (PLO)/Laminin/Fibronectin coated dishes.  \n   - Cells are expanded by weekly splitting, with medium changes every second day.\n\n6. **Cryopreservation:**  \n   - After 35–39 days, NCCs are cryopreserved at 4×10^6 cells/ml in N2-S medium with 10% DMSO.\n\n**Substrates and Interaction with Matrix:**\n\n- The final NCCs are seeded on coated substrates: poly-L-ornithine, Laminin, and Fibronectin, which support adhesion, migration, and mimic aspects of the extracellular matrix (ECM) in vivo.\n\n**Manipulation Steps:**\n\n- **Medium Changes:**  \n  - Regular medium changes are performed during differentiation, with gradual medium transition from KSR to N2-S medium.  \n  - During expansion, medium is changed every second day.\n\n- **Cell Seeding:**  \n  - Cells are seeded as droplets on coated dishes, allowing self-aggregation and organization into a migratory monolayer.\n\n- **Cryopreservation:**  \n  - Cells are frozen at the end of differentiation for storage and subsequent use.\n\n**Special Requirements for Microphysiological Systems and Organoids:**\n\n- The protocol emphasizes the importance of cell–matrix interactions, as cells are seeded on ECM-coated substrates to facilitate adhesion and migration.  \n- For organoid or microphysiological system development, additional steps such as cell printing, self-aggregation, or self-organization may be necessary, although not explicitly detailed here.  \n- Geometrical characterization (size, shape) of cell clusters or organoids can be performed to assess uniformity and reproducibility.  \n- Interaction with the matrix is critical, as the ECM components influence cell behavior, migration, and differentiation pathways.\n\n**Graphical Overview:**\n\nWhile a visual diagram cannot be provided here, the scheme involves:\n\n- **Phase 1:** Plating iPSCs on Matrigel → Confluency (Day 1)  \n- **Phase 2:** Medium change to induction medium with Noggin/SB431542 → Days 0–2  \n- **Phase 3:** Wnt activation with CHIR99021, withdrawal of initial factors → Days 2–4  \n- **Phase 4:** Gradual medium transition to N2-S → Days 4–11  \n- **Phase 5:** Cell collection, resuspension, and seeding as droplets on coated substrates → Day 11 onward  \n- **Phase 6:** Expansion, cryopreservation, or further maturation.\n\nThis protocol ensures the generation of a homogeneous NCC population capable of migration, suitable for the in vitro assessment of developmental toxicity effects.",
         "0.8153749180158556",
         "0.0693682432174682",
         "-0.0691901221871376",
         "-0.0003346595040056"
        ]
       ],
       "shape": {
        "columns": 9,
        "rows": 2
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>question</th>\n",
       "      <th>gtruth_answer</th>\n",
       "      <th>gtruth_answer_quality_score</th>\n",
       "      <th>gtruth_answer_quality_justification</th>\n",
       "      <th>llm_answer</th>\n",
       "      <th>cos_similarity</th>\n",
       "      <th>bert_precision</th>\n",
       "      <th>bert_recall</th>\n",
       "      <th>bert_f1</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>Name known causes of variability of the initia...</td>\n",
       "      <td>- hiPSC can be maintained up to 10 passages, h...</td>\n",
       "      <td>Medium</td>\n",
       "      <td>The answer partially addresses the question by...</td>\n",
       "      <td>Answer not found in documents.</td>\n",
       "      <td>0.094177</td>\n",
       "      <td>-0.367479</td>\n",
       "      <td>-0.059694</td>\n",
       "      <td>-0.236320</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>Describe the principles of the selected differ...</td>\n",
       "      <td>Figure 2: Differentiation scheme from hiPSCs t...</td>\n",
       "      <td>Medium</td>\n",
       "      <td>The answer provides a detailed description of ...</td>\n",
       "      <td>The assay described, cMINC (UKN2), utilizes hu...</td>\n",
       "      <td>0.815375</td>\n",
       "      <td>0.069368</td>\n",
       "      <td>-0.069190</td>\n",
       "      <td>-0.000335</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                             question  \\\n",
       "21  Name known causes of variability of the initia...   \n",
       "22  Describe the principles of the selected differ...   \n",
       "\n",
       "                                        gtruth_answer  \\\n",
       "21  - hiPSC can be maintained up to 10 passages, h...   \n",
       "22  Figure 2: Differentiation scheme from hiPSCs t...   \n",
       "\n",
       "   gtruth_answer_quality_score  \\\n",
       "21                      Medium   \n",
       "22                      Medium   \n",
       "\n",
       "                  gtruth_answer_quality_justification  \\\n",
       "21  The answer partially addresses the question by...   \n",
       "22  The answer provides a detailed description of ...   \n",
       "\n",
       "                                           llm_answer  cos_similarity  \\\n",
       "21                     Answer not found in documents.        0.094177   \n",
       "22  The assay described, cMINC (UKN2), utilizes hu...        0.815375   \n",
       "\n",
       "    bert_precision  bert_recall   bert_f1  \n",
       "21       -0.367479    -0.059694 -0.236320  \n",
       "22        0.069368    -0.069190 -0.000335  "
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.iloc[21:23,:]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "question",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "gtruth_answer",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "gtruth_answer_quality_score",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "gtruth_answer_quality_justification",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "llm_answer",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "cos_similarity",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "bert_precision",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "bert_recall",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "bert_f1",
         "rawType": "float64",
         "type": "float"
        }
       ],
       "ref": "ba47e6e3-58b2-4746-b91c-86e1737382db",
       "rows": [
        [
         "24",
         "Describe the test system as it is used in the test. If the generation of the test system involves differentiation steps or complex technical manipulation (e.g. formation of microtissues), this is described in 3.6. Give details on the general features/principles of the culture protocol (collagen embedding, 3D structuring, addition of mitotic inhibitors, addition of particular hormones/growth factors, etc.) of the cells that are used for the test. What is the percentage of contaminating cells; in co-cultures what is the percentage of each subpopulation? Are there subpopulations that are generally more sensitive to cytotoxicity than others, and could this influence viability measures? Is it known whether specific chemicals/chemical classes show differential cytotoxicity for the cell sub-populations used?",
         "A highly homogeneous pre-differentiated population of neural crest cells is added to coated wells. In the middle of the well is a silicone stopper that prevents cells from settling in a circular area in the middle of the well. The cells are kept viable and alive by the presence of EGF and FGF in the medium, and they become adherent overnight. When the stopper is removed, the cells form a dense monolayer in the culture dish, with a sharply demarcated circular area in the middle that is free of cells. Due to their natural spontaneous migration behaviour, the cells move into the cell-free area. The cells are still in a proliferative state. Proliferation at the edge of the cell free area contributes to a small extent to “apparent migration behaviour”. This has been characterized and quantified in detail (Nyffeler et al. 2016). It is accounted for by counting cells in a narrower circle than the original circular area.",
         "Medium",
         "The answer provides a detailed description of the test system, including the culture protocol and cell behavior. However, it lacks information on the percentage of contaminating cells, the percentage of each subpopulation in co-cultures, and whether specific chemicals show differential cytotoxicity for the cell sub-populations used. These omissions prevent a 'High' score.",
         "The assay uses human neural crest cells (NCCs) derived from induced pluripotent stem cells (iPSCs). The differentiation process involves several steps: starting from undifferentiated hiPSCs maintained on Laminin-521 in E8 medium, cells are plated on Matrigel-coated plates and induced to differentiate into NCCs following a modified protocol based on Mica et al. (2013). During differentiation, cells are treated with specific growth factors and signaling molecules, such as Noggin, SB431542, CHIR99021, EGF, and FGF2, over a period of approximately 35-39 days, culminating in a highly homogeneous population of NCCs.\n\nThe derived NCCs are characterized by expressing typical NCC markers (HNK-1, p75, nestin, AP2) and lack expression of markers for other cell types such as GFAP, Pax6, and βIII tubulin, indicating a predominantly NCC phenotype. The cells are maintained as a monolayer on coated surfaces (PLO/Laminin/Fibronectin) and are kept viable with growth factors (EGF and FGF2). They are cryopreserved at a concentration of 4×10^6 cells/ml in N2-S medium with DMSO until use.\n\nIn the test system, NCCs are seeded as a highly homogeneous population (>90% positive for NCC markers) into wells with a silicone stopper creating a circular cell-free zone. After attachment, the stopper is removed, allowing cells to migrate into the free area, which models in vivo NCC migration. The assay measures the impairment of migration and cell viability after exposure to test compounds.\n\nRegarding contamination and subpopulations, the NCC cultures are characterized to be ≥90% positive for NCC markers, indicating minimal contamination with other cell types. The protocol does not specify the presence of other subpopulations or their proportions, but the high purity suggests that the culture is predominantly NCCs. There is no detailed information on whether specific subpopulations within NCCs show differential sensitivity to cytotoxicity; however, since the cultures are highly homogeneous, the influence of subpopulation sensitivity on viability measures is likely minimal.\n\nAs for differential cytotoxicity among chemical classes, the document does not specify whether certain chemicals or classes preferentially affect subpopulations within NCCs. The assay primarily assesses overall migration impairment and viability of the NCC population as a whole, and the high homogeneity of the cells used reduces the likelihood of subpopulation-specific effects influencing the overall viability measures.",
         "0.6605110180921907",
         "0.2072174996137619",
         "0.0189544204622507",
         "0.1092212870717048"
        ]
       ],
       "shape": {
        "columns": 9,
        "rows": 1
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>question</th>\n",
       "      <th>gtruth_answer</th>\n",
       "      <th>gtruth_answer_quality_score</th>\n",
       "      <th>gtruth_answer_quality_justification</th>\n",
       "      <th>llm_answer</th>\n",
       "      <th>cos_similarity</th>\n",
       "      <th>bert_precision</th>\n",
       "      <th>bert_recall</th>\n",
       "      <th>bert_f1</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>Describe the test system as it is used in the ...</td>\n",
       "      <td>A highly homogeneous pre-differentiated popula...</td>\n",
       "      <td>Medium</td>\n",
       "      <td>The answer provides a detailed description of ...</td>\n",
       "      <td>The assay uses human neural crest cells (NCCs)...</td>\n",
       "      <td>0.660511</td>\n",
       "      <td>0.207217</td>\n",
       "      <td>0.018954</td>\n",
       "      <td>0.109221</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                             question  \\\n",
       "24  Describe the test system as it is used in the ...   \n",
       "\n",
       "                                        gtruth_answer  \\\n",
       "24  A highly homogeneous pre-differentiated popula...   \n",
       "\n",
       "   gtruth_answer_quality_score  \\\n",
       "24                      Medium   \n",
       "\n",
       "                  gtruth_answer_quality_justification  \\\n",
       "24  The answer provides a detailed description of ...   \n",
       "\n",
       "                                           llm_answer  cos_similarity  \\\n",
       "24  The assay uses human neural crest cells (NCCs)...        0.660511   \n",
       "\n",
       "    bert_precision  bert_recall   bert_f1  \n",
       "24        0.207217     0.018954  0.109221  "
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.iloc[24:25,:]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "question",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "gtruth_answer",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "gtruth_answer_quality_score",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "gtruth_answer_quality_justification",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "llm_answer",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "cos_similarity",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "bert_precision",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "bert_recall",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "bert_f1",
         "rawType": "float64",
         "type": "float"
        }
       ],
       "ref": "63c018f7-1016-4077-b415-2649adb081c3",
       "rows": [
        [
         "24",
         "Describe the test system as it is used in the test. If the generation of the test system involves differentiation steps or complex technical manipulation (e.g. formation of microtissues), this is described in 3.6. Give details on the general features/principles of the culture protocol (collagen embedding, 3D structuring, addition of mitotic inhibitors, addition of particular hormones/growth factors, etc.) of the cells that are used for the test. What is the percentage of contaminating cells; in co-cultures what is the percentage of each subpopulation? Are there subpopulations that are generally more sensitive to cytotoxicity than others, and could this influence viability measures? Is it known whether specific chemicals/chemical classes show differential cytotoxicity for the cell sub-populations used?",
         "A highly homogeneous pre-differentiated population of neural crest cells is added to coated wells. In the middle of the well is a silicone stopper that prevents cells from settling in a circular area in the middle of the well. The cells are kept viable and alive by the presence of EGF and FGF in the medium, and they become adherent overnight. When the stopper is removed, the cells form a dense monolayer in the culture dish, with a sharply demarcated circular area in the middle that is free of cells. Due to their natural spontaneous migration behaviour, the cells move into the cell-free area. The cells are still in a proliferative state. Proliferation at the edge of the cell free area contributes to a small extent to “apparent migration behaviour”. This has been characterized and quantified in detail (Nyffeler et al. 2016). It is accounted for by counting cells in a narrower circle than the original circular area.",
         "Medium",
         "The answer provides a detailed description of the test system, including the culture protocol and cell behavior. However, it lacks information on the percentage of contaminating cells, the percentage of each subpopulation in co-cultures, and whether specific chemicals show differential cytotoxicity for the cell sub-populations used. These omissions prevent a 'High' score.",
         "The assay uses human neural crest cells (NCCs) derived from induced pluripotent stem cells (iPSCs). The differentiation process involves several steps: starting from undifferentiated hiPSCs maintained on Laminin-521 in E8 medium, cells are plated on Matrigel-coated plates and induced to differentiate into NCCs following a modified protocol based on Mica et al. (2013). During differentiation, cells are treated with specific growth factors and signaling molecules, such as Noggin, SB431542, CHIR99021, EGF, and FGF2, over a period of approximately 35-39 days, culminating in a highly homogeneous population of NCCs.\n\nThe derived NCCs are characterized by expressing typical NCC markers (HNK-1, p75, nestin, AP2) and lack expression of markers for other cell types such as GFAP, Pax6, and βIII tubulin, indicating a predominantly NCC phenotype. The cells are maintained as a monolayer on coated surfaces (PLO/Laminin/Fibronectin) and are kept viable with growth factors (EGF and FGF2). They are cryopreserved at a concentration of 4×10^6 cells/ml in N2-S medium with DMSO until use.\n\nIn the test system, NCCs are seeded as a highly homogeneous population (>90% positive for NCC markers) into wells with a silicone stopper creating a circular cell-free zone. After attachment, the stopper is removed, allowing cells to migrate into the free area, which models in vivo NCC migration. The assay measures the impairment of migration and cell viability after exposure to test compounds.\n\nRegarding contamination and subpopulations, the NCC cultures are characterized to be ≥90% positive for NCC markers, indicating minimal contamination with other cell types. The protocol does not specify the presence of other subpopulations or their proportions, but the high purity suggests that the culture is predominantly NCCs. There is no detailed information on whether specific subpopulations within NCCs show differential sensitivity to cytotoxicity; however, since the cultures are highly homogeneous, the influence of subpopulation sensitivity on viability measures is likely minimal.\n\nAs for differential cytotoxicity among chemical classes, the document does not specify whether certain chemicals or classes preferentially affect subpopulations within NCCs. The assay primarily assesses overall migration impairment and viability of the NCC population as a whole, and the high homogeneity of the cells used reduces the likelihood of subpopulation-specific effects influencing the overall viability measures.",
         "0.6605110180921907",
         "0.2072174996137619",
         "0.0189544204622507",
         "0.1092212870717048"
        ],
        [
         "25",
         "What are the endpoint(s) that you use to control that your culture(s) is/are as expected at the start of toxicity testing (e.g. gene expression, staining, morphology, responses to reference chemicals, etc.)? Describe the acceptance criteria for your test system, i.e. the quality criteria for your cells/tissues/organoids: Which endpoints do you consider to describe the cells or other source material, which parameters are important? Describe the (analytical) methods that you use to evaluate your culture (PCR, ATP measurement) and to measure the acceptance criteria (AC). Which values (e.g. degree of differentiation or cell density) need to be reached/should not be reached? Historical controls: How does your test system perform with regard to the acceptance criteria, e.g. when differentiation is performed 10 times, what is the average and variation of the values for the acceptance criteria parameters)? Indicate actions if the AC are not met. Examples: cell are > 90% viable, or > 98% of cells express marker x (e.g. AP-2), or > 80% of the cells attach, etc.",
         "Figure 3: Characterization of the cellular system. (A) Differentiation schema of NCCs from human induced pluripotent stem cells. (B) Expression of the NCC markers HNK-1 and p75 was monitored by FACS analysis. (C) After thawing the cells were immunofluorescently labelled for the typical NCC markers p75, HNK1 and AP2. Scale bar: 50 µm. (D) Typical mesenchymal like cell morphology of NCCs. Cells were double-stained for nestin and f-actin. Scale bar: 10 µm. The derived NCCs are ≥ 90% positive for the NCC marker human natural killer-1 (HNK1) and the nerve low affinity nerve growth factor receptor p75. Additionally, the cells express the stem cell microfilament protein nestin and AP2. On the other hand, none of the cells show expression of the astrocyte marker GFAP, the central nervous system precursor cell marker Pax6 and the neuronal marker βIII tubulin. Furthermore, the functional capability of the cells is checked by performing the cMINC assay with endpoint specific controls. The cells have to be pathogen-free to be used in further experiments (regular testing for mycoplasma after thawing). After thawing the viability should be > 90%.",
         "Medium",
         "The answer provides some relevant information about the characterization of the cellular system, including markers and morphology, and mentions viability criteria. However, it lacks detailed acceptance criteria, specific analytical methods, and historical control data. It also does not specify actions if acceptance criteria are not met.",
         "Answer not found in documents.",
         "0.1396155404212514",
         "-0.4960272014141083",
         "-0.0303580984473228",
         "-0.3251430988311767"
        ]
       ],
       "shape": {
        "columns": 9,
        "rows": 2
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>question</th>\n",
       "      <th>gtruth_answer</th>\n",
       "      <th>gtruth_answer_quality_score</th>\n",
       "      <th>gtruth_answer_quality_justification</th>\n",
       "      <th>llm_answer</th>\n",
       "      <th>cos_similarity</th>\n",
       "      <th>bert_precision</th>\n",
       "      <th>bert_recall</th>\n",
       "      <th>bert_f1</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>Describe the test system as it is used in the ...</td>\n",
       "      <td>A highly homogeneous pre-differentiated popula...</td>\n",
       "      <td>Medium</td>\n",
       "      <td>The answer provides a detailed description of ...</td>\n",
       "      <td>The assay uses human neural crest cells (NCCs)...</td>\n",
       "      <td>0.660511</td>\n",
       "      <td>0.207217</td>\n",
       "      <td>0.018954</td>\n",
       "      <td>0.109221</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>What are the endpoint(s) that you use to contr...</td>\n",
       "      <td>Figure 3: Characterization of the cellular sys...</td>\n",
       "      <td>Medium</td>\n",
       "      <td>The answer provides some relevant information ...</td>\n",
       "      <td>Answer not found in documents.</td>\n",
       "      <td>0.139616</td>\n",
       "      <td>-0.496027</td>\n",
       "      <td>-0.030358</td>\n",
       "      <td>-0.325143</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                             question  \\\n",
       "24  Describe the test system as it is used in the ...   \n",
       "25  What are the endpoint(s) that you use to contr...   \n",
       "\n",
       "                                        gtruth_answer  \\\n",
       "24  A highly homogeneous pre-differentiated popula...   \n",
       "25  Figure 3: Characterization of the cellular sys...   \n",
       "\n",
       "   gtruth_answer_quality_score  \\\n",
       "24                      Medium   \n",
       "25                      Medium   \n",
       "\n",
       "                  gtruth_answer_quality_justification  \\\n",
       "24  The answer provides a detailed description of ...   \n",
       "25  The answer provides some relevant information ...   \n",
       "\n",
       "                                           llm_answer  cos_similarity  \\\n",
       "24  The assay uses human neural crest cells (NCCs)...        0.660511   \n",
       "25                     Answer not found in documents.        0.139616   \n",
       "\n",
       "    bert_precision  bert_recall   bert_f1  \n",
       "24        0.207217     0.018954  0.109221  \n",
       "25       -0.496027    -0.030358 -0.325143  "
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.iloc[24:26,:]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "question",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "gtruth_answer",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "gtruth_answer_quality_score",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "gtruth_answer_quality_justification",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "llm_answer",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "cos_similarity",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "bert_precision",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "bert_recall",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "bert_f1",
         "rawType": "float64",
         "type": "float"
        }
       ],
       "ref": "d3c39353-a6ef-4851-9fe8-b59e803a006b",
       "rows": [
        [
         "27",
         "Give known causes of variability for final test system state. Indicate critical consumables or batch effects (e.g. plate format and supplier, batch effects of FCS or serum replacement, additives). Indicate critical handling steps, and/or influencing factors identified (e.g. special care needed in pipetting, steps that need to be performed quickly, cell density). Indicate positive and negative controls and their expected values, and accepted deviation within and between the test repeats. Give recommendations to increase/ensure reproducibility and performance.",
         "Causes of variability: - High passage number of iPSC maintenance might influence NCC differentiation - Too little cell density at the start of differentiation can cause problems (confluency should be 80- 100%) - For the freeze and thaw processes a fast handling is important to avoid cells to stay at 10% DMSO for too long. This can decrease number of viable cells after thawing.",
         "Medium",
         "The answer partially addresses the question by mentioning some causes of variability such as high passage number, cell density, and handling during freeze and thaw processes. However, it lacks details on critical consumables, batch effects, specific handling steps, controls, expected values, and recommendations for reproducibility and performance.",
         "The known causes of variability for the final test system state in the cMINC (UKN2) assay include several factors related to cell maintenance, differentiation, handling, and assay execution. Critical consumables and batch effects encompass batch effects of critical additives such as holo-transferrin and TGF-β, which can influence cell differentiation and performance. Variability can also arise from differences in plate format and supplier, as well as from batch effects of fetal calf serum (FCS) or serum replacements used during cell culture.\n\nCritical handling steps and influencing factors include:\n- Maintaining cells at low passage numbers (up to 10 passages) to prevent performance decline.\n- Ensuring proper cell density at seeding (80–100% confluency) during differentiation; too low or too high density can cause detachment or spontaneous differentiation.\n- Handling of cells during thawing and freezing, where rapid processing is essential to preserve viability (>90%) and prevent DMSO toxicity.\n- Precise pipetting, especially during compound addition, as errors can lead to variability in exposure concentrations.\n- Performing medium changes and compound additions swiftly to minimize time cells spend at room temperature, which can affect cell viability and behavior.\n- Consistent coating procedures and well handling to prevent edge effects, with inner wells used for testing.\n\nPositive controls (e.g., cytochalasin D, LiCl, taxol) are expected to inhibit migration significantly, with migration reduced to ≤75% of control, and viability >90%. Negative controls (solvent DMSO, paracetamol, ASS) should show no significant inhibition, with migration >80% of control and viability >90%. Deviations beyond these thresholds (e.g., negative control decreasing migration by ≥10%) may lead to test discard.\n\nRecommendations to increase reproducibility and performance include:\n- Using well-characterized, consistent batches of critical additives and reagents.\n- Limiting cell passage number and verifying pluripotency markers regularly.\n- Standardizing cell seeding density and differentiation protocols.\n- Ensuring rapid and precise pipetting, with operator training to minimize technical variability.\n- Including internal controls in each run and monitoring their responses to detect assay drift.\n- Performing assay runs with multiple replicates and normalizing data to untreated controls.\n- Documenting all handling steps meticulously and adhering to SOPs.\n- Regularly calibrating and maintaining imaging equipment to ensure consistent image quality.\n- Conducting inter-operator training and, if possible, cross-validation between operators to reduce operator-dependent variability.",
         "0.653235214537423",
         "0.2374215871095657",
         "-0.0786594972014427",
         "0.0614935308694839"
        ]
       ],
       "shape": {
        "columns": 9,
        "rows": 1
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>question</th>\n",
       "      <th>gtruth_answer</th>\n",
       "      <th>gtruth_answer_quality_score</th>\n",
       "      <th>gtruth_answer_quality_justification</th>\n",
       "      <th>llm_answer</th>\n",
       "      <th>cos_similarity</th>\n",
       "      <th>bert_precision</th>\n",
       "      <th>bert_recall</th>\n",
       "      <th>bert_f1</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>Give known causes of variability for final tes...</td>\n",
       "      <td>Causes of variability: - High passage number o...</td>\n",
       "      <td>Medium</td>\n",
       "      <td>The answer partially addresses the question by...</td>\n",
       "      <td>The known causes of variability for the final ...</td>\n",
       "      <td>0.653235</td>\n",
       "      <td>0.237422</td>\n",
       "      <td>-0.078659</td>\n",
       "      <td>0.061494</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                             question  \\\n",
       "27  Give known causes of variability for final tes...   \n",
       "\n",
       "                                        gtruth_answer  \\\n",
       "27  Causes of variability: - High passage number o...   \n",
       "\n",
       "   gtruth_answer_quality_score  \\\n",
       "27                      Medium   \n",
       "\n",
       "                  gtruth_answer_quality_justification  \\\n",
       "27  The answer partially addresses the question by...   \n",
       "\n",
       "                                           llm_answer  cos_similarity  \\\n",
       "27  The known causes of variability for the final ...        0.653235   \n",
       "\n",
       "    bert_precision  bert_recall   bert_f1  \n",
       "27        0.237422    -0.078659  0.061494  "
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.iloc[27:28,:]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "question",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "gtruth_answer",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "gtruth_answer_quality_score",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "gtruth_answer_quality_justification",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "llm_answer",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "cos_similarity",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "bert_precision",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "bert_recall",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "bert_f1",
         "rawType": "float64",
         "type": "float"
        }
       ],
       "ref": "b27d23e1-8e5c-4c1f-8c7a-f41752dc5721",
       "rows": [
        [
         "24",
         "Describe the test system as it is used in the test. If the generation of the test system involves differentiation steps or complex technical manipulation (e.g. formation of microtissues), this is described in 3.6. Give details on the general features/principles of the culture protocol (collagen embedding, 3D structuring, addition of mitotic inhibitors, addition of particular hormones/growth factors, etc.) of the cells that are used for the test. What is the percentage of contaminating cells; in co-cultures what is the percentage of each subpopulation? Are there subpopulations that are generally more sensitive to cytotoxicity than others, and could this influence viability measures? Is it known whether specific chemicals/chemical classes show differential cytotoxicity for the cell sub-populations used?",
         "A highly homogeneous pre-differentiated population of neural crest cells is added to coated wells. In the middle of the well is a silicone stopper that prevents cells from settling in a circular area in the middle of the well. The cells are kept viable and alive by the presence of EGF and FGF in the medium, and they become adherent overnight. When the stopper is removed, the cells form a dense monolayer in the culture dish, with a sharply demarcated circular area in the middle that is free of cells. Due to their natural spontaneous migration behaviour, the cells move into the cell-free area. The cells are still in a proliferative state. Proliferation at the edge of the cell free area contributes to a small extent to “apparent migration behaviour”. This has been characterized and quantified in detail (Nyffeler et al. 2016). It is accounted for by counting cells in a narrower circle than the original circular area.",
         "Medium",
         "The answer provides a detailed description of the test system, including the culture protocol and cell behavior. However, it lacks information on the percentage of contaminating cells, the percentage of each subpopulation in co-cultures, and whether specific chemicals show differential cytotoxicity for the cell sub-populations used. These omissions prevent a 'High' score.",
         "The assay uses human neural crest cells (NCCs) derived from induced pluripotent stem cells (iPSCs). The differentiation process involves several steps: starting from undifferentiated hiPSCs maintained on Laminin-521 in E8 medium, cells are plated on Matrigel-coated plates and induced to differentiate into NCCs following a modified protocol based on Mica et al. (2013). During differentiation, cells are treated with specific growth factors and signaling molecules, such as Noggin, SB431542, CHIR99021, EGF, and FGF2, over a period of approximately 35-39 days, culminating in a highly homogeneous population of NCCs.\n\nThe derived NCCs are characterized by expressing typical NCC markers (HNK-1, p75, nestin, AP2) and lack expression of markers for other cell types such as GFAP, Pax6, and βIII tubulin, indicating a predominantly NCC phenotype. The cells are maintained as a monolayer on coated surfaces (PLO/Laminin/Fibronectin) and are kept viable with growth factors (EGF and FGF2). They are cryopreserved at a concentration of 4×10^6 cells/ml in N2-S medium with DMSO until use.\n\nIn the test system, NCCs are seeded as a highly homogeneous population (>90% positive for NCC markers) into wells with a silicone stopper creating a circular cell-free zone. After attachment, the stopper is removed, allowing cells to migrate into the free area, which models in vivo NCC migration. The assay measures the impairment of migration and cell viability after exposure to test compounds.\n\nRegarding contamination and subpopulations, the NCC cultures are characterized to be ≥90% positive for NCC markers, indicating minimal contamination with other cell types. The protocol does not specify the presence of other subpopulations or their proportions, but the high purity suggests that the culture is predominantly NCCs. There is no detailed information on whether specific subpopulations within NCCs show differential sensitivity to cytotoxicity; however, since the cultures are highly homogeneous, the influence of subpopulation sensitivity on viability measures is likely minimal.\n\nAs for differential cytotoxicity among chemical classes, the document does not specify whether certain chemicals or classes preferentially affect subpopulations within NCCs. The assay primarily assesses overall migration impairment and viability of the NCC population as a whole, and the high homogeneity of the cells used reduces the likelihood of subpopulation-specific effects influencing the overall viability measures.",
         "0.6605110180921907",
         "0.2072174996137619",
         "0.0189544204622507",
         "0.1092212870717048"
        ],
        [
         "25",
         "What are the endpoint(s) that you use to control that your culture(s) is/are as expected at the start of toxicity testing (e.g. gene expression, staining, morphology, responses to reference chemicals, etc.)? Describe the acceptance criteria for your test system, i.e. the quality criteria for your cells/tissues/organoids: Which endpoints do you consider to describe the cells or other source material, which parameters are important? Describe the (analytical) methods that you use to evaluate your culture (PCR, ATP measurement) and to measure the acceptance criteria (AC). Which values (e.g. degree of differentiation or cell density) need to be reached/should not be reached? Historical controls: How does your test system perform with regard to the acceptance criteria, e.g. when differentiation is performed 10 times, what is the average and variation of the values for the acceptance criteria parameters)? Indicate actions if the AC are not met. Examples: cell are > 90% viable, or > 98% of cells express marker x (e.g. AP-2), or > 80% of the cells attach, etc.",
         "Figure 3: Characterization of the cellular system. (A) Differentiation schema of NCCs from human induced pluripotent stem cells. (B) Expression of the NCC markers HNK-1 and p75 was monitored by FACS analysis. (C) After thawing the cells were immunofluorescently labelled for the typical NCC markers p75, HNK1 and AP2. Scale bar: 50 µm. (D) Typical mesenchymal like cell morphology of NCCs. Cells were double-stained for nestin and f-actin. Scale bar: 10 µm. The derived NCCs are ≥ 90% positive for the NCC marker human natural killer-1 (HNK1) and the nerve low affinity nerve growth factor receptor p75. Additionally, the cells express the stem cell microfilament protein nestin and AP2. On the other hand, none of the cells show expression of the astrocyte marker GFAP, the central nervous system precursor cell marker Pax6 and the neuronal marker βIII tubulin. Furthermore, the functional capability of the cells is checked by performing the cMINC assay with endpoint specific controls. The cells have to be pathogen-free to be used in further experiments (regular testing for mycoplasma after thawing). After thawing the viability should be > 90%.",
         "Medium",
         "The answer provides some relevant information about the characterization of the cellular system, including markers and morphology, and mentions viability criteria. However, it lacks detailed acceptance criteria, specific analytical methods, and historical control data. It also does not specify actions if acceptance criteria are not met.",
         "Answer not found in documents.",
         "0.1396155404212514",
         "-0.4960272014141083",
         "-0.0303580984473228",
         "-0.3251430988311767"
        ],
        [
         "26",
         "Describe the acceptance criteria for your test system, i.e. the quality criteria for your cells/tissues/organoids: Which endpoints do you consider to describe the cells or other source material, which parameters are important? Which values (e.g. degree of differentiation or cell density) need to be reached/should not be reached? Historical controls: How does your test system perform with regard to the acceptance criteria, e.g. when differentiation is performed 10 times, what is the average and variation of the values for the acceptance criteria parameters)? Indicate actions if the AC are not met. Examples: Usual neurite length is 50 ±15 μm; experiments with average neurite length below 25 μm in the negative controls (NC) are discarded. Usual nestin induction is 200 ±40 fold, experiments with inductions below 80-fold for NC are discarded.",
         "After compound treatment, the negative controls should fulfil the following: - cells should be migrated into the cell free area - cell viability should be > 90%",
         "Low",
         "The answer does not adequately address the question. It provides minimal information about acceptance criteria, focusing only on cell migration and viability, without discussing endpoints, parameters, historical controls, or actions if criteria are not met. It lacks detail and completeness required to fully address the question.",
         "The acceptance criteria for the cMINC (UKN2) assay's source cells focus on ensuring the quality and consistency of the neural crest cell (NCC) population used in the test. The key endpoints and parameters include:\n\n- **Expression of NCC markers:** The cells must be ≥ 90% positive for the NCC markers HNK-1 and p75, as confirmed by FACS analysis and immunofluorescence labeling (Source: cMINC(UKN2).pdf).\n- **Pathogen-free status:** Cells must be free of pathogens, including mycoplasma, verified through regular testing (Source: cMINC(UKN2).pdf).\n- **Viability after thawing:** Viability should be > 90% immediately after thawing (Source: cMINC(UKN2).pdf).\n- **Differentiation and characterization:** The cells should express pluripotency markers (Oct4, Nanog, Tra-1-60) prior to differentiation, and after differentiation, they should exhibit typical NCC marker expression and morphology, with ≥ 90% positivity for HNK-1 and p75 (Source: cMINC(UKN2).pdf).\n\n**Historical performance and variation:**\n- The source cells are maintained up to 10 passages, with high consistency in marker expression and viability.\n- Variability between plates within a single experiment is lower than 5%, and between different experiments is lower than 20% (Source: cMINC(UKN2).pdf).\n- When differentiation is performed 10 times, the average expression of NCC markers (HNK-1 and p75) remains ≥ 90%, with a variation typically within ±5–10%. Cell viability consistently exceeds 90%.\n\n**Actions if acceptance criteria are not met:**\n- Cells showing less than 90% marker expression or viability are discarded.\n- Differentiation batches with marker expression below the threshold are not used for testing.\n- If cell morphology or marker expression indicates spontaneous differentiation or contamination, the batch is rejected and replaced.\n\nThese criteria ensure the source material's quality, reproducibility, and reliability for the migration impairment assay.",
         "0.5561523408506475",
         "0.1792346537113189",
         "-0.2403205186128616",
         "-0.0684783086180687"
        ],
        [
         "27",
         "Give known causes of variability for final test system state. Indicate critical consumables or batch effects (e.g. plate format and supplier, batch effects of FCS or serum replacement, additives). Indicate critical handling steps, and/or influencing factors identified (e.g. special care needed in pipetting, steps that need to be performed quickly, cell density). Indicate positive and negative controls and their expected values, and accepted deviation within and between the test repeats. Give recommendations to increase/ensure reproducibility and performance.",
         "Causes of variability: - High passage number of iPSC maintenance might influence NCC differentiation - Too little cell density at the start of differentiation can cause problems (confluency should be 80- 100%) - For the freeze and thaw processes a fast handling is important to avoid cells to stay at 10% DMSO for too long. This can decrease number of viable cells after thawing.",
         "Medium",
         "The answer partially addresses the question by mentioning some causes of variability such as high passage number, cell density, and handling during freeze and thaw processes. However, it lacks details on critical consumables, batch effects, specific handling steps, controls, expected values, and recommendations for reproducibility and performance.",
         "The known causes of variability for the final test system state in the cMINC (UKN2) assay include several factors related to cell maintenance, differentiation, handling, and assay execution. Critical consumables and batch effects encompass batch effects of critical additives such as holo-transferrin and TGF-β, which can influence cell differentiation and performance. Variability can also arise from differences in plate format and supplier, as well as from batch effects of fetal calf serum (FCS) or serum replacements used during cell culture.\n\nCritical handling steps and influencing factors include:\n- Maintaining cells at low passage numbers (up to 10 passages) to prevent performance decline.\n- Ensuring proper cell density at seeding (80–100% confluency) during differentiation; too low or too high density can cause detachment or spontaneous differentiation.\n- Handling of cells during thawing and freezing, where rapid processing is essential to preserve viability (>90%) and prevent DMSO toxicity.\n- Precise pipetting, especially during compound addition, as errors can lead to variability in exposure concentrations.\n- Performing medium changes and compound additions swiftly to minimize time cells spend at room temperature, which can affect cell viability and behavior.\n- Consistent coating procedures and well handling to prevent edge effects, with inner wells used for testing.\n\nPositive controls (e.g., cytochalasin D, LiCl, taxol) are expected to inhibit migration significantly, with migration reduced to ≤75% of control, and viability >90%. Negative controls (solvent DMSO, paracetamol, ASS) should show no significant inhibition, with migration >80% of control and viability >90%. Deviations beyond these thresholds (e.g., negative control decreasing migration by ≥10%) may lead to test discard.\n\nRecommendations to increase reproducibility and performance include:\n- Using well-characterized, consistent batches of critical additives and reagents.\n- Limiting cell passage number and verifying pluripotency markers regularly.\n- Standardizing cell seeding density and differentiation protocols.\n- Ensuring rapid and precise pipetting, with operator training to minimize technical variability.\n- Including internal controls in each run and monitoring their responses to detect assay drift.\n- Performing assay runs with multiple replicates and normalizing data to untreated controls.\n- Documenting all handling steps meticulously and adhering to SOPs.\n- Regularly calibrating and maintaining imaging equipment to ensure consistent image quality.\n- Conducting inter-operator training and, if possible, cross-validation between operators to reduce operator-dependent variability.",
         "0.653235214537423",
         "0.2374215871095657",
         "-0.0786594972014427",
         "0.0614935308694839"
        ],
        [
         "28",
         "What is known about endogenous metabolic capacity (CYP system (phase I); relevant conjugation reactions (phase II))? What is known about other pathways relevant to xenobiotic metabolism? What specific information is there on transporter activity?",
         "No specific information available.",
         "Low",
         "The answer does not address the question as it provides no information about the endogenous metabolic capacity, relevant pathways, or transporter activity. It simply states that no specific information is available, which does not contribute to answering the question.",
         "Answer not found in documents.",
         "0.3188048178824792",
         "0.3032091856002807",
         "0.2845627665519714",
         "0.2966619729995727"
        ],
        [
         "29",
         "Are there transcriptomics data or other omics data available that describe the test system (characterization of cells without compounds)? Briefly list and describe such data. Indicate the type of data available (e.g. RNASeq or proteomics data). Refer to data file, data base or publication.",
         "Transcriptomics data (unpublished) will become available from the originator lab (Leist) upon request.",
         "Low",
         "The answer does not provide a list or description of the available omics data, nor does it specify the type of data (e.g., RNASeq or proteomics). It only mentions that transcriptomics data will be available upon request, which does not address the question adequately.",
         "Answer not found in documents.",
         "0.1304111291782479",
         "-0.0027272182051092",
         "0.0901263654232025",
         "0.045598741620779"
        ],
        [
         "30",
         "Give information on where the test system differs from the mimicked human tissue and which gaps of analogy need to be considered.",
         "- The cells are able to migrate mostly as single cells; they show some evidence of collective migration - Cells show invasive behaviour in a 3D environment (e.g. transwell assay)",
         "Low",
         "The answer does not address the question about differences between the test system and mimicked human tissue or the gaps of analogy. It only describes cell behavior without comparing it to human tissue.",
         "Answer not found in documents.",
         "0.0918829473527212",
         "-0.1728177815675735",
         "-0.0041292561218142",
         "-0.0913514196872711"
        ],
        [
         "31",
         "Are there elements of the test system that are protected by patents or any other means?",
         "The cells are not protected by patents or any other licences.",
         "Medium",
         "The answer addresses the question regarding patent protection for the cells but does not mention other elements of the test system that might be protected by patents or other means. It lacks completeness.",
         "Answer not found in documents.",
         "0.1879438574153945",
         "0.1285031288862228",
         "0.2187772691249847",
         "0.1753157377243042"
        ],
        [
         "32",
         "Fill only if section 3 has not been answered. Provide the SOP for the general maintenance procedure as a database link. This should also include the following information: How are the cells maintained outside the experiment (basic cell propagation)? How pure is the cell population (average, e.g. 95% of iPSC cells Oct4-positive)? What are the quality control measures and acceptance criteria for each cell batch? Which number(s) passage(s) can be used in the test? Is Good Cell Culture Practice (GCCP) and/or Good In Vitro Method Practice (GIVIMP) followed? How long can same cell batches be used? How are freezing stocks and cell banks prepared? For primary cells: how are they obtained in general and what are they characterized for (and what are inclusion and exclusion criteria).",
         "Brief description is in section 3 of this file. Detailed maintenance is described in the DB-ALM SOP n° 195 available at: http://cidportal.jrc.ec.europa.eu/ftp/jrc-opendata/EURL-ECVAM/datasets/DBALM/VER2- 0/online/DBALM_docs/195_P_cMINC.pdf A lab-internal handling protocol is also available upon request to the Leist-lab.",
         "Medium",
         "The answer provides a link to a detailed SOP and mentions an internal protocol, which partially addresses the question. However, it lacks specific information on cell maintenance, purity, quality control, passage numbers, GCCP/GIVIMP compliance, cell batch usage duration, freezing stocks preparation, and primary cell characterization. The answer is incomplete and lacks clarity on several required details.",
         "Answer not found in documents.",
         "0.1657412021722263",
         "-0.4586300253868103",
         "0.0792196691036224",
         "-0.2668550312519073"
        ],
        [
         "33",
         "Provide an exposure scheme (graphically, show timelines, addition of medium supplements and compounds, sampling, etc.), within the context of the overall cell culture scheme (e.g. freshly re-plated cells or confluent cells at start, certain coatings, etc.). Include medium changes, cell re-plating, whether compounds are re-added in cases of medium change, critical medium supplements, etc.",
         "Figure 4: Exposure scheme and assay procedure. Day -1: The wells are coated with PLO/laminin/fibronectin. Then, silicone stoppers are placed into the wells of a 96-well plate. Cells are seeded around the stoppers and allowed to attach. Day 0: The silicone stoppers are removed and the medium is replaced with pre-warmed, fresh N2-S medium containing the cytokines EGF and FGF. Cells are allowed to migrate into the cell free area. Day 1: 25 µl of the 5x concentrated toxicants are added to the wells. The cells plus toxicants are incubated for 24 h. Day 2: Cells are stained with calcein-AM and Hoechst (H-33342) for 30 min before imaging with a high content imaging microscope. Quantification of migration and viability is done by high content imaging analysis.",
         "High",
         "The answer provides a detailed and clear exposure scheme, including timelines, medium changes, and the addition of supplements and compounds. It specifies the initial cell culture conditions, the use of coatings, and the procedure for medium changes and compound addition. The description of the assay procedure and sampling is comprehensive and relevant to the question.",
         "The exposure scheme for the cMINC (UKN2) assay is integrated into the overall cell culture process as follows:\n\n- **Day -1:** Coating of wells with PLO/laminin/fibronectin, placement of silicone stoppers in 96-well plates, and seeding of neural crest cells (NCCs) around the stoppers. Cells are allowed to attach overnight.\n\n- **Day 0:** Removal of silicone stoppers to create a cell-free zone. The medium is replaced with pre-warmed N2-S medium containing EGF and FGF to promote cell viability and migration. Cells are allowed to adhere and start migrating into the free zone.\n\n- **Day 1:** Addition of test compounds (toxicants) at specified concentrations (25 µl of 5x concentrated solutions). The compounds are present during the 24-hour incubation period, allowing assessment of migration inhibition and viability.\n\n- **Day 2:** Post-exposure, cells are stained with calcein-AM and Hoechst 33342 for 30 minutes. Imaging is performed to quantify migration and viability.\n\n**Additional details:**\n\n- **Medium changes:** The medium is replaced at Day 0 after initial cell attachment and at the start of the migration phase. During the compound exposure (Day 1), no medium change occurs; compounds are added directly to the existing medium.\n\n- **Compound re-addition:** Compounds are only added once at Day 1; they are not re-added after medium changes, as the exposure duration is 24 hours.\n\n- **Critical medium supplements:** EGF and FGF are maintained in the medium throughout the migration phase to sustain cell viability and migration capacity.\n\n- **Cell culture context:** Cells are freshly seeded around the silicone stoppers on Day -1, ensuring they are in a proliferative, migratory state at the start of exposure. The assay duration from Day 0 to Day 2 is 24 hours of compound exposure.\n\nThis scheme ensures that the cells are in optimal conditions for migration during the exposure period, with compounds present throughout the critical migration window, and medium supplemented with necessary growth factors.",
         "0.8063022638028429",
         "0.4278606176376343",
         "0.1050155758857727",
         "0.2500127851963043"
        ],
        [
         "34",
         "Define the specific endpoint(s) of the test system that you use for toxicity testing (e.g. cytotoxicity, cell migration, etc.). Indicate whether cytotoxicity is the primary endpoint. What are secondary/further endpoints? Also describe here potential reference/normalization endpoints (e.g. cytotoxicity, protein content, housekeeping gene expression) that are used for normalization of the primary endpoint.",
         "Specific Endpoint: Migration inhibition Reference endpoint: Cell viability Note: Migration induction is also possible to assess, but complex in its toxicological interpretation. Therefore only unidirectional migration is assessed as an endpoint if the method is used in a standardized testing procedure in the prediction model.",
         "Medium",
         "The answer partially addresses the question by identifying migration inhibition as a specific endpoint and cell viability as a reference endpoint. However, it lacks clarity and completeness as it does not explicitly state whether cytotoxicity is the primary endpoint, nor does it mention any secondary endpoints or further reference/normalization endpoints beyond cell viability.",
         "The specific endpoint of the assay is migration inhibition of human neural crest cells (NCCs). Cell migration is the primary endpoint used for toxicity testing in this system. Cell viability is measured as a secondary endpoint to assess cytotoxicity and is used for normalization purposes. The assay quantifies the number of migrated NCCs into the cell-free zone after exposure to potential toxicants, with migration inhibition being the main focus. Cell viability is also measured to ensure that observed migration effects are not solely due to cytotoxicity, and it serves as a reference or normalization endpoint to interpret migration data accurately (Source: cMINC(UKN2).pdf).",
         "0.7786172728061955",
         "0.1705653965473175",
         "0.0301336105912923",
         "0.0997917056083679"
        ],
        [
         "35",
         "Define and describe the principle(s) of the analytical methods used. Provide here a general overview of the method’s key steps (e.g. cells are fixed or not, homogenized sample or not, etc.), sufficient for reviewers/regulators to understand what was done, but not in all detail for direct repetition. If you have two or more endpoints (e.g. viability and neurite outgrowth), do you measure both in the same well, under same conditions in parallel, or independently of each other? For imaging endpoints: Explain in general how quantification algorithm or how semi-quantitative estimates are obtained and how many cells are imaged (roughly).",
         "Migration inhibition: NCCs are plated around silicone stoppers in a culture dish and are allowed to migrate into the cell free area upon removal of the stopper. The number of migrated cells into the cell free zone is quantified 24 h after toxicant treatment. Migration inhibition of NCCs after treatment with toxicants is measured relative to control conditions (solvent control cells). For the quantification the cells are stained with calcein-AM and H-33342 for 30 min at 37 °C. The center of the well (migration zone) is imaged in four tiles with a 5x objective. Afterwards the four images are stitched together to obtain one image. For migration quantification, a software tool has been developed (http://invitrotox.uni-konstanz.de/). With the help of this software the previously cell-free area can be estimated and the number of H-33342 and calcein double-positive cells in the region of interest (ROI) can be counted. The diameter of the ROI was chosen so that 150 to 300 cells were in the ROI in untreated conditions. An Excel table containing the number of viable cells in the ROI of all wells of the plate is generated by the software. Cell viability: Cell viability is measured after 48 h outside the migration zone in the same well. The cells are stained with calcein-AM and H-33342 and four fields outside the migration zone are imaged with a 10x objective. Viability is defined as the number of H-33342 and calcein double-positive cells, viable cells are determined by an automated algorithm. An excel file is generated with the number of viable cells in each well. Migration and Viability are normalized to untreated controls.",
         "High",
         "The answer provides a comprehensive overview of the analytical methods used, including the key steps involved in the migration inhibition and cell viability assays. It describes the plating and imaging process, the staining procedure, and the software used for quantification. The explanation includes how endpoints are measured, both in the same well and under different conditions, and details the imaging and quantification process. This level of detail is sufficient for reviewers to understand the methodology without being able to directly replicate it, which aligns well with the requirements of the question.",
         "The assay employs high content imaging to assess two key endpoints: migration inhibition and cell viability, in human neural crest cells (NCCs). The process involves staining the cells with calcein-AM (for live cells) and Hoechst 33342 (for nuclei), followed by automated imaging. The cells are not fixed; live-cell dyes are used to enable real-time assessment of viability and migration behavior.\n\nFor the migration endpoint, NCCs are seeded around a silicone stopper in a well, allowed to adhere, and then the stopper is removed to create a cell-free zone. Cells migrate into this zone over 24 hours. After exposure to test compounds, the cells are stained with calcein-AM and Hoechst 33342, and images are acquired in four tiles per well using a high content imaging system. The quantification algorithm estimates the previously cell-free area and counts the number of double-positive (calcein and Hoechst) cells within a defined region of interest (ROI). Typically, 150–300 cells are imaged per ROI, and the software automatically counts viable cells based on fluorescence signals.\n\nCell viability is measured in the same wells, outside the migration zone, by imaging four fields per well with a 10x objective. The same fluorescent dyes are used, and automated algorithms determine the number of double-positive cells, representing viable nuclei. Both endpoints are measured under the same conditions and in parallel within the same well, allowing direct comparison of migration and viability data.\n\nThe quantification relies on automated image analysis software that estimates the number of viable cells based on fluorescence intensity and cell morphology, providing semi-quantitative counts. The software calculates the number of double-positive cells in the ROI, enabling objective and reproducible measurement of migration and viability.",
         "0.8323899274357207",
         "0.3053684830665588",
         "0.2706019878387451",
         "0.2906288802623749"
        ]
       ],
       "shape": {
        "columns": 9,
        "rows": 12
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>question</th>\n",
       "      <th>gtruth_answer</th>\n",
       "      <th>gtruth_answer_quality_score</th>\n",
       "      <th>gtruth_answer_quality_justification</th>\n",
       "      <th>llm_answer</th>\n",
       "      <th>cos_similarity</th>\n",
       "      <th>bert_precision</th>\n",
       "      <th>bert_recall</th>\n",
       "      <th>bert_f1</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>Describe the test system as it is used in the ...</td>\n",
       "      <td>A highly homogeneous pre-differentiated popula...</td>\n",
       "      <td>Medium</td>\n",
       "      <td>The answer provides a detailed description of ...</td>\n",
       "      <td>The assay uses human neural crest cells (NCCs)...</td>\n",
       "      <td>0.660511</td>\n",
       "      <td>0.207217</td>\n",
       "      <td>0.018954</td>\n",
       "      <td>0.109221</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>What are the endpoint(s) that you use to contr...</td>\n",
       "      <td>Figure 3: Characterization of the cellular sys...</td>\n",
       "      <td>Medium</td>\n",
       "      <td>The answer provides some relevant information ...</td>\n",
       "      <td>Answer not found in documents.</td>\n",
       "      <td>0.139616</td>\n",
       "      <td>-0.496027</td>\n",
       "      <td>-0.030358</td>\n",
       "      <td>-0.325143</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>Describe the acceptance criteria for your test...</td>\n",
       "      <td>After compound treatment, the negative control...</td>\n",
       "      <td>Low</td>\n",
       "      <td>The answer does not adequately address the que...</td>\n",
       "      <td>The acceptance criteria for the cMINC (UKN2) a...</td>\n",
       "      <td>0.556152</td>\n",
       "      <td>0.179235</td>\n",
       "      <td>-0.240321</td>\n",
       "      <td>-0.068478</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>Give known causes of variability for final tes...</td>\n",
       "      <td>Causes of variability: - High passage number o...</td>\n",
       "      <td>Medium</td>\n",
       "      <td>The answer partially addresses the question by...</td>\n",
       "      <td>The known causes of variability for the final ...</td>\n",
       "      <td>0.653235</td>\n",
       "      <td>0.237422</td>\n",
       "      <td>-0.078659</td>\n",
       "      <td>0.061494</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>What is known about endogenous metabolic capac...</td>\n",
       "      <td>No specific information available.</td>\n",
       "      <td>Low</td>\n",
       "      <td>The answer does not address the question as it...</td>\n",
       "      <td>Answer not found in documents.</td>\n",
       "      <td>0.318805</td>\n",
       "      <td>0.303209</td>\n",
       "      <td>0.284563</td>\n",
       "      <td>0.296662</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>Are there transcriptomics data or other omics ...</td>\n",
       "      <td>Transcriptomics data (unpublished) will become...</td>\n",
       "      <td>Low</td>\n",
       "      <td>The answer does not provide a list or descript...</td>\n",
       "      <td>Answer not found in documents.</td>\n",
       "      <td>0.130411</td>\n",
       "      <td>-0.002727</td>\n",
       "      <td>0.090126</td>\n",
       "      <td>0.045599</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>Give information on where the test system diff...</td>\n",
       "      <td>- The cells are able to migrate mostly as sing...</td>\n",
       "      <td>Low</td>\n",
       "      <td>The answer does not address the question about...</td>\n",
       "      <td>Answer not found in documents.</td>\n",
       "      <td>0.091883</td>\n",
       "      <td>-0.172818</td>\n",
       "      <td>-0.004129</td>\n",
       "      <td>-0.091351</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>Are there elements of the test system that are...</td>\n",
       "      <td>The cells are not protected by patents or any ...</td>\n",
       "      <td>Medium</td>\n",
       "      <td>The answer addresses the question regarding pa...</td>\n",
       "      <td>Answer not found in documents.</td>\n",
       "      <td>0.187944</td>\n",
       "      <td>0.128503</td>\n",
       "      <td>0.218777</td>\n",
       "      <td>0.175316</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>Fill only if section 3 has not been answered. ...</td>\n",
       "      <td>Brief description is in section 3 of this file...</td>\n",
       "      <td>Medium</td>\n",
       "      <td>The answer provides a link to a detailed SOP a...</td>\n",
       "      <td>Answer not found in documents.</td>\n",
       "      <td>0.165741</td>\n",
       "      <td>-0.458630</td>\n",
       "      <td>0.079220</td>\n",
       "      <td>-0.266855</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>Provide an exposure scheme (graphically, show ...</td>\n",
       "      <td>Figure 4: Exposure scheme and assay procedure....</td>\n",
       "      <td>High</td>\n",
       "      <td>The answer provides a detailed and clear expos...</td>\n",
       "      <td>The exposure scheme for the cMINC (UKN2) assay...</td>\n",
       "      <td>0.806302</td>\n",
       "      <td>0.427861</td>\n",
       "      <td>0.105016</td>\n",
       "      <td>0.250013</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>Define the specific endpoint(s) of the test sy...</td>\n",
       "      <td>Specific Endpoint: Migration inhibition Refere...</td>\n",
       "      <td>Medium</td>\n",
       "      <td>The answer partially addresses the question by...</td>\n",
       "      <td>The specific endpoint of the assay is migratio...</td>\n",
       "      <td>0.778617</td>\n",
       "      <td>0.170565</td>\n",
       "      <td>0.030134</td>\n",
       "      <td>0.099792</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>Define and describe the principle(s) of the an...</td>\n",
       "      <td>Migration inhibition: NCCs are plated around s...</td>\n",
       "      <td>High</td>\n",
       "      <td>The answer provides a comprehensive overview o...</td>\n",
       "      <td>The assay employs high content imaging to asse...</td>\n",
       "      <td>0.832390</td>\n",
       "      <td>0.305368</td>\n",
       "      <td>0.270602</td>\n",
       "      <td>0.290629</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                             question  \\\n",
       "24  Describe the test system as it is used in the ...   \n",
       "25  What are the endpoint(s) that you use to contr...   \n",
       "26  Describe the acceptance criteria for your test...   \n",
       "27  Give known causes of variability for final tes...   \n",
       "28  What is known about endogenous metabolic capac...   \n",
       "29  Are there transcriptomics data or other omics ...   \n",
       "30  Give information on where the test system diff...   \n",
       "31  Are there elements of the test system that are...   \n",
       "32  Fill only if section 3 has not been answered. ...   \n",
       "33  Provide an exposure scheme (graphically, show ...   \n",
       "34  Define the specific endpoint(s) of the test sy...   \n",
       "35  Define and describe the principle(s) of the an...   \n",
       "\n",
       "                                        gtruth_answer  \\\n",
       "24  A highly homogeneous pre-differentiated popula...   \n",
       "25  Figure 3: Characterization of the cellular sys...   \n",
       "26  After compound treatment, the negative control...   \n",
       "27  Causes of variability: - High passage number o...   \n",
       "28                 No specific information available.   \n",
       "29  Transcriptomics data (unpublished) will become...   \n",
       "30  - The cells are able to migrate mostly as sing...   \n",
       "31  The cells are not protected by patents or any ...   \n",
       "32  Brief description is in section 3 of this file...   \n",
       "33  Figure 4: Exposure scheme and assay procedure....   \n",
       "34  Specific Endpoint: Migration inhibition Refere...   \n",
       "35  Migration inhibition: NCCs are plated around s...   \n",
       "\n",
       "   gtruth_answer_quality_score  \\\n",
       "24                      Medium   \n",
       "25                      Medium   \n",
       "26                         Low   \n",
       "27                      Medium   \n",
       "28                         Low   \n",
       "29                         Low   \n",
       "30                         Low   \n",
       "31                      Medium   \n",
       "32                      Medium   \n",
       "33                        High   \n",
       "34                      Medium   \n",
       "35                        High   \n",
       "\n",
       "                  gtruth_answer_quality_justification  \\\n",
       "24  The answer provides a detailed description of ...   \n",
       "25  The answer provides some relevant information ...   \n",
       "26  The answer does not adequately address the que...   \n",
       "27  The answer partially addresses the question by...   \n",
       "28  The answer does not address the question as it...   \n",
       "29  The answer does not provide a list or descript...   \n",
       "30  The answer does not address the question about...   \n",
       "31  The answer addresses the question regarding pa...   \n",
       "32  The answer provides a link to a detailed SOP a...   \n",
       "33  The answer provides a detailed and clear expos...   \n",
       "34  The answer partially addresses the question by...   \n",
       "35  The answer provides a comprehensive overview o...   \n",
       "\n",
       "                                           llm_answer  cos_similarity  \\\n",
       "24  The assay uses human neural crest cells (NCCs)...        0.660511   \n",
       "25                     Answer not found in documents.        0.139616   \n",
       "26  The acceptance criteria for the cMINC (UKN2) a...        0.556152   \n",
       "27  The known causes of variability for the final ...        0.653235   \n",
       "28                     Answer not found in documents.        0.318805   \n",
       "29                     Answer not found in documents.        0.130411   \n",
       "30                     Answer not found in documents.        0.091883   \n",
       "31                     Answer not found in documents.        0.187944   \n",
       "32                     Answer not found in documents.        0.165741   \n",
       "33  The exposure scheme for the cMINC (UKN2) assay...        0.806302   \n",
       "34  The specific endpoint of the assay is migratio...        0.778617   \n",
       "35  The assay employs high content imaging to asse...        0.832390   \n",
       "\n",
       "    bert_precision  bert_recall   bert_f1  \n",
       "24        0.207217     0.018954  0.109221  \n",
       "25       -0.496027    -0.030358 -0.325143  \n",
       "26        0.179235    -0.240321 -0.068478  \n",
       "27        0.237422    -0.078659  0.061494  \n",
       "28        0.303209     0.284563  0.296662  \n",
       "29       -0.002727     0.090126  0.045599  \n",
       "30       -0.172818    -0.004129 -0.091351  \n",
       "31        0.128503     0.218777  0.175316  \n",
       "32       -0.458630     0.079220 -0.266855  \n",
       "33        0.427861     0.105016  0.250013  \n",
       "34        0.170565     0.030134  0.099792  \n",
       "35        0.305368     0.270602  0.290629  "
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.iloc[24:36,:]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "question",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "gtruth_answer",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "gtruth_answer_quality_score",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "gtruth_answer_quality_justification",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "llm_answer",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "cos_similarity",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "bert_precision",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "bert_recall",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "bert_f1",
         "rawType": "float64",
         "type": "float"
        }
       ],
       "ref": "0347ef5a-1fd6-420c-b1f8-3f6e01b43a3e",
       "rows": [
        [
         "34",
         "Define the specific endpoint(s) of the test system that you use for toxicity testing (e.g. cytotoxicity, cell migration, etc.). Indicate whether cytotoxicity is the primary endpoint. What are secondary/further endpoints? Also describe here potential reference/normalization endpoints (e.g. cytotoxicity, protein content, housekeeping gene expression) that are used for normalization of the primary endpoint.",
         "Specific Endpoint: Migration inhibition Reference endpoint: Cell viability Note: Migration induction is also possible to assess, but complex in its toxicological interpretation. Therefore only unidirectional migration is assessed as an endpoint if the method is used in a standardized testing procedure in the prediction model.",
         "Medium",
         "The answer partially addresses the question by identifying migration inhibition as a specific endpoint and cell viability as a reference endpoint. However, it lacks clarity and completeness as it does not explicitly state whether cytotoxicity is the primary endpoint, nor does it mention any secondary endpoints or further reference/normalization endpoints beyond cell viability.",
         "The specific endpoint of the assay is migration inhibition of human neural crest cells (NCCs). Cell migration is the primary endpoint used for toxicity testing in this system. Cell viability is measured as a secondary endpoint to assess cytotoxicity and is used for normalization purposes. The assay quantifies the number of migrated NCCs into the cell-free zone after exposure to potential toxicants, with migration inhibition being the main focus. Cell viability is also measured to ensure that observed migration effects are not solely due to cytotoxicity, and it serves as a reference or normalization endpoint to interpret migration data accurately (Source: cMINC(UKN2).pdf).",
         "0.7786172728061955",
         "0.1705653965473175",
         "0.0301336105912923",
         "0.0997917056083679"
        ],
        [
         "35",
         "Define and describe the principle(s) of the analytical methods used. Provide here a general overview of the method’s key steps (e.g. cells are fixed or not, homogenized sample or not, etc.), sufficient for reviewers/regulators to understand what was done, but not in all detail for direct repetition. If you have two or more endpoints (e.g. viability and neurite outgrowth), do you measure both in the same well, under same conditions in parallel, or independently of each other? For imaging endpoints: Explain in general how quantification algorithm or how semi-quantitative estimates are obtained and how many cells are imaged (roughly).",
         "Migration inhibition: NCCs are plated around silicone stoppers in a culture dish and are allowed to migrate into the cell free area upon removal of the stopper. The number of migrated cells into the cell free zone is quantified 24 h after toxicant treatment. Migration inhibition of NCCs after treatment with toxicants is measured relative to control conditions (solvent control cells). For the quantification the cells are stained with calcein-AM and H-33342 for 30 min at 37 °C. The center of the well (migration zone) is imaged in four tiles with a 5x objective. Afterwards the four images are stitched together to obtain one image. For migration quantification, a software tool has been developed (http://invitrotox.uni-konstanz.de/). With the help of this software the previously cell-free area can be estimated and the number of H-33342 and calcein double-positive cells in the region of interest (ROI) can be counted. The diameter of the ROI was chosen so that 150 to 300 cells were in the ROI in untreated conditions. An Excel table containing the number of viable cells in the ROI of all wells of the plate is generated by the software. Cell viability: Cell viability is measured after 48 h outside the migration zone in the same well. The cells are stained with calcein-AM and H-33342 and four fields outside the migration zone are imaged with a 10x objective. Viability is defined as the number of H-33342 and calcein double-positive cells, viable cells are determined by an automated algorithm. An excel file is generated with the number of viable cells in each well. Migration and Viability are normalized to untreated controls.",
         "High",
         "The answer provides a comprehensive overview of the analytical methods used, including the key steps involved in the migration inhibition and cell viability assays. It describes the plating and imaging process, the staining procedure, and the software used for quantification. The explanation includes how endpoints are measured, both in the same well and under different conditions, and details the imaging and quantification process. This level of detail is sufficient for reviewers to understand the methodology without being able to directly replicate it, which aligns well with the requirements of the question.",
         "The assay employs high content imaging to assess two key endpoints: migration inhibition and cell viability, in human neural crest cells (NCCs). The process involves staining the cells with calcein-AM (for live cells) and Hoechst 33342 (for nuclei), followed by automated imaging. The cells are not fixed; live-cell dyes are used to enable real-time assessment of viability and migration behavior.\n\nFor the migration endpoint, NCCs are seeded around a silicone stopper in a well, allowed to adhere, and then the stopper is removed to create a cell-free zone. Cells migrate into this zone over 24 hours. After exposure to test compounds, the cells are stained with calcein-AM and Hoechst 33342, and images are acquired in four tiles per well using a high content imaging system. The quantification algorithm estimates the previously cell-free area and counts the number of double-positive (calcein and Hoechst) cells within a defined region of interest (ROI). Typically, 150–300 cells are imaged per ROI, and the software automatically counts viable cells based on fluorescence signals.\n\nCell viability is measured in the same wells, outside the migration zone, by imaging four fields per well with a 10x objective. The same fluorescent dyes are used, and automated algorithms determine the number of double-positive cells, representing viable nuclei. Both endpoints are measured under the same conditions and in parallel within the same well, allowing direct comparison of migration and viability data.\n\nThe quantification relies on automated image analysis software that estimates the number of viable cells based on fluorescence intensity and cell morphology, providing semi-quantitative counts. The software calculates the number of double-positive cells in the ROI, enabling objective and reproducible measurement of migration and viability.",
         "0.8323899274357207",
         "0.3053684830665588",
         "0.2706019878387451",
         "0.2906288802623749"
        ]
       ],
       "shape": {
        "columns": 9,
        "rows": 2
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>question</th>\n",
       "      <th>gtruth_answer</th>\n",
       "      <th>gtruth_answer_quality_score</th>\n",
       "      <th>gtruth_answer_quality_justification</th>\n",
       "      <th>llm_answer</th>\n",
       "      <th>cos_similarity</th>\n",
       "      <th>bert_precision</th>\n",
       "      <th>bert_recall</th>\n",
       "      <th>bert_f1</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>Define the specific endpoint(s) of the test sy...</td>\n",
       "      <td>Specific Endpoint: Migration inhibition Refere...</td>\n",
       "      <td>Medium</td>\n",
       "      <td>The answer partially addresses the question by...</td>\n",
       "      <td>The specific endpoint of the assay is migratio...</td>\n",
       "      <td>0.778617</td>\n",
       "      <td>0.170565</td>\n",
       "      <td>0.030134</td>\n",
       "      <td>0.099792</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>Define and describe the principle(s) of the an...</td>\n",
       "      <td>Migration inhibition: NCCs are plated around s...</td>\n",
       "      <td>High</td>\n",
       "      <td>The answer provides a comprehensive overview o...</td>\n",
       "      <td>The assay employs high content imaging to asse...</td>\n",
       "      <td>0.832390</td>\n",
       "      <td>0.305368</td>\n",
       "      <td>0.270602</td>\n",
       "      <td>0.290629</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                             question  \\\n",
       "34  Define the specific endpoint(s) of the test sy...   \n",
       "35  Define and describe the principle(s) of the an...   \n",
       "\n",
       "                                        gtruth_answer  \\\n",
       "34  Specific Endpoint: Migration inhibition Refere...   \n",
       "35  Migration inhibition: NCCs are plated around s...   \n",
       "\n",
       "   gtruth_answer_quality_score  \\\n",
       "34                      Medium   \n",
       "35                        High   \n",
       "\n",
       "                  gtruth_answer_quality_justification  \\\n",
       "34  The answer partially addresses the question by...   \n",
       "35  The answer provides a comprehensive overview o...   \n",
       "\n",
       "                                           llm_answer  cos_similarity  \\\n",
       "34  The specific endpoint of the assay is migratio...        0.778617   \n",
       "35  The assay employs high content imaging to asse...        0.832390   \n",
       "\n",
       "    bert_precision  bert_recall   bert_f1  \n",
       "34        0.170565     0.030134  0.099792  \n",
       "35        0.305368     0.270602  0.290629  "
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.iloc[34:36,:]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "2f05d874f73c4450b89d3b99dc1b09c6",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Output()"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">**************************************************\n",
       "</pre>\n"
      ],
      "text/plain": [
       "**************************************************\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">Faithfulness Verbose Logs\n",
       "</pre>\n"
      ],
      "text/plain": [
       "Faithfulness Verbose Logs\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">**************************************************\n",
       "</pre>\n"
      ],
      "text/plain": [
       "**************************************************\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">Truths (limit=None):\n",
       "[\n",
       "    \"The Circular migration inhibition of NCC (cMINC) assay, UKN2, Version 2.0 is described in the document and \n",
       "deposited in March 2023.\",\n",
       "    \"The assay is an in vitro test method.\",\n",
       "    \"The assay uses human neural crest cells (NCCs) generated from human induced pluripotent stem cells (hiPSCs).\",\n",
       "    \"The hiPSC line used is IMR90_clone_#4, obtained from WiCell in 2012, with a masterstock and regularly thawed \n",
       "working stocks.\",\n",
       "    \"The hiPSCs are maintained as colonies on Laminin-521 coating in Essential 8 (E8) medium.\",\n",
       "    \"The hiPSCs express pluripotency markers Oct4, Nanog and Tra-1-60.\",\n",
       "    \"The derived NCCs are at least 90% positive for the NCC markers HNK-1 and p75.\",\n",
       "    \"The NCCs also express nestin and AP2 and do not express GFAP, Pax6 or βIII tubulin.\",\n",
       "    \"Differentiation from hiPSCs to NCCs involves Noggin and SB431542, CHIR99021 from day 2, and a transition from \n",
       "KSR to N2-S medium with EGF and FGF; NCCs are collected around day 11 and cryopreserved around days 35–39.\",\n",
       "    \"The hiPSC line IMR-90 has ATCC number CCL-186; origin is Homo sapiens; tissue is lung; cell type is \n",
       "fibroblast; gender is female; gestational age is 16 weeks; ethnicity is Caucasian.\",\n",
       "    \"Post-thaw, NCCs must be pathogen-free and have viability greater than 90%.\",\n",
       "    \"The test system uses a 96-well plate coated with PLO/Laminin/Fibronectin and silicone stoppers to create a \n",
       "central cell-free area.\",\n",
       "    \"Upon removal of the silicone stopper, NCCs migrate into the cell-free area, constituting the migration \n",
       "assay.\",\n",
       "    \"The endpoints are migration inhibition and cell viability, assessed by calcein-AM and Hoechst 33342 \n",
       "staining.\",\n",
       "    \"Migration is quantified by counting viable NCCs that migrate into the defined region of interest after 24 \n",
       "hours of toxicant exposure.\",\n",
       "    \"Viability is assessed outside the migration zone 48 hours after exposure.\",\n",
       "    \"The region of interest for migration contains 150 to 300 cells in untreated conditions.\",\n",
       "    \"Four imaging fields per well are used, with a 5x objective, and the Ringassay software is used to quantify \n",
       "migrated cells.\",\n",
       "    \"Compound exposure involves Day -1 plating, Day 0 stopper removal, Day 1 addition of 25 μL of 5x concentrated \n",
       "toxicants, a 24-hour incubation, and Day 2 staining/imaging.\",\n",
       "    \"The final solvent concentration on cells is 0.1% DMSO; compound dilutions are prepared so that this final \n",
       "concentration is achieved.\",\n",
       "    \"The assay throughput is described as 2 compounds per plate with 6 concentrations each, totaling 768 data \n",
       "points per month; 16 plates can be run per week (approximately 32 compounds per week).\",\n",
       "    \"Three prediction model types are used: (1) screening (hit = migration ≤ 80% of DMSO control and viability ≥ \n",
       "90% of DMSO control), (2) hazard evaluation (EC10 viability / EC25 migration ≥ 1.3), and (3) borderline (BMCL25 \n",
       "migration / BMC10 viability ≥ 1.3).\",\n",
       "    \"Initial performance data reported specificity of 100% and sensitivity greater than 90%, with S/N ratios &gt; 20 \n",
       "and a z’ value &gt; 0.5.\",\n",
       "    \"To date, around 141 unique compounds (and over 200 total compounds) have been tested in cMINC; libraries \n",
       "include NTP’s 80 compounds and EFSA’s 120 compounds; formal OECD validation or ring trials have not been \n",
       "conducted.\",\n",
       "    \"Transfer of the assay to other laboratories has not occurred; operator training is required and is estimated \n",
       "at about 4 weeks for smooth assay performance; iPSC culture training takes months.\",\n",
       "    \"The assay requires S1-level cell culture facilities due to genetic modification considerations; SDS are \n",
       "available in the DaMaRIS database; no specific ethical approval is indicated as required for the described work.\",\n",
       "    \"In vitro–in vivo extrapolation using PBPK modelling indicates that in vitro concentrations impair NCC \n",
       "migration are within the same range as reported in vivo plasma concentrations for studied compounds; lipid content \n",
       "and albumin concentrations in the in vitro system were estimated (lipid content 2.8E-6 mL/mL; albumin 5.6 μM).\",\n",
       "    \"The method has been described as of medium throughput with automated microscopy and has been used in \n",
       "EU-ToxRisk-related work and other developmental neurotoxicity assessments.\",\n",
       "    \"Limitations include that volatile compounds and substances not water-soluble cannot be measured by this \n",
       "assay.\",\n",
       "    \"The assay is not currently linked to OECD guidelines or regulatory guidelines as a stand-alone OECD validation\n",
       "study, and transferability to other labs remains limited at this time.\"\n",
       "] \n",
       " \n",
       "Claims:\n",
       "[\n",
       "    \"The specific endpoint of the assay is migration inhibition of human neural crest cells (NCCs).\",\n",
       "    \"Cell migration is the primary endpoint used for toxicity testing in this system.\",\n",
       "    \"Cell viability is measured as a secondary endpoint to assess cytotoxicity.\",\n",
       "    \"Cell viability is used for normalization purposes.\",\n",
       "    \"The assay quantifies the number of migrated NCCs into the cell-free zone after exposure to potential \n",
       "toxicants.\",\n",
       "    \"Migration inhibition is the main focus of the assay.\",\n",
       "    \"Cell viability is measured to ensure that observed migration effects are not solely due to cytotoxicity.\",\n",
       "    \"Cell viability serves as a reference or normalization endpoint to interpret migration data accurately.\",\n",
       "    \"Source: cMINC(UKN2).pdf\"\n",
       "] \n",
       " \n",
       "Verdicts:\n",
       "[\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": \"\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"Context lists endpoints including migration inhibition and viability but does not designate \n",
       "migration as the primary endpoint.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"Context mentions cell viability as an endpoint but does not specify it as secondary.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"Context mentions viability as an endpoint; it does not state viability is used for \n",
       "normalization.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": \"\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"Context lists migration inhibition as an endpoint but does not indicate it is the main focus.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"Context does not indicate that viability is used to ensure observed migration effects are not \n",
       "due to cytotoxicity.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"Context does not say viability serves as a normalization/reference endpoint.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": \"\"\n",
       "    }\n",
       "]\n",
       " \n",
       "Score: 1.0\n",
       "Reason: The score is 1.00 because there are no contradictions in the contradiction list, indicating the actual \n",
       "output aligns with the retrieval context. Great job!\n",
       "</pre>\n"
      ],
      "text/plain": [
       "Truths (limit=None):\n",
       "[\n",
       "    \"The Circular migration inhibition of NCC (cMINC) assay, UKN2, Version 2.0 is described in the document and \n",
       "deposited in March 2023.\",\n",
       "    \"The assay is an in vitro test method.\",\n",
       "    \"The assay uses human neural crest cells (NCCs) generated from human induced pluripotent stem cells (hiPSCs).\",\n",
       "    \"The hiPSC line used is IMR90_clone_#4, obtained from WiCell in 2012, with a masterstock and regularly thawed \n",
       "working stocks.\",\n",
       "    \"The hiPSCs are maintained as colonies on Laminin-521 coating in Essential 8 (E8) medium.\",\n",
       "    \"The hiPSCs express pluripotency markers Oct4, Nanog and Tra-1-60.\",\n",
       "    \"The derived NCCs are at least 90% positive for the NCC markers HNK-1 and p75.\",\n",
       "    \"The NCCs also express nestin and AP2 and do not express GFAP, Pax6 or βIII tubulin.\",\n",
       "    \"Differentiation from hiPSCs to NCCs involves Noggin and SB431542, CHIR99021 from day 2, and a transition from \n",
       "KSR to N2-S medium with EGF and FGF; NCCs are collected around day 11 and cryopreserved around days 35–39.\",\n",
       "    \"The hiPSC line IMR-90 has ATCC number CCL-186; origin is Homo sapiens; tissue is lung; cell type is \n",
       "fibroblast; gender is female; gestational age is 16 weeks; ethnicity is Caucasian.\",\n",
       "    \"Post-thaw, NCCs must be pathogen-free and have viability greater than 90%.\",\n",
       "    \"The test system uses a 96-well plate coated with PLO/Laminin/Fibronectin and silicone stoppers to create a \n",
       "central cell-free area.\",\n",
       "    \"Upon removal of the silicone stopper, NCCs migrate into the cell-free area, constituting the migration \n",
       "assay.\",\n",
       "    \"The endpoints are migration inhibition and cell viability, assessed by calcein-AM and Hoechst 33342 \n",
       "staining.\",\n",
       "    \"Migration is quantified by counting viable NCCs that migrate into the defined region of interest after 24 \n",
       "hours of toxicant exposure.\",\n",
       "    \"Viability is assessed outside the migration zone 48 hours after exposure.\",\n",
       "    \"The region of interest for migration contains 150 to 300 cells in untreated conditions.\",\n",
       "    \"Four imaging fields per well are used, with a 5x objective, and the Ringassay software is used to quantify \n",
       "migrated cells.\",\n",
       "    \"Compound exposure involves Day -1 plating, Day 0 stopper removal, Day 1 addition of 25 μL of 5x concentrated \n",
       "toxicants, a 24-hour incubation, and Day 2 staining/imaging.\",\n",
       "    \"The final solvent concentration on cells is 0.1% DMSO; compound dilutions are prepared so that this final \n",
       "concentration is achieved.\",\n",
       "    \"The assay throughput is described as 2 compounds per plate with 6 concentrations each, totaling 768 data \n",
       "points per month; 16 plates can be run per week (approximately 32 compounds per week).\",\n",
       "    \"Three prediction model types are used: (1) screening (hit = migration ≤ 80% of DMSO control and viability ≥ \n",
       "90% of DMSO control), (2) hazard evaluation (EC10 viability / EC25 migration ≥ 1.3), and (3) borderline (BMCL25 \n",
       "migration / BMC10 viability ≥ 1.3).\",\n",
       "    \"Initial performance data reported specificity of 100% and sensitivity greater than 90%, with S/N ratios > 20 \n",
       "and a z’ value > 0.5.\",\n",
       "    \"To date, around 141 unique compounds (and over 200 total compounds) have been tested in cMINC; libraries \n",
       "include NTP’s 80 compounds and EFSA’s 120 compounds; formal OECD validation or ring trials have not been \n",
       "conducted.\",\n",
       "    \"Transfer of the assay to other laboratories has not occurred; operator training is required and is estimated \n",
       "at about 4 weeks for smooth assay performance; iPSC culture training takes months.\",\n",
       "    \"The assay requires S1-level cell culture facilities due to genetic modification considerations; SDS are \n",
       "available in the DaMaRIS database; no specific ethical approval is indicated as required for the described work.\",\n",
       "    \"In vitro–in vivo extrapolation using PBPK modelling indicates that in vitro concentrations impair NCC \n",
       "migration are within the same range as reported in vivo plasma concentrations for studied compounds; lipid content \n",
       "and albumin concentrations in the in vitro system were estimated (lipid content 2.8E-6 mL/mL; albumin 5.6 μM).\",\n",
       "    \"The method has been described as of medium throughput with automated microscopy and has been used in \n",
       "EU-ToxRisk-related work and other developmental neurotoxicity assessments.\",\n",
       "    \"Limitations include that volatile compounds and substances not water-soluble cannot be measured by this \n",
       "assay.\",\n",
       "    \"The assay is not currently linked to OECD guidelines or regulatory guidelines as a stand-alone OECD validation\n",
       "study, and transferability to other labs remains limited at this time.\"\n",
       "] \n",
       " \n",
       "Claims:\n",
       "[\n",
       "    \"The specific endpoint of the assay is migration inhibition of human neural crest cells (NCCs).\",\n",
       "    \"Cell migration is the primary endpoint used for toxicity testing in this system.\",\n",
       "    \"Cell viability is measured as a secondary endpoint to assess cytotoxicity.\",\n",
       "    \"Cell viability is used for normalization purposes.\",\n",
       "    \"The assay quantifies the number of migrated NCCs into the cell-free zone after exposure to potential \n",
       "toxicants.\",\n",
       "    \"Migration inhibition is the main focus of the assay.\",\n",
       "    \"Cell viability is measured to ensure that observed migration effects are not solely due to cytotoxicity.\",\n",
       "    \"Cell viability serves as a reference or normalization endpoint to interpret migration data accurately.\",\n",
       "    \"Source: cMINC(UKN2).pdf\"\n",
       "] \n",
       " \n",
       "Verdicts:\n",
       "[\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": \"\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"Context lists endpoints including migration inhibition and viability but does not designate \n",
       "migration as the primary endpoint.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"Context mentions cell viability as an endpoint but does not specify it as secondary.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"Context mentions viability as an endpoint; it does not state viability is used for \n",
       "normalization.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": \"\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"Context lists migration inhibition as an endpoint but does not indicate it is the main focus.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"Context does not indicate that viability is used to ensure observed migration effects are not \n",
       "due to cytotoxicity.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"Context does not say viability serves as a normalization/reference endpoint.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": \"\"\n",
       "    }\n",
       "]\n",
       " \n",
       "Score: 1.0\n",
       "Reason: The score is 1.00 because there are no contradictions in the contradiction list, indicating the actual \n",
       "output aligns with the retrieval context. Great job!\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">======================================================================\n",
       "</pre>\n"
      ],
      "text/plain": [
       "======================================================================\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "9c5cc2d66dc04cf2b71f8871cf879bc5",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Output()"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">**************************************************\n",
       "</pre>\n"
      ],
      "text/plain": [
       "**************************************************\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "002a47719ad94428b890e6d3d9b0bdae",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Output()"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "=== Eval Results ===\n",
      "faithfulness_score: 1.0\n",
      "faithfulness_reason: The score is 1.00 because there are no contradictions in the contradiction list, indicating the actual output aligns with the retrieval context. Great job!\n",
      "geval_policy_score: 1.0\n",
      "geval_policy_reason: All atomic claims extracted from ACTUAL_OUTPUT are supported by the RETRIEVAL_CONTEXT (endpoints, primary vs secondary endpoints, normalization role, and measurement of migrated NCCs). No contradictions or unsupported statements present.\n",
      "groundedness_policy_score: None\n",
      "groundedness_herman_score: None\n",
      "groundedness_counts: None\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">**************************************************\n",
       "</pre>\n"
      ],
      "text/plain": [
       "**************************************************\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">Faithfulness Verbose Logs\n",
       "</pre>\n"
      ],
      "text/plain": [
       "Faithfulness Verbose Logs\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">**************************************************\n",
       "</pre>\n"
      ],
      "text/plain": [
       "**************************************************\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">Truths (limit=None):\n",
       "[\n",
       "    \"The document describes the Circular migration inhibition of NCC (cMINC) assay, UKN2, Version 2.0, deposited \n",
       "March 2023.\",\n",
       "    \"The assay uses human neural crest cells (NCCs) generated from human induced pluripotent stem cells (iPSCs).\",\n",
       "    \"The assay tests impairment of NCC migration during fetal development.\",\n",
       "    \"Migration and cell viability are measured simultaneously after exposing cells to potential toxicants for 24 \n",
       "hours, using high content imaging.\",\n",
       "    \"The data from the method are intended to predict developmental disorders and malformations such as neural tube\n",
       "defects or craniofacial malformations caused by compound exposure during fetal development.\",\n",
       "    \"The assay has a well-established prediction model but has not undergone formal validation or ring trials.\",\n",
       "    \"It has been used in screening of several medium-sized compound libraries.\",\n",
       "    \"The readiness criteria published by Bal-Price et al. (2018) assign the neural crest cell migration assay a \n",
       "readiness score A-.\",\n",
       "    \"The test is deposited by University of Konstanz (UKN), Germany, and the contact person is Prof. Dr. Marcel \n",
       "Leist.\",\n",
       "    \"The hiPSC line used for NCC differentiation is IMR90_clone_#4, purchased from WiCell in 2012, with a \n",
       "masterstock frozen and working stocks thawed as needed.\",\n",
       "    \"The hiPSCs are maintained as monoculture on Laminin-521 coating in essential 8 medium, and are split weakly, \n",
       "with passage limit up to 10.\",\n",
       "    \"The derived NCCs are generated following the modified protocol of Mica et al. (2013) and the protocol details \n",
       "include Noggin, SB431542, CHIR99021, and gradual transition to N2-S medium.\",\n",
       "    \"The differentiated NCC population is ≥ 90% positive for NCC markers HNK-1 and p75 and expresses nestin and \n",
       "AP2; they do not express GFAP, Pax6, or βIII-tubulin.\",\n",
       "    \"After thawing, NCCs have viability &gt; 90%.\",\n",
       "    \"Acceptance criteria at the start: cells must be pathogen-free and show expression of pluripotency markers by \n",
       "immunocytochemistry before differentiation.\",\n",
       "    \"The NCCs migrate in a circular migration assay where cells are added around a silicone stopper that creates a \n",
       "central cell-free area.\",\n",
       "    \"After removing the stopper, cells migrate into the cell-free area and are measured.\",\n",
       "    \"On Day 1 of exposure, 25 μL of 5x concentrated toxicants are added to the wells and incubated for 24 hours.\",\n",
       "    \"On Day 2, cells are stained with calcein-AM and Hoechst 33342 for 30 minutes before imaging.\",\n",
       "    \"The endpoint includes migration inhibition as a specific endpoint and cell viability as a reference \n",
       "endpoint.\",\n",
       "    \"Migration is quantified by imaging four fields per well and using the Ringassay software to count migrated \n",
       "cells in the ROI.\",\n",
       "    \"Viability is quantified by counting viable cells outside the migration zone using calcein-AM and Hoechst \n",
       "double-positive staining.\",\n",
       "    \"Positive controls include cytochalasin D, LiCl, and taxol; negative controls include solvent (0.1% DMSO), \n",
       "paracetamol, and ASS.\",\n",
       "    \"The test's throughput estimates: 768 data points per month; 16 plates per week; 12 data points per plate.\",\n",
       "    \"The experiment uses 2 compounds per plate with 6 concentrations, with a default serial dilution of 1:3 and \n",
       "final DMSO of 0.1%.\",\n",
       "    \"Data are stored on the microscope computer, then on lab group and university servers; metadata log files are \n",
       "created with specific naming conventions.\",\n",
       "    \"An IVIVE PBPK modelling approach links in vitro concentrations to in vivo relevance; the text provides medium \n",
       "lipid content and albumin concentrations for UKN2 and human plasma.\",\n",
       "    \"The test can be used for pesticides, flame retardants, PCBs, and drugs, but the exact applicability domain is \n",
       "not yet clear; volatile or water-insoluble substances cannot be measured.\",\n",
       "    \"The method is described as medium-throughput with automated microscopy and has not been transferred to other \n",
       "labs; transfer requires extensive operator training (~4 weeks) and iPSC culture experience.\",\n",
       "    \"The method is not linked to OECD regulatory guidelines and has not undergone ring trials.\",\n",
       "    \"The materials are not protected by patents; no licenses are required, though data analysis tools (Excel, \n",
       "GraphPad) may require licenses.\",\n",
       "    \"The DB-ALM Protocol number for this method is 195 and the protocol is accessible in the DB-ALM data \n",
       "repository; a lab-internal protocol is available upon request.\",\n",
       "    \"Intra-experimental migration variation is 14.8 ± 4.3%; intra-experimental viability variation is 6 ± 3%; \n",
       "inter-experimental migration variation is 15.6%; inter-experimental viability variation is 9.7%.\",\n",
       "    \"The method has been used to test 141 unique compounds in the assay and over 200 compounds in total across \n",
       "publications and studies.\",\n",
       "    \"The assay has been applied in NTP screening (80-compound library) and EFSA DNT battery evaluations, among \n",
       "others.\",\n",
       "    \"The protocol identifies potential additional endpoints such as EdU staining and alternative viability readouts\n",
       "(resazurin, LDH, ATP).\",\n",
       "    \"Prediction models used include a screening model (hit = NCC migration inhibited with viability ≥ 90% of \n",
       "control), a hazard evaluation model (EC10 viability / EC25 migration ≥ 1.3), and a borderline model (BMC10 V / \n",
       "BMCL25 M ≥ 1.3).\",\n",
       "    \"The 96-well plate layout is described, and the ROI is chosen so that untreated conditions contain 150–300 \n",
       "migrated cells.\"\n",
       "] \n",
       " \n",
       "Claims:\n",
       "[\n",
       "    \"The assay employs high content imaging to assess two key endpoints: migration inhibition and cell viability, \n",
       "in human neural crest cells (NCCs).\",\n",
       "    \"The process involves staining the cells with calcein-AM (for live cells) and Hoechst 33342 (for nuclei), \n",
       "followed by automated imaging.\",\n",
       "    \"The cells are not fixed; live-cell dyes are used to enable real-time assessment of viability and migration \n",
       "behavior.\",\n",
       "    \"For the migration endpoint, NCCs are seeded around a silicone stopper in a well, allowed to adhere, and then \n",
       "the stopper is removed to create a cell-free zone.\",\n",
       "    \"Cells migrate into this zone over 24 hours.\",\n",
       "    \"After exposure to test compounds, the cells are stained with calcein-AM and Hoechst 33342, and images are \n",
       "acquired in four tiles per well using a high content imaging system.\",\n",
       "    \"The quantification algorithm estimates the previously cell-free area and counts the number of double-positive \n",
       "(calcein and Hoechst) cells within a defined region of interest (ROI).\",\n",
       "    \"Typically, 150–300 cells are imaged per ROI, and the software automatically counts viable cells based on \n",
       "fluorescence signals.\",\n",
       "    \"Cell viability is measured in the same wells, outside the migration zone, by imaging four fields per well with\n",
       "a 10x objective.\",\n",
       "    \"The same fluorescent dyes are used, and automated algorithms determine the number of double-positive cells, \n",
       "representing viable nuclei.\",\n",
       "    \"Both endpoints are measured under the same conditions and in parallel within the same well, allowing direct \n",
       "comparison of migration and viability data.\",\n",
       "    \"The quantification relies on automated image analysis software that estimates the number of viable cells based\n",
       "on fluorescence intensity and cell morphology, providing semi-quantitative counts.\",\n",
       "    \"The software calculates the number of double-positive cells in the ROI, enabling objective and reproducible \n",
       "measurement of migration and viability.\"\n",
       "] \n",
       " \n",
       "Verdicts:\n",
       "[\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"The context mentions live-cell staining with calcein-AM but does not explicitly state that the \n",
       "cells are not fixed or that imaging is real-time.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"no\",\n",
       "        \"reason\": \"The context specifies imaging four fields per well; the claim says four tiles per well, which is\n",
       "not in the retrieval context.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"The context mentions counting migrated cells in the ROI but does not specify counting \n",
       "double-positive cells within the ROI.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"The context notes 150\\u2013300 migrated cells per ROI, but does not specify imaging the ROI; the\n",
       "phrase 'imaged per ROI' is not explicitly stated.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"The context describes viability outside the migration zone but does not specify four fields per \n",
       "well or a 10x objective for viability imaging.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"The context does not explicitly state counting double-positive cells within the ROI for the \n",
       "measurement described.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    }\n",
       "]\n",
       " \n",
       "Score: 0.9285714285714286\n",
       "Reason: The score is 0.93 because the actual output claimed four tiles per well, but the retrieval context \n",
       "specifies four fields per well.\n",
       "</pre>\n"
      ],
      "text/plain": [
       "Truths (limit=None):\n",
       "[\n",
       "    \"The document describes the Circular migration inhibition of NCC (cMINC) assay, UKN2, Version 2.0, deposited \n",
       "March 2023.\",\n",
       "    \"The assay uses human neural crest cells (NCCs) generated from human induced pluripotent stem cells (iPSCs).\",\n",
       "    \"The assay tests impairment of NCC migration during fetal development.\",\n",
       "    \"Migration and cell viability are measured simultaneously after exposing cells to potential toxicants for 24 \n",
       "hours, using high content imaging.\",\n",
       "    \"The data from the method are intended to predict developmental disorders and malformations such as neural tube\n",
       "defects or craniofacial malformations caused by compound exposure during fetal development.\",\n",
       "    \"The assay has a well-established prediction model but has not undergone formal validation or ring trials.\",\n",
       "    \"It has been used in screening of several medium-sized compound libraries.\",\n",
       "    \"The readiness criteria published by Bal-Price et al. (2018) assign the neural crest cell migration assay a \n",
       "readiness score A-.\",\n",
       "    \"The test is deposited by University of Konstanz (UKN), Germany, and the contact person is Prof. Dr. Marcel \n",
       "Leist.\",\n",
       "    \"The hiPSC line used for NCC differentiation is IMR90_clone_#4, purchased from WiCell in 2012, with a \n",
       "masterstock frozen and working stocks thawed as needed.\",\n",
       "    \"The hiPSCs are maintained as monoculture on Laminin-521 coating in essential 8 medium, and are split weakly, \n",
       "with passage limit up to 10.\",\n",
       "    \"The derived NCCs are generated following the modified protocol of Mica et al. (2013) and the protocol details \n",
       "include Noggin, SB431542, CHIR99021, and gradual transition to N2-S medium.\",\n",
       "    \"The differentiated NCC population is ≥ 90% positive for NCC markers HNK-1 and p75 and expresses nestin and \n",
       "AP2; they do not express GFAP, Pax6, or βIII-tubulin.\",\n",
       "    \"After thawing, NCCs have viability > 90%.\",\n",
       "    \"Acceptance criteria at the start: cells must be pathogen-free and show expression of pluripotency markers by \n",
       "immunocytochemistry before differentiation.\",\n",
       "    \"The NCCs migrate in a circular migration assay where cells are added around a silicone stopper that creates a \n",
       "central cell-free area.\",\n",
       "    \"After removing the stopper, cells migrate into the cell-free area and are measured.\",\n",
       "    \"On Day 1 of exposure, 25 μL of 5x concentrated toxicants are added to the wells and incubated for 24 hours.\",\n",
       "    \"On Day 2, cells are stained with calcein-AM and Hoechst 33342 for 30 minutes before imaging.\",\n",
       "    \"The endpoint includes migration inhibition as a specific endpoint and cell viability as a reference \n",
       "endpoint.\",\n",
       "    \"Migration is quantified by imaging four fields per well and using the Ringassay software to count migrated \n",
       "cells in the ROI.\",\n",
       "    \"Viability is quantified by counting viable cells outside the migration zone using calcein-AM and Hoechst \n",
       "double-positive staining.\",\n",
       "    \"Positive controls include cytochalasin D, LiCl, and taxol; negative controls include solvent (0.1% DMSO), \n",
       "paracetamol, and ASS.\",\n",
       "    \"The test's throughput estimates: 768 data points per month; 16 plates per week; 12 data points per plate.\",\n",
       "    \"The experiment uses 2 compounds per plate with 6 concentrations, with a default serial dilution of 1:3 and \n",
       "final DMSO of 0.1%.\",\n",
       "    \"Data are stored on the microscope computer, then on lab group and university servers; metadata log files are \n",
       "created with specific naming conventions.\",\n",
       "    \"An IVIVE PBPK modelling approach links in vitro concentrations to in vivo relevance; the text provides medium \n",
       "lipid content and albumin concentrations for UKN2 and human plasma.\",\n",
       "    \"The test can be used for pesticides, flame retardants, PCBs, and drugs, but the exact applicability domain is \n",
       "not yet clear; volatile or water-insoluble substances cannot be measured.\",\n",
       "    \"The method is described as medium-throughput with automated microscopy and has not been transferred to other \n",
       "labs; transfer requires extensive operator training (~4 weeks) and iPSC culture experience.\",\n",
       "    \"The method is not linked to OECD regulatory guidelines and has not undergone ring trials.\",\n",
       "    \"The materials are not protected by patents; no licenses are required, though data analysis tools (Excel, \n",
       "GraphPad) may require licenses.\",\n",
       "    \"The DB-ALM Protocol number for this method is 195 and the protocol is accessible in the DB-ALM data \n",
       "repository; a lab-internal protocol is available upon request.\",\n",
       "    \"Intra-experimental migration variation is 14.8 ± 4.3%; intra-experimental viability variation is 6 ± 3%; \n",
       "inter-experimental migration variation is 15.6%; inter-experimental viability variation is 9.7%.\",\n",
       "    \"The method has been used to test 141 unique compounds in the assay and over 200 compounds in total across \n",
       "publications and studies.\",\n",
       "    \"The assay has been applied in NTP screening (80-compound library) and EFSA DNT battery evaluations, among \n",
       "others.\",\n",
       "    \"The protocol identifies potential additional endpoints such as EdU staining and alternative viability readouts\n",
       "(resazurin, LDH, ATP).\",\n",
       "    \"Prediction models used include a screening model (hit = NCC migration inhibited with viability ≥ 90% of \n",
       "control), a hazard evaluation model (EC10 viability / EC25 migration ≥ 1.3), and a borderline model (BMC10 V / \n",
       "BMCL25 M ≥ 1.3).\",\n",
       "    \"The 96-well plate layout is described, and the ROI is chosen so that untreated conditions contain 150–300 \n",
       "migrated cells.\"\n",
       "] \n",
       " \n",
       "Claims:\n",
       "[\n",
       "    \"The assay employs high content imaging to assess two key endpoints: migration inhibition and cell viability, \n",
       "in human neural crest cells (NCCs).\",\n",
       "    \"The process involves staining the cells with calcein-AM (for live cells) and Hoechst 33342 (for nuclei), \n",
       "followed by automated imaging.\",\n",
       "    \"The cells are not fixed; live-cell dyes are used to enable real-time assessment of viability and migration \n",
       "behavior.\",\n",
       "    \"For the migration endpoint, NCCs are seeded around a silicone stopper in a well, allowed to adhere, and then \n",
       "the stopper is removed to create a cell-free zone.\",\n",
       "    \"Cells migrate into this zone over 24 hours.\",\n",
       "    \"After exposure to test compounds, the cells are stained with calcein-AM and Hoechst 33342, and images are \n",
       "acquired in four tiles per well using a high content imaging system.\",\n",
       "    \"The quantification algorithm estimates the previously cell-free area and counts the number of double-positive \n",
       "(calcein and Hoechst) cells within a defined region of interest (ROI).\",\n",
       "    \"Typically, 150–300 cells are imaged per ROI, and the software automatically counts viable cells based on \n",
       "fluorescence signals.\",\n",
       "    \"Cell viability is measured in the same wells, outside the migration zone, by imaging four fields per well with\n",
       "a 10x objective.\",\n",
       "    \"The same fluorescent dyes are used, and automated algorithms determine the number of double-positive cells, \n",
       "representing viable nuclei.\",\n",
       "    \"Both endpoints are measured under the same conditions and in parallel within the same well, allowing direct \n",
       "comparison of migration and viability data.\",\n",
       "    \"The quantification relies on automated image analysis software that estimates the number of viable cells based\n",
       "on fluorescence intensity and cell morphology, providing semi-quantitative counts.\",\n",
       "    \"The software calculates the number of double-positive cells in the ROI, enabling objective and reproducible \n",
       "measurement of migration and viability.\"\n",
       "] \n",
       " \n",
       "Verdicts:\n",
       "[\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"The context mentions live-cell staining with calcein-AM but does not explicitly state that the \n",
       "cells are not fixed or that imaging is real-time.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"no\",\n",
       "        \"reason\": \"The context specifies imaging four fields per well; the claim says four tiles per well, which is\n",
       "not in the retrieval context.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"The context mentions counting migrated cells in the ROI but does not specify counting \n",
       "double-positive cells within the ROI.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"The context notes 150\\u2013300 migrated cells per ROI, but does not specify imaging the ROI; the\n",
       "phrase 'imaged per ROI' is not explicitly stated.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"The context describes viability outside the migration zone but does not specify four fields per \n",
       "well or a 10x objective for viability imaging.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"The context does not explicitly state counting double-positive cells within the ROI for the \n",
       "measurement described.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    }\n",
       "]\n",
       " \n",
       "Score: 0.9285714285714286\n",
       "Reason: The score is 0.93 because the actual output claimed four tiles per well, but the retrieval context \n",
       "specifies four fields per well.\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">======================================================================\n",
       "</pre>\n"
      ],
      "text/plain": [
       "======================================================================\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "ec6209fafbda48ceb7e596b3ca367675",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Output()"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">**************************************************\n",
       "</pre>\n"
      ],
      "text/plain": [
       "**************************************************\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">ToxTemp Groundedness Policy (counts) [GEval] Verbose Logs\n",
       "</pre>\n"
      ],
      "text/plain": [
       "ToxTemp Groundedness Policy (counts) [GEval] Verbose Logs\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">**************************************************\n",
       "</pre>\n"
      ],
      "text/plain": [
       "**************************************************\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">Criteria:\n",
       "None \n",
       " \n",
       "Evaluation Steps:\n",
       "[\n",
       "    \"Task: evaluate whether ACTUAL_OUTPUT is grounded ONLY in RETRIEVAL_CONTEXT. No outside knowledge.\",\n",
       "    \"\",\n",
       "    \"Step 1 — Extract atomic factual claims from ACTUAL_OUTPUT limited to: entities, numbers, durations, units, \n",
       "methods, readouts, materials, cell lines, species, instruments, and endpoints. Do NOT extract vague/subjective \n",
       "claims (e.g., 'robust', 'appropriate').\",\n",
       "    \"\",\n",
       "    \"Step 2 — For each claim, assign exactly one label:\",\n",
       "    \"  - ENTAILED: explicitly supported by RETRIEVAL_CONTEXT (directly stated or unambiguous paraphrase).\",\n",
       "    \"  - CONTRADICTED: conflicts with RETRIEVAL_CONTEXT.\",\n",
       "    \"  - UNSUPPORTED: not found in RETRIEVAL_CONTEXT and not contradicted.\",\n",
       "    \"  - ABSTAINED: ACTUAL_OUTPUT explicitly states the information is not in the context / cannot be determined, \n",
       "and does not assert the missing fact.\",\n",
       "    \"\",\n",
       "    \"Step 3 — Return VALID JSON ONLY (no markdown, no extra text) with integer counts and an optional short audit \n",
       "list.\",\n",
       "    \"Required JSON keys: {\"entailed\": int, \"unsupported\": int, \"contradicted\": int, \"abstained\": int, \n",
       "\"total_claims\": int}.\",\n",
       "    \"Optional key: \"claims\": a list of up to 10 items, each with {\"claim\": str, \"label\": str, \"evidence\": str}. \n",
       "Evidence should be a short phrase from context or \"N/A\".\",\n",
       "    \"\",\n",
       "    \"Step 4 — Ensure: total_claims = entailed + unsupported + contradicted + abstained.\"\n",
       "] \n",
       " \n",
       "Rubric:\n",
       "None \n",
       " \n",
       "Score: 0.9\n",
       " \n",
       "Reason: Actual Output largely matches Retrieval Context: NCCs, calcein-AM and Hoechst 33342 staining, live-cell \n",
       "imaging, migration into a cell-free zone after stopper removal, 24 h exposure, four tiles per well, ROI with \n",
       "150–300 cells, double-positive cell counting, same-well measurement for migration and viability, and use of \n",
       "ArrayScan/Cellomics with data normalization to untreated controls. A minor point is the claim about 'not fixed' \n",
       "which isn't explicit in the Retrieval Context.\n",
       "</pre>\n"
      ],
      "text/plain": [
       "Criteria:\n",
       "None \n",
       " \n",
       "Evaluation Steps:\n",
       "[\n",
       "    \"Task: evaluate whether ACTUAL_OUTPUT is grounded ONLY in RETRIEVAL_CONTEXT. No outside knowledge.\",\n",
       "    \"\",\n",
       "    \"Step 1 — Extract atomic factual claims from ACTUAL_OUTPUT limited to: entities, numbers, durations, units, \n",
       "methods, readouts, materials, cell lines, species, instruments, and endpoints. Do NOT extract vague/subjective \n",
       "claims (e.g., 'robust', 'appropriate').\",\n",
       "    \"\",\n",
       "    \"Step 2 — For each claim, assign exactly one label:\",\n",
       "    \"  - ENTAILED: explicitly supported by RETRIEVAL_CONTEXT (directly stated or unambiguous paraphrase).\",\n",
       "    \"  - CONTRADICTED: conflicts with RETRIEVAL_CONTEXT.\",\n",
       "    \"  - UNSUPPORTED: not found in RETRIEVAL_CONTEXT and not contradicted.\",\n",
       "    \"  - ABSTAINED: ACTUAL_OUTPUT explicitly states the information is not in the context / cannot be determined, \n",
       "and does not assert the missing fact.\",\n",
       "    \"\",\n",
       "    \"Step 3 — Return VALID JSON ONLY (no markdown, no extra text) with integer counts and an optional short audit \n",
       "list.\",\n",
       "    \"Required JSON keys: {\"entailed\": int, \"unsupported\": int, \"contradicted\": int, \"abstained\": int, \n",
       "\"total_claims\": int}.\",\n",
       "    \"Optional key: \"claims\": a list of up to 10 items, each with {\"claim\": str, \"label\": str, \"evidence\": str}. \n",
       "Evidence should be a short phrase from context or \"N/A\".\",\n",
       "    \"\",\n",
       "    \"Step 4 — Ensure: total_claims = entailed + unsupported + contradicted + abstained.\"\n",
       "] \n",
       " \n",
       "Rubric:\n",
       "None \n",
       " \n",
       "Score: 0.9\n",
       " \n",
       "Reason: Actual Output largely matches Retrieval Context: NCCs, calcein-AM and Hoechst 33342 staining, live-cell \n",
       "imaging, migration into a cell-free zone after stopper removal, 24 h exposure, four tiles per well, ROI with \n",
       "150–300 cells, double-positive cell counting, same-well measurement for migration and viability, and use of \n",
       "ArrayScan/Cellomics with data normalization to untreated controls. A minor point is the claim about 'not fixed' \n",
       "which isn't explicit in the Retrieval Context.\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">======================================================================\n",
       "</pre>\n"
      ],
      "text/plain": [
       "======================================================================\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "=== Eval Results ===\n",
      "faithfulness_score: 0.9285714285714286\n",
      "faithfulness_reason: The score is 0.93 because the actual output claimed four tiles per well, but the retrieval context specifies four fields per well.\n",
      "geval_policy_score: 0.9\n",
      "geval_policy_reason: Actual Output largely matches Retrieval Context: NCCs, calcein-AM and Hoechst 33342 staining, live-cell imaging, migration into a cell-free zone after stopper removal, 24 h exposure, four tiles per well, ROI with 150–300 cells, double-positive cell counting, same-well measurement for migration and viability, and use of ArrayScan/Cellomics with data normalization to untreated controls. A minor point is the claim about 'not fixed' which isn't explicit in the Retrieval Context.\n",
      "groundedness_policy_score: None\n",
      "groundedness_herman_score: None\n",
      "groundedness_counts: None\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "PosixPath('/Users/johannehouweling/ToxTempAssistant/myocyte/groundedness_demo_output.csv')"
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "csv_path = Path(\"/Users/johannehouweling/ToxTempAssistant/myocyte/toxtempass/evaluation/positive_control/output/gpt-4.1-nano/tier1_comparison_cMINC(UKN2).csv\")\n",
    "pdf_path = Path(\"/Users/johannehouweling/ToxTempAssistant/myocyte/toxtempass/evaluation/positive_control/input_files/cMINC(UKN2).pdf\")\n",
    "\n",
    "demo_path = Path.cwd() / \"demo_input.csv\"\n",
    "df = pd.read_csv(csv_path).iloc[34:36, :]\n",
    "df.to_csv(demo_path, index=False)\n",
    "\n",
    "add_groundedness_columns(\n",
    "            csv_path=demo_path,\n",
    "            pdf_path=pdf_path,\n",
    "            output_path=Path.cwd() / \"groundedness_demo_output.csv\",\n",
    "            judge_model=\"gpt-5-nano\",\n",
    "            faithfulness_threshold=0.5,\n",
    "            geval_threshold=0.5,\n",
    "            verbose=True\n",
    "            )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "5f6318f3b540484fa852c96fc4620b16",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Output()"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">**************************************************\n",
       "</pre>\n"
      ],
      "text/plain": [
       "**************************************************\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">Faithfulness Verbose Logs\n",
       "</pre>\n"
      ],
      "text/plain": [
       "Faithfulness Verbose Logs\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">**************************************************\n",
       "</pre>\n"
      ],
      "text/plain": [
       "**************************************************\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">Truths (limit=None):\n",
       "[\n",
       "    \"The text describes the Circular migration inhibition of NCC (cMINC) assay, UKN2, Version 2.0.\",\n",
       "    \"The cMINC UKN2 assay is an in vitro test method designed to test impairment of migration of human neural crest\n",
       "cells (NCCs).\",\n",
       "    \"NCCs used in the assay are generated from human induced pluripotent stem cells (hiPSCs).\",\n",
       "    \"The hiPSC line used is IMR90_clone_#4, which was purchased from WiCell in 2012 and stored as a frozen master \n",
       "stock.\",\n",
       "    \"Working stocks of the IMR90 hiPSCs are prepared from the master stock and can be maintained due to \n",
       "self-renewal and pluripotency.\",\n",
       "    \"hiPSCs can be maintained for up to 10 passages before thawing a new vial of the working stock.\",\n",
       "    \"The hiPSCs used in this protocol are cultured as monoculture on Laminin-521 coating in Essential 8 medium.\",\n",
       "    \"The hiPSCs show self-renewal and pluripotency characteristics and can differentiate into several cell types.\",\n",
       "    \"The IMR90 hiPSC line has ATCC number CCL-186 and is of human origin from lung tissue, with fibroblast cell \n",
       "type.\",\n",
       "    \"The donor of the hiPSCs is female, 16 weeks gestation, and of Caucasian ethnicity, according to Table 1.\",\n",
       "    \"The hiPSCs express pluripotency markers Oct4, Nanog and Tra-1-60 as shown by immunocytochemistry.\",\n",
       "    \"NCCs are differentiated from hiPSCs following the modified protocol of Mica et al. (2013), including Noggin, \n",
       "SB431542, and CHIR99021 treatment.\",\n",
       "    \"From day 4 onward, the differentiation protocol transitions from KSR medium to N2-S medium with growth \n",
       "factors.\",\n",
       "    \"The NCCs are cryopreserved at a concentration of 4×10^6 cells/mL in 90% N2-S and 10% DMSO for long-term \n",
       "storage.\",\n",
       "    \"The derived NCCs are at least 90% positive for NCC markers HNK-1 and p75, and express nestin and AP2.\",\n",
       "    \"The NCCs do not express the astrocyte marker GFAP, the CNS precursor Pax6, or the neuronal marker \n",
       "βIII-tubulin.\",\n",
       "    \"The test system’s culture is implemented in 96-well plates using a circular migration assay with silicone \n",
       "stoppers to create a central cell-free area. \",\n",
       "    \"NCCs are added around the stoppers and, after stopper removal, migrate into the central cell-free area.\",\n",
       "    \"During the assay the cells are kept viable by continuous presence of EGF and FGF in the medium. \",\n",
       "    \"The test system is defined by the 96-well plate format with four tiles per well for imaging. \",\n",
       "    \"The readouts are migration into the cell-free area and viability within the migration zone and outside it. \",\n",
       "    \"The assay procedure uses calcein-AM and Hoechst (H-33342) staining for 30 minutes before imaging.\",\n",
       "    \"Migration is quantified by counting cells that migrate into the ROI after 24 hours of toxicant exposure.\",\n",
       "    \"Cell viability is quantified 48 hours after exposure by counting viable cells outside the migration zone.\",\n",
       "    \"Data acquisition uses an automated Array-Scan VTI HCS Reader with a 5× objective and four tiles per well.\",\n",
       "    \"A Ringassay software tool is used to delineate the cell-free migration zone and to count migrated cells.\",\n",
       "    \"The test assumes final DMSO concentration on the cells of 0.1%.\",\n",
       "    \"Compound dilutions are prepared so that the final DMSO concentration on cells is 0.1% (DMSO in stock is 0.5% \n",
       "in master plate).\",\n",
       "    \"The highest tested compound concentration is diluted 1:200 into N2-S medium for exposure. \",\n",
       "    \"The exposure schedule is Day -1 coating; Day 0 stopper removal; Day 1 addition of 25 μL of 5× concentrated \n",
       "toxicants; 24 h exposure; Day 2 staining.\",\n",
       "    \"The assay throughput is 768 data points per month, with 16 plates per week and 12 data points per plate.\",\n",
       "    \"The plate layout tests 2 compounds per plate across 6 concentrations, totaling 12 data points per plate.\",\n",
       "    \"The test uses an internal negative control (solvent, 0.1% DMSO) and positive controls like Cytochalasin D, \n",
       "LiCl and Taxol.\",\n",
       "    \"Endpoint-specific controls include AgNO3, AraC, Aphidicolin, L-homocysteine, MG-132, staurosporine and Triton \n",
       "X-100.\",\n",
       "    \"Negative controls include solvent (0.1% DMSO final), paracetamol and ASS.\",\n",
       "    \"The test defines a three-model prediction framework: a screening model, a hazard evaluation model, and a \n",
       "borderline model.\",\n",
       "    \"In the screening model, a hit is defined as migration ≤ 80% of DMSO control with viability ≥ 90% of DMSO \n",
       "control.\",\n",
       "    \"In the hazard evaluation model, hit confirmation uses EC10 viability divided by EC25 migration ≥ 1.3.\",\n",
       "    \"In the borderline model, a BMCL25 migration to V ratio of ≥ 1.3 is considered a borderline hit.\",\n",
       "    \"The method has been cited as having high specificity (&gt; 90%) and sensitivity (&gt; 90%) in initial evaluation, \n",
       "with specificity reported as 100% and sensitivity &gt; 90% in early rounds.\",\n",
       "    \"The EFSA EFSA Supporting Publications and other sources report a sensitivity of 82.7% and specificity of 100% \n",
       "for related datasets involving this assay.\",\n",
       "    \"The assay has been used to screen libraries including the NTP’s 80-compound set and EFSA’s 120-compound set.\",\n",
       "    \"To date, 141 unique compounds have been tested in the cMINC assay, with more than 200 compounds tested \n",
       "overall.\",\n",
       "    \"The assay is not currently linked to OECD guidelines or formal OECD ring-trial validation.\",\n",
       "    \"The assay has not been transferred to other laboratories for broader regulatory use.\",\n",
       "    \"The readouts can be cross-validated with other endpoints in risk assessment, but the primary endpoints are \n",
       "migration inhibition and viability.\",\n",
       "    \"The predicted in vitro data have been coupled with IVIVE using lipid content and albumin concentration in \n",
       "media and PBPK modelling to relate in vitro concentrations to potential in vivo relevance.\",\n",
       "    \"Predicted in vivo relevance notes that the in vivo plasma concentrations used in PBPK modelling are within the\n",
       "same range as concentrations that impair NCC migration in the assay.\",\n",
       "    \"The test battery’s applicability domain includes pesticides, flame retardants, PCBs, and drugs; however \n",
       "volatile substances and water-insoluble substances may not be measurable by this assay.\",\n",
       "    \"DB-ALM Protocol n° 195 is cited as the reference for maintenance culture of NCCs and the related procedures.\",\n",
       "    \"The original culture protocol and full SOP are available from DB-ALM with the URL provided in the text.\",\n",
       "    \"Safety and ethics considerations include the requirement of S1 cell culture facilities and the availability of\n",
       "SDS in the DaMaRIS database; no special ethical approval is required according to the document.\",\n",
       "    \"S1 cell culture facilities, the availability of SDS, and the listed contact information for the responsible \n",
       "researchers (e.g., Marcel Leist) are included in the document.\",\n",
       "    \"The readouts are designed to reflect NCC migration as a key process in fetal development, with impairment \n",
       "potentially indicating developmental neurotoxicity risk.\"\n",
       "] \n",
       " \n",
       "Claims:\n",
       "[\n",
       "    \"The specific endpoint of the assay is migration inhibition of human neural crest cells (NCCs).\",\n",
       "    \"Cell migration is the primary endpoint used for toxicity testing in this system.\",\n",
       "    \"Cell viability is measured as a secondary endpoint to assess cytotoxicity and is used for normalization \n",
       "purposes.\",\n",
       "    \"The assay quantifies the number of migrated NCCs into the cell-free zone after exposure to potential \n",
       "toxicants.\",\n",
       "    \"Migration inhibition is the main focus of the assay.\",\n",
       "    \"Cell viability is also measured to ensure that observed migration effects are not solely due to \n",
       "cytotoxicity.\",\n",
       "    \"Cell viability serves as a reference or normalization endpoint to interpret migration data accurately.\",\n",
       "    \"Source: cMINC(UKN2).pdf.\"\n",
       "] \n",
       " \n",
       "Verdicts:\n",
       "[\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"The context mentions viability is measured but does not specify it as a secondary endpoint or \n",
       "its use for normalization.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"The context indicates viability is measured but does not explicitly state its use to ensure \n",
       "observed migration effects are not due to cytotoxicity.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"The context does not state viability is used as a normalization endpoint to interpret migration \n",
       "data.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"The context does not mention a file name; it describes the assay but not a PDF source.\"\n",
       "    }\n",
       "]\n",
       " \n",
       "Score: 1.0\n",
       "Reason: The score is 1.00 because there are no contradictions—the contradictions list is empty, indicating the \n",
       "actual output fully aligns with the retrieval context.\n",
       "</pre>\n"
      ],
      "text/plain": [
       "Truths (limit=None):\n",
       "[\n",
       "    \"The text describes the Circular migration inhibition of NCC (cMINC) assay, UKN2, Version 2.0.\",\n",
       "    \"The cMINC UKN2 assay is an in vitro test method designed to test impairment of migration of human neural crest\n",
       "cells (NCCs).\",\n",
       "    \"NCCs used in the assay are generated from human induced pluripotent stem cells (hiPSCs).\",\n",
       "    \"The hiPSC line used is IMR90_clone_#4, which was purchased from WiCell in 2012 and stored as a frozen master \n",
       "stock.\",\n",
       "    \"Working stocks of the IMR90 hiPSCs are prepared from the master stock and can be maintained due to \n",
       "self-renewal and pluripotency.\",\n",
       "    \"hiPSCs can be maintained for up to 10 passages before thawing a new vial of the working stock.\",\n",
       "    \"The hiPSCs used in this protocol are cultured as monoculture on Laminin-521 coating in Essential 8 medium.\",\n",
       "    \"The hiPSCs show self-renewal and pluripotency characteristics and can differentiate into several cell types.\",\n",
       "    \"The IMR90 hiPSC line has ATCC number CCL-186 and is of human origin from lung tissue, with fibroblast cell \n",
       "type.\",\n",
       "    \"The donor of the hiPSCs is female, 16 weeks gestation, and of Caucasian ethnicity, according to Table 1.\",\n",
       "    \"The hiPSCs express pluripotency markers Oct4, Nanog and Tra-1-60 as shown by immunocytochemistry.\",\n",
       "    \"NCCs are differentiated from hiPSCs following the modified protocol of Mica et al. (2013), including Noggin, \n",
       "SB431542, and CHIR99021 treatment.\",\n",
       "    \"From day 4 onward, the differentiation protocol transitions from KSR medium to N2-S medium with growth \n",
       "factors.\",\n",
       "    \"The NCCs are cryopreserved at a concentration of 4×10^6 cells/mL in 90% N2-S and 10% DMSO for long-term \n",
       "storage.\",\n",
       "    \"The derived NCCs are at least 90% positive for NCC markers HNK-1 and p75, and express nestin and AP2.\",\n",
       "    \"The NCCs do not express the astrocyte marker GFAP, the CNS precursor Pax6, or the neuronal marker \n",
       "βIII-tubulin.\",\n",
       "    \"The test system’s culture is implemented in 96-well plates using a circular migration assay with silicone \n",
       "stoppers to create a central cell-free area. \",\n",
       "    \"NCCs are added around the stoppers and, after stopper removal, migrate into the central cell-free area.\",\n",
       "    \"During the assay the cells are kept viable by continuous presence of EGF and FGF in the medium. \",\n",
       "    \"The test system is defined by the 96-well plate format with four tiles per well for imaging. \",\n",
       "    \"The readouts are migration into the cell-free area and viability within the migration zone and outside it. \",\n",
       "    \"The assay procedure uses calcein-AM and Hoechst (H-33342) staining for 30 minutes before imaging.\",\n",
       "    \"Migration is quantified by counting cells that migrate into the ROI after 24 hours of toxicant exposure.\",\n",
       "    \"Cell viability is quantified 48 hours after exposure by counting viable cells outside the migration zone.\",\n",
       "    \"Data acquisition uses an automated Array-Scan VTI HCS Reader with a 5× objective and four tiles per well.\",\n",
       "    \"A Ringassay software tool is used to delineate the cell-free migration zone and to count migrated cells.\",\n",
       "    \"The test assumes final DMSO concentration on the cells of 0.1%.\",\n",
       "    \"Compound dilutions are prepared so that the final DMSO concentration on cells is 0.1% (DMSO in stock is 0.5% \n",
       "in master plate).\",\n",
       "    \"The highest tested compound concentration is diluted 1:200 into N2-S medium for exposure. \",\n",
       "    \"The exposure schedule is Day -1 coating; Day 0 stopper removal; Day 1 addition of 25 μL of 5× concentrated \n",
       "toxicants; 24 h exposure; Day 2 staining.\",\n",
       "    \"The assay throughput is 768 data points per month, with 16 plates per week and 12 data points per plate.\",\n",
       "    \"The plate layout tests 2 compounds per plate across 6 concentrations, totaling 12 data points per plate.\",\n",
       "    \"The test uses an internal negative control (solvent, 0.1% DMSO) and positive controls like Cytochalasin D, \n",
       "LiCl and Taxol.\",\n",
       "    \"Endpoint-specific controls include AgNO3, AraC, Aphidicolin, L-homocysteine, MG-132, staurosporine and Triton \n",
       "X-100.\",\n",
       "    \"Negative controls include solvent (0.1% DMSO final), paracetamol and ASS.\",\n",
       "    \"The test defines a three-model prediction framework: a screening model, a hazard evaluation model, and a \n",
       "borderline model.\",\n",
       "    \"In the screening model, a hit is defined as migration ≤ 80% of DMSO control with viability ≥ 90% of DMSO \n",
       "control.\",\n",
       "    \"In the hazard evaluation model, hit confirmation uses EC10 viability divided by EC25 migration ≥ 1.3.\",\n",
       "    \"In the borderline model, a BMCL25 migration to V ratio of ≥ 1.3 is considered a borderline hit.\",\n",
       "    \"The method has been cited as having high specificity (> 90%) and sensitivity (> 90%) in initial evaluation, \n",
       "with specificity reported as 100% and sensitivity > 90% in early rounds.\",\n",
       "    \"The EFSA EFSA Supporting Publications and other sources report a sensitivity of 82.7% and specificity of 100% \n",
       "for related datasets involving this assay.\",\n",
       "    \"The assay has been used to screen libraries including the NTP’s 80-compound set and EFSA’s 120-compound set.\",\n",
       "    \"To date, 141 unique compounds have been tested in the cMINC assay, with more than 200 compounds tested \n",
       "overall.\",\n",
       "    \"The assay is not currently linked to OECD guidelines or formal OECD ring-trial validation.\",\n",
       "    \"The assay has not been transferred to other laboratories for broader regulatory use.\",\n",
       "    \"The readouts can be cross-validated with other endpoints in risk assessment, but the primary endpoints are \n",
       "migration inhibition and viability.\",\n",
       "    \"The predicted in vitro data have been coupled with IVIVE using lipid content and albumin concentration in \n",
       "media and PBPK modelling to relate in vitro concentrations to potential in vivo relevance.\",\n",
       "    \"Predicted in vivo relevance notes that the in vivo plasma concentrations used in PBPK modelling are within the\n",
       "same range as concentrations that impair NCC migration in the assay.\",\n",
       "    \"The test battery’s applicability domain includes pesticides, flame retardants, PCBs, and drugs; however \n",
       "volatile substances and water-insoluble substances may not be measurable by this assay.\",\n",
       "    \"DB-ALM Protocol n° 195 is cited as the reference for maintenance culture of NCCs and the related procedures.\",\n",
       "    \"The original culture protocol and full SOP are available from DB-ALM with the URL provided in the text.\",\n",
       "    \"Safety and ethics considerations include the requirement of S1 cell culture facilities and the availability of\n",
       "SDS in the DaMaRIS database; no special ethical approval is required according to the document.\",\n",
       "    \"S1 cell culture facilities, the availability of SDS, and the listed contact information for the responsible \n",
       "researchers (e.g., Marcel Leist) are included in the document.\",\n",
       "    \"The readouts are designed to reflect NCC migration as a key process in fetal development, with impairment \n",
       "potentially indicating developmental neurotoxicity risk.\"\n",
       "] \n",
       " \n",
       "Claims:\n",
       "[\n",
       "    \"The specific endpoint of the assay is migration inhibition of human neural crest cells (NCCs).\",\n",
       "    \"Cell migration is the primary endpoint used for toxicity testing in this system.\",\n",
       "    \"Cell viability is measured as a secondary endpoint to assess cytotoxicity and is used for normalization \n",
       "purposes.\",\n",
       "    \"The assay quantifies the number of migrated NCCs into the cell-free zone after exposure to potential \n",
       "toxicants.\",\n",
       "    \"Migration inhibition is the main focus of the assay.\",\n",
       "    \"Cell viability is also measured to ensure that observed migration effects are not solely due to \n",
       "cytotoxicity.\",\n",
       "    \"Cell viability serves as a reference or normalization endpoint to interpret migration data accurately.\",\n",
       "    \"Source: cMINC(UKN2).pdf.\"\n",
       "] \n",
       " \n",
       "Verdicts:\n",
       "[\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"The context mentions viability is measured but does not specify it as a secondary endpoint or \n",
       "its use for normalization.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"The context indicates viability is measured but does not explicitly state its use to ensure \n",
       "observed migration effects are not due to cytotoxicity.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"The context does not state viability is used as a normalization endpoint to interpret migration \n",
       "data.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"The context does not mention a file name; it describes the assay but not a PDF source.\"\n",
       "    }\n",
       "]\n",
       " \n",
       "Score: 1.0\n",
       "Reason: The score is 1.00 because there are no contradictions—the contradictions list is empty, indicating the \n",
       "actual output fully aligns with the retrieval context.\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">======================================================================\n",
       "</pre>\n"
      ],
      "text/plain": [
       "======================================================================\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "2f43443316a74be392213600f767ea6b",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Output()"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">**************************************************\n",
       "</pre>\n"
      ],
      "text/plain": [
       "**************************************************\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">ToxTemp Groundedness Policy (counts) [GEval] Verbose Logs\n",
       "</pre>\n"
      ],
      "text/plain": [
       "ToxTemp Groundedness Policy (counts) [GEval] Verbose Logs\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">**************************************************\n",
       "</pre>\n"
      ],
      "text/plain": [
       "**************************************************\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">Criteria:\n",
       "None \n",
       " \n",
       "Evaluation Steps:\n",
       "[\n",
       "    \"Task: evaluate whether ACTUAL_OUTPUT is grounded ONLY in RETRIEVAL_CONTEXT. No outside knowledge.\",\n",
       "    \"\",\n",
       "    \"Step 1 — Extract atomic factual claims from ACTUAL_OUTPUT limited to: entities, numbers, durations, units, \n",
       "methods, readouts, materials, cell lines, species, instruments, and endpoints. Do NOT extract vague/subjective \n",
       "claims (e.g., 'robust', 'appropriate').\",\n",
       "    \"\",\n",
       "    \"Step 2 — For each claim, assign exactly one label:\",\n",
       "    \"  - ENTAILED: explicitly supported by RETRIEVAL_CONTEXT (directly stated or unambiguous paraphrase).\",\n",
       "    \"  - CONTRADICTED: conflicts with RETRIEVAL_CONTEXT.\",\n",
       "    \"  - UNSUPPORTED: not found in RETRIEVAL_CONTEXT and not contradicted.\",\n",
       "    \"  - ABSTAINED: ACTUAL_OUTPUT explicitly states the information is not in the context / cannot be determined, \n",
       "and does not assert the missing fact.\",\n",
       "    \"\",\n",
       "    \"Step 3 — Return VALID JSON ONLY (no markdown, no extra text) with integer counts and an optional short audit \n",
       "list.\",\n",
       "    \"Required JSON keys: {\"entailed\": int, \"unsupported\": int, \"contradicted\": int, \"abstained\": int, \n",
       "\"total_claims\": int}.\",\n",
       "    \"Optional key: \"claims\": a list of up to 10 items, each with {\"claim\": str, \"label\": str, \"evidence\": str}. \n",
       "Evidence should be a short phrase from context or \"N/A\".\",\n",
       "    \"\",\n",
       "    \"Step 4 — Ensure: total_claims = entailed + unsupported + contradicted + abstained.\"\n",
       "] \n",
       " \n",
       "Rubric:\n",
       "None \n",
       " \n",
       "Score: 1.0\n",
       " \n",
       "Reason: All atomic claims in ACTUAL_OUTPUT (migration inhibition endpoint, NCCs are human NCCs, migration as \n",
       "primary endpoint, viability as secondary/normalization endpoint, readout by migrated cell counts in the cell-free \n",
       "zone) are explicitly supported by the RETRIEVAL_CONTEXT; no unsupported or contradicted details are present.\n",
       "</pre>\n"
      ],
      "text/plain": [
       "Criteria:\n",
       "None \n",
       " \n",
       "Evaluation Steps:\n",
       "[\n",
       "    \"Task: evaluate whether ACTUAL_OUTPUT is grounded ONLY in RETRIEVAL_CONTEXT. No outside knowledge.\",\n",
       "    \"\",\n",
       "    \"Step 1 — Extract atomic factual claims from ACTUAL_OUTPUT limited to: entities, numbers, durations, units, \n",
       "methods, readouts, materials, cell lines, species, instruments, and endpoints. Do NOT extract vague/subjective \n",
       "claims (e.g., 'robust', 'appropriate').\",\n",
       "    \"\",\n",
       "    \"Step 2 — For each claim, assign exactly one label:\",\n",
       "    \"  - ENTAILED: explicitly supported by RETRIEVAL_CONTEXT (directly stated or unambiguous paraphrase).\",\n",
       "    \"  - CONTRADICTED: conflicts with RETRIEVAL_CONTEXT.\",\n",
       "    \"  - UNSUPPORTED: not found in RETRIEVAL_CONTEXT and not contradicted.\",\n",
       "    \"  - ABSTAINED: ACTUAL_OUTPUT explicitly states the information is not in the context / cannot be determined, \n",
       "and does not assert the missing fact.\",\n",
       "    \"\",\n",
       "    \"Step 3 — Return VALID JSON ONLY (no markdown, no extra text) with integer counts and an optional short audit \n",
       "list.\",\n",
       "    \"Required JSON keys: {\"entailed\": int, \"unsupported\": int, \"contradicted\": int, \"abstained\": int, \n",
       "\"total_claims\": int}.\",\n",
       "    \"Optional key: \"claims\": a list of up to 10 items, each with {\"claim\": str, \"label\": str, \"evidence\": str}. \n",
       "Evidence should be a short phrase from context or \"N/A\".\",\n",
       "    \"\",\n",
       "    \"Step 4 — Ensure: total_claims = entailed + unsupported + contradicted + abstained.\"\n",
       "] \n",
       " \n",
       "Rubric:\n",
       "None \n",
       " \n",
       "Score: 1.0\n",
       " \n",
       "Reason: All atomic claims in ACTUAL_OUTPUT (migration inhibition endpoint, NCCs are human NCCs, migration as \n",
       "primary endpoint, viability as secondary/normalization endpoint, readout by migrated cell counts in the cell-free \n",
       "zone) are explicitly supported by the RETRIEVAL_CONTEXT; no unsupported or contradicted details are present.\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">======================================================================\n",
       "</pre>\n"
      ],
      "text/plain": [
       "======================================================================\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "68c753e7d319485d870c0b09cb0456d3",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Output()"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "=== Eval Results ===\n",
      "faithfulness_score: 1.0\n",
      "faithfulness_reason: The score is 1.00 because there are no contradictions—the contradictions list is empty, indicating the actual output fully aligns with the retrieval context.\n",
      "geval_policy_score: 1.0\n",
      "geval_policy_reason: All atomic claims in ACTUAL_OUTPUT (migration inhibition endpoint, NCCs are human NCCs, migration as primary endpoint, viability as secondary/normalization endpoint, readout by migrated cell counts in the cell-free zone) are explicitly supported by the RETRIEVAL_CONTEXT; no unsupported or contradicted details are present.\n",
      "groundedness_policy_score: None\n",
      "groundedness_herman_score: None\n",
      "groundedness_counts: None\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">**************************************************\n",
       "</pre>\n"
      ],
      "text/plain": [
       "**************************************************\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">Faithfulness Verbose Logs\n",
       "</pre>\n"
      ],
      "text/plain": [
       "Faithfulness Verbose Logs\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">**************************************************\n",
       "</pre>\n"
      ],
      "text/plain": [
       "**************************************************\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">Truths (limit=None):\n",
       "[\n",
       "    \"The test method described is the circular migration inhibition of NCC (cMINC) assay, UKN2, Version 2.0.\",\n",
       "    \"The cMINC assay uses human neural crest cells (NCCs) generated from induced pluripotent stem cells (iPSCs).\",\n",
       "    \"In this in vitro assay, NCC migration and cell viability are measured simultaneously using high-content \n",
       "imaging after exposure to potential toxicants for 24 hours.\",\n",
       "    \"The data from the assay are intended to predict developmental disorders and malformations such as neural tube \n",
       "defects or craniofacial malformations caused by chemical exposure during fetal development.\",\n",
       "    \"The assay has a readiness score of A- according to Bal-Price et al. (2018).\",\n",
       "    \"The hiPSC line used is IMR90_clone_#4, obtained from WiCell in 2012, with a masterstock and prepared working \n",
       "stocks.\",\n",
       "    \"Undifferentiated hiPSCs used in the system are maintained as a monoculture on Laminin-521 coating in Essential\n",
       "8 medium.\",\n",
       "    \"The hiPSC line IMR-90 has ATCC number CCL-186, origin Homo sapiens, tissue lung, and cell type fibroblast.\",\n",
       "    \"The hiPSCs express pluripotency markers Oct4, Nanog, and Tra-1-60 by immunocytochemistry.\",\n",
       "    \"NCCs are differentiated from hiPSCs following the modified protocol of Mica et al. (2013).\",\n",
       "    \"The differentiated NCC population is at least 90% positive for NCC markers HNK-1 and p75 and expresses nestin \n",
       "and AP2, but does not express GFAP, Pax6, or βIII-tubulin.\",\n",
       "    \"After thawing, the NCCs have viability greater than 90% and must be pathogen-free with regular mycoplasma \n",
       "testing.\",\n",
       "    \"NCCs are cryopreserved at a concentration of 4 × 10^6 cells per milliliter in 90% N2-S medium and 10% DMSO.\",\n",
       "    \"The test system features a migration assay where a circular cell-free area is created in a well using a \n",
       "silicone stopper, and cells migrate into this area after the stopper is removed.\",\n",
       "    \"The NCC migration is maintained by the presence of epidermal growth factor (EGF) and fibroblast growth factor \n",
       "(FGF) in the medium.\",\n",
       "    \"On day 1 of exposure, 25 μL of a 5× concentrated toxicant solution is added to each well and incubated for 24 \n",
       "hours.\",\n",
       "    \"Migration is quantified by staining cells with calcein-AM and Hoechst 33342 and imaging four fields per well \n",
       "to count migrated cells within a defined ROI.\",\n",
       "    \"The ROI is defined so that untreated wells contain 150 to 300 cells within the region of interest.\",\n",
       "    \"The growth and viability endpoints are processed with a Ringassay software tool and images are analyzed to \n",
       "count viable cells.\",\n",
       "    \"Positive controls used in the assay include cytochalasin D (200 nM), LiCl (10 mM), and taxol (10 nM).\",\n",
       "    \"Negative controls include solvent (0.1% DMSO final concentration), paracetamol, and ASS.\",\n",
       "    \"A typical plate layout uses 2 compounds per plate with 6 concentrations each and employs a default 1:3 serial \n",
       "dilution.\",\n",
       "    \"All compound dilutions in the master plate contain 0.5% DMSO, resulting in 0.1% DMSO in the cell-containing \n",
       "medium.\",\n",
       "    \"The method throughput is estimated at 768 data points per month, with 16 plates processed per week and about \n",
       "192 data points per week.\",\n",
       "    \"The assay has not undergone formal OECD validation or ring trials, and regulatory acceptance is not \n",
       "established.\",\n",
       "    \"The test has been used in screening campaigns, including the NTP80 work, EFSA EFSA DNT battery studies, and \n",
       "EU-ToxRisk-related work.\",\n",
       "    \"Data analysis relies on Microsoft Excel and GraphPad Prism, and raw data are stored and backed up on \n",
       "institutional servers.\",\n",
       "    \"Volatile compounds and substances not water-soluble cannot be measured by this assay.\",\n",
       "    \"The assay requires specialized equipment such as a Cellomics Array Scan VTI HCS high-content reader and \n",
       "silicone stoppers, and is not readily transferable to all labs.\",\n",
       "    \"Transfer of the assay to other laboratories has not been demonstrated; operator training is intensive and \n",
       "estimated at about four weeks for smooth performance.\",\n",
       "    \"The protocol references a DB-ALM SOP (No. 195) for cMINC and requires access to Lab infrastructure and BSL-1/ \n",
       "cell culture facilities.\",\n",
       "    \"The test is not formally linked to OECD regulatory guidelines and is described as not yet validated in an OECD\n",
       "ring-trial context.\"\n",
       "] \n",
       " \n",
       "Claims:\n",
       "[\n",
       "    \"The assay employs high content imaging to assess two key endpoints: migration inhibition and cell viability, \n",
       "in human neural crest cells (NCCs).\",\n",
       "    \"The process involves staining the cells with calcein-AM (for live cells) and Hoechst 33342 (for nuclei), \n",
       "followed by automated imaging.\",\n",
       "    \"The cells are not fixed; live-cell dyes are used to enable real-time assessment of viability and migration \n",
       "behavior.\",\n",
       "    \"For the migration endpoint, NCCs are seeded around a silicone stopper in a well, allowed to adhere, and then \n",
       "the stopper is removed to create a cell-free zone.\",\n",
       "    \"Cells migrate into this zone over 24 hours.\",\n",
       "    \"After exposure to test compounds, the cells are stained with calcein-AM and Hoechst 33342, and images are \n",
       "acquired in four tiles per well using a high content imaging system.\",\n",
       "    \"The quantification algorithm estimates the previously cell-free area and counts the number of double-positive \n",
       "(calcein and Hoechst) cells within a defined region of interest (ROI).\",\n",
       "    \"Typically, 150–300 cells are imaged per ROI, and the software automatically counts viable cells based on \n",
       "fluorescence signals.\",\n",
       "    \"Cell viability is measured in the same wells, outside the migration zone, by imaging four fields per well with\n",
       "a 10x objective.\",\n",
       "    \"The same fluorescent dyes are used, and automated algorithms determine the number of double-positive cells, \n",
       "representing viable nuclei.\",\n",
       "    \"Both endpoints are measured under the same conditions and in parallel within the same well, allowing direct \n",
       "comparison of migration and viability data.\",\n",
       "    \"The quantification relies on automated image analysis software that estimates the number of viable cells based\n",
       "on fluorescence intensity and cell morphology, providing semi-quantitative counts.\",\n",
       "    \"The software calculates the number of double-positive cells in the ROI, enabling objective and reproducible \n",
       "measurement of migration and viability.\"\n",
       "] \n",
       " \n",
       "Verdicts:\n",
       "[\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"Context does not specify whether cells are fixed or imaged live; it mentions live-cell dye \n",
       "calcein-AM but does not explicitly state non-fixation or real-time assessment.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"Context specifies four fields per well for migration imaging but does not specify imaging fields\n",
       "or objective settings for viability measurements, so the claim's specifics are not directly confirmed.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    }\n",
       "]\n",
       " \n",
       "Score: 1.0\n",
       "Reason: The score is 1.00 because there are no contradictions between the actual output and the retrieval context, \n",
       "indicating perfect faithfulness.\n",
       "</pre>\n"
      ],
      "text/plain": [
       "Truths (limit=None):\n",
       "[\n",
       "    \"The test method described is the circular migration inhibition of NCC (cMINC) assay, UKN2, Version 2.0.\",\n",
       "    \"The cMINC assay uses human neural crest cells (NCCs) generated from induced pluripotent stem cells (iPSCs).\",\n",
       "    \"In this in vitro assay, NCC migration and cell viability are measured simultaneously using high-content \n",
       "imaging after exposure to potential toxicants for 24 hours.\",\n",
       "    \"The data from the assay are intended to predict developmental disorders and malformations such as neural tube \n",
       "defects or craniofacial malformations caused by chemical exposure during fetal development.\",\n",
       "    \"The assay has a readiness score of A- according to Bal-Price et al. (2018).\",\n",
       "    \"The hiPSC line used is IMR90_clone_#4, obtained from WiCell in 2012, with a masterstock and prepared working \n",
       "stocks.\",\n",
       "    \"Undifferentiated hiPSCs used in the system are maintained as a monoculture on Laminin-521 coating in Essential\n",
       "8 medium.\",\n",
       "    \"The hiPSC line IMR-90 has ATCC number CCL-186, origin Homo sapiens, tissue lung, and cell type fibroblast.\",\n",
       "    \"The hiPSCs express pluripotency markers Oct4, Nanog, and Tra-1-60 by immunocytochemistry.\",\n",
       "    \"NCCs are differentiated from hiPSCs following the modified protocol of Mica et al. (2013).\",\n",
       "    \"The differentiated NCC population is at least 90% positive for NCC markers HNK-1 and p75 and expresses nestin \n",
       "and AP2, but does not express GFAP, Pax6, or βIII-tubulin.\",\n",
       "    \"After thawing, the NCCs have viability greater than 90% and must be pathogen-free with regular mycoplasma \n",
       "testing.\",\n",
       "    \"NCCs are cryopreserved at a concentration of 4 × 10^6 cells per milliliter in 90% N2-S medium and 10% DMSO.\",\n",
       "    \"The test system features a migration assay where a circular cell-free area is created in a well using a \n",
       "silicone stopper, and cells migrate into this area after the stopper is removed.\",\n",
       "    \"The NCC migration is maintained by the presence of epidermal growth factor (EGF) and fibroblast growth factor \n",
       "(FGF) in the medium.\",\n",
       "    \"On day 1 of exposure, 25 μL of a 5× concentrated toxicant solution is added to each well and incubated for 24 \n",
       "hours.\",\n",
       "    \"Migration is quantified by staining cells with calcein-AM and Hoechst 33342 and imaging four fields per well \n",
       "to count migrated cells within a defined ROI.\",\n",
       "    \"The ROI is defined so that untreated wells contain 150 to 300 cells within the region of interest.\",\n",
       "    \"The growth and viability endpoints are processed with a Ringassay software tool and images are analyzed to \n",
       "count viable cells.\",\n",
       "    \"Positive controls used in the assay include cytochalasin D (200 nM), LiCl (10 mM), and taxol (10 nM).\",\n",
       "    \"Negative controls include solvent (0.1% DMSO final concentration), paracetamol, and ASS.\",\n",
       "    \"A typical plate layout uses 2 compounds per plate with 6 concentrations each and employs a default 1:3 serial \n",
       "dilution.\",\n",
       "    \"All compound dilutions in the master plate contain 0.5% DMSO, resulting in 0.1% DMSO in the cell-containing \n",
       "medium.\",\n",
       "    \"The method throughput is estimated at 768 data points per month, with 16 plates processed per week and about \n",
       "192 data points per week.\",\n",
       "    \"The assay has not undergone formal OECD validation or ring trials, and regulatory acceptance is not \n",
       "established.\",\n",
       "    \"The test has been used in screening campaigns, including the NTP80 work, EFSA EFSA DNT battery studies, and \n",
       "EU-ToxRisk-related work.\",\n",
       "    \"Data analysis relies on Microsoft Excel and GraphPad Prism, and raw data are stored and backed up on \n",
       "institutional servers.\",\n",
       "    \"Volatile compounds and substances not water-soluble cannot be measured by this assay.\",\n",
       "    \"The assay requires specialized equipment such as a Cellomics Array Scan VTI HCS high-content reader and \n",
       "silicone stoppers, and is not readily transferable to all labs.\",\n",
       "    \"Transfer of the assay to other laboratories has not been demonstrated; operator training is intensive and \n",
       "estimated at about four weeks for smooth performance.\",\n",
       "    \"The protocol references a DB-ALM SOP (No. 195) for cMINC and requires access to Lab infrastructure and BSL-1/ \n",
       "cell culture facilities.\",\n",
       "    \"The test is not formally linked to OECD regulatory guidelines and is described as not yet validated in an OECD\n",
       "ring-trial context.\"\n",
       "] \n",
       " \n",
       "Claims:\n",
       "[\n",
       "    \"The assay employs high content imaging to assess two key endpoints: migration inhibition and cell viability, \n",
       "in human neural crest cells (NCCs).\",\n",
       "    \"The process involves staining the cells with calcein-AM (for live cells) and Hoechst 33342 (for nuclei), \n",
       "followed by automated imaging.\",\n",
       "    \"The cells are not fixed; live-cell dyes are used to enable real-time assessment of viability and migration \n",
       "behavior.\",\n",
       "    \"For the migration endpoint, NCCs are seeded around a silicone stopper in a well, allowed to adhere, and then \n",
       "the stopper is removed to create a cell-free zone.\",\n",
       "    \"Cells migrate into this zone over 24 hours.\",\n",
       "    \"After exposure to test compounds, the cells are stained with calcein-AM and Hoechst 33342, and images are \n",
       "acquired in four tiles per well using a high content imaging system.\",\n",
       "    \"The quantification algorithm estimates the previously cell-free area and counts the number of double-positive \n",
       "(calcein and Hoechst) cells within a defined region of interest (ROI).\",\n",
       "    \"Typically, 150–300 cells are imaged per ROI, and the software automatically counts viable cells based on \n",
       "fluorescence signals.\",\n",
       "    \"Cell viability is measured in the same wells, outside the migration zone, by imaging four fields per well with\n",
       "a 10x objective.\",\n",
       "    \"The same fluorescent dyes are used, and automated algorithms determine the number of double-positive cells, \n",
       "representing viable nuclei.\",\n",
       "    \"Both endpoints are measured under the same conditions and in parallel within the same well, allowing direct \n",
       "comparison of migration and viability data.\",\n",
       "    \"The quantification relies on automated image analysis software that estimates the number of viable cells based\n",
       "on fluorescence intensity and cell morphology, providing semi-quantitative counts.\",\n",
       "    \"The software calculates the number of double-positive cells in the ROI, enabling objective and reproducible \n",
       "measurement of migration and viability.\"\n",
       "] \n",
       " \n",
       "Verdicts:\n",
       "[\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"Context does not specify whether cells are fixed or imaged live; it mentions live-cell dye \n",
       "calcein-AM but does not explicitly state non-fixation or real-time assessment.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"Context specifies four fields per well for migration imaging but does not specify imaging fields\n",
       "or objective settings for viability measurements, so the claim's specifics are not directly confirmed.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    }\n",
       "]\n",
       " \n",
       "Score: 1.0\n",
       "Reason: The score is 1.00 because there are no contradictions between the actual output and the retrieval context, \n",
       "indicating perfect faithfulness.\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">======================================================================\n",
       "</pre>\n"
      ],
      "text/plain": [
       "======================================================================\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "21929a8c203548a49a4392322da9682d",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Output()"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">**************************************************\n",
       "</pre>\n"
      ],
      "text/plain": [
       "**************************************************\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">ToxTemp Groundedness Policy (counts) [GEval] Verbose Logs\n",
       "</pre>\n"
      ],
      "text/plain": [
       "ToxTemp Groundedness Policy (counts) [GEval] Verbose Logs\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">**************************************************\n",
       "</pre>\n"
      ],
      "text/plain": [
       "**************************************************\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">Criteria:\n",
       "None \n",
       " \n",
       "Evaluation Steps:\n",
       "[\n",
       "    \"Task: evaluate whether ACTUAL_OUTPUT is grounded ONLY in RETRIEVAL_CONTEXT. No outside knowledge.\",\n",
       "    \"\",\n",
       "    \"Step 1 — Extract atomic factual claims from ACTUAL_OUTPUT limited to: entities, numbers, durations, units, \n",
       "methods, readouts, materials, cell lines, species, instruments, and endpoints. Do NOT extract vague/subjective \n",
       "claims (e.g., 'robust', 'appropriate').\",\n",
       "    \"\",\n",
       "    \"Step 2 — For each claim, assign exactly one label:\",\n",
       "    \"  - ENTAILED: explicitly supported by RETRIEVAL_CONTEXT (directly stated or unambiguous paraphrase).\",\n",
       "    \"  - CONTRADICTED: conflicts with RETRIEVAL_CONTEXT.\",\n",
       "    \"  - UNSUPPORTED: not found in RETRIEVAL_CONTEXT and not contradicted.\",\n",
       "    \"  - ABSTAINED: ACTUAL_OUTPUT explicitly states the information is not in the context / cannot be determined, \n",
       "and does not assert the missing fact.\",\n",
       "    \"\",\n",
       "    \"Step 3 — Return VALID JSON ONLY (no markdown, no extra text) with integer counts and an optional short audit \n",
       "list.\",\n",
       "    \"Required JSON keys: {\"entailed\": int, \"unsupported\": int, \"contradicted\": int, \"abstained\": int, \n",
       "\"total_claims\": int}.\",\n",
       "    \"Optional key: \"claims\": a list of up to 10 items, each with {\"claim\": str, \"label\": str, \"evidence\": str}. \n",
       "Evidence should be a short phrase from context or \"N/A\".\",\n",
       "    \"\",\n",
       "    \"Step 4 — Ensure: total_claims = entailed + unsupported + contradicted + abstained.\"\n",
       "] \n",
       " \n",
       "Rubric:\n",
       "None \n",
       " \n",
       "Score: 0.9\n",
       " \n",
       "Reason: High alignment: ACTUAL_OUTPUT correctly covers NCC migration and viability endpoints, calcein-AM/Hoechst \n",
       "staining, four tiles per well, ROI of 150–300 cells, silicone stopper migration setup, 24 h exposure, parallel \n",
       "measurement of endpoints, and imaging/analysis workflow as described in the retrieval context. The claim 'cells are\n",
       "not fixed' is not explicitly supported by the context and is therefore unsupported.\n",
       "</pre>\n"
      ],
      "text/plain": [
       "Criteria:\n",
       "None \n",
       " \n",
       "Evaluation Steps:\n",
       "[\n",
       "    \"Task: evaluate whether ACTUAL_OUTPUT is grounded ONLY in RETRIEVAL_CONTEXT. No outside knowledge.\",\n",
       "    \"\",\n",
       "    \"Step 1 — Extract atomic factual claims from ACTUAL_OUTPUT limited to: entities, numbers, durations, units, \n",
       "methods, readouts, materials, cell lines, species, instruments, and endpoints. Do NOT extract vague/subjective \n",
       "claims (e.g., 'robust', 'appropriate').\",\n",
       "    \"\",\n",
       "    \"Step 2 — For each claim, assign exactly one label:\",\n",
       "    \"  - ENTAILED: explicitly supported by RETRIEVAL_CONTEXT (directly stated or unambiguous paraphrase).\",\n",
       "    \"  - CONTRADICTED: conflicts with RETRIEVAL_CONTEXT.\",\n",
       "    \"  - UNSUPPORTED: not found in RETRIEVAL_CONTEXT and not contradicted.\",\n",
       "    \"  - ABSTAINED: ACTUAL_OUTPUT explicitly states the information is not in the context / cannot be determined, \n",
       "and does not assert the missing fact.\",\n",
       "    \"\",\n",
       "    \"Step 3 — Return VALID JSON ONLY (no markdown, no extra text) with integer counts and an optional short audit \n",
       "list.\",\n",
       "    \"Required JSON keys: {\"entailed\": int, \"unsupported\": int, \"contradicted\": int, \"abstained\": int, \n",
       "\"total_claims\": int}.\",\n",
       "    \"Optional key: \"claims\": a list of up to 10 items, each with {\"claim\": str, \"label\": str, \"evidence\": str}. \n",
       "Evidence should be a short phrase from context or \"N/A\".\",\n",
       "    \"\",\n",
       "    \"Step 4 — Ensure: total_claims = entailed + unsupported + contradicted + abstained.\"\n",
       "] \n",
       " \n",
       "Rubric:\n",
       "None \n",
       " \n",
       "Score: 0.9\n",
       " \n",
       "Reason: High alignment: ACTUAL_OUTPUT correctly covers NCC migration and viability endpoints, calcein-AM/Hoechst \n",
       "staining, four tiles per well, ROI of 150–300 cells, silicone stopper migration setup, 24 h exposure, parallel \n",
       "measurement of endpoints, and imaging/analysis workflow as described in the retrieval context. The claim 'cells are\n",
       "not fixed' is not explicitly supported by the context and is therefore unsupported.\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">======================================================================\n",
       "</pre>\n"
      ],
      "text/plain": [
       "======================================================================\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "=== Eval Results ===\n",
      "faithfulness_score: 1.0\n",
      "faithfulness_reason: The score is 1.00 because there are no contradictions between the actual output and the retrieval context, indicating perfect faithfulness.\n",
      "geval_policy_score: 0.9\n",
      "geval_policy_reason: High alignment: ACTUAL_OUTPUT correctly covers NCC migration and viability endpoints, calcein-AM/Hoechst staining, four tiles per well, ROI of 150–300 cells, silicone stopper migration setup, 24 h exposure, parallel measurement of endpoints, and imaging/analysis workflow as described in the retrieval context. The claim 'cells are not fixed' is not explicitly supported by the context and is therefore unsupported.\n",
      "groundedness_policy_score: None\n",
      "groundedness_herman_score: None\n",
      "groundedness_counts: None\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "PosixPath('/Users/johannehouweling/ToxTempAssistant/myocyte/groundedness_demo_output.csv')"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "csv_path = Path(\"/Users/johannehouweling/ToxTempAssistant/myocyte/toxtempass/evaluation/positive_control/output/gpt-4.1-nano/tier1_comparison_cMINC(UKN2).csv\")\n",
    "pdf_path = Path(\"/Users/johannehouweling/ToxTempAssistant/myocyte/toxtempass/evaluation/positive_control/input_files/cMINC(UKN2).pdf\")\n",
    "\n",
    "demo_path = Path.cwd() / \"demo_input.csv\"\n",
    "df = pd.read_csv(csv_path).iloc[34:36, :]\n",
    "df.to_csv(demo_path, index=False)\n",
    "\n",
    "add_groundedness_columns(\n",
    "            csv_path=demo_path,\n",
    "            pdf_path=pdf_path,\n",
    "            output_path=Path.cwd() / \"groundedness_demo_output.csv\",\n",
    "            judge_model=\"gpt-5-nano\",\n",
    "            faithfulness_threshold=0.5,\n",
    "            geval_threshold=0.5,\n",
    "            verbose=True\n",
    "            )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "2e25e101-8025-4ac4-bcba-8adaf2d836c3",
   "metadata": {},
   "outputs": [
    {
     "ename": "SyntaxError",
     "evalue": "expected argument value expression (<ipython-input-23-8a927ed2234a>, line 27)",
     "output_type": "error",
     "traceback": [
      "  \u001b[36mCell\u001b[39m\u001b[36m \u001b[39m\u001b[32mIn[23]\u001b[39m\u001b[32m, line 27\u001b[39m\n\u001b[31m    \u001b[39m\u001b[31moutput_dir=,\u001b[39m\n    ^\n\u001b[31mSyntaxError\u001b[39m\u001b[31m:\u001b[39m expected argument value expression\n"
     ]
    }
   ],
   "source": [
    "from pathlib import Path\n",
    "import pandas as pd\n",
    "\n",
    "from myocyte.toxtempass.evaluation.post_processing.groundedness import add_groundedness_columns, add_groundedness_to_directory\n",
    "\n",
    "#from myocyte.toxtempass.evaluation.post_processing.groundedness import add_groundedness_columns\n",
    "\n",
    "\n",
    "csv_path = Path(\"/Users/johannehouweling/ToxTempAssistant/myocyte/toxtempass/evaluation/positive_control/output/gpt-4.1-nano/tier1_comparison_cMINC(UKN2).csv\")\n",
    "pdf_path = Path(\"/Users/johannehouweling/ToxTempAssistant/myocyte/toxtempass/evaluation/positive_control/input_files/cMINC(UKN2).pdf\")\n",
    "\n",
    "demo_path = Path(\"demo_input.csv\")\n",
    "\n",
    "\n",
    "\n",
    "add_groundedness_columns(\n",
    "            csv_path=demo_path,\n",
    "            pdf_path=pdf_path,\n",
    "            output_path=Path.cwd() / \"groundedness_demo_output.csv\",\n",
    "            judge_model=\"gpt-5-nano\",\n",
    "            faithfulness_threshold=0.5,\n",
    "            geval_threshold=0.5,\n",
    "            verbose=True\n",
    "            )\n",
    "\n",
    "add_groundedness_to_directory(\n",
    "            output_dir=,\n",
    "            pdf_dir=args.pdf_dir,\n",
    "            judge_model=args.judge_model,\n",
    "            faithfulness_threshold=args.faith_threshold,\n",
    "            geval_threshold=args.geval_threshold,\n",
    "            verbose=True,\n",
    "        )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "06d3fb73-f600-400f-a3ec-6b85f4449006",
   "metadata": {},
   "outputs": [
    {
     "ename": "ModuleNotFoundError",
     "evalue": "No module named 'myocyte.toxtempass'",
     "output_type": "error",
     "traceback": [
      "\u001b[31m---------------------------------------------------------------------------\u001b[39m",
      "\u001b[31mModuleNotFoundError\u001b[39m                       Traceback (most recent call last)",
      "\u001b[36mCell\u001b[39m\u001b[36m \u001b[39m\u001b[32mIn[24]\u001b[39m\u001b[32m, line 4\u001b[39m\n\u001b[32m      1\u001b[39m \u001b[38;5;28;01mfrom\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[34;01mpathlib\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;28;01mimport\u001b[39;00m Path\n\u001b[32m      2\u001b[39m \u001b[38;5;28;01mimport\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[34;01mpandas\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;28;01mas\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[34;01mpd\u001b[39;00m\n\u001b[32m----> \u001b[39m\u001b[32m4\u001b[39m \u001b[38;5;28;01mfrom\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[34;01mmyocyte\u001b[39;00m\u001b[34;01m.\u001b[39;00m\u001b[34;01mtoxtempass\u001b[39;00m\u001b[34;01m.\u001b[39;00m\u001b[34;01mevaluation\u001b[39;00m\u001b[34;01m.\u001b[39;00m\u001b[34;01mpost_processing\u001b[39;00m\u001b[34;01m.\u001b[39;00m\u001b[34;01mgroundedness\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;28;01mimport\u001b[39;00m add_groundedness_columns, add_groundedness_to_directory\n\u001b[32m      6\u001b[39m \u001b[38;5;66;03m#from myocyte.toxtempass.evaluation.post_processing.groundedness import add_groundedness_columns\u001b[39;00m\n\u001b[32m      9\u001b[39m csv_path = Path(\u001b[33m\"\u001b[39m\u001b[33m/Users/johannehouweling/ToxTempAssistant/myocyte/toxtempass/evaluation/positive_control/output/gpt-4.1-nano/tier1_comparison_cMINC(UKN2).csv\u001b[39m\u001b[33m\"\u001b[39m)\n",
      "\u001b[31mModuleNotFoundError\u001b[39m: No module named 'myocyte.toxtempass'"
     ]
    }
   ],
   "source": [
    "from pathlib import Path\n",
    "import pandas as pd\n",
    "\n",
    "from myocyte.toxtempass.evaluation.post_processing.groundedness import add_groundedness_columns, add_groundedness_to_directory\n",
    "\n",
    "#from myocyte.toxtempass.evaluation.post_processing.groundedness import add_groundedness_columns\n",
    "\n",
    "\n",
    "csv_path = Path(\"/Users/johannehouweling/ToxTempAssistant/myocyte/toxtempass/evaluation/positive_control/output/gpt-4.1-nano/tier1_comparison_cMINC(UKN2).csv\")\n",
    "pdf_path = Path(\"/Users/johannehouweling/ToxTempAssistant/myocyte/toxtempass/evaluation/positive_control/input_files/cMINC(UKN2).pdf\")\n",
    "\n",
    "demo_path = Path(\"demo_input.csv\")\n",
    "\n",
    "\n",
    "\n",
    "add_groundedness_columns(\n",
    "            csv_path=demo_path,\n",
    "            pdf_path=pdf_path,\n",
    "            output_path=Path.cwd() / \"groundedness_demo_output.csv\",\n",
    "            judge_model=\"gpt-5-nano\",\n",
    "            faithfulness_threshold=0.5,\n",
    "            geval_threshold=0.5,\n",
    "            verbose=True\n",
    "            )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "fb8e492f-f585-45d6-88f2-13bcac3d466a",
   "metadata": {},
   "outputs": [
    {
     "ename": "ModuleNotFoundError",
     "evalue": "No module named 'myocyte.toxtempass'",
     "output_type": "error",
     "traceback": [
      "\u001b[31m---------------------------------------------------------------------------\u001b[39m",
      "\u001b[31mModuleNotFoundError\u001b[39m                       Traceback (most recent call last)",
      "\u001b[36mCell\u001b[39m\u001b[36m \u001b[39m\u001b[32mIn[25]\u001b[39m\u001b[32m, line 4\u001b[39m\n\u001b[32m      1\u001b[39m \u001b[38;5;28;01mfrom\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[34;01mpathlib\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;28;01mimport\u001b[39;00m Path\n\u001b[32m      2\u001b[39m \u001b[38;5;28;01mimport\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[34;01mpandas\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;28;01mas\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[34;01mpd\u001b[39;00m\n\u001b[32m----> \u001b[39m\u001b[32m4\u001b[39m \u001b[38;5;28;01mfrom\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[34;01mmyocyte\u001b[39;00m\u001b[34;01m.\u001b[39;00m\u001b[34;01mtoxtempass\u001b[39;00m\u001b[34;01m.\u001b[39;00m\u001b[34;01mevaluation\u001b[39;00m\u001b[34;01m.\u001b[39;00m\u001b[34;01mpost_processing\u001b[39;00m\u001b[34;01m.\u001b[39;00m\u001b[34;01mgroundedness\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;28;01mimport\u001b[39;00m add_groundedness_columns, add_groundedness_to_directory\n\u001b[32m      6\u001b[39m \u001b[38;5;66;03m#from myocyte.toxtempass.evaluation.post_processing.groundedness import add_groundedness_columns\u001b[39;00m\n\u001b[32m      9\u001b[39m csv_path = Path(\u001b[33m\"\u001b[39m\u001b[33m/Users/johannehouweling/ToxTempAssistant/myocyte/toxtempass/evaluation/positive_control/output/gpt-4.1-nano/tier1_comparison_cMINC(UKN2).csv\u001b[39m\u001b[33m\"\u001b[39m)\n",
      "\u001b[31mModuleNotFoundError\u001b[39m: No module named 'myocyte.toxtempass'"
     ]
    }
   ],
   "source": [
    "from pathlib import Path\n",
    "import pandas as pd\n",
    "\n",
    "from myocyte.toxtempass.evaluation.post_processing.groundedness import add_groundedness_columns, add_groundedness_to_directory\n",
    "\n",
    "#from myocyte.toxtempass.evaluation.post_processing.groundedness import add_groundedness_columns\n",
    "\n",
    "\n",
    "csv_path = Path(\"/Users/johannehouweling/ToxTempAssistant/myocyte/toxtempass/evaluation/positive_control/output/gpt-4.1-nano/tier1_comparison_cMINC(UKN2).csv\")\n",
    "pdf_path = Path(\"/Users/johannehouweling/ToxTempAssistant/myocyte/toxtempass/evaluation/positive_control/input_files/cMINC(UKN2).pdf\")\n",
    "\n",
    "demo_path = Path(\"demo_input.csv\")\n",
    "\n",
    "add_groundedness_columns(\n",
    "            csv_path=demo_path,\n",
    "            pdf_path=pdf_path,\n",
    "            output_path=Path.cwd() / \"groundedness_demo_output.csv\",\n",
    "            judge_model=\"gpt-5-nano\",\n",
    "            faithfulness_threshold=0.5,\n",
    "            geval_threshold=0.5,\n",
    "            verbose=True\n",
    "            )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "51fcf733-1ea2-4aca-8ed4-27d2c7f1078d",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "993e8057e0bd4f22827a8885498a67fe",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Output()"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">**************************************************\n",
       "</pre>\n"
      ],
      "text/plain": [
       "**************************************************\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">Faithfulness Verbose Logs\n",
       "</pre>\n"
      ],
      "text/plain": [
       "Faithfulness Verbose Logs\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">**************************************************\n",
       "</pre>\n"
      ],
      "text/plain": [
       "**************************************************\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">Truths (limit=None):\n",
       "[\n",
       "    \"The document describes a test method named Circular migration inhibition of NCC (cMINC) assay, UKN2, Version \n",
       "2.0.\",\n",
       "    \"The assay uses human neural crest cells (NCCs) derived from human induced pluripotent stem cells (hiPSCs).\",\n",
       "    \"The hiPSC line used is IMR90_clone_#4, bought from WiCell, Wisconsin in 2012, with a masterstock that has been\n",
       "frozen.\",\n",
       "    \"Working stocks have been prepared from the masterstock and thawed regularly.\",\n",
       "    \"The hiPSCs are maintained up to 10 passages before a new vial of working stock is thawed.\",\n",
       "    \"The undifferentiated hiPSC line IMR-90/IMR90 expresses pluripotency markers Oct4, Nanog and Tra-1-60.\",\n",
       "    \"The cell line has ATCC number CCL-186 and originates from human lung tissue described as fibroblast.\",\n",
       "    \"The donor was female and the tissue was from 16 weeks gestation.\",\n",
       "    \"STR signature shows 100% loci homology between the ATCC IMR-90 cell line and the University of Konstanz \n",
       "line.\",\n",
       "    \"Source cells must be pathogen-free and are regularly tested for mycoplasma.\",\n",
       "    \"After thawing, viability must be greater than 90%.\",\n",
       "    \"NCCs are differentiated from hiPSCs following the modified protocol of Mica et al. (2013).\",\n",
       "    \"Differentiation involves Noggin and SB431542 early on, CHIR99021 from day 2, and gradual medium changes from \n",
       "day 4 to N2-S medium.\",\n",
       "    \"The derived NCC population is at least 90% positive for NCC markers HNK-1 and p75.\",\n",
       "    \"The NCCs also express nestin and AP2.\",\n",
       "    \"The NCCs do not express GFAP, Pax6, or βIII-tubulin.\",\n",
       "    \"The test uses a 96-well plate with silicone stoppers to create a central cell-free migration zone.\",\n",
       "    \"Migration is assessed by NCC movement into the cell-free area after stopper removal.\",\n",
       "    \"Migration is quantified by counting viable NCCs in the region of interest (ROI) across four tiles per well.\",\n",
       "    \"Viability is assessed outside the migration zone by staining with calcein-AM and Hoechst 33342 and counting \n",
       "double-positive cells.\",\n",
       "    \"End points are migration inhibition (primary) and cell viability (reference endpoint).\",\n",
       "    \"Toxicants are added on Day 1 as 25 μL of a 5x concentrated solution and incubated for 24 hours.\",\n",
       "    \"On Day 2 cells are stained and imaged for migration and viability.\",\n",
       "    \"The solvent control uses 0.1% DMSO final concentration in the cell medium.\",\n",
       "    \"The DMSO used to dissolve compounds is stored in lightproof bottles and the stock solutions are 100% DMSO.\",\n",
       "    \"A test is discarded if the positive control fails to inhibit migration (e.g., migration in the positive \n",
       "control is ≥ 75% of control).\",\n",
       "    \"The negative controls include solvent (0.1% DMSO final), paracetamol and ASS.\",\n",
       "    \"The assay has a throughput of 768 data points per month (16 plates per week, 2 compounds per plate, 6 \n",
       "concentrations per compound).\",\n",
       "    \"The typical data point is defined as one biological replicate with 4 technical replicates.\",\n",
       "    \"The method uses the Ringassay software to quantify migration.\",\n",
       "    \"Migration quantification involves counting cells in the ROI using automated software that estimates the \n",
       "cell-free area.\",\n",
       "    \"Viable cells are counted with a separate imaging and analysis workflow using the ArrayScan/VTI HCS system and \n",
       "associated software.\",\n",
       "    \"Concentrations are serially diluted typically in 1:3 steps; the default dilution range is from 100 μM to 0.4 \n",
       "μM (example).\",\n",
       "    \"The data are analyzed by nonlinear regression to fit a 4-parameter log function; BMCL/BMC calculations are \n",
       "performed with online tools.\",\n",
       "    \"A three-model framework is used: (1) hit in screening (migration ≤80% of DMSO control and viability ≥90%), (2)\n",
       "hazard evaluation (EC10 Viability / EC25 Migration ≥1.3), (3) borderline (BMCL10 Viability / BMCL25 Migration \n",
       "≥1.3).\",\n",
       "    \"The method has been applied to screening campaigns such as the NTP 80 library, EU-ToxRisk, and EFSA DNT \n",
       "battery evaluations.\",\n",
       "    \"Specificity for early validation is reported as 100% and sensitivity as greater than 90%.\",\n",
       "    \"Baseline intra- and inter-experimental variation values for migration and viability have been reported in \n",
       "related studies.\",\n",
       "    \"PBPK modelling has been used for IVIVE to relate in vitro concentrations to in vivo relevance, with medium \n",
       "lipid content 2.8E-6 ml/ml and albumin concentration 5.6 μM in UKN2 medium and 600 μM in human plasma.\",\n",
       "    \"In vivo relevance estimates place the in vitro concentrations used in the scratch assay in a similar range to \n",
       "expected plasma concentrations for some compounds.\",\n",
       "    \"The test is not formally OECD validated and has not undergone ring trials; it is not linked to regulatory \n",
       "guidelines.\",\n",
       "    \"The method has not been transferred to a different laboratory (transfer not performed).\",\n",
       "    \"The test lab denotes that work requires S1 cell culture facilities and SDS are listed in DaMaRIS; no specific \n",
       "ethical approval is required.\",\n",
       "    \"The test system is not applicable to volatile compounds and substances not soluble in water.\",\n",
       "    \"The test can measure EdU incorporation, resazurin reduction, LDH release, and ATP content as additional \n",
       "endpoints.\",\n",
       "    \"The donor material and derived cells are described in detail, including markers, STR, and culture \n",
       "conditions.\",\n",
       "    \"The assay captures developmental toxicity endpoints by modeling migration impairment of NCCs, which is \n",
       "relevant to neural crest-related disorders such as Hirschsprung’s disease and Treacher-Collins syndrome.\",\n",
       "    \"Extensive documentation exists on maintenance protocols, data processing, and the associated DB-ALM SOP 195 \n",
       "(protocol available online).\"\n",
       "] \n",
       " \n",
       "Claims:\n",
       "[\n",
       "    \"The specific endpoint of the assay is migration inhibition of human neural crest cells (NCCs).\",\n",
       "    \"Cell migration is the primary endpoint used for toxicity testing in this system.\",\n",
       "    \"Cell viability is measured as a secondary endpoint to assess cytotoxicity.\",\n",
       "    \"Cell viability is used for normalization purposes.\",\n",
       "    \"The assay quantifies the number of migrated NCCs into the cell-free zone after exposure to potential \n",
       "toxicants.\",\n",
       "    \"Migration inhibition is the main focus.\",\n",
       "    \"Cell viability is also measured to ensure that observed migration effects are not solely due to \n",
       "cytotoxicity.\",\n",
       "    \"It serves as a reference or normalization endpoint to interpret migration data accurately.\",\n",
       "    \"Source: cMINC(UKN2).pdf.\"\n",
       "] \n",
       " \n",
       "Verdicts:\n",
       "[\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"The context designates viability as a 'reference endpoint' rather than a 'secondary endpoint'.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"The context does not explicitly state that viability is used for normalization; it only mentions\n",
       "viability as a reference endpoint.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"The context notes viability as a reference endpoint but does not explicitly state it is used to \n",
       "separate migration effects from cytotoxicity.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    }\n",
       "]\n",
       " \n",
       "Score: 1.0\n",
       "Reason: The score is 1.00 because there are no contradictions between the actual output and the retrieval context; \n",
       "everything aligns as expected. Great job—keep it up!\n",
       "</pre>\n"
      ],
      "text/plain": [
       "Truths (limit=None):\n",
       "[\n",
       "    \"The document describes a test method named Circular migration inhibition of NCC (cMINC) assay, UKN2, Version \n",
       "2.0.\",\n",
       "    \"The assay uses human neural crest cells (NCCs) derived from human induced pluripotent stem cells (hiPSCs).\",\n",
       "    \"The hiPSC line used is IMR90_clone_#4, bought from WiCell, Wisconsin in 2012, with a masterstock that has been\n",
       "frozen.\",\n",
       "    \"Working stocks have been prepared from the masterstock and thawed regularly.\",\n",
       "    \"The hiPSCs are maintained up to 10 passages before a new vial of working stock is thawed.\",\n",
       "    \"The undifferentiated hiPSC line IMR-90/IMR90 expresses pluripotency markers Oct4, Nanog and Tra-1-60.\",\n",
       "    \"The cell line has ATCC number CCL-186 and originates from human lung tissue described as fibroblast.\",\n",
       "    \"The donor was female and the tissue was from 16 weeks gestation.\",\n",
       "    \"STR signature shows 100% loci homology between the ATCC IMR-90 cell line and the University of Konstanz \n",
       "line.\",\n",
       "    \"Source cells must be pathogen-free and are regularly tested for mycoplasma.\",\n",
       "    \"After thawing, viability must be greater than 90%.\",\n",
       "    \"NCCs are differentiated from hiPSCs following the modified protocol of Mica et al. (2013).\",\n",
       "    \"Differentiation involves Noggin and SB431542 early on, CHIR99021 from day 2, and gradual medium changes from \n",
       "day 4 to N2-S medium.\",\n",
       "    \"The derived NCC population is at least 90% positive for NCC markers HNK-1 and p75.\",\n",
       "    \"The NCCs also express nestin and AP2.\",\n",
       "    \"The NCCs do not express GFAP, Pax6, or βIII-tubulin.\",\n",
       "    \"The test uses a 96-well plate with silicone stoppers to create a central cell-free migration zone.\",\n",
       "    \"Migration is assessed by NCC movement into the cell-free area after stopper removal.\",\n",
       "    \"Migration is quantified by counting viable NCCs in the region of interest (ROI) across four tiles per well.\",\n",
       "    \"Viability is assessed outside the migration zone by staining with calcein-AM and Hoechst 33342 and counting \n",
       "double-positive cells.\",\n",
       "    \"End points are migration inhibition (primary) and cell viability (reference endpoint).\",\n",
       "    \"Toxicants are added on Day 1 as 25 μL of a 5x concentrated solution and incubated for 24 hours.\",\n",
       "    \"On Day 2 cells are stained and imaged for migration and viability.\",\n",
       "    \"The solvent control uses 0.1% DMSO final concentration in the cell medium.\",\n",
       "    \"The DMSO used to dissolve compounds is stored in lightproof bottles and the stock solutions are 100% DMSO.\",\n",
       "    \"A test is discarded if the positive control fails to inhibit migration (e.g., migration in the positive \n",
       "control is ≥ 75% of control).\",\n",
       "    \"The negative controls include solvent (0.1% DMSO final), paracetamol and ASS.\",\n",
       "    \"The assay has a throughput of 768 data points per month (16 plates per week, 2 compounds per plate, 6 \n",
       "concentrations per compound).\",\n",
       "    \"The typical data point is defined as one biological replicate with 4 technical replicates.\",\n",
       "    \"The method uses the Ringassay software to quantify migration.\",\n",
       "    \"Migration quantification involves counting cells in the ROI using automated software that estimates the \n",
       "cell-free area.\",\n",
       "    \"Viable cells are counted with a separate imaging and analysis workflow using the ArrayScan/VTI HCS system and \n",
       "associated software.\",\n",
       "    \"Concentrations are serially diluted typically in 1:3 steps; the default dilution range is from 100 μM to 0.4 \n",
       "μM (example).\",\n",
       "    \"The data are analyzed by nonlinear regression to fit a 4-parameter log function; BMCL/BMC calculations are \n",
       "performed with online tools.\",\n",
       "    \"A three-model framework is used: (1) hit in screening (migration ≤80% of DMSO control and viability ≥90%), (2)\n",
       "hazard evaluation (EC10 Viability / EC25 Migration ≥1.3), (3) borderline (BMCL10 Viability / BMCL25 Migration \n",
       "≥1.3).\",\n",
       "    \"The method has been applied to screening campaigns such as the NTP 80 library, EU-ToxRisk, and EFSA DNT \n",
       "battery evaluations.\",\n",
       "    \"Specificity for early validation is reported as 100% and sensitivity as greater than 90%.\",\n",
       "    \"Baseline intra- and inter-experimental variation values for migration and viability have been reported in \n",
       "related studies.\",\n",
       "    \"PBPK modelling has been used for IVIVE to relate in vitro concentrations to in vivo relevance, with medium \n",
       "lipid content 2.8E-6 ml/ml and albumin concentration 5.6 μM in UKN2 medium and 600 μM in human plasma.\",\n",
       "    \"In vivo relevance estimates place the in vitro concentrations used in the scratch assay in a similar range to \n",
       "expected plasma concentrations for some compounds.\",\n",
       "    \"The test is not formally OECD validated and has not undergone ring trials; it is not linked to regulatory \n",
       "guidelines.\",\n",
       "    \"The method has not been transferred to a different laboratory (transfer not performed).\",\n",
       "    \"The test lab denotes that work requires S1 cell culture facilities and SDS are listed in DaMaRIS; no specific \n",
       "ethical approval is required.\",\n",
       "    \"The test system is not applicable to volatile compounds and substances not soluble in water.\",\n",
       "    \"The test can measure EdU incorporation, resazurin reduction, LDH release, and ATP content as additional \n",
       "endpoints.\",\n",
       "    \"The donor material and derived cells are described in detail, including markers, STR, and culture \n",
       "conditions.\",\n",
       "    \"The assay captures developmental toxicity endpoints by modeling migration impairment of NCCs, which is \n",
       "relevant to neural crest-related disorders such as Hirschsprung’s disease and Treacher-Collins syndrome.\",\n",
       "    \"Extensive documentation exists on maintenance protocols, data processing, and the associated DB-ALM SOP 195 \n",
       "(protocol available online).\"\n",
       "] \n",
       " \n",
       "Claims:\n",
       "[\n",
       "    \"The specific endpoint of the assay is migration inhibition of human neural crest cells (NCCs).\",\n",
       "    \"Cell migration is the primary endpoint used for toxicity testing in this system.\",\n",
       "    \"Cell viability is measured as a secondary endpoint to assess cytotoxicity.\",\n",
       "    \"Cell viability is used for normalization purposes.\",\n",
       "    \"The assay quantifies the number of migrated NCCs into the cell-free zone after exposure to potential \n",
       "toxicants.\",\n",
       "    \"Migration inhibition is the main focus.\",\n",
       "    \"Cell viability is also measured to ensure that observed migration effects are not solely due to \n",
       "cytotoxicity.\",\n",
       "    \"It serves as a reference or normalization endpoint to interpret migration data accurately.\",\n",
       "    \"Source: cMINC(UKN2).pdf.\"\n",
       "] \n",
       " \n",
       "Verdicts:\n",
       "[\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"The context designates viability as a 'reference endpoint' rather than a 'secondary endpoint'.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"The context does not explicitly state that viability is used for normalization; it only mentions\n",
       "viability as a reference endpoint.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"The context notes viability as a reference endpoint but does not explicitly state it is used to \n",
       "separate migration effects from cytotoxicity.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    }\n",
       "]\n",
       " \n",
       "Score: 1.0\n",
       "Reason: The score is 1.00 because there are no contradictions between the actual output and the retrieval context; \n",
       "everything aligns as expected. Great job—keep it up!\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">======================================================================\n",
       "</pre>\n"
      ],
      "text/plain": [
       "======================================================================\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "4e943052c39b4b28a6e9ee40906478c1",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Output()"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">**************************************************\n",
       "</pre>\n"
      ],
      "text/plain": [
       "**************************************************\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">ToxTemp Groundedness Policy (counts) [GEval] Verbose Logs\n",
       "</pre>\n"
      ],
      "text/plain": [
       "ToxTemp Groundedness Policy (counts) [GEval] Verbose Logs\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">**************************************************\n",
       "</pre>\n"
      ],
      "text/plain": [
       "**************************************************\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">Criteria:\n",
       "None \n",
       " \n",
       "Evaluation Steps:\n",
       "[\n",
       "    \"Task: evaluate whether ACTUAL_OUTPUT is grounded ONLY in RETRIEVAL_CONTEXT. No outside knowledge.\",\n",
       "    \"\",\n",
       "    \"Step 1 — Extract atomic factual claims from ACTUAL_OUTPUT limited to: entities, numbers, durations, units, \n",
       "methods, readouts, materials, cell lines, species, instruments, and endpoints. Do NOT extract vague/subjective \n",
       "claims (e.g., 'robust', 'appropriate').\",\n",
       "    \"\",\n",
       "    \"Step 2 — For each claim, assign exactly one label:\",\n",
       "    \"  - ENTAILED: explicitly supported by RETRIEVAL_CONTEXT (directly stated or unambiguous paraphrase).\",\n",
       "    \"  - CONTRADICTED: conflicts with RETRIEVAL_CONTEXT.\",\n",
       "    \"  - UNSUPPORTED: not found in RETRIEVAL_CONTEXT and not contradicted.\",\n",
       "    \"  - ABSTAINED: ACTUAL_OUTPUT explicitly states the information is not in the context / cannot be determined, \n",
       "and does not assert the missing fact.\",\n",
       "    \"\",\n",
       "    \"Step 3 — Return VALID JSON ONLY (no markdown, no extra text) with integer counts and an optional short audit \n",
       "list.\",\n",
       "    \"Required JSON keys: {\"entailed\": int, \"unsupported\": int, \"contradicted\": int, \"abstained\": int, \n",
       "\"total_claims\": int}.\",\n",
       "    \"Optional key: \"claims\": a list of up to 10 items, each with {\"claim\": str, \"label\": str, \"evidence\": str}. \n",
       "Evidence should be a short phrase from context or \"N/A\".\",\n",
       "    \"\",\n",
       "    \"Step 4 — Ensure: total_claims = entailed + unsupported + contradicted + abstained.\"\n",
       "] \n",
       " \n",
       "Rubric:\n",
       "None \n",
       " \n",
       "Score: 1.0\n",
       " \n",
       "Reason: ACTUAL_OUTPUT's atomic claims (endpoint = migration inhibition on human NCCs; primary endpoint = cell \n",
       "migration; secondary/normalization endpoint = cell viability; measurement of migrated NCCs into the cell-free zone)\n",
       "are explicitly supported by the Retrieval Context and there are no contradictions or unsupported facts; the output \n",
       "also references the same cMINC UKN2.pdf source.\n",
       "</pre>\n"
      ],
      "text/plain": [
       "Criteria:\n",
       "None \n",
       " \n",
       "Evaluation Steps:\n",
       "[\n",
       "    \"Task: evaluate whether ACTUAL_OUTPUT is grounded ONLY in RETRIEVAL_CONTEXT. No outside knowledge.\",\n",
       "    \"\",\n",
       "    \"Step 1 — Extract atomic factual claims from ACTUAL_OUTPUT limited to: entities, numbers, durations, units, \n",
       "methods, readouts, materials, cell lines, species, instruments, and endpoints. Do NOT extract vague/subjective \n",
       "claims (e.g., 'robust', 'appropriate').\",\n",
       "    \"\",\n",
       "    \"Step 2 — For each claim, assign exactly one label:\",\n",
       "    \"  - ENTAILED: explicitly supported by RETRIEVAL_CONTEXT (directly stated or unambiguous paraphrase).\",\n",
       "    \"  - CONTRADICTED: conflicts with RETRIEVAL_CONTEXT.\",\n",
       "    \"  - UNSUPPORTED: not found in RETRIEVAL_CONTEXT and not contradicted.\",\n",
       "    \"  - ABSTAINED: ACTUAL_OUTPUT explicitly states the information is not in the context / cannot be determined, \n",
       "and does not assert the missing fact.\",\n",
       "    \"\",\n",
       "    \"Step 3 — Return VALID JSON ONLY (no markdown, no extra text) with integer counts and an optional short audit \n",
       "list.\",\n",
       "    \"Required JSON keys: {\"entailed\": int, \"unsupported\": int, \"contradicted\": int, \"abstained\": int, \n",
       "\"total_claims\": int}.\",\n",
       "    \"Optional key: \"claims\": a list of up to 10 items, each with {\"claim\": str, \"label\": str, \"evidence\": str}. \n",
       "Evidence should be a short phrase from context or \"N/A\".\",\n",
       "    \"\",\n",
       "    \"Step 4 — Ensure: total_claims = entailed + unsupported + contradicted + abstained.\"\n",
       "] \n",
       " \n",
       "Rubric:\n",
       "None \n",
       " \n",
       "Score: 1.0\n",
       " \n",
       "Reason: ACTUAL_OUTPUT's atomic claims (endpoint = migration inhibition on human NCCs; primary endpoint = cell \n",
       "migration; secondary/normalization endpoint = cell viability; measurement of migrated NCCs into the cell-free zone)\n",
       "are explicitly supported by the Retrieval Context and there are no contradictions or unsupported facts; the output \n",
       "also references the same cMINC UKN2.pdf source.\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">======================================================================\n",
       "</pre>\n"
      ],
      "text/plain": [
       "======================================================================\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "392176b7f5f9432e9490b41d69c3a04b",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Output()"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "=== Eval Results ===\n",
      "faithfulness_score: 1.0\n",
      "faithfulness_reason: The score is 1.00 because there are no contradictions between the actual output and the retrieval context; everything aligns as expected. Great job—keep it up!\n",
      "geval_policy_score: 1.0\n",
      "geval_policy_reason: ACTUAL_OUTPUT's atomic claims (endpoint = migration inhibition on human NCCs; primary endpoint = cell migration; secondary/normalization endpoint = cell viability; measurement of migrated NCCs into the cell-free zone) are explicitly supported by the Retrieval Context and there are no contradictions or unsupported facts; the output also references the same cMINC UKN2.pdf source.\n",
      "groundedness_policy_score: None\n",
      "groundedness_herman_score: None\n",
      "groundedness_counts: None\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">**************************************************\n",
       "</pre>\n"
      ],
      "text/plain": [
       "**************************************************\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">Faithfulness Verbose Logs\n",
       "</pre>\n"
      ],
      "text/plain": [
       "Faithfulness Verbose Logs\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">**************************************************\n",
       "</pre>\n"
      ],
      "text/plain": [
       "**************************************************\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">Truths (limit=None):\n",
       "[\n",
       "    \"The document describes the circular migration inhibition of neural crest cells (cMINC) assay, UKN2, Version \n",
       "2.0.\",\n",
       "    \"The assay uses human neural crest cells (NCCs) generated from induced pluripotent stem cells (iPSC).\",\n",
       "    \"The assay aims to assess disturbances of NCC migration during fetal development.\",\n",
       "    \"The method measures the number of migrated NCCs and cell viability concurrently after 24 hours of exposure to \n",
       "potential toxicants.\",\n",
       "    \"Migration and viability are quantified by high-content imaging.\",\n",
       "    \"Cells are stained with calcein-AM and Hoechst (H-33342) for imaging.\",\n",
       "    \"The NCCs are differentiated from hiPSCs according to a protocol derived from Mica et al. (2013).\",\n",
       "    \"The hiPSC source line used is IMR90_clone_#4, obtained from WiCell in 2012.\",\n",
       "    \"IMR90 hiPSCs are maintained on Laminin-521 coating in Essential 8 medium and grow in colonies.\",\n",
       "    \"The hiPSC line IMR-90 (ATCC number CCL-186) has been characterized for pluripotency markers Oct4, Nanog and \n",
       "Tra-1-60.\",\n",
       "    \"The donor cell characteristics listed include female gender, gestational age 16 weeks, and ethnicity \n",
       "Caucasian.\",\n",
       "    \"The short tandem repeat (STR) signature confirms 100% loci homology between ATCC IMR-186 and the University of\n",
       "Konstanz cell line.\",\n",
       "    \"Cells used in the test must be pathogen-free (regular mycoplasma testing).\",\n",
       "    \"The differentiated NCCs are ≥ 90% positive for NCC markers HNK-1 and p75, and express nestin and AP2, but do \n",
       "not express GFAP, Pax6, or βIII tubulin.\",\n",
       "    \"After thawing, viability should be greater than 90%.\",\n",
       "    \"The assay uses a circular migration zone created by a silicone stopper in a 96-well plate; removal allows \n",
       "cells to migrate into the cell-free area.\",\n",
       "    \"Migration is quantified by imaging the ROI and counting migrated cells; viability is quantified outside the \n",
       "migration zone.\",\n",
       "    \"Four fields per well are imaged for viability, using calcein-AM and H-33342.\",\n",
       "    \"The typical plate layout involves 96 wells with an ROI diameter selected to contain 150–300 cells in untreated\n",
       "conditions.\",\n",
       "    \"The assay predicts developmental neurotoxicity using three models: screening (hit = migration inhibited, \n",
       "viability unchanged; Migration ≤ 80% of DMSO control; Viability ≥ 90% of control), compound hazard evaluation (EC10\n",
       "Viability / EC25 Migration ≥ 1.3), and borderline (BMC10 Viability / BMCL25 Migration ≥ 1.3).\",\n",
       "    \"The method has been used to screen about 141 unique compounds, and more than 200 compounds overall, across \n",
       "several campaigns.\",\n",
       "    \"Positive controls include Cytochalasin D, LiCl, and Taxol; endpoint-specific controls include AgNO3, AraC, \n",
       "aphidicolin, L-homocysteine, MG-132, staurosporine, and Triton X-100.\",\n",
       "    \"Negative controls include solvent (0.1% DMSO final), paracetamol, and ASS.\",\n",
       "    \"The method is described as medium-throughput with a planned throughput of 768 data points per month (16 plates\n",
       "per week; 2 compounds per plate, 6 concentrations).\",\n",
       "    \"The method is not yet OECD validated and has not undergone ring trials; readiness score published as A-.\",\n",
       "    \"The method uses a Cellomics Array Scan VTI HCS reader and Ringassay software for migration quantification; the\n",
       "analysis also uses Excel and GraphPad Prism.\",\n",
       "    \"The exposure scheme permits a 24-hour toxicant exposure; the 0.1% final DMSO concentration is maintained in \n",
       "all dilutions.\",\n",
       "    \"The assay supports extending exposure to 48 hours, though longer exposure increases toxicant effects on \n",
       "viability and migration.\",\n",
       "    \"In vitro–in vivo extrapolation (IVIVE) uses a PBPK approach; UKN2 medium lipid content is 2.8e-6 and albumin \n",
       "concentration is 5.6 µM, with in vivo plasma concentrations estimated to be in the same range as the in vitro \n",
       "concentrations.\",\n",
       "    \"The UKN2 system has been discussed in the context of EU-ToxRisk and other developmental toxicity test \n",
       "batteries; it is not strictly regulatory guidelines in OECD sense.\",\n",
       "    \"The method requires access to S1-level cell culture facilities due to genetic modification of cells.\",\n",
       "    \"The protocol and SOP are stored in DB-ALM (Protocol 195) and are available upon request; a publicly accessible\n",
       "link is provided.\",\n",
       "    \"The method has not been transferred to other laboratories and transfer requires operator training; typical \n",
       "training duration is about 4 weeks after which routine performance is smoother, while iPSC culture training takes \n",
       "months.\",\n",
       "    \"Data management includes raw data stored in Excel, and metadata logs; measurement outcomes are normalized to \n",
       "untreated controls.\",\n",
       "    \"The method is considered not well defined for volatile compounds or water-insoluble substances.\"\n",
       "] \n",
       " \n",
       "Claims:\n",
       "[\n",
       "    \"The assay employs high content imaging to assess two key endpoints: migration inhibition and cell viability, \n",
       "in human neural crest cells (NCCs).\",\n",
       "    \"Calcein-AM is used to stain live cells.\",\n",
       "    \"Hoechst 33342 is used to stain nuclei.\",\n",
       "    \"The cells are not fixed; live-cell dyes are used to enable real-time assessment of viability and migration \n",
       "behavior.\",\n",
       "    \"For the migration endpoint, NCCs are seeded around a silicone stopper in a well, allowed to adhere, and then \n",
       "the stopper is removed to create a cell-free zone.\",\n",
       "    \"Cells migrate into this zone over 24 hours.\",\n",
       "    \"After exposure to test compounds, the cells are stained with calcein-AM and Hoechst 33342, and images are \n",
       "acquired in four tiles per well using a high content imaging system.\",\n",
       "    \"The quantification algorithm estimates the previously cell-free area and counts the number of double-positive \n",
       "(calcein and Hoechst) cells within a defined region of interest (ROI).\",\n",
       "    \"Typically, 150–300 cells are imaged per ROI.\",\n",
       "    \"The software automatically counts viable cells based on fluorescence signals.\",\n",
       "    \"Cell viability is measured in the same wells, outside the migration zone, by imaging four fields per well with\n",
       "a 10x objective.\",\n",
       "    \"The same fluorescent dyes are used, and automated algorithms determine the number of double-positive cells, \n",
       "representing viable nuclei.\",\n",
       "    \"Both endpoints are measured under the same conditions and in parallel within the same well, allowing direct \n",
       "comparison of migration and viability data.\",\n",
       "    \"The quantification relies on automated image analysis software that estimates the number of viable cells based\n",
       "on fluorescence intensity and cell morphology, providing semi-quantitative counts.\",\n",
       "    \"The software calculates the number of double-positive cells in the ROI, enabling objective and reproducible \n",
       "measurement of migration and viability.\"\n",
       "] \n",
       " \n",
       "Verdicts:\n",
       "[\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"The context does not specify whether cells are fixed or whether assessment is real-time; it only\n",
       "mentions staining with calcein-AM and Hoechst and endpoint imaging after 24 h.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"The text mentions a 24-hour exposure but does not explicitly state that migration occurs over 24\n",
       "hours.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"The context states four fields per well for viability but does not specify a 10x objective.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"no\",\n",
       "        \"reason\": \"Context states objective and reproducible measurement; the claim says semi-quantitative counts.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    }\n",
       "]\n",
       " \n",
       "Score: 0.9333333333333333\n",
       "Reason: The score is 0.93 because the actual output claims semi-quantitative counts, whereas the context states \n",
       "objective and reproducible measurement.\n",
       "</pre>\n"
      ],
      "text/plain": [
       "Truths (limit=None):\n",
       "[\n",
       "    \"The document describes the circular migration inhibition of neural crest cells (cMINC) assay, UKN2, Version \n",
       "2.0.\",\n",
       "    \"The assay uses human neural crest cells (NCCs) generated from induced pluripotent stem cells (iPSC).\",\n",
       "    \"The assay aims to assess disturbances of NCC migration during fetal development.\",\n",
       "    \"The method measures the number of migrated NCCs and cell viability concurrently after 24 hours of exposure to \n",
       "potential toxicants.\",\n",
       "    \"Migration and viability are quantified by high-content imaging.\",\n",
       "    \"Cells are stained with calcein-AM and Hoechst (H-33342) for imaging.\",\n",
       "    \"The NCCs are differentiated from hiPSCs according to a protocol derived from Mica et al. (2013).\",\n",
       "    \"The hiPSC source line used is IMR90_clone_#4, obtained from WiCell in 2012.\",\n",
       "    \"IMR90 hiPSCs are maintained on Laminin-521 coating in Essential 8 medium and grow in colonies.\",\n",
       "    \"The hiPSC line IMR-90 (ATCC number CCL-186) has been characterized for pluripotency markers Oct4, Nanog and \n",
       "Tra-1-60.\",\n",
       "    \"The donor cell characteristics listed include female gender, gestational age 16 weeks, and ethnicity \n",
       "Caucasian.\",\n",
       "    \"The short tandem repeat (STR) signature confirms 100% loci homology between ATCC IMR-186 and the University of\n",
       "Konstanz cell line.\",\n",
       "    \"Cells used in the test must be pathogen-free (regular mycoplasma testing).\",\n",
       "    \"The differentiated NCCs are ≥ 90% positive for NCC markers HNK-1 and p75, and express nestin and AP2, but do \n",
       "not express GFAP, Pax6, or βIII tubulin.\",\n",
       "    \"After thawing, viability should be greater than 90%.\",\n",
       "    \"The assay uses a circular migration zone created by a silicone stopper in a 96-well plate; removal allows \n",
       "cells to migrate into the cell-free area.\",\n",
       "    \"Migration is quantified by imaging the ROI and counting migrated cells; viability is quantified outside the \n",
       "migration zone.\",\n",
       "    \"Four fields per well are imaged for viability, using calcein-AM and H-33342.\",\n",
       "    \"The typical plate layout involves 96 wells with an ROI diameter selected to contain 150–300 cells in untreated\n",
       "conditions.\",\n",
       "    \"The assay predicts developmental neurotoxicity using three models: screening (hit = migration inhibited, \n",
       "viability unchanged; Migration ≤ 80% of DMSO control; Viability ≥ 90% of control), compound hazard evaluation (EC10\n",
       "Viability / EC25 Migration ≥ 1.3), and borderline (BMC10 Viability / BMCL25 Migration ≥ 1.3).\",\n",
       "    \"The method has been used to screen about 141 unique compounds, and more than 200 compounds overall, across \n",
       "several campaigns.\",\n",
       "    \"Positive controls include Cytochalasin D, LiCl, and Taxol; endpoint-specific controls include AgNO3, AraC, \n",
       "aphidicolin, L-homocysteine, MG-132, staurosporine, and Triton X-100.\",\n",
       "    \"Negative controls include solvent (0.1% DMSO final), paracetamol, and ASS.\",\n",
       "    \"The method is described as medium-throughput with a planned throughput of 768 data points per month (16 plates\n",
       "per week; 2 compounds per plate, 6 concentrations).\",\n",
       "    \"The method is not yet OECD validated and has not undergone ring trials; readiness score published as A-.\",\n",
       "    \"The method uses a Cellomics Array Scan VTI HCS reader and Ringassay software for migration quantification; the\n",
       "analysis also uses Excel and GraphPad Prism.\",\n",
       "    \"The exposure scheme permits a 24-hour toxicant exposure; the 0.1% final DMSO concentration is maintained in \n",
       "all dilutions.\",\n",
       "    \"The assay supports extending exposure to 48 hours, though longer exposure increases toxicant effects on \n",
       "viability and migration.\",\n",
       "    \"In vitro–in vivo extrapolation (IVIVE) uses a PBPK approach; UKN2 medium lipid content is 2.8e-6 and albumin \n",
       "concentration is 5.6 µM, with in vivo plasma concentrations estimated to be in the same range as the in vitro \n",
       "concentrations.\",\n",
       "    \"The UKN2 system has been discussed in the context of EU-ToxRisk and other developmental toxicity test \n",
       "batteries; it is not strictly regulatory guidelines in OECD sense.\",\n",
       "    \"The method requires access to S1-level cell culture facilities due to genetic modification of cells.\",\n",
       "    \"The protocol and SOP are stored in DB-ALM (Protocol 195) and are available upon request; a publicly accessible\n",
       "link is provided.\",\n",
       "    \"The method has not been transferred to other laboratories and transfer requires operator training; typical \n",
       "training duration is about 4 weeks after which routine performance is smoother, while iPSC culture training takes \n",
       "months.\",\n",
       "    \"Data management includes raw data stored in Excel, and metadata logs; measurement outcomes are normalized to \n",
       "untreated controls.\",\n",
       "    \"The method is considered not well defined for volatile compounds or water-insoluble substances.\"\n",
       "] \n",
       " \n",
       "Claims:\n",
       "[\n",
       "    \"The assay employs high content imaging to assess two key endpoints: migration inhibition and cell viability, \n",
       "in human neural crest cells (NCCs).\",\n",
       "    \"Calcein-AM is used to stain live cells.\",\n",
       "    \"Hoechst 33342 is used to stain nuclei.\",\n",
       "    \"The cells are not fixed; live-cell dyes are used to enable real-time assessment of viability and migration \n",
       "behavior.\",\n",
       "    \"For the migration endpoint, NCCs are seeded around a silicone stopper in a well, allowed to adhere, and then \n",
       "the stopper is removed to create a cell-free zone.\",\n",
       "    \"Cells migrate into this zone over 24 hours.\",\n",
       "    \"After exposure to test compounds, the cells are stained with calcein-AM and Hoechst 33342, and images are \n",
       "acquired in four tiles per well using a high content imaging system.\",\n",
       "    \"The quantification algorithm estimates the previously cell-free area and counts the number of double-positive \n",
       "(calcein and Hoechst) cells within a defined region of interest (ROI).\",\n",
       "    \"Typically, 150–300 cells are imaged per ROI.\",\n",
       "    \"The software automatically counts viable cells based on fluorescence signals.\",\n",
       "    \"Cell viability is measured in the same wells, outside the migration zone, by imaging four fields per well with\n",
       "a 10x objective.\",\n",
       "    \"The same fluorescent dyes are used, and automated algorithms determine the number of double-positive cells, \n",
       "representing viable nuclei.\",\n",
       "    \"Both endpoints are measured under the same conditions and in parallel within the same well, allowing direct \n",
       "comparison of migration and viability data.\",\n",
       "    \"The quantification relies on automated image analysis software that estimates the number of viable cells based\n",
       "on fluorescence intensity and cell morphology, providing semi-quantitative counts.\",\n",
       "    \"The software calculates the number of double-positive cells in the ROI, enabling objective and reproducible \n",
       "measurement of migration and viability.\"\n",
       "] \n",
       " \n",
       "Verdicts:\n",
       "[\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"The context does not specify whether cells are fixed or whether assessment is real-time; it only\n",
       "mentions staining with calcein-AM and Hoechst and endpoint imaging after 24 h.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"The text mentions a 24-hour exposure but does not explicitly state that migration occurs over 24\n",
       "hours.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"The context states four fields per well for viability but does not specify a 10x objective.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"no\",\n",
       "        \"reason\": \"Context states objective and reproducible measurement; the claim says semi-quantitative counts.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    }\n",
       "]\n",
       " \n",
       "Score: 0.9333333333333333\n",
       "Reason: The score is 0.93 because the actual output claims semi-quantitative counts, whereas the context states \n",
       "objective and reproducible measurement.\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">======================================================================\n",
       "</pre>\n"
      ],
      "text/plain": [
       "======================================================================\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "3a99696fe0024b2590e7ac1423bc2afe",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Output()"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">**************************************************\n",
       "</pre>\n"
      ],
      "text/plain": [
       "**************************************************\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">ToxTemp Groundedness Policy (counts) [GEval] Verbose Logs\n",
       "</pre>\n"
      ],
      "text/plain": [
       "ToxTemp Groundedness Policy (counts) [GEval] Verbose Logs\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">**************************************************\n",
       "</pre>\n"
      ],
      "text/plain": [
       "**************************************************\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">Criteria:\n",
       "None \n",
       " \n",
       "Evaluation Steps:\n",
       "[\n",
       "    \"Task: evaluate whether ACTUAL_OUTPUT is grounded ONLY in RETRIEVAL_CONTEXT. No outside knowledge.\",\n",
       "    \"\",\n",
       "    \"Step 1 — Extract atomic factual claims from ACTUAL_OUTPUT limited to: entities, numbers, durations, units, \n",
       "methods, readouts, materials, cell lines, species, instruments, and endpoints. Do NOT extract vague/subjective \n",
       "claims (e.g., 'robust', 'appropriate').\",\n",
       "    \"\",\n",
       "    \"Step 2 — For each claim, assign exactly one label:\",\n",
       "    \"  - ENTAILED: explicitly supported by RETRIEVAL_CONTEXT (directly stated or unambiguous paraphrase).\",\n",
       "    \"  - CONTRADICTED: conflicts with RETRIEVAL_CONTEXT.\",\n",
       "    \"  - UNSUPPORTED: not found in RETRIEVAL_CONTEXT and not contradicted.\",\n",
       "    \"  - ABSTAINED: ACTUAL_OUTPUT explicitly states the information is not in the context / cannot be determined, \n",
       "and does not assert the missing fact.\",\n",
       "    \"\",\n",
       "    \"Step 3 — Return VALID JSON ONLY (no markdown, no extra text) with integer counts and an optional short audit \n",
       "list.\",\n",
       "    \"Required JSON keys: {\"entailed\": int, \"unsupported\": int, \"contradicted\": int, \"abstained\": int, \n",
       "\"total_claims\": int}.\",\n",
       "    \"Optional key: \"claims\": a list of up to 10 items, each with {\"claim\": str, \"label\": str, \"evidence\": str}. \n",
       "Evidence should be a short phrase from context or \"N/A\".\",\n",
       "    \"\",\n",
       "    \"Step 4 — Ensure: total_claims = entailed + unsupported + contradicted + abstained.\"\n",
       "] \n",
       " \n",
       "Rubric:\n",
       "None \n",
       " \n",
       "Score: 1.0\n",
       " \n",
       "Reason: All atomic factual claims in the ACTUAL_OUTPUT (NCCs derived from hiPSCs; calcein-AM and Hoechst staining; \n",
       "live-cell imaging; migration into a cell-free zone around a silicone stopper; 24 h exposure; four imaging tiles per\n",
       "well for migration; ROI-based counting of double-positive cells; viability measured in four fields outside the \n",
       "migration zone; same dyes and automated analysis; parallel measurement in the same well) are explicitly supported \n",
       "by the RETRIEVAL_CONTEXT; there are no claims requiring outside knowledge or contradictions.\n",
       "</pre>\n"
      ],
      "text/plain": [
       "Criteria:\n",
       "None \n",
       " \n",
       "Evaluation Steps:\n",
       "[\n",
       "    \"Task: evaluate whether ACTUAL_OUTPUT is grounded ONLY in RETRIEVAL_CONTEXT. No outside knowledge.\",\n",
       "    \"\",\n",
       "    \"Step 1 — Extract atomic factual claims from ACTUAL_OUTPUT limited to: entities, numbers, durations, units, \n",
       "methods, readouts, materials, cell lines, species, instruments, and endpoints. Do NOT extract vague/subjective \n",
       "claims (e.g., 'robust', 'appropriate').\",\n",
       "    \"\",\n",
       "    \"Step 2 — For each claim, assign exactly one label:\",\n",
       "    \"  - ENTAILED: explicitly supported by RETRIEVAL_CONTEXT (directly stated or unambiguous paraphrase).\",\n",
       "    \"  - CONTRADICTED: conflicts with RETRIEVAL_CONTEXT.\",\n",
       "    \"  - UNSUPPORTED: not found in RETRIEVAL_CONTEXT and not contradicted.\",\n",
       "    \"  - ABSTAINED: ACTUAL_OUTPUT explicitly states the information is not in the context / cannot be determined, \n",
       "and does not assert the missing fact.\",\n",
       "    \"\",\n",
       "    \"Step 3 — Return VALID JSON ONLY (no markdown, no extra text) with integer counts and an optional short audit \n",
       "list.\",\n",
       "    \"Required JSON keys: {\"entailed\": int, \"unsupported\": int, \"contradicted\": int, \"abstained\": int, \n",
       "\"total_claims\": int}.\",\n",
       "    \"Optional key: \"claims\": a list of up to 10 items, each with {\"claim\": str, \"label\": str, \"evidence\": str}. \n",
       "Evidence should be a short phrase from context or \"N/A\".\",\n",
       "    \"\",\n",
       "    \"Step 4 — Ensure: total_claims = entailed + unsupported + contradicted + abstained.\"\n",
       "] \n",
       " \n",
       "Rubric:\n",
       "None \n",
       " \n",
       "Score: 1.0\n",
       " \n",
       "Reason: All atomic factual claims in the ACTUAL_OUTPUT (NCCs derived from hiPSCs; calcein-AM and Hoechst staining; \n",
       "live-cell imaging; migration into a cell-free zone around a silicone stopper; 24 h exposure; four imaging tiles per\n",
       "well for migration; ROI-based counting of double-positive cells; viability measured in four fields outside the \n",
       "migration zone; same dyes and automated analysis; parallel measurement in the same well) are explicitly supported \n",
       "by the RETRIEVAL_CONTEXT; there are no claims requiring outside knowledge or contradictions.\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">======================================================================\n",
       "</pre>\n"
      ],
      "text/plain": [
       "======================================================================\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "566de7fd6c4c46d19c808f932efbef0b",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Output()"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "=== Eval Results ===\n",
      "faithfulness_score: 0.9333333333333333\n",
      "faithfulness_reason: The score is 0.93 because the actual output claims semi-quantitative counts, whereas the context states objective and reproducible measurement.\n",
      "geval_policy_score: 1.0\n",
      "geval_policy_reason: All atomic factual claims in the ACTUAL_OUTPUT (NCCs derived from hiPSCs; calcein-AM and Hoechst staining; live-cell imaging; migration into a cell-free zone around a silicone stopper; 24 h exposure; four imaging tiles per well for migration; ROI-based counting of double-positive cells; viability measured in four fields outside the migration zone; same dyes and automated analysis; parallel measurement in the same well) are explicitly supported by the RETRIEVAL_CONTEXT; there are no claims requiring outside knowledge or contradictions.\n",
      "groundedness_policy_score: None\n",
      "groundedness_herman_score: None\n",
      "groundedness_counts: None\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">**************************************************\n",
       "</pre>\n"
      ],
      "text/plain": [
       "**************************************************\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">Faithfulness Verbose Logs\n",
       "</pre>\n"
      ],
      "text/plain": [
       "Faithfulness Verbose Logs\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">**************************************************\n",
       "</pre>\n"
      ],
      "text/plain": [
       "**************************************************\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">Truths (limit=None):\n",
       "[\n",
       "    \"The text describes the Circular migration inhibition of NCC (cMINC) assay, UKN2, Version 2.0.\",\n",
       "    \"The assay uses human neural crest cells (NCCs) generated from human induced pluripotent stem cells (hiPSCs).\",\n",
       "    \"The hiPSC line used is IMR90_clone_#4, obtained from WiCell in 2012, with a masterstock frozen and working \n",
       "stocks prepared.\",\n",
       "    \"The hiPSCs are maintained as a monoculture on Laminin-521 coating in essential 8 (E8) medium.\",\n",
       "    \"The hiPSC lines can be maintained up to 10 passages before thawing a new vial.\",\n",
       "    \"The hiPSCs grow in colonies and are split weakly.\",\n",
       "    \"The hiPSC line IMR-90 (ATCC CCL-186) originates from Homo sapiens, tissue from lung, cell type fibroblast, \n",
       "gender female, gestational age 16 weeks.\",\n",
       "    \"The hiPSCs express pluripotency markers Oct4, Nanog and Tra-1-60.\",\n",
       "    \"NCCs were differentiated from hiPSCs following a protocol (Mica et al. 2013) and used in this assay.\",\n",
       "    \"The derived NCCs are ≥90% positive for NCC markers HNK-1 and p75 and express nestin and AP2.\",\n",
       "    \"The NCCs do not express GFAP, Pax6 or βIII tubulin.\",\n",
       "    \"The NCCs can migrate in a culture dish after removal of a central silicone stopper that creates a cell-free \n",
       "area.\",\n",
       "    \"Migration and viability are measured after 24 hours of exposure to toxicants, with viability assessed outside \n",
       "the migration zone after 48 hours.\",\n",
       "    \"After thawing, NCCs should have viability greater than 90%.\",\n",
       "    \"The test uses a 96-well plate with silicone stoppers to create the migration zone in the center of each \n",
       "well.\",\n",
       "    \"The migration zone is imaged in four tiles per well using a 5x objective.\",\n",
       "    \"The ROI for migration is defined to contain 150–300 cells in untreated conditions.\",\n",
       "    \"The endpoints are migration inhibition and cell viability; migration is quantified by counting viable cells in\n",
       "the migration ROI after 24 hours, viability by counting double-positive calcein-AM and Hoechst cells outside the \n",
       "migration zone after 48 hours.\",\n",
       "    \"Positive controls include cytochalasin D, LiCl and taxol; negative controls include solvent (0.1% DMSO), \n",
       "paracetamol and ASS.\",\n",
       "    \"Final solvent concentration in the cells is 0.1% DMSO.\",\n",
       "    \"Compound dilutions begin as 5x concentrated stocks and are added as 25 µL to each well.\",\n",
       "    \"The method uses Ringassay software and an ArrayScan VTI HCS Reader for data acquisition and analysis.\",\n",
       "    \"Migration quantification uses Ringassay software, while viability is assessed by automated image analysis of \n",
       "calcein-AM and Hoechst staining.\",\n",
       "    \"The typical throughput is 768 data points per month (16 plates per week, ~32 compounds per week, ~192 data \n",
       "points per week).\",\n",
       "    \"The cMINC assay defines a hit in screening as migration inhibited with viability unchanged (Migration ≤ 80% of\n",
       "DMSO control and Viability ≥ 90% of DMSO control).\",\n",
       "    \"The hazard evaluation model uses EC10 Viability / EC25 Migration ≥ 1.3 to define a hit; a borderline hit uses \n",
       "BMCL/BMC10 ratios.\",\n",
       "    \"A formal OECD Directive (OECD 34) validation or ring trials have not been performed for this method.\",\n",
       "    \"The test has been used in multiple screening campaigns and has produced performance metrics such as \n",
       "specificity and sensitivity in various evaluations (e.g., specificity reported as 100% in some analyses, \n",
       "sensitivity &gt;90% in others).\",\n",
       "    \"The method is not linked to regulatory guidelines and has not been transferred to other laboratories; operator\n",
       "training is required, with approximately 4 weeks for performance, and learning iPSC culture taking several \n",
       "months.\",\n",
       "    \"The test has been conducted with &gt;200 different compounds; 141 unique compounds (DTXSIDs) have been tested \n",
       "successfully in this assay.\",\n",
       "    \"The cells are not protected by patents or any other licenses.\",\n",
       "    \"The protocol references the DB-ALM Protocol n° 195 and provides a link to the full protocol \n",
       "(195_P_cMINC.pdf).\",\n",
       "    \"The assay models NCC migration to reflect key developmental processes and potential developmental toxicities \n",
       "such as Hirschsprung’s disease and Treacher-Collins syndrome.\",\n",
       "    \"The NCCs migrate mostly as single cells with some evidence of collective migration and can show invasive \n",
       "behavior in a 3D environment.\",\n",
       "    \"The test uses a S1-level (unmodified) cell culture facility; safety data sheets are available in the \n",
       "university’s DaMaRIS system.\",\n",
       "    \"The components and data analysis tools (e.g., Ringassay, Excel, GraphPad Prism) require licensing or \n",
       "purchasing agreements.\"\n",
       "] \n",
       " \n",
       "Claims:\n",
       "[\n",
       "    \"Cells are exposed for 24 hours before the migration readout.\",\n",
       "    \"Some protocols mention a 20-hour window.\",\n",
       "    \"The standard is 24 hours.\"\n",
       "] \n",
       " \n",
       "Verdicts:\n",
       "[\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"The retrieval context specifies a 24-hour exposure and migration readout at 24 hours; it does \n",
       "not mention a 20-hour window.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    }\n",
       "]\n",
       " \n",
       "Score: 1.0\n",
       "Reason: The score is 1.00 because there are no contradictions between the actual output and the retrieval context; \n",
       "the output is fully faithful.\n",
       "</pre>\n"
      ],
      "text/plain": [
       "Truths (limit=None):\n",
       "[\n",
       "    \"The text describes the Circular migration inhibition of NCC (cMINC) assay, UKN2, Version 2.0.\",\n",
       "    \"The assay uses human neural crest cells (NCCs) generated from human induced pluripotent stem cells (hiPSCs).\",\n",
       "    \"The hiPSC line used is IMR90_clone_#4, obtained from WiCell in 2012, with a masterstock frozen and working \n",
       "stocks prepared.\",\n",
       "    \"The hiPSCs are maintained as a monoculture on Laminin-521 coating in essential 8 (E8) medium.\",\n",
       "    \"The hiPSC lines can be maintained up to 10 passages before thawing a new vial.\",\n",
       "    \"The hiPSCs grow in colonies and are split weakly.\",\n",
       "    \"The hiPSC line IMR-90 (ATCC CCL-186) originates from Homo sapiens, tissue from lung, cell type fibroblast, \n",
       "gender female, gestational age 16 weeks.\",\n",
       "    \"The hiPSCs express pluripotency markers Oct4, Nanog and Tra-1-60.\",\n",
       "    \"NCCs were differentiated from hiPSCs following a protocol (Mica et al. 2013) and used in this assay.\",\n",
       "    \"The derived NCCs are ≥90% positive for NCC markers HNK-1 and p75 and express nestin and AP2.\",\n",
       "    \"The NCCs do not express GFAP, Pax6 or βIII tubulin.\",\n",
       "    \"The NCCs can migrate in a culture dish after removal of a central silicone stopper that creates a cell-free \n",
       "area.\",\n",
       "    \"Migration and viability are measured after 24 hours of exposure to toxicants, with viability assessed outside \n",
       "the migration zone after 48 hours.\",\n",
       "    \"After thawing, NCCs should have viability greater than 90%.\",\n",
       "    \"The test uses a 96-well plate with silicone stoppers to create the migration zone in the center of each \n",
       "well.\",\n",
       "    \"The migration zone is imaged in four tiles per well using a 5x objective.\",\n",
       "    \"The ROI for migration is defined to contain 150–300 cells in untreated conditions.\",\n",
       "    \"The endpoints are migration inhibition and cell viability; migration is quantified by counting viable cells in\n",
       "the migration ROI after 24 hours, viability by counting double-positive calcein-AM and Hoechst cells outside the \n",
       "migration zone after 48 hours.\",\n",
       "    \"Positive controls include cytochalasin D, LiCl and taxol; negative controls include solvent (0.1% DMSO), \n",
       "paracetamol and ASS.\",\n",
       "    \"Final solvent concentration in the cells is 0.1% DMSO.\",\n",
       "    \"Compound dilutions begin as 5x concentrated stocks and are added as 25 µL to each well.\",\n",
       "    \"The method uses Ringassay software and an ArrayScan VTI HCS Reader for data acquisition and analysis.\",\n",
       "    \"Migration quantification uses Ringassay software, while viability is assessed by automated image analysis of \n",
       "calcein-AM and Hoechst staining.\",\n",
       "    \"The typical throughput is 768 data points per month (16 plates per week, ~32 compounds per week, ~192 data \n",
       "points per week).\",\n",
       "    \"The cMINC assay defines a hit in screening as migration inhibited with viability unchanged (Migration ≤ 80% of\n",
       "DMSO control and Viability ≥ 90% of DMSO control).\",\n",
       "    \"The hazard evaluation model uses EC10 Viability / EC25 Migration ≥ 1.3 to define a hit; a borderline hit uses \n",
       "BMCL/BMC10 ratios.\",\n",
       "    \"A formal OECD Directive (OECD 34) validation or ring trials have not been performed for this method.\",\n",
       "    \"The test has been used in multiple screening campaigns and has produced performance metrics such as \n",
       "specificity and sensitivity in various evaluations (e.g., specificity reported as 100% in some analyses, \n",
       "sensitivity >90% in others).\",\n",
       "    \"The method is not linked to regulatory guidelines and has not been transferred to other laboratories; operator\n",
       "training is required, with approximately 4 weeks for performance, and learning iPSC culture taking several \n",
       "months.\",\n",
       "    \"The test has been conducted with >200 different compounds; 141 unique compounds (DTXSIDs) have been tested \n",
       "successfully in this assay.\",\n",
       "    \"The cells are not protected by patents or any other licenses.\",\n",
       "    \"The protocol references the DB-ALM Protocol n° 195 and provides a link to the full protocol \n",
       "(195_P_cMINC.pdf).\",\n",
       "    \"The assay models NCC migration to reflect key developmental processes and potential developmental toxicities \n",
       "such as Hirschsprung’s disease and Treacher-Collins syndrome.\",\n",
       "    \"The NCCs migrate mostly as single cells with some evidence of collective migration and can show invasive \n",
       "behavior in a 3D environment.\",\n",
       "    \"The test uses a S1-level (unmodified) cell culture facility; safety data sheets are available in the \n",
       "university’s DaMaRIS system.\",\n",
       "    \"The components and data analysis tools (e.g., Ringassay, Excel, GraphPad Prism) require licensing or \n",
       "purchasing agreements.\"\n",
       "] \n",
       " \n",
       "Claims:\n",
       "[\n",
       "    \"Cells are exposed for 24 hours before the migration readout.\",\n",
       "    \"Some protocols mention a 20-hour window.\",\n",
       "    \"The standard is 24 hours.\"\n",
       "] \n",
       " \n",
       "Verdicts:\n",
       "[\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"The retrieval context specifies a 24-hour exposure and migration readout at 24 hours; it does \n",
       "not mention a 20-hour window.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    }\n",
       "]\n",
       " \n",
       "Score: 1.0\n",
       "Reason: The score is 1.00 because there are no contradictions between the actual output and the retrieval context; \n",
       "the output is fully faithful.\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">======================================================================\n",
       "</pre>\n"
      ],
      "text/plain": [
       "======================================================================\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "cfa0429e0e0f4cc18b51d67742fddfaa",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Output()"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">**************************************************\n",
       "</pre>\n"
      ],
      "text/plain": [
       "**************************************************\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">ToxTemp Groundedness Policy (counts) [GEval] Verbose Logs\n",
       "</pre>\n"
      ],
      "text/plain": [
       "ToxTemp Groundedness Policy (counts) [GEval] Verbose Logs\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">**************************************************\n",
       "</pre>\n"
      ],
      "text/plain": [
       "**************************************************\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">Criteria:\n",
       "None \n",
       " \n",
       "Evaluation Steps:\n",
       "[\n",
       "    \"Task: evaluate whether ACTUAL_OUTPUT is grounded ONLY in RETRIEVAL_CONTEXT. No outside knowledge.\",\n",
       "    \"\",\n",
       "    \"Step 1 — Extract atomic factual claims from ACTUAL_OUTPUT limited to: entities, numbers, durations, units, \n",
       "methods, readouts, materials, cell lines, species, instruments, and endpoints. Do NOT extract vague/subjective \n",
       "claims (e.g., 'robust', 'appropriate').\",\n",
       "    \"\",\n",
       "    \"Step 2 — For each claim, assign exactly one label:\",\n",
       "    \"  - ENTAILED: explicitly supported by RETRIEVAL_CONTEXT (directly stated or unambiguous paraphrase).\",\n",
       "    \"  - CONTRADICTED: conflicts with RETRIEVAL_CONTEXT.\",\n",
       "    \"  - UNSUPPORTED: not found in RETRIEVAL_CONTEXT and not contradicted.\",\n",
       "    \"  - ABSTAINED: ACTUAL_OUTPUT explicitly states the information is not in the context / cannot be determined, \n",
       "and does not assert the missing fact.\",\n",
       "    \"\",\n",
       "    \"Step 3 — Return VALID JSON ONLY (no markdown, no extra text) with integer counts and an optional short audit \n",
       "list.\",\n",
       "    \"Required JSON keys: {\"entailed\": int, \"unsupported\": int, \"contradicted\": int, \"abstained\": int, \n",
       "\"total_claims\": int}.\",\n",
       "    \"Optional key: \"claims\": a list of up to 10 items, each with {\"claim\": str, \"label\": str, \"evidence\": str}. \n",
       "Evidence should be a short phrase from context or \"N/A\".\",\n",
       "    \"\",\n",
       "    \"Step 4 — Ensure: total_claims = entailed + unsupported + contradicted + abstained.\"\n",
       "] \n",
       " \n",
       "Rubric:\n",
       "None \n",
       " \n",
       "Score: 0.7\n",
       " \n",
       "Reason: The output correctly notes a 24-hour exposure before migration readout and treats 24 h as the standard per \n",
       "the retrieval context, which mentions 24 h incubation. However, the claim about a 20-hour window is not supported \n",
       "by the context (the context does not mention 20 h, only 24 h and possible longer exposures), leading to partial \n",
       "grounding.\n",
       "</pre>\n"
      ],
      "text/plain": [
       "Criteria:\n",
       "None \n",
       " \n",
       "Evaluation Steps:\n",
       "[\n",
       "    \"Task: evaluate whether ACTUAL_OUTPUT is grounded ONLY in RETRIEVAL_CONTEXT. No outside knowledge.\",\n",
       "    \"\",\n",
       "    \"Step 1 — Extract atomic factual claims from ACTUAL_OUTPUT limited to: entities, numbers, durations, units, \n",
       "methods, readouts, materials, cell lines, species, instruments, and endpoints. Do NOT extract vague/subjective \n",
       "claims (e.g., 'robust', 'appropriate').\",\n",
       "    \"\",\n",
       "    \"Step 2 — For each claim, assign exactly one label:\",\n",
       "    \"  - ENTAILED: explicitly supported by RETRIEVAL_CONTEXT (directly stated or unambiguous paraphrase).\",\n",
       "    \"  - CONTRADICTED: conflicts with RETRIEVAL_CONTEXT.\",\n",
       "    \"  - UNSUPPORTED: not found in RETRIEVAL_CONTEXT and not contradicted.\",\n",
       "    \"  - ABSTAINED: ACTUAL_OUTPUT explicitly states the information is not in the context / cannot be determined, \n",
       "and does not assert the missing fact.\",\n",
       "    \"\",\n",
       "    \"Step 3 — Return VALID JSON ONLY (no markdown, no extra text) with integer counts and an optional short audit \n",
       "list.\",\n",
       "    \"Required JSON keys: {\"entailed\": int, \"unsupported\": int, \"contradicted\": int, \"abstained\": int, \n",
       "\"total_claims\": int}.\",\n",
       "    \"Optional key: \"claims\": a list of up to 10 items, each with {\"claim\": str, \"label\": str, \"evidence\": str}. \n",
       "Evidence should be a short phrase from context or \"N/A\".\",\n",
       "    \"\",\n",
       "    \"Step 4 — Ensure: total_claims = entailed + unsupported + contradicted + abstained.\"\n",
       "] \n",
       " \n",
       "Rubric:\n",
       "None \n",
       " \n",
       "Score: 0.7\n",
       " \n",
       "Reason: The output correctly notes a 24-hour exposure before migration readout and treats 24 h as the standard per \n",
       "the retrieval context, which mentions 24 h incubation. However, the claim about a 20-hour window is not supported \n",
       "by the context (the context does not mention 20 h, only 24 h and possible longer exposures), leading to partial \n",
       "grounding.\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">======================================================================\n",
       "</pre>\n"
      ],
      "text/plain": [
       "======================================================================\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "aad78ce9a3d74257b39ed63df83fb721",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Output()"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "=== Eval Results ===\n",
      "faithfulness_score: 1.0\n",
      "faithfulness_reason: The score is 1.00 because there are no contradictions between the actual output and the retrieval context; the output is fully faithful.\n",
      "geval_policy_score: 0.7\n",
      "geval_policy_reason: The output correctly notes a 24-hour exposure before migration readout and treats 24 h as the standard per the retrieval context, which mentions 24 h incubation. However, the claim about a 20-hour window is not supported by the context (the context does not mention 20 h, only 24 h and possible longer exposures), leading to partial grounding.\n",
      "groundedness_policy_score: None\n",
      "groundedness_herman_score: None\n",
      "groundedness_counts: None\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">**************************************************\n",
       "</pre>\n"
      ],
      "text/plain": [
       "**************************************************\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">Faithfulness Verbose Logs\n",
       "</pre>\n"
      ],
      "text/plain": [
       "Faithfulness Verbose Logs\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">**************************************************\n",
       "</pre>\n"
      ],
      "text/plain": [
       "**************************************************\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">Truths (limit=None):\n",
       "[\n",
       "    \"The cMINC assay UKN2 is Version 2.0 and was deposited in March 2023.\",\n",
       "    \"It is an in vitro test method that uses human neural crest cells (NCCs) generated from human induced \n",
       "pluripotent stem cells (hiPSCs).\",\n",
       "    \"The assay assesses disturbances of NCC migration during fetal development.\",\n",
       "    \"The method measures the number of migrated NCCs and cell viability simultaneously using high content \n",
       "imaging.\",\n",
       "    \"NCCs are exposed to potential toxicants for 24 hours during the assay.\",\n",
       "    \"The data from this method are intended to predict developmental disorders and malformations such as neural \n",
       "tube defects or craniofacial malformations caused by chemical exposure during fetal development.\",\n",
       "    \"The assay has a readiness score of A- according to Bal-Price et al. (2018) readiness criteria.\",\n",
       "    \"A previous version of the protocol was assembled in 2019 in the context of the EU-ToxRisk project.\",\n",
       "    \"The hiPSC line used is IMR90_clone_#4, which was bought from WiCell (Wisconsin) in 2012 and has a master stock\n",
       "that was frozen.\",\n",
       "    \"Working stocks are prepared from the master stock and can be continuously maintained because of self-renewal \n",
       "and pluripotency.\",\n",
       "    \"The cells are maintained up to 10 passages before thawing a new vial of the working stock.\",\n",
       "    \"The undifferentiated hiPSC cells used are IMR-90/IMR90 with ATCC number CCL-186.\",\n",
       "    \"The cell line is described as originating from Homo sapiens (human) tissue: lung, cell type: fibroblast; \n",
       "gender: female; age: 16 weeks gestation; ethnicity: Caucasian.\",\n",
       "    \"The cells express pluripotency markers Oct4, Nanog and Tra-1-60 as shown by immunocytochemistry.\",\n",
       "    \"NCCs were differentiated from hiPSCs following a modified protocol of Mica et al. (2013), including Matrigel \n",
       "coating, ROCK inhibitor Y-27632, Noggin, SB431542, CHIR99021, and transition from KSR to N2-S medium with gradual \n",
       "changes.\",\n",
       "    \"The derived NCCs are ≥90% positive for NCC markers HNK-1 and p75 and also express nestin and AP2.\",\n",
       "    \"The NCCs do not express GFAP, Pax6 or βIII tubulin.\",\n",
       "    \"After thawing, NCCs have viability &gt;90%.\",\n",
       "    \"Source cells must be pathogen-free (mycoplasma-free) and maintenance is regularly checked for expression of \n",
       "pluripotency markers by immunocytochemistry.\",\n",
       "    \"The test system is defined as a highly homogeneous pre-differentiated population of neural crest cells added \n",
       "to coated wells in the migration assay.\",\n",
       "    \"A silicone stopper is placed in the middle of the well to create a central cell-free migration zone that NCCs \n",
       "migrate out of after stopper removal.\",\n",
       "    \"NCCs are maintained in the presence of epidermal growth factor (EGF) and fibroblast growth factor (FGF) in the\n",
       "medium to remain viable.\",\n",
       "    \"Migration and viability are quantified by staining with calcein-AM and Hoechst 33342 and imaging with a high \n",
       "content imaging microscope.\",\n",
       "    \"The region of interest (ROI) for migration is defined so that untreated conditions contain 150–300 viable \n",
       "cells.\",\n",
       "    \"Ringassay software is used to quantify migrated cells; four tiles per well are imaged with a 5x objective and \n",
       "the images are stitched for analysis.\",\n",
       "    \"Viability outside the migration zone is quantified using calcein-AM and Hoechst 33342 double-positive cells \n",
       "with an automated algorithm, and data are normalized to untreated controls.\",\n",
       "    \"The exposure scheme includes Day -1 coating with PLO/laminin/fibronectin, Day 0 stopper removal, Day 1 \n",
       "addition of 25 µL of 5x concentrated toxicants, and Day 2 staining/imaging and analysis.\",\n",
       "    \"Compounds are dissolved in DMSO with final DMSO concentration on cells of 0.1%; an internal dilution scheme \n",
       "uses 0.5% DMSO in master plates and 1:200 serial dilutions in N2-S medium containing 20 ng/mL EGF and 20 ng/mL \n",
       "FGF.\",\n",
       "    \"A 96-well plate layout typically involves two compounds per plate with six concentrations per compound, using \n",
       "a default serial dilution of 1:3 (e.g., 100 µM down to 0.4 µM).\",\n",
       "    \"The primary endpoint is migration inhibition; the endpoint reference is cell viability; migration induction \n",
       "can be assessed but is complex to interpret toxically.\",\n",
       "    \"There are endpoint-specific controls: positive controls include Cytochalasin D, LiCl, and Taxol; negative \n",
       "controls include solvent (0.1% DMSO), paracetamol, and ASS.\",\n",
       "    \"The test system allows optional additional endpoints such as EdU staining for proliferation; other analytical \n",
       "endpoints for viability include resazurin, LDH, and ATP measurements.\",\n",
       "    \"The method is described as medium-throughput with automated microscopy.\",\n",
       "    \"The method has been used in several screening campaigns, including the NTP80 screen and EFSA DNT battery \n",
       "evaluations.\",\n",
       "    \"In EFSA evaluations, reported performance includes specificity of 100% and sensitivity around 82.7% in certain\n",
       "settings.\",\n",
       "    \"A formal OECD validation (e.g., ring trials with a standard set of controls) has not been performed for this \n",
       "method.\",\n",
       "    \"No transfer of the assay to other laboratories has occurred; operator training is required and approximately \n",
       "four weeks are needed for routine performance; learning iPSC culture and differentiation takes several months.\",\n",
       "    \"The test requires S1 containment due to the use of genetically modified cells; SDS details are available in \n",
       "the university’s DaMaRIS database.\",\n",
       "    \"No elements required to conduct the experimental part of the test are known to be protected by IP; software \n",
       "used for analysis (Ringassay, Excel, GraphPad Prism) may require licenses.\",\n",
       "    \"Raw data are stored and managed with metadata; raw data are stored on microscope computers and university \n",
       "servers with regular backups; metadata are stored in log files detailing protocol and scan steps.\",\n",
       "    \"PBPK-based in vitro–in vivo extrapolation (IVIVE) has been applied; lipid content of UKN2 medium is 2.8×10^-6 \n",
       "and albumin concentration in plasma is 5.6 µM; three-step PBPK modelling suggests in vivo plasma concentrations \n",
       "that impair NCC migration are within the same range as assay concentrations.\",\n",
       "    \"The applicability domain includes pesticides, flame retardants, PCBs and some drugs; volatile or poorly \n",
       "water-soluble substances may not be measurable by this assay.\",\n",
       "    \"The assay has been integrated into broader testing batteries such as ESNA TS (Embryonic Stem Cell-based Novel \n",
       "Alternative Testing Strategies) and EU-ToxRisk pipelines, but is not currently linked to OECD guidelines or \n",
       "regulatory policy.\",\n",
       "    \"Operator training is required (roughly 4 weeks for routine performance) and hands-on iPSC culture experience \n",
       "is needed; transfer to other labs has not occurred.\",\n",
       "    \"The process documentation includes references to experimental SOPs (DB-ALM Protocol n° 195) and available \n",
       "internal SOPs and external publications.\",\n",
       "    \"The assay has demonstrated cross-study applicability in multiple publications (Nyffeler et al. 2016, 2017; \n",
       "Blum et al. 2022; Krebs et al. 2020; Masjosthusmann et al. 2020) and is described as part of a DNT hazard \n",
       "assessment battery.\"\n",
       "] \n",
       " \n",
       "Claims:\n",
       "[\n",
       "    \"Viability is assessed with calcein-AM and Hoechst 33342.\",\n",
       "    \"Four fields outside the migration zone are imaged.\",\n",
       "    \"Imaging is performed using a 10x objective.\",\n",
       "    \"A live/dead green-red overlay is reported for each well.\"\n",
       "] \n",
       " \n",
       "Verdicts:\n",
       "[\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"The context notes four tiles per well are imaged for ringassay analysis but does not specify \n",
       "imaging outside the migration zone, so the claim cannot be confirmed from the provided context.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"no\",\n",
       "        \"reason\": \"The context states imaging was performed with a 5x objective, not 10x.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"Viability is assessed using calcein-AM and Hoechst 33342, but there is no mention of a live/dead\n",
       "green-red overlay being reported for each well.\"\n",
       "    }\n",
       "]\n",
       " \n",
       "Score: 0.75\n",
       "Reason: The score is 0.75 because the actual output claims imaging was performed with a 10x objective, but the \n",
       "retrieval context states it was performed with a 5x objective.\n",
       "</pre>\n"
      ],
      "text/plain": [
       "Truths (limit=None):\n",
       "[\n",
       "    \"The cMINC assay UKN2 is Version 2.0 and was deposited in March 2023.\",\n",
       "    \"It is an in vitro test method that uses human neural crest cells (NCCs) generated from human induced \n",
       "pluripotent stem cells (hiPSCs).\",\n",
       "    \"The assay assesses disturbances of NCC migration during fetal development.\",\n",
       "    \"The method measures the number of migrated NCCs and cell viability simultaneously using high content \n",
       "imaging.\",\n",
       "    \"NCCs are exposed to potential toxicants for 24 hours during the assay.\",\n",
       "    \"The data from this method are intended to predict developmental disorders and malformations such as neural \n",
       "tube defects or craniofacial malformations caused by chemical exposure during fetal development.\",\n",
       "    \"The assay has a readiness score of A- according to Bal-Price et al. (2018) readiness criteria.\",\n",
       "    \"A previous version of the protocol was assembled in 2019 in the context of the EU-ToxRisk project.\",\n",
       "    \"The hiPSC line used is IMR90_clone_#4, which was bought from WiCell (Wisconsin) in 2012 and has a master stock\n",
       "that was frozen.\",\n",
       "    \"Working stocks are prepared from the master stock and can be continuously maintained because of self-renewal \n",
       "and pluripotency.\",\n",
       "    \"The cells are maintained up to 10 passages before thawing a new vial of the working stock.\",\n",
       "    \"The undifferentiated hiPSC cells used are IMR-90/IMR90 with ATCC number CCL-186.\",\n",
       "    \"The cell line is described as originating from Homo sapiens (human) tissue: lung, cell type: fibroblast; \n",
       "gender: female; age: 16 weeks gestation; ethnicity: Caucasian.\",\n",
       "    \"The cells express pluripotency markers Oct4, Nanog and Tra-1-60 as shown by immunocytochemistry.\",\n",
       "    \"NCCs were differentiated from hiPSCs following a modified protocol of Mica et al. (2013), including Matrigel \n",
       "coating, ROCK inhibitor Y-27632, Noggin, SB431542, CHIR99021, and transition from KSR to N2-S medium with gradual \n",
       "changes.\",\n",
       "    \"The derived NCCs are ≥90% positive for NCC markers HNK-1 and p75 and also express nestin and AP2.\",\n",
       "    \"The NCCs do not express GFAP, Pax6 or βIII tubulin.\",\n",
       "    \"After thawing, NCCs have viability >90%.\",\n",
       "    \"Source cells must be pathogen-free (mycoplasma-free) and maintenance is regularly checked for expression of \n",
       "pluripotency markers by immunocytochemistry.\",\n",
       "    \"The test system is defined as a highly homogeneous pre-differentiated population of neural crest cells added \n",
       "to coated wells in the migration assay.\",\n",
       "    \"A silicone stopper is placed in the middle of the well to create a central cell-free migration zone that NCCs \n",
       "migrate out of after stopper removal.\",\n",
       "    \"NCCs are maintained in the presence of epidermal growth factor (EGF) and fibroblast growth factor (FGF) in the\n",
       "medium to remain viable.\",\n",
       "    \"Migration and viability are quantified by staining with calcein-AM and Hoechst 33342 and imaging with a high \n",
       "content imaging microscope.\",\n",
       "    \"The region of interest (ROI) for migration is defined so that untreated conditions contain 150–300 viable \n",
       "cells.\",\n",
       "    \"Ringassay software is used to quantify migrated cells; four tiles per well are imaged with a 5x objective and \n",
       "the images are stitched for analysis.\",\n",
       "    \"Viability outside the migration zone is quantified using calcein-AM and Hoechst 33342 double-positive cells \n",
       "with an automated algorithm, and data are normalized to untreated controls.\",\n",
       "    \"The exposure scheme includes Day -1 coating with PLO/laminin/fibronectin, Day 0 stopper removal, Day 1 \n",
       "addition of 25 µL of 5x concentrated toxicants, and Day 2 staining/imaging and analysis.\",\n",
       "    \"Compounds are dissolved in DMSO with final DMSO concentration on cells of 0.1%; an internal dilution scheme \n",
       "uses 0.5% DMSO in master plates and 1:200 serial dilutions in N2-S medium containing 20 ng/mL EGF and 20 ng/mL \n",
       "FGF.\",\n",
       "    \"A 96-well plate layout typically involves two compounds per plate with six concentrations per compound, using \n",
       "a default serial dilution of 1:3 (e.g., 100 µM down to 0.4 µM).\",\n",
       "    \"The primary endpoint is migration inhibition; the endpoint reference is cell viability; migration induction \n",
       "can be assessed but is complex to interpret toxically.\",\n",
       "    \"There are endpoint-specific controls: positive controls include Cytochalasin D, LiCl, and Taxol; negative \n",
       "controls include solvent (0.1% DMSO), paracetamol, and ASS.\",\n",
       "    \"The test system allows optional additional endpoints such as EdU staining for proliferation; other analytical \n",
       "endpoints for viability include resazurin, LDH, and ATP measurements.\",\n",
       "    \"The method is described as medium-throughput with automated microscopy.\",\n",
       "    \"The method has been used in several screening campaigns, including the NTP80 screen and EFSA DNT battery \n",
       "evaluations.\",\n",
       "    \"In EFSA evaluations, reported performance includes specificity of 100% and sensitivity around 82.7% in certain\n",
       "settings.\",\n",
       "    \"A formal OECD validation (e.g., ring trials with a standard set of controls) has not been performed for this \n",
       "method.\",\n",
       "    \"No transfer of the assay to other laboratories has occurred; operator training is required and approximately \n",
       "four weeks are needed for routine performance; learning iPSC culture and differentiation takes several months.\",\n",
       "    \"The test requires S1 containment due to the use of genetically modified cells; SDS details are available in \n",
       "the university’s DaMaRIS database.\",\n",
       "    \"No elements required to conduct the experimental part of the test are known to be protected by IP; software \n",
       "used for analysis (Ringassay, Excel, GraphPad Prism) may require licenses.\",\n",
       "    \"Raw data are stored and managed with metadata; raw data are stored on microscope computers and university \n",
       "servers with regular backups; metadata are stored in log files detailing protocol and scan steps.\",\n",
       "    \"PBPK-based in vitro–in vivo extrapolation (IVIVE) has been applied; lipid content of UKN2 medium is 2.8×10^-6 \n",
       "and albumin concentration in plasma is 5.6 µM; three-step PBPK modelling suggests in vivo plasma concentrations \n",
       "that impair NCC migration are within the same range as assay concentrations.\",\n",
       "    \"The applicability domain includes pesticides, flame retardants, PCBs and some drugs; volatile or poorly \n",
       "water-soluble substances may not be measurable by this assay.\",\n",
       "    \"The assay has been integrated into broader testing batteries such as ESNA TS (Embryonic Stem Cell-based Novel \n",
       "Alternative Testing Strategies) and EU-ToxRisk pipelines, but is not currently linked to OECD guidelines or \n",
       "regulatory policy.\",\n",
       "    \"Operator training is required (roughly 4 weeks for routine performance) and hands-on iPSC culture experience \n",
       "is needed; transfer to other labs has not occurred.\",\n",
       "    \"The process documentation includes references to experimental SOPs (DB-ALM Protocol n° 195) and available \n",
       "internal SOPs and external publications.\",\n",
       "    \"The assay has demonstrated cross-study applicability in multiple publications (Nyffeler et al. 2016, 2017; \n",
       "Blum et al. 2022; Krebs et al. 2020; Masjosthusmann et al. 2020) and is described as part of a DNT hazard \n",
       "assessment battery.\"\n",
       "] \n",
       " \n",
       "Claims:\n",
       "[\n",
       "    \"Viability is assessed with calcein-AM and Hoechst 33342.\",\n",
       "    \"Four fields outside the migration zone are imaged.\",\n",
       "    \"Imaging is performed using a 10x objective.\",\n",
       "    \"A live/dead green-red overlay is reported for each well.\"\n",
       "] \n",
       " \n",
       "Verdicts:\n",
       "[\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"The context notes four tiles per well are imaged for ringassay analysis but does not specify \n",
       "imaging outside the migration zone, so the claim cannot be confirmed from the provided context.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"no\",\n",
       "        \"reason\": \"The context states imaging was performed with a 5x objective, not 10x.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"Viability is assessed using calcein-AM and Hoechst 33342, but there is no mention of a live/dead\n",
       "green-red overlay being reported for each well.\"\n",
       "    }\n",
       "]\n",
       " \n",
       "Score: 0.75\n",
       "Reason: The score is 0.75 because the actual output claims imaging was performed with a 10x objective, but the \n",
       "retrieval context states it was performed with a 5x objective.\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">======================================================================\n",
       "</pre>\n"
      ],
      "text/plain": [
       "======================================================================\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "ea42960985ea48d3875719084fc91e94",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Output()"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">**************************************************\n",
       "</pre>\n"
      ],
      "text/plain": [
       "**************************************************\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">ToxTemp Groundedness Policy (counts) [GEval] Verbose Logs\n",
       "</pre>\n"
      ],
      "text/plain": [
       "ToxTemp Groundedness Policy (counts) [GEval] Verbose Logs\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">**************************************************\n",
       "</pre>\n"
      ],
      "text/plain": [
       "**************************************************\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">Criteria:\n",
       "None \n",
       " \n",
       "Evaluation Steps:\n",
       "[\n",
       "    \"Task: evaluate whether ACTUAL_OUTPUT is grounded ONLY in RETRIEVAL_CONTEXT. No outside knowledge.\",\n",
       "    \"\",\n",
       "    \"Step 1 — Extract atomic factual claims from ACTUAL_OUTPUT limited to: entities, numbers, durations, units, \n",
       "methods, readouts, materials, cell lines, species, instruments, and endpoints. Do NOT extract vague/subjective \n",
       "claims (e.g., 'robust', 'appropriate').\",\n",
       "    \"\",\n",
       "    \"Step 2 — For each claim, assign exactly one label:\",\n",
       "    \"  - ENTAILED: explicitly supported by RETRIEVAL_CONTEXT (directly stated or unambiguous paraphrase).\",\n",
       "    \"  - CONTRADICTED: conflicts with RETRIEVAL_CONTEXT.\",\n",
       "    \"  - UNSUPPORTED: not found in RETRIEVAL_CONTEXT and not contradicted.\",\n",
       "    \"  - ABSTAINED: ACTUAL_OUTPUT explicitly states the information is not in the context / cannot be determined, \n",
       "and does not assert the missing fact.\",\n",
       "    \"\",\n",
       "    \"Step 3 — Return VALID JSON ONLY (no markdown, no extra text) with integer counts and an optional short audit \n",
       "list.\",\n",
       "    \"Required JSON keys: {\"entailed\": int, \"unsupported\": int, \"contradicted\": int, \"abstained\": int, \n",
       "\"total_claims\": int}.\",\n",
       "    \"Optional key: \"claims\": a list of up to 10 items, each with {\"claim\": str, \"label\": str, \"evidence\": str}. \n",
       "Evidence should be a short phrase from context or \"N/A\".\",\n",
       "    \"\",\n",
       "    \"Step 4 — Ensure: total_claims = entailed + unsupported + contradicted + abstained.\"\n",
       "] \n",
       " \n",
       "Rubric:\n",
       "None \n",
       " \n",
       "Score: 0.6\n",
       " \n",
       "Reason: The response correctly identifies three atomic facts as entailed by the retrieval context (calcein-AM and \n",
       "H-33342 staining for viability, four imaging fields outside migration, and 10x objective imaging). It marks the \n",
       "live/dead overlay claim as unsupported since the exact phrase ‘live/dead overlay’ is not present in the retrieval \n",
       "context. The claims are precisely mapped to the provided context.\n",
       "</pre>\n"
      ],
      "text/plain": [
       "Criteria:\n",
       "None \n",
       " \n",
       "Evaluation Steps:\n",
       "[\n",
       "    \"Task: evaluate whether ACTUAL_OUTPUT is grounded ONLY in RETRIEVAL_CONTEXT. No outside knowledge.\",\n",
       "    \"\",\n",
       "    \"Step 1 — Extract atomic factual claims from ACTUAL_OUTPUT limited to: entities, numbers, durations, units, \n",
       "methods, readouts, materials, cell lines, species, instruments, and endpoints. Do NOT extract vague/subjective \n",
       "claims (e.g., 'robust', 'appropriate').\",\n",
       "    \"\",\n",
       "    \"Step 2 — For each claim, assign exactly one label:\",\n",
       "    \"  - ENTAILED: explicitly supported by RETRIEVAL_CONTEXT (directly stated or unambiguous paraphrase).\",\n",
       "    \"  - CONTRADICTED: conflicts with RETRIEVAL_CONTEXT.\",\n",
       "    \"  - UNSUPPORTED: not found in RETRIEVAL_CONTEXT and not contradicted.\",\n",
       "    \"  - ABSTAINED: ACTUAL_OUTPUT explicitly states the information is not in the context / cannot be determined, \n",
       "and does not assert the missing fact.\",\n",
       "    \"\",\n",
       "    \"Step 3 — Return VALID JSON ONLY (no markdown, no extra text) with integer counts and an optional short audit \n",
       "list.\",\n",
       "    \"Required JSON keys: {\"entailed\": int, \"unsupported\": int, \"contradicted\": int, \"abstained\": int, \n",
       "\"total_claims\": int}.\",\n",
       "    \"Optional key: \"claims\": a list of up to 10 items, each with {\"claim\": str, \"label\": str, \"evidence\": str}. \n",
       "Evidence should be a short phrase from context or \"N/A\".\",\n",
       "    \"\",\n",
       "    \"Step 4 — Ensure: total_claims = entailed + unsupported + contradicted + abstained.\"\n",
       "] \n",
       " \n",
       "Rubric:\n",
       "None \n",
       " \n",
       "Score: 0.6\n",
       " \n",
       "Reason: The response correctly identifies three atomic facts as entailed by the retrieval context (calcein-AM and \n",
       "H-33342 staining for viability, four imaging fields outside migration, and 10x objective imaging). It marks the \n",
       "live/dead overlay claim as unsupported since the exact phrase ‘live/dead overlay’ is not present in the retrieval \n",
       "context. The claims are precisely mapped to the provided context.\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">======================================================================\n",
       "</pre>\n"
      ],
      "text/plain": [
       "======================================================================\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "31bd58bb89ef4ca5af4eee7064c28867",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Output()"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "=== Eval Results ===\n",
      "faithfulness_score: 0.75\n",
      "faithfulness_reason: The score is 0.75 because the actual output claims imaging was performed with a 10x objective, but the retrieval context states it was performed with a 5x objective.\n",
      "geval_policy_score: 0.6\n",
      "geval_policy_reason: The response correctly identifies three atomic facts as entailed by the retrieval context (calcein-AM and H-33342 staining for viability, four imaging fields outside migration, and 10x objective imaging). It marks the live/dead overlay claim as unsupported since the exact phrase ‘live/dead overlay’ is not present in the retrieval context. The claims are precisely mapped to the provided context.\n",
      "groundedness_policy_score: None\n",
      "groundedness_herman_score: None\n",
      "groundedness_counts: None\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">**************************************************\n",
       "</pre>\n"
      ],
      "text/plain": [
       "**************************************************\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">Faithfulness Verbose Logs\n",
       "</pre>\n"
      ],
      "text/plain": [
       "Faithfulness Verbose Logs\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">**************************************************\n",
       "</pre>\n"
      ],
      "text/plain": [
       "**************************************************\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">Truths (limit=None):\n",
       "[\n",
       "    \"The document describes the circular migration inhibition of NCC (cMINC) assay, UKN2, Version 2.0, as an in \n",
       "vitro test method.\",\n",
       "    \"The cMINC UKN2 assay uses human neural crest cells generated from human induced pluripotent stem cells \n",
       "(hiPSCs).\",\n",
       "    \"The assay assesses disturbances of neural crest cell (NCC) migration during fetal development.\",\n",
       "    \"The assay measures the number of migrated NCCs and cell viability simultaneously using high-content imaging \n",
       "after 24 hours of exposure to potential toxicants.\",\n",
       "    \"The data from the assay are intended to predict developmental disorders and malformations such as neural tube \n",
       "defects or craniofacial malformations caused by compound exposure.\",\n",
       "    \"The cMINC assay has a readiness score of A- according to Bal-Price et al. (2018).\",\n",
       "    \"The assay has not undergone formal validation and has not participated in a ring trial.\",\n",
       "    \"The method has been used in the screening of several medium-sized compound libraries.\",\n",
       "    \"The assay was developed at the University of Konstanz (UKN), Germany, with Marcel Leist listed as a contact \n",
       "person and other involved researchers named (Xenia Dolde, Jonathan Blum, Heidrun Leisner).\",\n",
       "    \"The hiPSC line used is IMR90_clone_#4, obtained from WiCell in 2012, with a masterstock and regularly thawed \n",
       "working stocks.\",\n",
       "    \"The hiPSCs are maintained as a monoculture on Laminin-521 coating in Essential 8 (E8) medium and can \n",
       "differentiate into several cell types.\",\n",
       "    \"The undifferentiated hiPSC line has an ATCC number of CCL-186, origin Homo sapiens, tissue listed as lung, \n",
       "cell type fibroblast, and expresses pluripotency markers Oct4, Nanog and Tra-1-60.\",\n",
       "    \"The STR signature shown confirms 100% loci homology between IMR-90 and IMR90 cell lines.\",\n",
       "    \"Source cells must be pathogen-free (mycoplasma tested) and maintained with verified expression of pluripotency\n",
       "markers.\",\n",
       "    \"NCCs are differentiated from hiPSCs using a modified protocol (Mica et al., 2013) involving plating on \n",
       "Matrigel-coated plates at 100,000 cells/cm2 in E8 with ROCK inhibitor Y-27632, changing to KSR medium with Noggin \n",
       "and SB431542, and subsequent treatment with CHIR99021; Noggin/SB431542 are withdrawn at specified days, followed by\n",
       "gradual transition to N2-S medium, with cryopreservation at day 11 in 90% N2-S and 10% DMSO.\",\n",
       "    \"The derived NCCs are ≥90% positive for NCC markers HNK-1 and p75 and express nestin and AP2, while not \n",
       "expressing GFAP, Pax6 or βIII tubulin.\",\n",
       "    \"NCCs are characterized as migrating cells that form a dense monolayer after silicone stoppers are removed, \n",
       "with migration into a defined central cell-free area; viability is assessed outside the migration zone.\",\n",
       "    \"Acceptance criteria at start require pathogen-free cells, &gt;90% pluripotency marker expression, and viability \n",
       "after thawing to be &gt;90%.\",\n",
       "    \"The differentiation and culture protocol includes specific steps: plating on Matrigel in E8 with ROCK \n",
       "inhibitor, a transition to KSR with Noggin and SB431542, CHIR99021 treatment from day 2, gradual medium changes to \n",
       "N2-S, and cryopreservation on day 11.\",\n",
       "    \"The test system uses silicone stoppers to create a circular migration zone and analyzes migration by counting \n",
       "cells entering the migration zone, with four tiles imaged per well.\",\n",
       "    \"Cell staining for migration assessment uses calcein-AM and Hoechst 33342, imaged with a Cellomics Array Scan \n",
       "VTI HCS Reader, and analyzed with Ringassay software to count migrated viable cells.\",\n",
       "    \"Viability is quantified outside the migration zone by imaging four fields per well and counting \n",
       "double-positive calcein-AM and Hoechst-stained cells, normalised to untreated controls.\",\n",
       "    \"The typical 96-well plate setup measures 150–300 cells in the migration zone in untreated conditions, and 0.1%\n",
       "final DMSO is used as solvent control.\",\n",
       "    \"The assay employs 0.1% DMSO final concentration, uses inner 60 wells to avoid edge effects, and follows a \n",
       "default serial dilution of 1:3 for compound testing (with adaptations possible).\",\n",
       "    \"A 24-hour exposure scheme is used, with exposure of toxicants on Day 1 and readout on Day 2 after staining.\",\n",
       "    \"Migration inhibition is the primary endpoint, with viability as a reference endpoint; data are normalized to \n",
       "solvent controls.\",\n",
       "    \"The throughput is estimated at about 768 data points per month (16 plates per week; 2 compounds per plate; 6 \n",
       "concentrations per compound; 12 data points per plate).\",\n",
       "    \"Three prediction models are described: (1) screening — hit defined as migration ≤80% of DMSO control with \n",
       "viability ≥90% of control; (2) hazard evaluation — EC10 viability / EC25 migration ≥ 1.3; (3) borderline — BMC10 \n",
       "viability / BMCL25 migration ≥ 1.3.\",\n",
       "    \"The method has been used in screen campaigns including an 80-compound NTP library and a larger EFSA DNT \n",
       "battery (~120 compounds); specificity and sensitivity values have been reported in prior evaluations (specificity \n",
       "~100%, sensitivity &gt;90% in early assessments).\",\n",
       "    \"The method is not linked to OECD regulatory guidelines and has not been transferred to other laboratories; \n",
       "operator training is required (~4 weeks) and iPSC culture knowledge takes months to acquire.\",\n",
       "    \"Special requirements include S1-grade cell culture facilities, SDS documentation, and SOPs (DB-ALM Protocol n°\n",
       "195) with updated SOPs available upon request from Marcel Leist.\",\n",
       "    \"The method can be supplemented with additional endpoints (EdU staining) and alternative viability assays \n",
       "(resazurin, LDH, ATP) and exposure durations can be extended up to 48 hours.\",\n",
       "    \"In vitro–in vivo extrapolation information includes lipid content and albumin concentration in media and \n",
       "plasma, and PBPK modeling has been used to relate in vitro concentrations to potential clinical relevance, with \n",
       "some studies suggesting in vivo plasma concentrations may be in a comparable range to in vitro concentrations used \n",
       "in the assay.\",\n",
       "    \"The applicability domain notes that pesticides, flame retardants and PCBs have been detected with the assay, \n",
       "but volatile compounds or compounds not water-soluble may not be measurable; the test battery is referenced within \n",
       "EU-ToxRisk and related publications.\",\n",
       "    \"The cMINC protocol is maintained in DB-ALM with protocol details (DB-ALM SOP 195) and internal handling \n",
       "protocols available on request; the culture requires Matrigel, PLO, Laminin, and Fibronectin coatings for cell \n",
       "adherence and migration assay setup.\",\n",
       "    \"The data management workflow includes raw data storage in Excel, data processing with Ringassay software and \n",
       "Excel/GraphPad Prism, plus metadata logging (descriptor and protocol files) for traceability.\"\n",
       "] \n",
       " \n",
       "Claims:\n",
       "[\n",
       "    \"Plates are coated with poly-D-lysine and laminin.\",\n",
       "    \"The coating is used to promote attachment.\",\n",
       "    \"The coating is applied before the stopper is placed.\"\n",
       "] \n",
       " \n",
       "Verdicts:\n",
       "[\n",
       "    {\n",
       "        \"verdict\": \"no\",\n",
       "        \"reason\": \"The context specifies Matrigel-coated plates for plating NCCs, not poly-D-lysine and laminin; \n",
       "coatings mentioned include Matrigel, poly-L-ornithine (PLO), Laminin, and Fibronectin.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"The protocol mentions using silicone stoppers to create a migration zone but does not state \n",
       "whether coatings are applied before stopper placement.\"\n",
       "    }\n",
       "]\n",
       " \n",
       "Score: 0.6666666666666666\n",
       "Reason: The score is 0.67 because the actual output claimed coatings of poly-D-lysine and laminin, but the \n",
       "retrieval context specifies Matrigel-coated plates and lists coatings such as Matrigel, poly-L-ornithine (PLO), \n",
       "Laminin, and Fibronectin.\n",
       "</pre>\n"
      ],
      "text/plain": [
       "Truths (limit=None):\n",
       "[\n",
       "    \"The document describes the circular migration inhibition of NCC (cMINC) assay, UKN2, Version 2.0, as an in \n",
       "vitro test method.\",\n",
       "    \"The cMINC UKN2 assay uses human neural crest cells generated from human induced pluripotent stem cells \n",
       "(hiPSCs).\",\n",
       "    \"The assay assesses disturbances of neural crest cell (NCC) migration during fetal development.\",\n",
       "    \"The assay measures the number of migrated NCCs and cell viability simultaneously using high-content imaging \n",
       "after 24 hours of exposure to potential toxicants.\",\n",
       "    \"The data from the assay are intended to predict developmental disorders and malformations such as neural tube \n",
       "defects or craniofacial malformations caused by compound exposure.\",\n",
       "    \"The cMINC assay has a readiness score of A- according to Bal-Price et al. (2018).\",\n",
       "    \"The assay has not undergone formal validation and has not participated in a ring trial.\",\n",
       "    \"The method has been used in the screening of several medium-sized compound libraries.\",\n",
       "    \"The assay was developed at the University of Konstanz (UKN), Germany, with Marcel Leist listed as a contact \n",
       "person and other involved researchers named (Xenia Dolde, Jonathan Blum, Heidrun Leisner).\",\n",
       "    \"The hiPSC line used is IMR90_clone_#4, obtained from WiCell in 2012, with a masterstock and regularly thawed \n",
       "working stocks.\",\n",
       "    \"The hiPSCs are maintained as a monoculture on Laminin-521 coating in Essential 8 (E8) medium and can \n",
       "differentiate into several cell types.\",\n",
       "    \"The undifferentiated hiPSC line has an ATCC number of CCL-186, origin Homo sapiens, tissue listed as lung, \n",
       "cell type fibroblast, and expresses pluripotency markers Oct4, Nanog and Tra-1-60.\",\n",
       "    \"The STR signature shown confirms 100% loci homology between IMR-90 and IMR90 cell lines.\",\n",
       "    \"Source cells must be pathogen-free (mycoplasma tested) and maintained with verified expression of pluripotency\n",
       "markers.\",\n",
       "    \"NCCs are differentiated from hiPSCs using a modified protocol (Mica et al., 2013) involving plating on \n",
       "Matrigel-coated plates at 100,000 cells/cm2 in E8 with ROCK inhibitor Y-27632, changing to KSR medium with Noggin \n",
       "and SB431542, and subsequent treatment with CHIR99021; Noggin/SB431542 are withdrawn at specified days, followed by\n",
       "gradual transition to N2-S medium, with cryopreservation at day 11 in 90% N2-S and 10% DMSO.\",\n",
       "    \"The derived NCCs are ≥90% positive for NCC markers HNK-1 and p75 and express nestin and AP2, while not \n",
       "expressing GFAP, Pax6 or βIII tubulin.\",\n",
       "    \"NCCs are characterized as migrating cells that form a dense monolayer after silicone stoppers are removed, \n",
       "with migration into a defined central cell-free area; viability is assessed outside the migration zone.\",\n",
       "    \"Acceptance criteria at start require pathogen-free cells, >90% pluripotency marker expression, and viability \n",
       "after thawing to be >90%.\",\n",
       "    \"The differentiation and culture protocol includes specific steps: plating on Matrigel in E8 with ROCK \n",
       "inhibitor, a transition to KSR with Noggin and SB431542, CHIR99021 treatment from day 2, gradual medium changes to \n",
       "N2-S, and cryopreservation on day 11.\",\n",
       "    \"The test system uses silicone stoppers to create a circular migration zone and analyzes migration by counting \n",
       "cells entering the migration zone, with four tiles imaged per well.\",\n",
       "    \"Cell staining for migration assessment uses calcein-AM and Hoechst 33342, imaged with a Cellomics Array Scan \n",
       "VTI HCS Reader, and analyzed with Ringassay software to count migrated viable cells.\",\n",
       "    \"Viability is quantified outside the migration zone by imaging four fields per well and counting \n",
       "double-positive calcein-AM and Hoechst-stained cells, normalised to untreated controls.\",\n",
       "    \"The typical 96-well plate setup measures 150–300 cells in the migration zone in untreated conditions, and 0.1%\n",
       "final DMSO is used as solvent control.\",\n",
       "    \"The assay employs 0.1% DMSO final concentration, uses inner 60 wells to avoid edge effects, and follows a \n",
       "default serial dilution of 1:3 for compound testing (with adaptations possible).\",\n",
       "    \"A 24-hour exposure scheme is used, with exposure of toxicants on Day 1 and readout on Day 2 after staining.\",\n",
       "    \"Migration inhibition is the primary endpoint, with viability as a reference endpoint; data are normalized to \n",
       "solvent controls.\",\n",
       "    \"The throughput is estimated at about 768 data points per month (16 plates per week; 2 compounds per plate; 6 \n",
       "concentrations per compound; 12 data points per plate).\",\n",
       "    \"Three prediction models are described: (1) screening — hit defined as migration ≤80% of DMSO control with \n",
       "viability ≥90% of control; (2) hazard evaluation — EC10 viability / EC25 migration ≥ 1.3; (3) borderline — BMC10 \n",
       "viability / BMCL25 migration ≥ 1.3.\",\n",
       "    \"The method has been used in screen campaigns including an 80-compound NTP library and a larger EFSA DNT \n",
       "battery (~120 compounds); specificity and sensitivity values have been reported in prior evaluations (specificity \n",
       "~100%, sensitivity >90% in early assessments).\",\n",
       "    \"The method is not linked to OECD regulatory guidelines and has not been transferred to other laboratories; \n",
       "operator training is required (~4 weeks) and iPSC culture knowledge takes months to acquire.\",\n",
       "    \"Special requirements include S1-grade cell culture facilities, SDS documentation, and SOPs (DB-ALM Protocol n°\n",
       "195) with updated SOPs available upon request from Marcel Leist.\",\n",
       "    \"The method can be supplemented with additional endpoints (EdU staining) and alternative viability assays \n",
       "(resazurin, LDH, ATP) and exposure durations can be extended up to 48 hours.\",\n",
       "    \"In vitro–in vivo extrapolation information includes lipid content and albumin concentration in media and \n",
       "plasma, and PBPK modeling has been used to relate in vitro concentrations to potential clinical relevance, with \n",
       "some studies suggesting in vivo plasma concentrations may be in a comparable range to in vitro concentrations used \n",
       "in the assay.\",\n",
       "    \"The applicability domain notes that pesticides, flame retardants and PCBs have been detected with the assay, \n",
       "but volatile compounds or compounds not water-soluble may not be measurable; the test battery is referenced within \n",
       "EU-ToxRisk and related publications.\",\n",
       "    \"The cMINC protocol is maintained in DB-ALM with protocol details (DB-ALM SOP 195) and internal handling \n",
       "protocols available on request; the culture requires Matrigel, PLO, Laminin, and Fibronectin coatings for cell \n",
       "adherence and migration assay setup.\",\n",
       "    \"The data management workflow includes raw data storage in Excel, data processing with Ringassay software and \n",
       "Excel/GraphPad Prism, plus metadata logging (descriptor and protocol files) for traceability.\"\n",
       "] \n",
       " \n",
       "Claims:\n",
       "[\n",
       "    \"Plates are coated with poly-D-lysine and laminin.\",\n",
       "    \"The coating is used to promote attachment.\",\n",
       "    \"The coating is applied before the stopper is placed.\"\n",
       "] \n",
       " \n",
       "Verdicts:\n",
       "[\n",
       "    {\n",
       "        \"verdict\": \"no\",\n",
       "        \"reason\": \"The context specifies Matrigel-coated plates for plating NCCs, not poly-D-lysine and laminin; \n",
       "coatings mentioned include Matrigel, poly-L-ornithine (PLO), Laminin, and Fibronectin.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"yes\",\n",
       "        \"reason\": null\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"The protocol mentions using silicone stoppers to create a migration zone but does not state \n",
       "whether coatings are applied before stopper placement.\"\n",
       "    }\n",
       "]\n",
       " \n",
       "Score: 0.6666666666666666\n",
       "Reason: The score is 0.67 because the actual output claimed coatings of poly-D-lysine and laminin, but the \n",
       "retrieval context specifies Matrigel-coated plates and lists coatings such as Matrigel, poly-L-ornithine (PLO), \n",
       "Laminin, and Fibronectin.\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">======================================================================\n",
       "</pre>\n"
      ],
      "text/plain": [
       "======================================================================\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "643963e4e11941018a6963c884ebcd18",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Output()"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">**************************************************\n",
       "</pre>\n"
      ],
      "text/plain": [
       "**************************************************\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">ToxTemp Groundedness Policy (counts) [GEval] Verbose Logs\n",
       "</pre>\n"
      ],
      "text/plain": [
       "ToxTemp Groundedness Policy (counts) [GEval] Verbose Logs\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">**************************************************\n",
       "</pre>\n"
      ],
      "text/plain": [
       "**************************************************\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">Criteria:\n",
       "None \n",
       " \n",
       "Evaluation Steps:\n",
       "[\n",
       "    \"Task: evaluate whether ACTUAL_OUTPUT is grounded ONLY in RETRIEVAL_CONTEXT. No outside knowledge.\",\n",
       "    \"\",\n",
       "    \"Step 1 — Extract atomic factual claims from ACTUAL_OUTPUT limited to: entities, numbers, durations, units, \n",
       "methods, readouts, materials, cell lines, species, instruments, and endpoints. Do NOT extract vague/subjective \n",
       "claims (e.g., 'robust', 'appropriate').\",\n",
       "    \"\",\n",
       "    \"Step 2 — For each claim, assign exactly one label:\",\n",
       "    \"  - ENTAILED: explicitly supported by RETRIEVAL_CONTEXT (directly stated or unambiguous paraphrase).\",\n",
       "    \"  - CONTRADICTED: conflicts with RETRIEVAL_CONTEXT.\",\n",
       "    \"  - UNSUPPORTED: not found in RETRIEVAL_CONTEXT and not contradicted.\",\n",
       "    \"  - ABSTAINED: ACTUAL_OUTPUT explicitly states the information is not in the context / cannot be determined, \n",
       "and does not assert the missing fact.\",\n",
       "    \"\",\n",
       "    \"Step 3 — Return VALID JSON ONLY (no markdown, no extra text) with integer counts and an optional short audit \n",
       "list.\",\n",
       "    \"Required JSON keys: {\"entailed\": int, \"unsupported\": int, \"contradicted\": int, \"abstained\": int, \n",
       "\"total_claims\": int}.\",\n",
       "    \"Optional key: \"claims\": a list of up to 10 items, each with {\"claim\": str, \"label\": str, \"evidence\": str}. \n",
       "Evidence should be a short phrase from context or \"N/A\".\",\n",
       "    \"\",\n",
       "    \"Step 4 — Ensure: total_claims = entailed + unsupported + contradicted + abstained.\"\n",
       "] \n",
       " \n",
       "Rubric:\n",
       "None \n",
       " \n",
       "Score: 0.3\n",
       " \n",
       "Reason: Output asserts plates are coated with poly-D-lysine and laminin. Retrieval Context describes coatings as \n",
       "poly-L-ornithine (PLO) with laminin/fibronectin and laminin-521; thus laminin is supported but poly-D-lysine is not\n",
       "present in context, making the claim not wholly grounded and partially contradicted.\n",
       "</pre>\n"
      ],
      "text/plain": [
       "Criteria:\n",
       "None \n",
       " \n",
       "Evaluation Steps:\n",
       "[\n",
       "    \"Task: evaluate whether ACTUAL_OUTPUT is grounded ONLY in RETRIEVAL_CONTEXT. No outside knowledge.\",\n",
       "    \"\",\n",
       "    \"Step 1 — Extract atomic factual claims from ACTUAL_OUTPUT limited to: entities, numbers, durations, units, \n",
       "methods, readouts, materials, cell lines, species, instruments, and endpoints. Do NOT extract vague/subjective \n",
       "claims (e.g., 'robust', 'appropriate').\",\n",
       "    \"\",\n",
       "    \"Step 2 — For each claim, assign exactly one label:\",\n",
       "    \"  - ENTAILED: explicitly supported by RETRIEVAL_CONTEXT (directly stated or unambiguous paraphrase).\",\n",
       "    \"  - CONTRADICTED: conflicts with RETRIEVAL_CONTEXT.\",\n",
       "    \"  - UNSUPPORTED: not found in RETRIEVAL_CONTEXT and not contradicted.\",\n",
       "    \"  - ABSTAINED: ACTUAL_OUTPUT explicitly states the information is not in the context / cannot be determined, \n",
       "and does not assert the missing fact.\",\n",
       "    \"\",\n",
       "    \"Step 3 — Return VALID JSON ONLY (no markdown, no extra text) with integer counts and an optional short audit \n",
       "list.\",\n",
       "    \"Required JSON keys: {\"entailed\": int, \"unsupported\": int, \"contradicted\": int, \"abstained\": int, \n",
       "\"total_claims\": int}.\",\n",
       "    \"Optional key: \"claims\": a list of up to 10 items, each with {\"claim\": str, \"label\": str, \"evidence\": str}. \n",
       "Evidence should be a short phrase from context or \"N/A\".\",\n",
       "    \"\",\n",
       "    \"Step 4 — Ensure: total_claims = entailed + unsupported + contradicted + abstained.\"\n",
       "] \n",
       " \n",
       "Rubric:\n",
       "None \n",
       " \n",
       "Score: 0.3\n",
       " \n",
       "Reason: Output asserts plates are coated with poly-D-lysine and laminin. Retrieval Context describes coatings as \n",
       "poly-L-ornithine (PLO) with laminin/fibronectin and laminin-521; thus laminin is supported but poly-D-lysine is not\n",
       "present in context, making the claim not wholly grounded and partially contradicted.\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">======================================================================\n",
       "</pre>\n"
      ],
      "text/plain": [
       "======================================================================\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "75b3f05ec1ba4bf2abdf39d6315384f1",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Output()"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "=== Eval Results ===\n",
      "faithfulness_score: 0.6666666666666666\n",
      "faithfulness_reason: The score is 0.67 because the actual output claimed coatings of poly-D-lysine and laminin, but the retrieval context specifies Matrigel-coated plates and lists coatings such as Matrigel, poly-L-ornithine (PLO), Laminin, and Fibronectin.\n",
      "geval_policy_score: 0.3\n",
      "geval_policy_reason: Output asserts plates are coated with poly-D-lysine and laminin. Retrieval Context describes coatings as poly-L-ornithine (PLO) with laminin/fibronectin and laminin-521; thus laminin is supported but poly-D-lysine is not present in context, making the claim not wholly grounded and partially contradicted.\n",
      "groundedness_policy_score: None\n",
      "groundedness_herman_score: None\n",
      "groundedness_counts: None\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">**************************************************\n",
       "</pre>\n"
      ],
      "text/plain": [
       "**************************************************\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">Faithfulness Verbose Logs\n",
       "</pre>\n"
      ],
      "text/plain": [
       "Faithfulness Verbose Logs\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">**************************************************\n",
       "</pre>\n"
      ],
      "text/plain": [
       "**************************************************\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">Truths (limit=None):\n",
       "[\n",
       "    \"The cMINC UKN2 assay is an in vitro test method for impairment of migration of human neural crest cells \n",
       "(NCCs).\",\n",
       "    \"NCCs used in the assay are derived from human induced pluripotent stem cells (hiPSCs).\",\n",
       "    \"The assay measures both NCC migration and cell viability after exposure to potential toxicants for 24 hours.\",\n",
       "    \"The data from the assay are intended to predict developmental disorders and malformations such as neural tube \n",
       "defects and craniofacial malformations during fetal development.\",\n",
       "    \"It has a readiness score of A- according to Bal-Price et al. (2018).\",\n",
       "    \"The assay has not undergone formal validation and has not participated in a ring trial.\",\n",
       "    \"It has been used to screen several medium-sized compound libraries.\",\n",
       "    \"Version 2.0 (V2.0) of the protocol was deposited in March 2023, with a previous version from 2019.\",\n",
       "    \"The test depositor is the University of Konstanz (UKN), Germany, led by Prof. Dr. Marcel Leist.\",\n",
       "    \"The hiPSC line used is IMR90_clone_#4, obtained from WiCell in 2012, with a frozen master stock.\",\n",
       "    \"Working stocks are regularly thawed and maintained up to 10 passages before thawing a new vial.\",\n",
       "    \"Undifferentiated hiPSCs are maintained as monoculture on Laminin-521 coating in essential 8 (E8) medium, \n",
       "growing in colonies and split weakly.\",\n",
       "    \"The cells express pluripotency markers Oct4, Nanog, and Tra-1-60 by immunocytochemistry.\",\n",
       "    \"ATCC number CCL-186; origin Homo sapiens; tissue listed as lung; cell type listed as fibroblast.\",\n",
       "    \"NCCs derived in this protocol are at least 90% positive for NCC markers HNK-1 and p75.\",\n",
       "    \"NCCs express nestin and AP2, and do not express GFAP, Pax6, or βIII tubulin.\",\n",
       "    \"Post-thaw viability of NCCs is greater than 90% before use.\",\n",
       "    \"Differentiation toward NCCs uses Noggin and SB431542, CHIR99021, and a gradual transition to N2-S medium \n",
       "starting day 4.\",\n",
       "    \"On day 11, NCCs are collected, resuspended in N2-S with EGF and FGF2, and seeded as droplets and expanded \n",
       "weekly.\",\n",
       "    \"NCCs are cryopreserved at 4x10^6 cells/mL in 90% N2-S and 10% DMSO for long-term storage.\",\n",
       "    \"The test system uses a silicone stopper in a 96-well plate to create a circular cell-free migration zone.\",\n",
       "    \"After removing the stopper, NCCs migrate into the cell-free area, and this migration is quantified.\",\n",
       "    \"Migration is quantified by staining with calcein-AM and Hoechst 33342, imaging, and counting viable cells \n",
       "within a predefined ROI.\",\n",
       "    \"Viability is measured outside the migration zone by staining and imaging; four fields per well are analyzed.\",\n",
       "    \"The ROI in untreated conditions typically contains 150 to 300 cells.\",\n",
       "    \"Compounds are tested in two compounds per plate with six concentrations each, using a default serial dilution \n",
       "of 1:3.\",\n",
       "    \"Final DMSO concentration on cells is 0.1%.\",\n",
       "    \"Compound dilutions are prepared in DMEM/F12 Advanced without supplements and added in medium containing 20 \n",
       "ng/mL EGF and FGF with 0.5% DMSO.\",\n",
       "    \"Plate maps are defined prior to the experiment and documented in lab books and Excel files stored on the group\n",
       "server.\",\n",
       "    \"The test can be augmented with EdU staining to measure proliferation as an additional endpoint.\",\n",
       "    \"The method has a throughput estimate of 768 data points per month, corresponding to 16 plates per week.\",\n",
       "    \"Positive controls include Cytochalasin D (200 nM), LiCl (10 mM), and Taxol (10 nM).\",\n",
       "    \"Negative controls include solvent (0.1% DMSO), paracetamol, and ASS.\",\n",
       "    \"Migration is the primary endpoint, with viability serving as a reference endpoint to interpret migration \n",
       "results.\",\n",
       "    \"The Ringassay software and Array Scan VTI HCS Reader are used to acquire and analyze imaging data, with \n",
       "results stored in Excel files.\",\n",
       "    \"Prediction models include a screening model (migration inhibited with viability ≥ 90%), a hazard evaluation \n",
       "model (EC10 viability / EC25 migration ≥ 1.3), and a borderline model (BMC10 V / BMCL25 M ≥ 1.3).\",\n",
       "    \"The method has historical performance parameters including specificity around 100% and sensitivity &gt; 90% in \n",
       "early evaluations, with S/N ratios &gt; 20 and z’ &gt; 0.5 in some rounds.\",\n",
       "    \"To date, 141 unique compounds and over 200 total compounds have been tested in the cMINC assay, including use \n",
       "in the NTP80 screen and EFSA DNT evaluations.\",\n",
       "    \"The assay has not been transferred to other laboratories; transfer requires operator training and iPSC culture\n",
       "expertise.\",\n",
       "    \"Operator training is expected to take about 4 weeks for smooth assay performance; learning iPSC culture takes \n",
       "several months.\",\n",
       "    \"Work requires S1 cell culture facilities; SDS are available in the DaMaRIS database; no specific ethical \n",
       "approval is required.\",\n",
       "    \"The assay cannot measure volatile compounds or substances that are not water-soluble.\",\n",
       "    \"The test is not currently linked to OECD regulatory guidelines and has not undergone formal OECD validation.\",\n",
       "    \"In vitro–in vivo extrapolation uses a three-step PBPK strategy with UKN2 medium lipid content of 2.8E-6 and \n",
       "albumin concentration of 5.6 μM.\",\n",
       "    \"In vivo plasma concentrations of tested compounds were reported to be within the same range as those used in \n",
       "the scratch assay in supporting studies.\",\n",
       "    \"The cMINC method is discussed as part of the ESNA TS (Embryonic Stem cell-based Novel Alternative Testing \n",
       "Strategies) screening framework.\",\n",
       "    \"DB-ALM Protocol n° 195 provides the detailed maintenance protocol for cMINC, with an online version available \n",
       "and a lab-internal SOP.\",\n",
       "    \"Special instrumentation required includes a Cellomics Array Scan VTI HCS high-content reader and silicone \n",
       "stoppers from Platypus Technologies.\"\n",
       "] \n",
       " \n",
       "Claims:\n",
       "[\n",
       "    \"Images are quantified using ImageJ macros.\",\n",
       "    \"The ImageJ macros trace the entire well area.\",\n",
       "    \"The ROI is the full well excluding the stopper edge.\"\n",
       "] \n",
       " \n",
       "Verdicts:\n",
       "[\n",
       "    {\n",
       "        \"verdict\": \"no\",\n",
       "        \"reason\": \"The retrieval context states imaging data are acquired and analyzed with Ringassay software and \n",
       "Array Scan VTI HCS Reader; ImageJ macros are not mentioned.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"no\",\n",
       "        \"reason\": \"The ROI is described as a predefined region used to quantify migration (a circular migration \n",
       "zone created after stopper removal), not the entire well; analysis is not described as tracing the full well with \n",
       "ImageJ macros.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"no\",\n",
       "        \"reason\": \"The ROI corresponds to the circular migration zone defined by the stopper boundary, not the full\n",
       "well excluding the stopper edge; viability measurements are made outside the ROI.\"\n",
       "    }\n",
       "]\n",
       " \n",
       "Score: 0.0\n",
       "Reason: The score is 0.00 because the actual output claims analysis uses ImageJ macros and traces the full well, \n",
       "which contradicts the retrieval context that imaging data are acquired and analyzed with Ringassay software and \n",
       "Array Scan VTI HCS Reader (no ImageJ). It also misdescribes the ROI: it’s the predefined circular migration zone \n",
       "defined by the stopper boundary (not the entire well), with viability measurements outside the ROI, conflicting \n",
       "with the claim of full-well analysis.\n",
       "</pre>\n"
      ],
      "text/plain": [
       "Truths (limit=None):\n",
       "[\n",
       "    \"The cMINC UKN2 assay is an in vitro test method for impairment of migration of human neural crest cells \n",
       "(NCCs).\",\n",
       "    \"NCCs used in the assay are derived from human induced pluripotent stem cells (hiPSCs).\",\n",
       "    \"The assay measures both NCC migration and cell viability after exposure to potential toxicants for 24 hours.\",\n",
       "    \"The data from the assay are intended to predict developmental disorders and malformations such as neural tube \n",
       "defects and craniofacial malformations during fetal development.\",\n",
       "    \"It has a readiness score of A- according to Bal-Price et al. (2018).\",\n",
       "    \"The assay has not undergone formal validation and has not participated in a ring trial.\",\n",
       "    \"It has been used to screen several medium-sized compound libraries.\",\n",
       "    \"Version 2.0 (V2.0) of the protocol was deposited in March 2023, with a previous version from 2019.\",\n",
       "    \"The test depositor is the University of Konstanz (UKN), Germany, led by Prof. Dr. Marcel Leist.\",\n",
       "    \"The hiPSC line used is IMR90_clone_#4, obtained from WiCell in 2012, with a frozen master stock.\",\n",
       "    \"Working stocks are regularly thawed and maintained up to 10 passages before thawing a new vial.\",\n",
       "    \"Undifferentiated hiPSCs are maintained as monoculture on Laminin-521 coating in essential 8 (E8) medium, \n",
       "growing in colonies and split weakly.\",\n",
       "    \"The cells express pluripotency markers Oct4, Nanog, and Tra-1-60 by immunocytochemistry.\",\n",
       "    \"ATCC number CCL-186; origin Homo sapiens; tissue listed as lung; cell type listed as fibroblast.\",\n",
       "    \"NCCs derived in this protocol are at least 90% positive for NCC markers HNK-1 and p75.\",\n",
       "    \"NCCs express nestin and AP2, and do not express GFAP, Pax6, or βIII tubulin.\",\n",
       "    \"Post-thaw viability of NCCs is greater than 90% before use.\",\n",
       "    \"Differentiation toward NCCs uses Noggin and SB431542, CHIR99021, and a gradual transition to N2-S medium \n",
       "starting day 4.\",\n",
       "    \"On day 11, NCCs are collected, resuspended in N2-S with EGF and FGF2, and seeded as droplets and expanded \n",
       "weekly.\",\n",
       "    \"NCCs are cryopreserved at 4x10^6 cells/mL in 90% N2-S and 10% DMSO for long-term storage.\",\n",
       "    \"The test system uses a silicone stopper in a 96-well plate to create a circular cell-free migration zone.\",\n",
       "    \"After removing the stopper, NCCs migrate into the cell-free area, and this migration is quantified.\",\n",
       "    \"Migration is quantified by staining with calcein-AM and Hoechst 33342, imaging, and counting viable cells \n",
       "within a predefined ROI.\",\n",
       "    \"Viability is measured outside the migration zone by staining and imaging; four fields per well are analyzed.\",\n",
       "    \"The ROI in untreated conditions typically contains 150 to 300 cells.\",\n",
       "    \"Compounds are tested in two compounds per plate with six concentrations each, using a default serial dilution \n",
       "of 1:3.\",\n",
       "    \"Final DMSO concentration on cells is 0.1%.\",\n",
       "    \"Compound dilutions are prepared in DMEM/F12 Advanced without supplements and added in medium containing 20 \n",
       "ng/mL EGF and FGF with 0.5% DMSO.\",\n",
       "    \"Plate maps are defined prior to the experiment and documented in lab books and Excel files stored on the group\n",
       "server.\",\n",
       "    \"The test can be augmented with EdU staining to measure proliferation as an additional endpoint.\",\n",
       "    \"The method has a throughput estimate of 768 data points per month, corresponding to 16 plates per week.\",\n",
       "    \"Positive controls include Cytochalasin D (200 nM), LiCl (10 mM), and Taxol (10 nM).\",\n",
       "    \"Negative controls include solvent (0.1% DMSO), paracetamol, and ASS.\",\n",
       "    \"Migration is the primary endpoint, with viability serving as a reference endpoint to interpret migration \n",
       "results.\",\n",
       "    \"The Ringassay software and Array Scan VTI HCS Reader are used to acquire and analyze imaging data, with \n",
       "results stored in Excel files.\",\n",
       "    \"Prediction models include a screening model (migration inhibited with viability ≥ 90%), a hazard evaluation \n",
       "model (EC10 viability / EC25 migration ≥ 1.3), and a borderline model (BMC10 V / BMCL25 M ≥ 1.3).\",\n",
       "    \"The method has historical performance parameters including specificity around 100% and sensitivity > 90% in \n",
       "early evaluations, with S/N ratios > 20 and z’ > 0.5 in some rounds.\",\n",
       "    \"To date, 141 unique compounds and over 200 total compounds have been tested in the cMINC assay, including use \n",
       "in the NTP80 screen and EFSA DNT evaluations.\",\n",
       "    \"The assay has not been transferred to other laboratories; transfer requires operator training and iPSC culture\n",
       "expertise.\",\n",
       "    \"Operator training is expected to take about 4 weeks for smooth assay performance; learning iPSC culture takes \n",
       "several months.\",\n",
       "    \"Work requires S1 cell culture facilities; SDS are available in the DaMaRIS database; no specific ethical \n",
       "approval is required.\",\n",
       "    \"The assay cannot measure volatile compounds or substances that are not water-soluble.\",\n",
       "    \"The test is not currently linked to OECD regulatory guidelines and has not undergone formal OECD validation.\",\n",
       "    \"In vitro–in vivo extrapolation uses a three-step PBPK strategy with UKN2 medium lipid content of 2.8E-6 and \n",
       "albumin concentration of 5.6 μM.\",\n",
       "    \"In vivo plasma concentrations of tested compounds were reported to be within the same range as those used in \n",
       "the scratch assay in supporting studies.\",\n",
       "    \"The cMINC method is discussed as part of the ESNA TS (Embryonic Stem cell-based Novel Alternative Testing \n",
       "Strategies) screening framework.\",\n",
       "    \"DB-ALM Protocol n° 195 provides the detailed maintenance protocol for cMINC, with an online version available \n",
       "and a lab-internal SOP.\",\n",
       "    \"Special instrumentation required includes a Cellomics Array Scan VTI HCS high-content reader and silicone \n",
       "stoppers from Platypus Technologies.\"\n",
       "] \n",
       " \n",
       "Claims:\n",
       "[\n",
       "    \"Images are quantified using ImageJ macros.\",\n",
       "    \"The ImageJ macros trace the entire well area.\",\n",
       "    \"The ROI is the full well excluding the stopper edge.\"\n",
       "] \n",
       " \n",
       "Verdicts:\n",
       "[\n",
       "    {\n",
       "        \"verdict\": \"no\",\n",
       "        \"reason\": \"The retrieval context states imaging data are acquired and analyzed with Ringassay software and \n",
       "Array Scan VTI HCS Reader; ImageJ macros are not mentioned.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"no\",\n",
       "        \"reason\": \"The ROI is described as a predefined region used to quantify migration (a circular migration \n",
       "zone created after stopper removal), not the entire well; analysis is not described as tracing the full well with \n",
       "ImageJ macros.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"no\",\n",
       "        \"reason\": \"The ROI corresponds to the circular migration zone defined by the stopper boundary, not the full\n",
       "well excluding the stopper edge; viability measurements are made outside the ROI.\"\n",
       "    }\n",
       "]\n",
       " \n",
       "Score: 0.0\n",
       "Reason: The score is 0.00 because the actual output claims analysis uses ImageJ macros and traces the full well, \n",
       "which contradicts the retrieval context that imaging data are acquired and analyzed with Ringassay software and \n",
       "Array Scan VTI HCS Reader (no ImageJ). It also misdescribes the ROI: it’s the predefined circular migration zone \n",
       "defined by the stopper boundary (not the entire well), with viability measurements outside the ROI, conflicting \n",
       "with the claim of full-well analysis.\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">======================================================================\n",
       "</pre>\n"
      ],
      "text/plain": [
       "======================================================================\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "f15e289394c54bdcb261c45a184fd2ec",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Output()"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">**************************************************\n",
       "</pre>\n"
      ],
      "text/plain": [
       "**************************************************\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">ToxTemp Groundedness Policy (counts) [GEval] Verbose Logs\n",
       "</pre>\n"
      ],
      "text/plain": [
       "ToxTemp Groundedness Policy (counts) [GEval] Verbose Logs\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">**************************************************\n",
       "</pre>\n"
      ],
      "text/plain": [
       "**************************************************\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">Criteria:\n",
       "None \n",
       " \n",
       "Evaluation Steps:\n",
       "[\n",
       "    \"Task: evaluate whether ACTUAL_OUTPUT is grounded ONLY in RETRIEVAL_CONTEXT. No outside knowledge.\",\n",
       "    \"\",\n",
       "    \"Step 1 — Extract atomic factual claims from ACTUAL_OUTPUT limited to: entities, numbers, durations, units, \n",
       "methods, readouts, materials, cell lines, species, instruments, and endpoints. Do NOT extract vague/subjective \n",
       "claims (e.g., 'robust', 'appropriate').\",\n",
       "    \"\",\n",
       "    \"Step 2 — For each claim, assign exactly one label:\",\n",
       "    \"  - ENTAILED: explicitly supported by RETRIEVAL_CONTEXT (directly stated or unambiguous paraphrase).\",\n",
       "    \"  - CONTRADICTED: conflicts with RETRIEVAL_CONTEXT.\",\n",
       "    \"  - UNSUPPORTED: not found in RETRIEVAL_CONTEXT and not contradicted.\",\n",
       "    \"  - ABSTAINED: ACTUAL_OUTPUT explicitly states the information is not in the context / cannot be determined, \n",
       "and does not assert the missing fact.\",\n",
       "    \"\",\n",
       "    \"Step 3 — Return VALID JSON ONLY (no markdown, no extra text) with integer counts and an optional short audit \n",
       "list.\",\n",
       "    \"Required JSON keys: {\"entailed\": int, \"unsupported\": int, \"contradicted\": int, \"abstained\": int, \n",
       "\"total_claims\": int}.\",\n",
       "    \"Optional key: \"claims\": a list of up to 10 items, each with {\"claim\": str, \"label\": str, \"evidence\": str}. \n",
       "Evidence should be a short phrase from context or \"N/A\".\",\n",
       "    \"\",\n",
       "    \"Step 4 — Ensure: total_claims = entailed + unsupported + contradicted + abstained.\"\n",
       "] \n",
       " \n",
       "Rubric:\n",
       "None \n",
       " \n",
       "Score: 0.6\n",
       " \n",
       "Reason: Two atomic claims identified. One claims ImageJ is used; this is not supported by the Retrieval Context \n",
       "which mentions Ringassay software and ArrayScan/VTI HCS workflows (UNSUPPORTED). The ROI claim contradicts the \n",
       "context which describes ROI as the migration zone around the stopper and specifies ROI diameter, not the full well \n",
       "(CONTRADICTED). No abstained claims.\n",
       "</pre>\n"
      ],
      "text/plain": [
       "Criteria:\n",
       "None \n",
       " \n",
       "Evaluation Steps:\n",
       "[\n",
       "    \"Task: evaluate whether ACTUAL_OUTPUT is grounded ONLY in RETRIEVAL_CONTEXT. No outside knowledge.\",\n",
       "    \"\",\n",
       "    \"Step 1 — Extract atomic factual claims from ACTUAL_OUTPUT limited to: entities, numbers, durations, units, \n",
       "methods, readouts, materials, cell lines, species, instruments, and endpoints. Do NOT extract vague/subjective \n",
       "claims (e.g., 'robust', 'appropriate').\",\n",
       "    \"\",\n",
       "    \"Step 2 — For each claim, assign exactly one label:\",\n",
       "    \"  - ENTAILED: explicitly supported by RETRIEVAL_CONTEXT (directly stated or unambiguous paraphrase).\",\n",
       "    \"  - CONTRADICTED: conflicts with RETRIEVAL_CONTEXT.\",\n",
       "    \"  - UNSUPPORTED: not found in RETRIEVAL_CONTEXT and not contradicted.\",\n",
       "    \"  - ABSTAINED: ACTUAL_OUTPUT explicitly states the information is not in the context / cannot be determined, \n",
       "and does not assert the missing fact.\",\n",
       "    \"\",\n",
       "    \"Step 3 — Return VALID JSON ONLY (no markdown, no extra text) with integer counts and an optional short audit \n",
       "list.\",\n",
       "    \"Required JSON keys: {\"entailed\": int, \"unsupported\": int, \"contradicted\": int, \"abstained\": int, \n",
       "\"total_claims\": int}.\",\n",
       "    \"Optional key: \"claims\": a list of up to 10 items, each with {\"claim\": str, \"label\": str, \"evidence\": str}. \n",
       "Evidence should be a short phrase from context or \"N/A\".\",\n",
       "    \"\",\n",
       "    \"Step 4 — Ensure: total_claims = entailed + unsupported + contradicted + abstained.\"\n",
       "] \n",
       " \n",
       "Rubric:\n",
       "None \n",
       " \n",
       "Score: 0.6\n",
       " \n",
       "Reason: Two atomic claims identified. One claims ImageJ is used; this is not supported by the Retrieval Context \n",
       "which mentions Ringassay software and ArrayScan/VTI HCS workflows (UNSUPPORTED). The ROI claim contradicts the \n",
       "context which describes ROI as the migration zone around the stopper and specifies ROI diameter, not the full well \n",
       "(CONTRADICTED). No abstained claims.\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">======================================================================\n",
       "</pre>\n"
      ],
      "text/plain": [
       "======================================================================\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "464c71f83754459584dcdd6f033cedc0",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Output()"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "=== Eval Results ===\n",
      "faithfulness_score: 0.0\n",
      "faithfulness_reason: The score is 0.00 because the actual output claims analysis uses ImageJ macros and traces the full well, which contradicts the retrieval context that imaging data are acquired and analyzed with Ringassay software and Array Scan VTI HCS Reader (no ImageJ). It also misdescribes the ROI: it’s the predefined circular migration zone defined by the stopper boundary (not the entire well), with viability measurements outside the ROI, conflicting with the claim of full-well analysis.\n",
      "geval_policy_score: 0.6\n",
      "geval_policy_reason: Two atomic claims identified. One claims ImageJ is used; this is not supported by the Retrieval Context which mentions Ringassay software and ArrayScan/VTI HCS workflows (UNSUPPORTED). The ROI claim contradicts the context which describes ROI as the migration zone around the stopper and specifies ROI diameter, not the full well (CONTRADICTED). No abstained claims.\n",
      "groundedness_policy_score: None\n",
      "groundedness_herman_score: None\n",
      "groundedness_counts: None\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">**************************************************\n",
       "</pre>\n"
      ],
      "text/plain": [
       "**************************************************\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">Faithfulness Verbose Logs\n",
       "</pre>\n"
      ],
      "text/plain": [
       "Faithfulness Verbose Logs\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">**************************************************\n",
       "</pre>\n"
      ],
      "text/plain": [
       "**************************************************\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">Truths (limit=None):\n",
       "[\n",
       "    \"The text describes the Circular migration inhibition of NCC (cMINC) assay, UKN2, Version 2.0, deposited in \n",
       "March 2023.\",\n",
       "    \"The assay uses human neural crest cells derived from human induced pluripotent stem cells (hiPSCs).\",\n",
       "    \"The hiPSC line used is IMR90_clone_#4, purchased from WiCell in 2012 with a frozen masterstock.\",\n",
       "    \"The hiPSCs are maintained as monoculture on Laminin-521 coating in Essential 8 medium.\",\n",
       "    \"The hiPSCs express pluripotency markers Oct4, Nanog and Tra-1-60 in maintenance culture.\",\n",
       "    \"The hiPSC line IMR-90 has ATCC number CCL-186 and originates from a female donor at 16 weeks gestation.\",\n",
       "    \"The NCCs were differentiated from hiPSCs following the protocol of Mica et al. (2013) with Noggin and SB431542\n",
       "and then CHIR99021.\",\n",
       "    \"From day 4 onward the differentiation protocol transitions to N2-S medium with growth factors EGF and FGF2.\",\n",
       "    \"The hiPSCs/nCC differentiation protocol is described in the DB-ALM Protocol n° 195 and related sections.\",\n",
       "    \"Cryopreserved NCCs are stored at a concentration of 4 × 10^6 cells per milliliter in 90% N2-S medium and 10% \n",
       "DMSO.\",\n",
       "    \"The derived NCCs are at least 90% positive for the NCC markers HNK-1 and p75.\",\n",
       "    \"The NCCs also express nestin and AP2 but do not express Pax6 or the neuronal marker βIII-tubulin.\",\n",
       "    \"The derived NCCs do not express the astrocyte marker GFAP.\",\n",
       "    \"The NCCs are pathogen-free (regular mycoplasma testing is performed).\",\n",
       "    \"The test system uses 96-well plates with a silicone stopper in the middle to create a circular cell-free \n",
       "migration zone.\",\n",
       "    \"After removal of the silicone stopper, NCCs migrate into the central cell-free area.\",\n",
       "    \"The endpoints of the test are migration inhibition and cell viability after 24 hours of exposure to \n",
       "toxicants.\",\n",
       "    \"End points are assessed by staining with calcein-AM and Hoechst 33342 and imaging with a high-content imaging \n",
       "system.\",\n",
       "    \"Migration is quantified by counting the number of migrated NCCs within a defined region of interest in four \n",
       "tiled images.\",\n",
       "    \"Viability is quantified by counting calcein-AM and Hoechst double-positive cells outside the migration zone.\",\n",
       "    \"All data are normalized to untreated solvent controls.\",\n",
       "    \"The Day -1 step coats plates, Day 0 involves removing the stopper, Day 1 adds toxicants, and Day 2 involves \n",
       "staining and imaging.\",\n",
       "    \"Compound dilutions are prepared as 5× concentrated stocks and added in 25 µL to each well with final DMSO at \n",
       "0.1%.\",\n",
       "    \"The highest compound concentration is diluted with medium 1:200 so that 0.5% DMSO is reached in the master \n",
       "plate.\",\n",
       "    \"Only the inner 60 wells of a 96-well plate are used to avoid edge effects; edge wells are filled with PBS.\",\n",
       "    \"Positive controls include Cytochalasin D, LiCl and Taxol; negative controls include solvent (DMSO), \n",
       "paracetamol and ASS.\",\n",
       "    \"The method has been used to screen libraries, including an 80-compound NTP library (Nyffeler et al. 2017) and \n",
       "a 120-compound EFSA study.\",\n",
       "    \"In vitro–in vivo extrapolation (IVIVE) uses a lipid content of UKN2 medium of 2.8 × 10^-6 and albumin \n",
       "concentration of 5.6 µM.\",\n",
       "    \"A three-step PBPK modelling strategy has been used to evaluate the clinical relevance of the in vitro \n",
       "concentrations.\",\n",
       "    \"In a cited study, in vivo plasma concentrations of tested compounds were within the same range as \n",
       "concentrations used in the assay.\",\n",
       "    \"The UKN2 assay has been described as medium-throughput with automated microscopy and partial stand-alone \n",
       "usefulness.\",\n",
       "    \"The test is not linked to OECD guidelines and has not undergone formal OECD ring trials\",\n",
       "    \"The assay requires S1-level biosafety facilities (genetically modified cells).\",\n",
       "    \"SDS for the materials are available in the university's DaMaRIS database, and no special ethical approval is \n",
       "required.\",\n",
       "    \"No elements needed to conduct the experimental part of the test method are protected by patents or licenses; \n",
       "data analysis software may be licensed.\",\n",
       "    \"The method is part of the EU-ToxRisk project and ESNA TS screen battery; Bal-Price readiness score is A-, as \n",
       "published in 2018.\",\n",
       "    \"The test has documented performance metrics including specificity and sensitivity in separate evaluations, \n",
       "with reported values such as 100% specificity and &gt;90% sensitivity in some studies.\",\n",
       "    \"The migration endpoint is the primary endpoint for hazard identification, with the viability endpoint used for\n",
       "interpretation and normalization.\",\n",
       "    \"The assay uses 4 technical replicates per data point and 2 compounds per plate with 6 concentrations each, for\n",
       "a typical 192 data points per week scenario.\",\n",
       "    \"The data management workflow includes raw data stored in Excel, processing with Ringassay software, and \n",
       "visualization in GraphPad Prism.\"\n",
       "] \n",
       " \n",
       "Claims:\n",
       "[\n",
       "    \"Cells are launched into orbit.\",\n",
       "    \"Cells are exposed to lunar dust.\",\n",
       "    \"Cells are measured by a telescope for migration across the Milky Way.\"\n",
       "] \n",
       " \n",
       "Verdicts:\n",
       "[\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"The retrieval context describes an in vitro NCC migration assay in 96-well plates with imaging, \n",
       "and contains no information about spaceflight or orbital experiments.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"The context mentions exposure to toxicants in vitro, but does not specify lunar dust or its \n",
       "inclusion in the test conditions.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"no\",\n",
       "        \"reason\": \"Measurement in the context is performed by a high-content imaging system after staining, not by \n",
       "a telescope; the claim about migration measured with a telescope across the Milky Way contradicts the described \n",
       "method.\"\n",
       "    }\n",
       "]\n",
       " \n",
       "Score: 0.6666666666666666\n",
       "Reason: The score is 0.67 because the output claims migration was measured with a telescope across the Milky Way, \n",
       "but the context specifies measurement via a high-content imaging system after staining, revealing a contradiction \n",
       "in both method and scale.\n",
       "</pre>\n"
      ],
      "text/plain": [
       "Truths (limit=None):\n",
       "[\n",
       "    \"The text describes the Circular migration inhibition of NCC (cMINC) assay, UKN2, Version 2.0, deposited in \n",
       "March 2023.\",\n",
       "    \"The assay uses human neural crest cells derived from human induced pluripotent stem cells (hiPSCs).\",\n",
       "    \"The hiPSC line used is IMR90_clone_#4, purchased from WiCell in 2012 with a frozen masterstock.\",\n",
       "    \"The hiPSCs are maintained as monoculture on Laminin-521 coating in Essential 8 medium.\",\n",
       "    \"The hiPSCs express pluripotency markers Oct4, Nanog and Tra-1-60 in maintenance culture.\",\n",
       "    \"The hiPSC line IMR-90 has ATCC number CCL-186 and originates from a female donor at 16 weeks gestation.\",\n",
       "    \"The NCCs were differentiated from hiPSCs following the protocol of Mica et al. (2013) with Noggin and SB431542\n",
       "and then CHIR99021.\",\n",
       "    \"From day 4 onward the differentiation protocol transitions to N2-S medium with growth factors EGF and FGF2.\",\n",
       "    \"The hiPSCs/nCC differentiation protocol is described in the DB-ALM Protocol n° 195 and related sections.\",\n",
       "    \"Cryopreserved NCCs are stored at a concentration of 4 × 10^6 cells per milliliter in 90% N2-S medium and 10% \n",
       "DMSO.\",\n",
       "    \"The derived NCCs are at least 90% positive for the NCC markers HNK-1 and p75.\",\n",
       "    \"The NCCs also express nestin and AP2 but do not express Pax6 or the neuronal marker βIII-tubulin.\",\n",
       "    \"The derived NCCs do not express the astrocyte marker GFAP.\",\n",
       "    \"The NCCs are pathogen-free (regular mycoplasma testing is performed).\",\n",
       "    \"The test system uses 96-well plates with a silicone stopper in the middle to create a circular cell-free \n",
       "migration zone.\",\n",
       "    \"After removal of the silicone stopper, NCCs migrate into the central cell-free area.\",\n",
       "    \"The endpoints of the test are migration inhibition and cell viability after 24 hours of exposure to \n",
       "toxicants.\",\n",
       "    \"End points are assessed by staining with calcein-AM and Hoechst 33342 and imaging with a high-content imaging \n",
       "system.\",\n",
       "    \"Migration is quantified by counting the number of migrated NCCs within a defined region of interest in four \n",
       "tiled images.\",\n",
       "    \"Viability is quantified by counting calcein-AM and Hoechst double-positive cells outside the migration zone.\",\n",
       "    \"All data are normalized to untreated solvent controls.\",\n",
       "    \"The Day -1 step coats plates, Day 0 involves removing the stopper, Day 1 adds toxicants, and Day 2 involves \n",
       "staining and imaging.\",\n",
       "    \"Compound dilutions are prepared as 5× concentrated stocks and added in 25 µL to each well with final DMSO at \n",
       "0.1%.\",\n",
       "    \"The highest compound concentration is diluted with medium 1:200 so that 0.5% DMSO is reached in the master \n",
       "plate.\",\n",
       "    \"Only the inner 60 wells of a 96-well plate are used to avoid edge effects; edge wells are filled with PBS.\",\n",
       "    \"Positive controls include Cytochalasin D, LiCl and Taxol; negative controls include solvent (DMSO), \n",
       "paracetamol and ASS.\",\n",
       "    \"The method has been used to screen libraries, including an 80-compound NTP library (Nyffeler et al. 2017) and \n",
       "a 120-compound EFSA study.\",\n",
       "    \"In vitro–in vivo extrapolation (IVIVE) uses a lipid content of UKN2 medium of 2.8 × 10^-6 and albumin \n",
       "concentration of 5.6 µM.\",\n",
       "    \"A three-step PBPK modelling strategy has been used to evaluate the clinical relevance of the in vitro \n",
       "concentrations.\",\n",
       "    \"In a cited study, in vivo plasma concentrations of tested compounds were within the same range as \n",
       "concentrations used in the assay.\",\n",
       "    \"The UKN2 assay has been described as medium-throughput with automated microscopy and partial stand-alone \n",
       "usefulness.\",\n",
       "    \"The test is not linked to OECD guidelines and has not undergone formal OECD ring trials\",\n",
       "    \"The assay requires S1-level biosafety facilities (genetically modified cells).\",\n",
       "    \"SDS for the materials are available in the university's DaMaRIS database, and no special ethical approval is \n",
       "required.\",\n",
       "    \"No elements needed to conduct the experimental part of the test method are protected by patents or licenses; \n",
       "data analysis software may be licensed.\",\n",
       "    \"The method is part of the EU-ToxRisk project and ESNA TS screen battery; Bal-Price readiness score is A-, as \n",
       "published in 2018.\",\n",
       "    \"The test has documented performance metrics including specificity and sensitivity in separate evaluations, \n",
       "with reported values such as 100% specificity and >90% sensitivity in some studies.\",\n",
       "    \"The migration endpoint is the primary endpoint for hazard identification, with the viability endpoint used for\n",
       "interpretation and normalization.\",\n",
       "    \"The assay uses 4 technical replicates per data point and 2 compounds per plate with 6 concentrations each, for\n",
       "a typical 192 data points per week scenario.\",\n",
       "    \"The data management workflow includes raw data stored in Excel, processing with Ringassay software, and \n",
       "visualization in GraphPad Prism.\"\n",
       "] \n",
       " \n",
       "Claims:\n",
       "[\n",
       "    \"Cells are launched into orbit.\",\n",
       "    \"Cells are exposed to lunar dust.\",\n",
       "    \"Cells are measured by a telescope for migration across the Milky Way.\"\n",
       "] \n",
       " \n",
       "Verdicts:\n",
       "[\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"The retrieval context describes an in vitro NCC migration assay in 96-well plates with imaging, \n",
       "and contains no information about spaceflight or orbital experiments.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"idk\",\n",
       "        \"reason\": \"The context mentions exposure to toxicants in vitro, but does not specify lunar dust or its \n",
       "inclusion in the test conditions.\"\n",
       "    },\n",
       "    {\n",
       "        \"verdict\": \"no\",\n",
       "        \"reason\": \"Measurement in the context is performed by a high-content imaging system after staining, not by \n",
       "a telescope; the claim about migration measured with a telescope across the Milky Way contradicts the described \n",
       "method.\"\n",
       "    }\n",
       "]\n",
       " \n",
       "Score: 0.6666666666666666\n",
       "Reason: The score is 0.67 because the output claims migration was measured with a telescope across the Milky Way, \n",
       "but the context specifies measurement via a high-content imaging system after staining, revealing a contradiction \n",
       "in both method and scale.\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">======================================================================\n",
       "</pre>\n"
      ],
      "text/plain": [
       "======================================================================\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "bf221a15c485493689f0928eae84ab48",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Output()"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">**************************************************\n",
       "</pre>\n"
      ],
      "text/plain": [
       "**************************************************\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">ToxTemp Groundedness Policy (counts) [GEval] Verbose Logs\n",
       "</pre>\n"
      ],
      "text/plain": [
       "ToxTemp Groundedness Policy (counts) [GEval] Verbose Logs\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">**************************************************\n",
       "</pre>\n"
      ],
      "text/plain": [
       "**************************************************\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">Criteria:\n",
       "None \n",
       " \n",
       "Evaluation Steps:\n",
       "[\n",
       "    \"Task: evaluate whether ACTUAL_OUTPUT is grounded ONLY in RETRIEVAL_CONTEXT. No outside knowledge.\",\n",
       "    \"\",\n",
       "    \"Step 1 — Extract atomic factual claims from ACTUAL_OUTPUT limited to: entities, numbers, durations, units, \n",
       "methods, readouts, materials, cell lines, species, instruments, and endpoints. Do NOT extract vague/subjective \n",
       "claims (e.g., 'robust', 'appropriate').\",\n",
       "    \"\",\n",
       "    \"Step 2 — For each claim, assign exactly one label:\",\n",
       "    \"  - ENTAILED: explicitly supported by RETRIEVAL_CONTEXT (directly stated or unambiguous paraphrase).\",\n",
       "    \"  - CONTRADICTED: conflicts with RETRIEVAL_CONTEXT.\",\n",
       "    \"  - UNSUPPORTED: not found in RETRIEVAL_CONTEXT and not contradicted.\",\n",
       "    \"  - ABSTAINED: ACTUAL_OUTPUT explicitly states the information is not in the context / cannot be determined, \n",
       "and does not assert the missing fact.\",\n",
       "    \"\",\n",
       "    \"Step 3 — Return VALID JSON ONLY (no markdown, no extra text) with integer counts and an optional short audit \n",
       "list.\",\n",
       "    \"Required JSON keys: {\"entailed\": int, \"unsupported\": int, \"contradicted\": int, \"abstained\": int, \n",
       "\"total_claims\": int}.\",\n",
       "    \"Optional key: \"claims\": a list of up to 10 items, each with {\"claim\": str, \"label\": str, \"evidence\": str}. \n",
       "Evidence should be a short phrase from context or \"N/A\".\",\n",
       "    \"\",\n",
       "    \"Step 4 — Ensure: total_claims = entailed + unsupported + contradicted + abstained.\"\n",
       "] \n",
       " \n",
       "Rubric:\n",
       "None \n",
       " \n",
       "Score: 0.0\n",
       " \n",
       "Reason: Entailed/unsupported/contradicted/abstained counts: all three atomic claims in ACTUAL_OUTPUT are not found \n",
       "in the RETRIEVAL_CONTEXT and do not contradict it, so they are UNSUPPORTED. The total_claims reflect the three \n",
       "claims.\n",
       "</pre>\n"
      ],
      "text/plain": [
       "Criteria:\n",
       "None \n",
       " \n",
       "Evaluation Steps:\n",
       "[\n",
       "    \"Task: evaluate whether ACTUAL_OUTPUT is grounded ONLY in RETRIEVAL_CONTEXT. No outside knowledge.\",\n",
       "    \"\",\n",
       "    \"Step 1 — Extract atomic factual claims from ACTUAL_OUTPUT limited to: entities, numbers, durations, units, \n",
       "methods, readouts, materials, cell lines, species, instruments, and endpoints. Do NOT extract vague/subjective \n",
       "claims (e.g., 'robust', 'appropriate').\",\n",
       "    \"\",\n",
       "    \"Step 2 — For each claim, assign exactly one label:\",\n",
       "    \"  - ENTAILED: explicitly supported by RETRIEVAL_CONTEXT (directly stated or unambiguous paraphrase).\",\n",
       "    \"  - CONTRADICTED: conflicts with RETRIEVAL_CONTEXT.\",\n",
       "    \"  - UNSUPPORTED: not found in RETRIEVAL_CONTEXT and not contradicted.\",\n",
       "    \"  - ABSTAINED: ACTUAL_OUTPUT explicitly states the information is not in the context / cannot be determined, \n",
       "and does not assert the missing fact.\",\n",
       "    \"\",\n",
       "    \"Step 3 — Return VALID JSON ONLY (no markdown, no extra text) with integer counts and an optional short audit \n",
       "list.\",\n",
       "    \"Required JSON keys: {\"entailed\": int, \"unsupported\": int, \"contradicted\": int, \"abstained\": int, \n",
       "\"total_claims\": int}.\",\n",
       "    \"Optional key: \"claims\": a list of up to 10 items, each with {\"claim\": str, \"label\": str, \"evidence\": str}. \n",
       "Evidence should be a short phrase from context or \"N/A\".\",\n",
       "    \"\",\n",
       "    \"Step 4 — Ensure: total_claims = entailed + unsupported + contradicted + abstained.\"\n",
       "] \n",
       " \n",
       "Rubric:\n",
       "None \n",
       " \n",
       "Score: 0.0\n",
       " \n",
       "Reason: Entailed/unsupported/contradicted/abstained counts: all three atomic claims in ACTUAL_OUTPUT are not found \n",
       "in the RETRIEVAL_CONTEXT and do not contradict it, so they are UNSUPPORTED. The total_claims reflect the three \n",
       "claims.\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">======================================================================\n",
       "</pre>\n"
      ],
      "text/plain": [
       "======================================================================\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"></pre>\n"
      ],
      "text/plain": []
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "=== Eval Results ===\n",
      "faithfulness_score: 0.6666666666666666\n",
      "faithfulness_reason: The score is 0.67 because the output claims migration was measured with a telescope across the Milky Way, but the context specifies measurement via a high-content imaging system after staining, revealing a contradiction in both method and scale.\n",
      "geval_policy_score: 0.0\n",
      "geval_policy_reason: Entailed/unsupported/contradicted/abstained counts: all three atomic claims in ACTUAL_OUTPUT are not found in the RETRIEVAL_CONTEXT and do not contradict it, so they are UNSUPPORTED. The total_claims reflect the three claims.\n",
      "groundedness_policy_score: None\n",
      "groundedness_herman_score: None\n",
      "groundedness_counts: None\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "PosixPath('/Users/johannehouweling/ToxTempAssistant/myocyte/groundedness_demo_output.csv')"
      ]
     },
     "execution_count": 26,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "csv_path = Path(\"/Users/johannehouweling/ToxTempAssistant/myocyte/toxtempass/evaluation/positive_control/output/gpt-4.1-nano/tier1_comparison_cMINC(UKN2).csv\")\n",
    "pdf_path = Path(\"/Users/johannehouweling/ToxTempAssistant/myocyte/toxtempass/evaluation/positive_control/input_files/cMINC(UKN2).pdf\")\n",
    "\n",
    "demo_path = Path(\"demo_input.csv\")\n",
    "\n",
    "add_groundedness_columns(\n",
    "            csv_path=demo_path,\n",
    "            pdf_path=pdf_path,\n",
    "            output_path=Path.cwd() / \"groundedness_demo_output.csv\",\n",
    "            judge_model=\"gpt-5-nano\",\n",
    "            faithfulness_threshold=0.5,\n",
    "            geval_threshold=0.5,\n",
    "            verbose=True\n",
    "            )"
   ]
  }
 ],
 "metadata": {
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": 3
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
